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A Tribute to Edward Pulling
The retirement of Edward Pulling as Chairman of the Long Island Biological
Association (MBA) in January 1986 marks the end of an era. Over the past 18
years, he has quietly worked to galvanize public support of the Laboratory and
understanding of its mission. In the whole history of Cold Spring Harbor, there are
few who have done more to advance the cause of science than Edward Pulling.
Born in the London suburb of Ealing in 1898 and reared in the English
countryside, Pittsburgh, and Baltimore, Mr. Pulling was educated at Princeton and
Trinity College, Cambridge. Choosing the career of an educator, he went on to
teach at Groton and Avon Old Farms Schools.
In the year following his marriage to Lucy Leffingwell in 1928, the Pullings
decided to found the Millbrook School, which opened in 1931. Upon retirement as
headmaster, Mr. Pulling became a LIBA Director and Vice-Chairman of the Board
of Trustees of the Laboratory in 1968. In joining the LIBA board, he followed in the
tradition of his father-in-law, Russell C. Leffingwell, a founding director of LIBA.
Mr. Pulling assumed the Chairmanship of LIBA in 1969, and within one year
had doubled membership to nearly 500 families. During his tenure, LIBA success-
fully completed four major capital fund drives. The first, conducted during
1972-1973, raised $250,000 toward construction of the west addition to James lab
for cancer virus research, winterization of Blackford Hall, and purchase and
renovation of the Takami residence as a dormitory, now called Olney House. In
1977, with $225,000 from LIBA, Williams House was completely rebuilt as a year-
round residence with five apartments.
Just three years later, in 1980, LIBA provided $200,000 to purchase 20 acres of
land from the Carnegie Institution of Washington. The Harris Building, completed
in 1982, and the new Oliver and Lorraine Grace Auditorium are located on this
property. The most recent LIBA fund drive (1982-1985) yielded $600,000 toward
construction of the Grace Auditorium.
A mere chronicling of LIBA fund drives, however, does not take into account
the many important gifts that came, in large measure, through his bidding-for
example, the creation of Banbury Center, the Robertson Research Fund, and the
Doubleday Professorship for Advanced Cancer Research.
We have benefited not only from his help, but also from the example of his
wisdom and integrity. Consummate teacher, mentor, and friend, Edward Pulling
has immeasurably enriched our lives.
DIRECTOR'S
REPORT
That our forthcoming 51st Cold Spring Harbor Symposia on Quantitative Biology
will focus on the molecular biology of Homo sapiens indicates the extraordinary
advances now resulting from the application of molecular biology to human
beings. As with most new major technological breakthroughs, however, these
advances are accompanied by social, economic, and moral implications that
should not be ignored. In particular, we must begin to consider the consequences
of our newly found abilities to analyze human DNA molecules, capabilities that
over the next several decades should witness the working out of the complete
sequence of the some 3 x 109 base pairs that comprise the human genome.
Now we are just beginning to see the details of how we humans, as well as
other forms of life, are the products of random evolution of DNA molecules that
began when the first forms of life emerged in an early phase of the earth's
existence some four billion years ago. Then, as now, the various enzymatic steps
through which DNA is replicated were constantly generating a broad range of new
DNA molecules. These mutant DNAs in turn created genetic variants, some better
adapted for existence on the earth as it now exists and others terminal misfits,
unable to survive under any conditions. This constant production of new variability
is itself under genetic control and now expresses itself most strongly among the
larger higher plants and animals whose generation times are relatively long and
whose populations are relatively small. Such species have to possess a high
degree of inherent variants so that even in times of reduced numbers they contain
sufficient genetic variants to survive when confronted with new forms of environ-
mental stress. Humans are thus extraordinarily polymorphic animals, with each
individual (except for identical twins) being highly unique, not only at the level of
external appearance, but also at the level of the structure of their individual genes.
Already it is clear that each of us has easily computerizable DNA fingerprints
that distinguish us from all other individuals and that, for example, can unambigu-
ously establish our hereditary relationship to others. As each of us possesses
perhaps some hundred thousand different genes, it is clear that none of us
possesses only "good" examples of these genes. Each of us contains a mixture of
genes, some of which help greatly to favor our existence and reproduction; others,
perhaps the large majority, are evolutionally neutral, and still others diminish our
chances to have functionally meaningful lives. In some cases, a given gene will
always be bad, but in many cases the final effects will depend upon where and
how we live. Those genes, for example, that bring about light-color skin help to
promote necessary vitamin D synthesis in the skin of those who live in colder
northern regions but promote skin cancer for those individuals who live near the
equator.
Although initially it was possible to talk about good and bad genes largely only
in the abstract, the arrival of recombinant DNA procedures, in particular the use of
DNA polymorphisms in gene mapping, has transformed the field of human
genetics into a virtual beehive of activity. Each week more and more genes are
being mapped to precise chromosomal locations, and long-intractable genetic
problems such as epilepsy, schizophrenia, and manic-depressive syndromes may
be resolved over the next decade. Even more important, many of the genes
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behind the already well-defined genetic diseases like sickle cell anemia are being
isolated and their protein products identified. Once we have the culprit proteins,
we shall be able to zoom in much more effectively on the pathogenesis of still very
mysterious diseases like cystic fibrosis. Equally important, once a bad gene has
been isolated, tests can be developed to diagnose its presence in newly develop-
ing fetuses. Antenatal diagnosis, for example, will soon almost routinely reveal
whether a given fetus is doomed to develop into a child with muscular dystrophy
or give the reassuring good news that the respective bad gene is lacking and that
the arrival of a healthy baby should be anticipated. The possibility thus will soon
be at hand of greatly reducing the long-term social and financial burdens placed
on society by genetic diseases, particularly those manifested in childhood.
In accepting genetic disease as an inevitable consequence of human evolution,
we are accepting the premise that the human beings who exist on earth today are
not the result of any predetermined plan that has given human beings a manifest
destiny to dominate the earth. Instead, our unique capabilities as humans come
from the evolutionary events that have allowed our species to develop our very
powerful brains. It is this specialized collection of nerve cells that allows us to be
so conscious of the outside world, memorizing some of this information, and later
selectively recalling some of these facts as we think. None of these cognitive
attributes by themselves, however, are unique to humans. There is every reason to
believe that many higher animals think in some ways like humans, possessing
senses of beauty, having friends and enemies, and being anxious, happy, or sad,
depending upon how their respective lives go. What makes us so remarkable as
higher animals is not our ability to perceive pleasure or pain and act accordingly
but our capacity to develop highly structured languages both spoken and written.
Through the use of these languages, we can share deeply the experiences of
other humans as well as collect this information in forms that can be passed from
one generation to another in ever-increasing sophistication. Without the capability
that languages provide to transmit complex thought patterns, the amazingly
complex, if not wonderful, civilizations in which the temples of Greece could be
designed and built, in which Bach and Beethoven could compose, or in which
Newton, Darwin, and Einstein could think would never have developed.
As extraordinary as we are, however, there is no reason to assume that we will
necessarily continue to exist. No guarantee exists that the human species shall not
be eliminated by some virulent disease entity or through the action of man-made
toxic products, in particular the radioactive compounds that would be unleashed
as a result of an unlimited nuclear exchange. Thus man, like all other forms of life,
has no guaranteed "right" of perpetual existence. Only if as a species we continue
to behave sensibly will we have a realistic chance to go on. Our survival, at least
within the lifetime of the earth's current solar environment, thus always must be
seen as in our own hands.
Our rights as humans thus come to us not from any inherent order (purpose)
within the universe but as reflections of religious and legal edicts that we have
acquired during the course of human history. The Ten Commandments, for
example, express sensible rules imposed to let us work together effectively toward
the common goals that have made our Western civilization so successful. Not
surprisingly, human rights have varied from one civilization to another, and while
each of us as individuals may have very strong ideas as to what types of freedom
are generally needed for meaningful lives, those freedoms we wish the most vary
from time to time depending upon the respective environments in which we find
ourselves.
Just as it has been useful to convey specific rights to ourselves, we have also
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conveyed them to selected animals like the dog, cat, or cow that have long
coexisted with humans and whose absence would bring us sorrow or economic
distress if they were to be arbitrarily eliminated by other humans. Until recently,
however, virtually no one regarded all forms of even higher life (vertebrates) as
inherently worthy of protection. Pests were pests that should be removed if at all
possible from interactions with human civilization. Rattlesnakes, coyotes, and rats
were invariably perceived as animals to be eliminated, not protected. Today,
however, ironically, most likely because of a gradual subconscious acceptance of
the theory of evolution, there is a growing tendency among many diverse groups
of people to regard the human imposition of harm (be it death or merely pain) on
any form of life to be an essentially wicked act. For such people, the killing of the
fox is incarnate evil, even though this means more chickens will be eaten by foxes.
And even the mice and rats that we used to call vermin now have very vocal
protectors who are disturbed if we use these rodents to search for cancer-causing
chemicals or for experiments to discover the molecular uniqueness of the various
forms of cancer. To such people, mice and rats have inherent rights that must be
taken into account when we experiment upon them. I, however, find this concept
totally without any merit. If it is not effectively challenged, even its partial
acceptance will impede further medical research and limit its potential for
reducing human misery.
Unfortunately, the current mood among government officials is to compromise
with the animal-rights fanatics, with much credence given to the use of "alternative
forms of testing" that do not involve living animals. I fear that such temporizing
capitulation will lead to even further capitulation. Instead, we should stand our
ground and label nonsense for what it is. To do so, we must have the courage to
say that all forms of life are not necessarily good per se and that if the quality of
human life is to be improved, we must experiment upon animals like mice. We
should get on with our jobs without feeling that we are in any sense heartless
because we lack compassion for the mouse. Our survival as humans demands
that we put ourselves first, and to think for a long time in a different fashion would
be to invite extinction. Of course, this is not to say that we condone any senseless
diminution of the earth's still multitudinous forms of plants and animals. I, for
example, object greatly to reducing the numbers of those most remarkable of
animals, the whales.
Mankind's current inability to feel nonmystically about animal life manifests itself
in its current unease with recombinant DNA experimentation. Just as most people
still want to believe that there is something more extraordinary than molecules at
the heart of living existence, they cannot easily accept that DNA is all that
important, being the crucial difference between the various forms of life, without
endowing it with virtual genie-like properties that we will never be totally able to
handle. Many individuals thus fear that in subjecting the potential hidden genii to
the abnormal manipulations of recombinant DNA, we may stir them into revengeful
acts that would incalculably harm the human species. As a result of such worries,
the mere process of using recombinant DNA is now being singled out as much
more potentially dangerous than other breeding and selection processes, which,
of necessity, also yield new gene combinations that have never existed before.
Thus, a herbicide-resistant plant, if created through recombinant DNA procedures,
must be subjected to painstaking safety checks, whereas no such checks are
required if it were generated, say, through the recently developed somatoclonal
selection procedures. The ultimate irrationality of this situation is now more than
clear not only to scientists but also to many giant industrial corporations who are
attempting to create commercially useful new plants.
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This preoccupation with DNA as a potentially uncontrollable genie explains, in
part, the concern that many individuals have about current attempts to develop
procedures for curing genetic diseases using DNA therapy. Also behind much of
this hesitation is the feeling of many people that the DNA within us is not the
result of stochastic processes, but of design, and that we have no right to interfere
with the destiny that lies behind our individual existences. To me, however, the
moral question to be settled is whether such gene therapy procedures have
reasonable chances of effecting real cures. Hopefully, this dilemma will evaporate
once it becomes clear that gene therapy is a valid procedure for curing sick
individuals.
Much more difficult to resolve will be the question of whether selective abortion
of genetically disabled fetuses should occur. Here again, the heart of the problem
lies in how we perceive of human life per se. Does its very existence demand that
we cherish and protect it? Those of us who are scientifically knowledgeable about
DNA instinctively act on the premise that the random processes that govern the
replication of DNA are bound to lead to some human fetuses that can never grow
up into happy, functional individuals. Must these genetically damaged fetuses be
allowed to develop into babies whose suffering is bound to bring unmitigated pain
not only to themselves, but also to their parents and all others who must try to
help them? Should we deny the existence of what we perceive to be the essence
of a real human life, the capacity to develop into a person who by interacting
successfully with others helps make this a more interesting and compassionate
world?
With time, we can hope that those individuals who give us worldwide
governmental and religious leadership will, through their respective paths of either
reason or revelation, resolve the dilemma of whether a life without a realistic
chance to develop into an effective person must go out into the daunting
conditions that the earth will always provide.
HIGHLIGHTS OF THE YEAR
The Joe Sambrook Era Draws to a Close
On September 5th, we bade farewell to Joe Sambrook and dedicated to him a
6400-square-foot addition to the James lab which he directed so effectively for
some 16 years. The dedication of the Sambrook Laboratory gave us good reason
to call together many of the past inhabitants of James lab to reflect on the
Sambrook era, when the universe of the tumor virus world was still small enough
that Cold Spring Harbor could lie at its exact center.
Before coming to the Laboratory in the summer of 1969, Joe organized the
writing of our first DNA tumor virus grant to the National Cancer Institute. Only two
years later, he led the team that put together a major $1-million program project
grant which began in 1972, emphasizing the DNA tumor viruses. Renewed in
1977 and 1982, this large grant ($2.1 million of direct support in 1985) has long
been the backbone of our cancer effort here. Its long-term program support
allowed James lab to play a major role in helping to establish the small DNA
tumor viruses as the first good model system for studying eukaryotic genes. From
James lab came a succession of techniques for isolating and analyzing DNA and
RNA at the molecular level.
Joe's success, over the years, in attracting talented young scientists was attested
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Sambrook Laboratory dedication
to by those who returned to honor him at a meeting on "DNA Tumor Viruses:
Gene Expression and Replication; during which the dedication ceremonies
occurred. No institution of this era has helped train more outstanding scientists in
academic cancer research than Cold Spring Harbor, and we are proud that so
many of them now hold leading academic positions throughout the world at
institutions such as MIT, Harvard, Berkeley, Rochester, Yale, Princeton, Zurich,
Heidelberg, and Melbourne.
One such alumnus, Mike Botchan, now at the University of California at
Berkeley, provided a personal view of the James experience for the 300 scientists
and visitors who gathered in 100-degree heat for the dedication ceremony. Renato
Dulbecco of the Salk Institute, under whom Joe spent several of his postdoctoral
years, then spoke on the development of tumor virus research and made a plea
for a multinational effort to determine the DNA sequence of the entire human
genome.
We wish Joe every success in his new role as Chairman of the Department of
Biochemistry at the Southwestern Medical School of the University of Texas at
Dallas.
Joint Agreement with Pioneer Hi-Bred to Study Corn Genetics
On August 29th, the Laboratory signed a five-year, $2.5-million agreement to
conduct cooperative research with Pioneer Hi-Bred International, Inc. of Des
Moines, Iowa. Research will center on the use of recombinant DNA techniques to
genetically manipulate maize (corn), the most important crop in the United States
and a staple food throughout much of the world. The Pioneer accord follows other
Cold Spring Harbor research agreements with Exxon Research & Engineering
Company (1982, $7.5 million) and Monsanto Company (1984, $2.06 million).
Pioneer is the world's largest producer of hybrid seed corn, with 1985 revenues
of $821 million. Merging the Laboratory's expertise in recombinant DNA
techniques with Pioneer's experience in plant breeding should accelerate the
development of superior corn plants. Pioneers nationwide network for testing and
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Jonathan Wood, farm
manager, pollinating corn
at Uplands facility
Firehouse being moved
marketing new plant varieties ensures that advances in the laboratory can be most
quickly brought to farmers.
The Cold Spring Harbor-Pioneer program is especially fitting in light of the
significant role each organization has played in the development of hybrid corn.
Cold Spring Harbor's involvement in plant genetics dates to 1908, when Dr.
George Shull grew the first high-yielding hybrid corn on a small plot on the
Laboratory grounds. His method of "pure-line" breeding marked the beginning of
modern agricultural genetics and has already been called one of the 20 greatest
discoveries of this century. However, it was Henry A. Wallace-editor of Wallaces
Farmer and later Secretary of Agriculture and Vice President of the United
States-who applied Shull's breeding methods to the commercial production of
hybrid seed. Founded by Wallace in 1926, Pioneer (initially called the Hi-Bred
Corn Company) first popularized the use of hybrid seed corn by American
farmers.
Expansion of Plant Research Facilities
The Pioneer agreement is part of a major effort to make Cold Spring Harbor a
center for advanced plant research in the northeast. Thus, in 1984, we began a
$3-million capital program to develop specialized research facilities to accommo-
date an expanded staff. Using a $700,000 grant from the National Science
Foundation, in 1985 we substantially completed the Uplands Farm Genetics Field
Experiment Station, where we have 11 acres of fields and farm buildings. The
former garage has been renovated into a 6000-square-foot cytogenetics laboratory
for the microscopic examination and storage of corn kernels. Also completed was
a new 2200-square-foot research greenhouse, tall enough for growing a winter
corn crop.
Included in the Pioneer funding is a $750,000 grant toward the second phase of
the capital program: renovating 1800 square feet of lab space in DelbrOck and
building a 6500-square-foot extension to the north. To make room for the
extension, in late March 1986 we moved the historic Firehouse (now the site of
three staff apartments) some one hundred feet down Bungtown Road. This is the
second relocation of the Firehouse; it was barged over to the Laboratory from
Cold Spring Harbor Village in 1929.
To date, we have received $435,000 in pledges from private sources, including
the Pritchard Charitable Trust, De Camp Foundation, Culpeper Foundation, Surdna
Foundation, Hearst Foundation, and Griggs and Burke Foundation. In addition,
the Long Island Biological Association has pledged $110,000. Although an
aggregate of $2 million has already been raised for the Plant Genetics Capital
Fund-the largest amount ever raised for a single project here-we will need to
find an additional $1 million by early 1987 if facilities development is to proceed
on schedule. Also, we ultimately will need a further $700,000 to purchase the
Uplands Farm property from The Nature Conservancy, with payments scheduled
over an eight-year period.
Making Plans for an X-ray Structural Analysis Group
No matter how well we understand a gene at the DNA level, there is no way we
can go from a DNA sequence to the three-dimensional structure of its respective
protein. To find a protein structure, there is still no alternative to growing crystals
whose structures can be solved by X-ray crystallographic analyses. Until recently,
however, establishing an X-ray crystallographic group seemed beyond our
resources. We were not strong in computers or the instrument-making facilities that
are much more the mark of chemistry than biology labs.
Now, however, the needed rotating anode X-ray tubes and associated area
detectors can be bought off the shelf, admittedly at no modest cost. Moreover, the
cost and size of high-powered computers have also become manageable by an
organization of our scope. Even more important, the average time necessary to
solve a protein of average complexity by X-ray analysis has fallen to the two-to-five-
year interval that we associate with many other research objectives at Cold Spring
Harbor.
The time thus seemed propitious to start up an X-ray structure group to give us
the capability to work out the detailed structures of oncogene proteins such as
ras, myc, and E1A, as well as the receptors for the growth factors that give the
signals to commence cell growth and division.
Already we have appointed two highly experienced young crystallographers to
start this effort. Coming here in the fall of 1986 will be John Anderson, trained in
the laboratories of Steve Harrison and Mark Ptashne of Harvard, and Jim
Pflugrath, a product of F. Quiochos laboratory at Rice University and who now
has a postdoctoral position with Robert Huber in Munich. They will use lab space
in Demerec as well as occupy newly created facilities for computer-graphic
analysis in the Hershey Building.
Preparing of Plans for a New Neurobiology Building
Regretably, the absence of a suitable year-round facility for neurobiology made
virtually inevitable the departure last fall of Susan Hockfield for a position in the
Neurobiology Department of Yale Medical School. Fortunately, we were able to
persuade her to remain as Program Director for our Summer Neurobiology
Courses, thereby ensuring their continued existence for the foreseeable future.
Susan's departure emphasized the fact, already known to us for several years,
that we cannot build up a stable neurobiology effort until our summer teaching
space in Jones lab is supplemented by a major new building that will give us
modern year-round research space, as well as still more labs for advanced
teaching in neurobiology. Strongly encouraged by the Neurobiology Committee of
our Board of Trustees, we have drawn up schematic plans for a 16,000-square-foot
building to be located behind James lab on the site presently occupied by several
of our more than 50-year-old unheated summer cabins. We estimate the cost of
the building and equipment will be approximately $5 million. Raising this sum will
not be easy, but we must, if we are to stay at the forefront of biology.
Happily, Daniel Marshak, who will join Demerec lab in April 1986 to head our
protein chemistry efforts, has among his major research interests the isolation of a
glial cell growth factor. Hopefully, he will soon attract to work with him a trained
neurobiologist who can use the Jones lab facilities when they are not occupied by
our summer courses. Greatly facilitating the rapid start-up of Dan's research will be
funds provided by the Marie Robertson Fund for Neurobiology, which will initially
cover his growth factor research until appropriate federal grant support is
obtained.
Holding of Our 50th Symposium on Quantitative Biology
The 50th meeting gave us cause to celebrate our Symposium's major role in the
development of molecular biology over the last half century. During the first
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Sydney Brenner, Francois
Jacob, and Seymour Benzer
at the 50th Symposium
decades of this century, biology was considered a descriptive science, intellectu-
ally inferior to the "hard numbers" of physics and chemistry. The published "red
book" proceedings of the Symposium have done much to change this image and
to promote the development of biology as a quantitative discipline. In a real way,
therefore, the founding of the Symposium in 1933 by Reginald Harris marked a
watershed in the development of modern biology.
For the 50th Symposium we wanted to focus on a topic clearly to be of
importance over the next half century. So, we chose molecular biology of develop-
ment, which concerns itself with how a fertilized egg cell develops into a complex
organism composed of many highly specialized tissues and structures. Joe
Sambrook was responsible for the organization of the meeting, which brought
back to Cold Spring Harbor many of the scientists whose papers at earlier Cold
Spring Harbor Symposia helped found molecular biology. In particular, it was a
pleasure to again have here Francois Jacob, Sydney Brenner, and Seymour
Benzer.
A Record Number of Summer Course Applicants
Our summer courses continue to remain very popular, with a total of 684 applica-
tions received in 1985 compared with 598 in 1984. Most popular remain those
courses that emphasize recombinant DNA procedures. The Molecular Cloning
Course (16 places) was requested by 240 students and Advanced Cloning (16
places) by 114 students, numbers so large that the selection process by the
respective instructors had to be arbitrated in many cases. Greatly aiding the
teaching of the Cloning Courses was the total renovation of the teaching laboratory
on the top floor of James lab, as well as the use of the new areas for centrifuges
and coldrooms provided by the adjacent Sambrook lab space. For the first time,
we have facilities equal to the teaching of such qualified students.
Our Neurobiology Courses included for the first time one on Computational
Neuroscience, which was supported by the Sloan Foundation and led by Tony
Movshon of New York University and Emilio Bizzi of MIT Covering material that
until recently has gone under the name of Artificial Intelligence, the course's new
designation indicates the growing optimism that the mathematical models for
certain cognitive processes may reflect what is actually happening in our neural
circuitry as opposed to being proposed without any expectation that they reflect
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reality. Most encouraging was the exceptional quality of the student body, which
led the Sloan Foundation to give us a further grant for three more years of
operation.
Toward the general support of neurobiology teaching, we have again received a
large grant ($150,000) from the Klingenstein Foundation, as well as much needed
funds from the Grass Foundation for scholarship support. Equally important has
been the awarding of major federal training grant support in 1985 from the
National Institute of Mental Health and in 1986 from the Institute of Neurological
Diseases and Blindness. Thus, if we do not experience serious recisions in already
awarded federal funds, we have the resources now available to guarantee very
high level teaching in neurobiology over the next several years.
Greatly aiding our potential to ensure that no qualified applicant is denied
admission for lack of funds is the new grant made to us in May by the Markey
Foundation. Over a three-year interval, it provides $50,000 per year of support,
primarily to offset student costs.
Undergraduate Research Expands
In 1985, the Undergraduate Research Program was expanded to allow 15
students to experience a summer of research under the tutelage of Cold Spring
Harbor staff scientists. Previously, 11 students had been funded.
This expansion was made possible by receipt of a four-year grant from the
Sloan Foundation ($74,000), which also helped us to challenge other foundations.
Joining with Sloan to provide $39,000 for the 1985 program were the Burroughs
Wellcome Fund and Metropolitan Life Foundation. As is traditional, the Olney
Fund provided support for one fellow.
Looking ahead to the Undergraduate Research Program's 30th Anniversary, in
1989, we need to find a benefactor to endow this worthwhile activity. One of the
oldest in the nation, our program plays a significant role in developing the
research of future scientists.
We Extend DNA Education into Secondary Schools
For many years, the Laboratory has functioned as a specialized university in DNA
science, bringing high-level training to graduate students and practicing research-
ers. Through a new program, begun in 1985 by David Mick los, we are now
lending our unique expertise to train high school science teachers so they are
better able to teach about molecular biology and its social implications. The Cold
Spring Harbor Curriculum Study, initiated with strong support from Cold Spring
Harbor Superintendent of Schools Fran Roberts and seed money from Citibank,
N.A., and eight local school districts, has already grown to involve 19 school
districts on Long Island and in Westchester County.
With the help of Postdoctoral Fellow Greg Freyer, now at Sloan-Kettering Cancer
Center, Dave has fashioned a laboratory course that gives students hands-on
experience with the tools of biotechnology. With grants from Citibank, the J.M.
Foundation, New England Biolabs Foundation, Amervham Corporation, and
Fotodyne, Inc., we are initiating in the summer of 1986 a series of teacher-training
workshops to bring this unique course to teachers in New York State, New
Hampshire, Massachusetts, Wisconsin, Illinois, and California. So enthusiastically
has this program been received, both by scientists and lay people alike, that we
are now making plans for a DNA Education Center to be located in Cold Spring
Harbor Village.
Syosset school teachers
Steve Sponenberg and
Lois Miller at
Curriculum Study workshop
Michael Shodell
Steve Prentis
Another Very Successful Year for the Banbury Center
Our long-running Risk Assessment Program that emphasizes cancer prevention
continues to hold important meetings of relevance to human health. Very timely
this year was an April meeting on Human Genital Cancer, which explored the
involvement of several human papillomaviruses, and a September meeting that
analyzed the molecular ways in which tobacco is a carcinogen. Also highly
successful was our workshop for Congressional staff, which explored newer
reproductive technologies, and the journalism workshop that focused on the
possibility that tissue implants might be used to treat degenerative neurological
disorders.
Each of these occasions attested to the innovative leadership of Michael
Shodell, and it is with regret that I report that Mike came to me in September
saying that he wished to return to his teaching and writing careers. Fortunately, we
were able to persuade Mike to stay on until his replacement could be found and
move here. Starting on April 1, 1986, the Banbury Director will be Steve Prentis,
currently editor of Trends in Genetics published by Elsevier out of Cambridge,
England.
In choosing Steve, we have decided to focus initially on integrating the publica-
tion aspects of the Banbury program more closely into our main publishing
program on the lab grounds. So, Steve will also function as the Executive Director
of our entire publication program, in charge of overseeing which books to publish.
In this capacity, Steve will take on the role long played by me, but no longer
possible because of my increasingly complex duties as Director.
To oversee directly our Risk Assessment Program, we shall be making a new
staff position specifically for this task. Hopefully, this appointment can be made
during the fall of 1986. Greatly aiding this search is a recent grant of $100,000 per
year for three years from the James S. McDonnell Foundation that will not only
cover the costs of two meetings per year, but also ensure the publication of their
proceedings.
More Important Uses of the Robertson Research Fund
A continued key to my functioning as Director is the availability of monies
generated each year by the investments held by the Robertson Research Fund.
Particularly important this year was my ability to draw upon them to undertake the
extensive renovations to James lab necessary for its continued functioning for
research on vertebrate gene expression. In addition, Robertson funds helped
support the stipends of three visiting scientists and seven postdoctoral fellows, as
well as supplementing many other postdoctoral and student stipends to meet the
ever-increasing high costs of living on Long Island, recently emphasized as one of
the most desirable places to live in the United States. We also used Robertson
monies to cover the shortfall created by the underfunding of our summer meetings
grant, as well as to provide support for two undergraduates (URPs) who did
summer research here. The decreasing availability of federal funds for research
over the next several years makes it very likely that the Robertson monies will be
more important than ever in maintaining our research potential.
Grace Auditorium Readied for 1986 Meeting Season
During this year we have worked feverishly to complete the 360-seat Grace
Auditorium in time for the spring 1986 meetings. Financed through a major gift
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from Oliver and Lorraine Grace and the proceeds from a $600,000 fund drive by
the Long Island Biological Association, the more than 20,000-square-foot Grace
Auditorium will be formally dedicated on June 1, 1986.
Inside, three massive dormers and several skylights flood the lobby with light
and lend to it the quality of an atrium continuously connected with the Long
Island landscape. Equipped with the latest in audiovisual equipment, including
wireless microphones, xenon-lamp projectors, and closed-circuit television, the
Grace Auditorium should be technically equal to the high-level science present at
our meetings.
In addition to its conference function, the auditorium will be home to some
18-20 staff members. Located just off the main lobby is the Development and
Public Affairs Office, headed by David Mick los. Downstairs is the Meetings Office,
which administers our summer conferences and courses, under the direction of
Barbara Ward.
Also on the lower level is the Samuel Freeman Computer Center, the hub of a
distributed computing network that serves the entire scientific staff. It was created
by a major grant from the Samuel Freeman Charitable Trust, which has allowed us
to totally upgrade our major computer facilities, including six interconnected SUN
workstations. Here, Mike Balamuth, Chris Keller, and their group of programmers
are developing state-of-the-art software for deciphering the genetic information
stored in DNA. Allied with this Freeman grant will be a grant from the Donaldson
Charitable Trust to purchase the computer equipment that we will need to use
X-ray and computer-graphic techniques to solve the structures of a variety of
oncogenic proteins and DNA-binding proteins.
Another section of the lower level is occupied by the QUEST Biotechnology
Resource Center, headed by Jim Garrels. This facility, funded through a major
grant from the National Institutes of Health, will allow visiting scientists from many
major research universities to apply computerized analysis of two-dimensional
protein gels to biomedical research.
We Welcome G. Morgan Browne as Administrative Director
On June 2nd, G. Morgan Browne, Jr, joined the Laboratory as Administrative
Director, filling a vacancy created by Bill Udry's departure in January. Morgan
brings financial experience essential to running the business operation of the
Laboratory which has become increasingly complex over the last several years.
Prior to coming here, Morgan had worked for 25 years as a management
consultant to a variety of technically based companies. Interested in what he terms
"business architecture:" Morgan worked within the organizational structure of his
client companies to provide business focusing and financial expertise needed for
corporate growth. Serving as part of top management for extended periods of up
to five years, he was involved in corporate and legal planning, joint ventures, and
patent licensing.
Morgan received a B.A. in history and political science from Yale. No stranger to
the Laboratory, Morgan and his wife Jo Ann have been LIBA members for several
years. They reside in Locust Valley and have three sons-Doug, Tenney, and
Morgan.
Professorship and Honors for Michael Wig ler
In June, Michael Wig ler became one of only 18 investigators nationwide to receive
an Outstanding Investigator Grant from the National Cancer Institute. Expected to
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Michael Wig ler
total over $8 million in support over the next seven years, this is the largest single-
investment grant ever awarded to a Cold Spring Harbor scientist. Then, in
December, Mike was appointed American Cancer Society Research Professor of
Molecular Genetics, which provides $50,000 per year until the year 2012. He also
became the fifth recipient of the Pfizer Biomedical Research Award, which
provides $500,000 in unrestricted support over five years.
Using the tools of genetics, recombinant DNA, and biochemistry, Mike has done
much to usher in the new era in basic cancer research that directly studies human
cancer genes. While still a graduate student at the College of Physicians and
Surgeons of Columbia University, Mike developed powerful methods to introduce
foreign genes into animal cells growing in culture. In 1981, he and his associates
here were among the first to show that human cancer has its origins in changes in
a normal human gene.
In this research, they isolated several of the ras oncogenes that transform
healthy cells into malignant ones. In 1984, he began an intensive study of
homologs to the ras oncogenes in the yeast Saccharomyces cerevisiae. Yeasts
provide a much simpler biochemical and genetic environment in which to dissect
the role of ras in normal cell life than any form of higher vertebrate cell. So yeast
may actually provide the ideal system in which we can first understand at the
molecular level the functioning of a ras protein.
Promotion of Bruce Stillman to the Rolling-Five Position
In May, the Trustees of the Laboratory approved the appointment of Bruce Stillman
as Senior Scientist in recognition of his incisive experimentation on DNA replica-
tion in eukaryotic cells. Coming to us as a postdoctoral fellow after his Ph.D.
research on adenovirus DNA at the Australian National University, Bruce soon
established himself as a totally independent scientist capable of focusing
effectively not only on his own research, but also on that of many others in the
lab. Especially important recently have been Bruce's investigations of the in vitro
replication of SV40 DNA and on the cell-free formation of SV40 chromatin that
goes in parallel with DNA replication.
The Senior Scientist position carries with it a rolling five-year appointment, which
means that his salary is now guaranteed by the Laboratory for a five-year period
that continuously moves forward with time. Unfortunately, this guarantee falls short
of the academic tenure offered by many universities, and if we are to retain key
scientists like Bruce for most of their research careers, we must greatly increase
endowment funds specifically earmarked to fund truly tenured positions.
Changes in Our Scientific Staff
Senior Staff Investigator Stephen Blose accepted a position as Research and
Development Director at Protein Databases, Inc. Steve came to the Laboratory in
1978 from the University of Pennsylvania, where he had been an assistant
professor. Initially a member of the McClintock Cell Biology group under Guenter
Albrecht-Buehler, he helped develop and characterize many useful monoclonal
antibodies against cytoskeletal proteins.
Four other Senior Staff Investigators left the Laboratory in 1985 for positions in
academia: Susan Hockfield, Fuyuhiko Tamanoi, Russell Malmberg, and Mary-Jane
Gething.
Susan Hockfield, who used monoclonal antibodies to study cell-specific markers
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that may play a role in the development of the visual system, accepted an
assistant professorship in the Neuroanatomy Department of Yale University School
of Medicine. Susan came to Cold Spring Harbor in 1980, after completing a
postdoctoral fellowship at the University of California in San Francisco. We are
indebted to Sue for setting the Neurobiology Training Program on a solid financial
footing.
Fuyuhiko Tamanoi is now an assistant professor in the Department of Biochemis-
try at the University of Chicago. Fuyuhiko was a research fellow at Harvard
University until he came to the Laboratory in 1980. Along with Bruce Stillman, he
set up the DNA synthesis lab to study the enzymatic mechanisms of DNA replica-
tion in eukaryotes.
Russell Malmberg, who used cell-culture mutagenesis to dissect the polyamine
pathway in tobacco, has become an associate professor in the Department of
Botany at the University of Georgia. Russell was an assistant professor at
Michigan State University before coming to the Laboratory in 1981 to help
establish a plant research group in Delbruck lab.
Mary-Jane Gething moved to the Department of Biochemistry at the University
of Texas Health Sciences Center. Mary-Jane came to the Laboratory in 1982 to
work with Joe Sambrook on the transport and secretion of the hemagglutinin
protein. She was formerly with the Imperial Cancer Research Fund in London.
Staff Investigators John Lewis and Fumio Matsumura also left the Laboratory.
John, who came to the Laboratory in 1980 as a postdoctoral fellow from Memorial
Sloan-Kettering Cancer Center to work on cell-cycle-dependent gene expression, is
now with Smith Kline & French Laboratories in Philadelphia. Fumio, who came to
the Laboratory in 1980 as a postdoctoral fellow, has become an assistant
professor in the Biochemistry Department at Rutgers University. While at Cold
sin in transformed cells.
New Staff Members
Joining the Laboratory this year are David Spector as a Senior Staff Investigator
and Andrew Rice as a Staff Investigator. Dave comes to us from Baylor College of
Medicine, where he was an assistant professor. He will be in charge of a new
electron microscopy facility that will occupy the former "Mouse House; which has
been enlarged and entirely renovated. Andy, who came from Ian Kerr's lab at the
Imperial Cancer Research Fund, now works with the protein synthesis group in
Demerec. Ronald Guggenheimer also came to the Laboratory as a Staff Investiga-
tor from a postdoctoral fellowship at Memorial Sloan-Kettering Cancer Center, but
left in December to join his family's publishing business.
Visiting scientists who completed their studies at Cold Spring Harbor during the
year and returned to their previous or new positions were Eric Hunter, University
of Alabama; Daniel Birnbaum, Centre d'Immunology, INSERM-CNRS de Marseille-
Luminy in Paris; and Timothy Harrison, University of Leichester in England.
Three other visiting scientists who moved on to new positions were Ling Pai
Ting, who is now a graduate instructor of microbiology and immunology at the
National Yang-Ming Medical College in Taiwan; Asao Fujiyama, who is continuing
his studies with Fuyuhiko Tamanoi at the University of Chicago; and Ottavio
Fasano, who has moved to the European Molecular Biology Laboratory,
Heidelberg, Germany.
Newcomers on the visiting scientist roster are Marcel lo Siniscalco, on sabbatical
from Memorial Sloan-Kettering Cancer Center; Massimo Romani from Italy's
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National Cancer Institute in Genoa; Diane Esposito, who received her Ph.D. from
Fordham University and is continuing her studies with Marcel lo; Krystyna Slaska-
Kiss from the Biological Research Center in Szeged, Hungary; Esa Kuismanen
from the University of Helsinki in Finland; and Junichi Nikawa from Gunma
University School of Medicine in Osaka, Japan. Seth Grant, who received his
medical degree from the University of Sydney in his native Australia, came to the
Laboratory as a postdoctoral fellow working with Jim Hicks but decided in
October to stay on as a visiting scientist in Doug Hanahan's lab.
Staff Promotions
In recognition of his work in developing one of the only computerized systems to
analyze two-dimensional protein gels, Jim Garrels was promoted from Senior Staff
Investigator to Senior Staff Scientist. Jim came to the Laboratory in 1978 after
doing postdoctoral work at the Salk Institute.
Promoted from Staff Investigator to Senior Staff Investigator were Steve
Dellaporta, Doug Hanahan, Ed Harlow, Winship Herr, and Bill Welch. Steve, who
has worked out an elegant method to clone maize genes using the Ac transpo-
son, was instrumental in attracting Pioneer Hi-Bred's support of our plant genetics
research. Doug has effectively used fusion genes to study tissue-specific develop-
ment and oncogenesis in transgenic mice. Ed, who set up the new monoclonal
antibody facility in Sambrook lab, has developed a host of antibodies to study
adenovirus E1A proteins and the human p53 tumor antigen. Winship has done
important fine-structure analysis of the SV40 enhancer region. Bill has purified and
characterized several of the mammalian stress proteins.
Visiting scientist Tohru Kataoka, from Osaka University, became a Staff Investiga-
tor in February. Working in conjunction with Mike Wig ler, Tohru has cloned genes
for key proteins in the ras/cyclic AMP pathway in the yeast Saccharomyces
cerevisiae.
Postdoctoral Fellows
Leaving after completion of their postdoctoral terms were Tim Adams to the School
of Veterinary Sciences at the University of Melbourne; Tom Flanagan and Susan
Watts to the University of North Carolina at Chapel Hill; Greg Freyer to Dr. Jerry
Hurwitz's lab at Memorial Sloan-Kettering Cancer Center; Howard Fox to the
Medical School at the University of California at San Francisco; John Ivy to the
Oceanic Institute in Hawaii; Mike Krangel to Jack Strominger's lab at the Dana-
Farber Cancer Center; Janet Maclnnes to the Department of Veterinary Microbiol-
ogy and Immunology at the University of Guelph in Canada; Shigeko Matsumura
to the Department of Biochemistry at Rutgers University; Reza Sadaie to Bob
Gallo's lab at the National Institutes of Health; Masao Yamada for the National
Children's Medical Research Center in Japan; and Patricia Cotton to pursue other
interests.
Postdoctoral fellows Beth Friedman and Sam Zaremba moved with Susan
Hockfield to Yale University. Philip Bird, Patricia Gallagher, and Michael Roth
moved with Joe Sambrook and Mary-Jane Gething to the University of Texas
Health Sciences Center.
Receiving their doctorates were Carolyn Doyle and Kevin Van Doren from SUNY
at Stony Brook. After a brief postdoctoral period with Guenter Blobel at Rockefeller
University, Carolyn accepted a position at Oncogene Sciences in Mineola. Kevin
has moved to David Hirsch's lab at Synergen in Boulder, Colorado.
Graduate students Ramaninder Bhasin and Madan Rao have returned to SUNY
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at Stony Brook to continue their studies, and William Costello is with the Law
School of Stanford, California.
Changes to Our Board of Trustees
One of the strongest assets of the Laboratory is the diversity of the backgrounds
and experience of the members of the Board of Trustees. Not only do I have the
counsel of scientists from our ten participating institutions, but I also have the
advice and support of Trustees from the public sector for a multiplicity of
problems.
In November, the statutory six-year terms of three institutional Trustees expired.
Dr. Norton Zinder from Rockefeller University, Dr. Boris Magasanik from MIT, and
Dr. Charles F. Stevens from Yale University have all served the Laboratory with
distinction. In particular, I want to recognize Dr. Zinder, who served as Secretary of
the Board and as Trustee from 1967 to 1975.
At the same time, we welcomed three distinguished scientists as institutional
Trustees: Dr. David Botstein from MIT, Dr. James E. Darnell, Jr, from Rockefeller
University, and Dr. Frederic M. Richards from Yale University.
Dr. Botstein has long been associated with the Laboratory. We showed bad
judgement in not choosing him for the Undergraduate Research Program in 1960,
but he nevertheless began to attend our summer meetings on phage as a
graduate student and presented his first paper at the 1968 Symposium. While on
sabbatical from MIT in 1974, he formed the first yeast group here in the then
Davenport lab with Gerry Fink and John Roth. For five years, beginning in 1976,
he taught the advanced bacterial genetics course each summer with Ron Davis
and John Roth. As Professor of Genetics in the Department of Biology at MIT, he
teaches and does research on yeast and human genetics.
Dr Darnell is serving as Trustee for the second time. His first appointment was
as a representative of Columbia University. He is now the Vincent Astor Professor
at Rockefeller University, with research interests in animal cell biology and virology.
He, too, has long been associated with Cold Spring Harbor. In conjunction with
his early work in animal viruses, he came to lecture every summer for 15 years,
beginning in 1958.
Since 1963, Dr. Richards has been a professor with the Department of
Molecular Biophysics and Biochemistry at Yale. In 1971, with David Phillips, he
helped organize our Symposium on the "Structure and Function of Proteins at the
Three-dimensional Lever His experience in protein chemistry and X-ray crystallog-
raphy will benefit us as we expand our research into this field.
In September, the Laboratory mourned the death of Ambassador John P
Humes, who joined the Board in 1981 and served with distinction on the Finance
and Investment Committee. Most recently, he headed a special fund drive that led
to over $100,000 in grants and gifts for the plants genetics program. His
commitment to basic biological research has provided a legacy of promise for a
healthier world. He was appointed Ambassador to Austria by President Richard M.
Nixon in 1969, and before his retirement in 1975, he was awarded the Great
Golden Medal of Honor, the highest honor the Austrian government can bestow
on a civilian. Before his appointment as Ambassador, he was a partner in the law
firm established by his father.
Appointed in February 1986 to fill Ambassador Humes position is David L. Luke
III, the CEO of the Westvaco Corporation and a resident of Locust Valley. Mr. Luke
has previously served on the Board of the American Museum of Natural History
and as Chairman of the Board of Trustees of The Hotchkiss School.
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Retirement of Edward Pulling from LIBA Chairmanship
In January 1986, the 1985 Annual Meeting of the Long Island Biological Associa-
tion (LIBA) and the retirement of Ed Pulling as LIBAs Chairman marked the first
public showing of the Oliver and Lorraine Grace Auditorium. It was a marvelous
occasion, with an overflowing audience coming together to thank and pay tribute
to Ed Pulling. His extraordinarily effective leadership of 17 years brought into
existence four highly successful fund drives, which made possible the urgently
required construction, purchase, or renovation of many Laboratory facilities,
including Williams House, Olney House, Blackford Hall, the James West Annex,
and the land on which the Harris Building and the Grace Auditorium are sited.
The Grace Auditorium itself is perhaps the greatest achievement of LIBA and Ed
to date.
LIBAs Annual Meeting marked the end of Ed's chairmanship, and to show our
affection and admiration, short tributes to him were made by myself, George
Hossfeld, the Vice Chairman of LIBA, Clarence Galston, and Reese Alsop. In
response, Ed pointed out the enormous pleasure he experienced in leading LIBA
and thanked the audience for giving him the opportunity to serve a cause in
which he so ardently believed.
Succeeding Ed as the new Chairman of LIBA is George Cutting, a director of
LIBA and a long-time resident of Oyster Bay Cove. We remain very fortunate in
that we still continue to receive the effective support and close friendship of so
many nearby residents.
Maintaining Cold Spring Harbor as a Haven for Bright Minds
Science became a full-time concern at Cold Spring Harbor in 1904, when funding
from the Carnegie Institution of Washington created a safe haven here for serious
science. Its unflagging support, for example, allowed Barbara McClintock and
Alfred Hershey the freedom to pursue ideas-once considered esoteric and
arcane-that would lead to their Nobel Prizes. Since the withdrawal of the
Carnegie Institution in 1962, the Laboratory no longer enjoys the relative luxury of
a full-time, externally sited mentor. Our funding now comes from many disparate
sources, which subtly steer the course of our research and ultimately limit our
freedom to explore new realms of bioscience.
Thus, we increasingly need to offer the financial incentives for key staff members
to stay on at the Laboratory and the security for them to aggressively pursue novel
ideas-regardless of trends in government or foundation funding. Unfortunately,
we now have internal funding for only one tenured research position, the
Doubleday Chair. Over the next several years, we must establish four or five
additional endowed positions, if we are to remain competitive with our sister
research institutions and universities.
Ten years ago, the lack of tenured positions was not such a serious problem.
Molecular biologists could only aspire to relatively poor-paying jobs in academia.
There was no great disparity in salary offered here or at other institutions.
However, the explosive growth of biotechnology has upped the ante. Now both
specialty biotechnology firms and established pharmaceutical and chemical
companies offer handsome salaries to molecular biologists. Many well-endowed
universities have responded to this competition by offering salaries in line with
those offered by industry. The economics of the situation make it difficult for us to
both find and keep bright young scientists.
The problem will only be compounded if the budget-cutting axe of Gramm-
Rudman falls severely on the National Institutes of Health, our major source of
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research support. If that happens, all too often bright young scientists will not
almost automatically acquire the grants needed to support their independent
research. In addition to endowed research positions, we need to create a staff-
development endowment to support young scientists at the beginnings of their
research careers.
Under our newly established Cold Spring Harbor Fellows Program, exceptional
postdoctoral fellows are offered the opportunity to accelerate into funded junior-
staff positions. During the three-year period, fellows work independently to
establish their research credentials prior to seeking competitive grants. First
appointed to one of these positions is Adrian Krainer, whose Ph.D. research was
done at Tom Maniatis lab at Harvard on the problem of RNA splicing.
We Must Retain Our Sense of Being a Closely Knit Village of Science
The intellectual tie that so easily brings our staff together and makes it so natural
for them to attend each other's seminars is our focus on DNA. Whenever possible,
we go for the gene behind the biological phenomenon that intrigues us, and
much more often than not we are surprised by what we find.
Now, through our return to a serious interest in plants, and hopefully through
our not-too-distant acquisition of the year-round neurobiology building we need so
badly, we are inevitably acquiring the attributes of a graduate university of DNA.
Though we lack degree-granting ability, our joint program in genetics with the
State University of New York at Stony Brook now gives us the presence of some
20 graduate students.
Most importantly, our intensive set of summer courses and our combined set of
large and small meetings that collectively number some 20 each year provide an
educational experience and exposure to first-class scientists, matched at best in
only a few other institutions throughout the world. In recruiting new staff and
postdocs, we have not only the success of the past to argue from, but, more
important, the probability that their scientific future at Cold Spring Harbor will be
highly productive.
Always attractive bait in recruitment has been our ability to offer many of our
key scientists, especially when they first arrive, the opportunity to live on the
Laboratory grounds. It not only lets them be minutes away from their experiments,
but greatly facilitates the speed of forming friendships with other Laboratory
members. With the expansion of our science, however, we have begun to lose
housing units that we formerly had in the Hershey Building, Urey Cottage, the
Power House, and McClintock lab. So, our ability to house our staff has not at all
been commensurate with our expansion in science. Increasingly, we have had to
rent off-campus dwellings for our postdoctoral fellows and graduate students,
which of necessity generates commuting trips not faced by those who live on the
Laboratory grounds.
We badly need to formulate a long-term housing policy that optimally will let us
acquire dwellings in the very immediate neighborhood. Given, however, the
extraordinarily rapid increase in real estate values on Long Island, this objective
will require much financial ingenuity. To the outside world, Cold Spring Harbor has
always stood as a village of resident, as opposed to commuting, scientists. So, we
must not only retain our semi-19th century appearance, but also maintain some of
the inherent tranquility that went with that era.
March 26, 1986 James D. Watson
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ADMINISTRATION
Whatever the fate of Gramm-Rudman, it is clear that efforts to reduce the federal
deficit will increasingly restrict the federal funding of scientific research and,
particularly, the recovery of associated indirect costs. The Laboratory is fortunate,
therefore, to have in place a staff of experienced managers fully capable of
controlling costs while continuing to provide the fast, flexible, and innovative
services that our scientific community expects.
As a newcomer to the Laboratory at mid-year, my task was made infinitely easier
by the dedication and support of these individuals, who managed so well during
the approximately six-month period when the Laboratory was without an Adminis-
trative Director. Special recognition is due to John Maroney, our Assistant Admin-
istrative Director, who served so effectively during that period, and to our
Treasurer, Robert Cummings, who was most generous with his time, energy, and
experience.
During 1985, after the rapid growth of recent years as portrayed by the charts
on the facing page, operations of the Laboratory stabilized at a high level. This
provided an opportunity to prove and refine the new and more automated
management systems that had been installed with considerable foresight in prior
years to manage finances, purchasing, grant control, personnel, and other
functions. Core services operated for a full year under the centralized
management system established in 1984. These vital services, which include the
safety department, machine shop, electronic and equipment repair, animal care,
photographic and technical illustrating, and scientific computing, all operated more
efficiently and will be increasingly useful to our scientific staff in future years.
The Laboratory has long been distinguished by its ability to attract the finest
scientific minds. We have first-rate facilities and much state-of-the-art equipment.
The world-class science that results has proved to be a powerful magnet for the
needed funding. In the future, however, more of this funding is going to have to
come from corporate and private sources, lessening our dependence on the
uncertainties of government support. During 1985, the Commercial Relations
Committee, in its second year of existence, played a key role in reviewing and
guiding the Laboratory in its increasing numbers of commercial partnerships. A
good beginning was made on the difficult task of writing a commercial relations
manual to assist our scientific staff in managing the often complex issues that
arise out of their involvement with commercial organizations. We are deeply
indebted to Townsend Knight, chairman of this committee, for the extraordinary
amount of time he devoted to these efforts.
Already, early in 1986, we can see that the brief pause in the Laboratory's
expansion will soon give way to renewed growth. The administrative staff will need
to manage this growth with the limited resources currently at hand and with the
present number of support personnel. It is essential that we continue to decrease
indirect costs as a percentage of overall research costs. We are most fortunate to
have the kinds of individuals who will accomplish this through competence,
dedication, and hard work.
G. Morgan Browne
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BUILDINGS AND GROUNDS
With the new construction, renovations, installations, extensions, landscaping, and
planning for future buildings, 1985 must go on record as one of our busiest years
so far.
The work on Grace Auditorium is nearing completion. Final touches are being
added to the exterior of the building and the first floor. Office furniture for the
basement-level offices has been planned and ordered and landscaping has been
started. A gazebo donated to the Laboratory was transported to its new location at
the top of the hill on the north side of Grace Auditorium. To accommodate the
expected increase in parking, construction of a new road and parking lot was
begun on the west side of the Motel.
The exterior of Hooper House was sandblasted and painted a pale beige with
light-mauve trim; the house now blends well with the others along Bungtown
Road. Davenport House exterior was also redone, retaining its Victorian color
scheme. A small extension was begun on the old Mouse House, which will be
converted into an electron microscopy facility.
Earlier in the year, fighting the clock to complete the project in time for the
summer courses, the entire top floor of James lab was gutted, the labs reworked,
and new heating and air-conditioning systems installed. At the same time, the
finishing touches were being done on Sambrook lab in preparation for the
Dedication.
In the fall, two labs on the first floor of James lab were completed and new
heating and air-conditioning systems were installed. In Demerec, two labs and
one-half of another were completed, the kitchen was renovated, and a coldroom
was installed. In addition, a second-floor laboratory in McClintock was renovated,
and in the Buildings and Grounds building, a new Safety/Core office was
completed.
The first floor of the south wing of the Nichols administration building was
reworked and a new lobby and new offices were added. Installation of built-in
furniture is scheduled for next year. A large section of the ongoing electrical loop
system was completed when electrical lines were buried between Grace
Auditorium and James lab. To make the exchange of information by computer
more efficient, new Ethernet cable has been installed throughout the Laboratory.
At Uplands Farm, the garage was converted into a Field Station, and the top-
floor apartment was renovated. A potting shed and greenhouse were started, with
an estimated completion date of January 1986. Over at Banbury, exterior lighting
was installed.
A complete reorganization of the custodial staff resulted when Charlie Marshall
left after five years of service. Willie Gardner is now in charge of the custodial staff,
and Dorothy Youngs now has charge of the housekeeping staff. As a result, we
have seen a great improvement in both departments and in all of our buildings.
We mourn the loss of two good friends and fellow workers: Tom Lyden, who
died in June of this year, and Joe Brodawchuck, who died in September. They
were the best and we will miss them both.
Despite the completion of so much work, we will be starting the new year with
the expectation of a heavier workload than ever. May it ever be so.
Jack Richards
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DEVELOPMENT AND PUBLIC AFFAIRS
Science Phobia and the "Two Cultures"
Although essayist C.P. Snow argued that the schism between the science system
and the social system is so large that they constitute two separate cultures,
science is merely one phase in the continuum of human endeavor. Science does
not exist in isolation from society; all scientific advances take place within the
context of culture.
The impact of science and technology on our society is so ubiquitous that we
tend to take it for granted: Concorde jets whisk away to London in three hours,
computers disgorge $20 checks and accurately debit accounts, sonic waves
pulverize gallstones with only a scant incision necessary, microwave ovens
produce hot meals in minutes, satellites beam live events from halfway around the
globe, and ultrasound and gene probes detect birth defects antenatally.
Although we are immersed in technology, too many people have too little ken
about the workings of science. So, in a world increasingly dictated by science,
many suffer from a sort of "science phobia," which makes them believe that they
cannot possibly understand this culture of researchers. This attitude prevents them
from participating in the excitement of our scientific age and, in a sense, alienates
them from their own technological life-styles.
Science is no different from any specialized cultural endeavor, such as orchestra
conducting or French cooking. How many of us understand the intricacies of
meter in Beethoven's Fifth Symphony or the lift in a seafood souffle? But we need
not be conductors or chefs to enjoy these cultural activities; our technical
ignorance does not thwart our enjoyment. Indeed, appreciation of any cultural
activity begins in relative ignorance-the potential to understand and master the
intricacies only adds depth to our enjoyment.
Nor should the technicalities of science prevent us from enjoying its intellectual
challenge. There is no excuse for scientific illiteracy in today's society. Most major
newspapers employ professional science writers who make it their business to
explain research in terms a nonscientist can understand; many have weekly "Part
II" sections devoted entirely to science and technology. There now exist several
popular magazines, such as Science 86 and Discover, that accurately present an
amazing array of scientific activities. Excellent science programming, such as
Nova and Innovation, is available almost nightly on PBS channels.
A serious attempt to attend to any of these mass media channels can lead any
intelligent person to an appreciation and understanding of modern science. When
intelligent people spend as much time attending to science articles and telebroad-
casts as they do to the Dow Jones Index and Wall Street Week, then the "two
cultures" will become one.
Looking toward a Second Century
On July 7, 1990, the Laboratory will celebrate the 100th anniversary of its founding
as one of the first American field stations for experimental biology. During 1985,
preliminary plans were laid for a major development program to coincide with the
centennial celebration.
As a center for advanced research and education, the Laboratory has exerted
an influence on the development of modern science that is far out of proportion to
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Greg McLaughlin and editor
Jayne Grote in the editing
suite at Rainbow
Network Communications
its small size. Now is the proper time to reflect on this great success as one of the
few independent research institutions in this nation and to take action to ensure a
second century of scientific excellence at Cold Spring Harbor.
Critical to the success of the program will be increased volunteerism on the part
of all who believe in the importance of basic research and who recognize the
special place Cold Spring Harbor occupies in the history of modern genetics. We
will depend on our friends to introduce us to individuals, foundations, and
corporations that can aid in the Laboratory's continued development as a village of
science where researchers can work relatively free from distractions.
The Biological Revolution Documentary
In commemoration of the centennial, we recently completed a documentary video,
The Biological Revolution: 100 Years of Science at Cold Spring Harbor.
Produced under a special grant from the Long Island Biological Association, the
30-minute video presents a kaleidoscopic history of Cold Spring Harbor-from
quiet camp site of Matinecock Indians, to bustling milling and whaling center, to
enclave of scientists who seek to explain life in terms of the molecular interactions
that take place within cells.
Through events that occurred at Cold Spring Harbor, the video recounts the
quest to understand the nature of the genetic code, beginning with Darwin's
theory of evolution and culminating with powerful techniques to precisely
manipulate the DNA molecule. Laboratory Director James Watson and four other
Nobel Prize-winning scientists lend their own insights on the genetic revolution
they helped launch.
Coproducer and director Gregory McLaughlin brought to the production a fast-
paced news style learned through extensive work as editor and field producer for
Cablevision and Cable News Network. Peter Thomas, one of the truly great voices
in the mass communications industry, breathed life into narration written by
coproducer David Mick los. Arranged through the generosity of Helen and Charles
Dolan, the donation of editorial and dubbing facilities by Cablevision reduced
production costs by one-half. The documentary will air on the Cablevision system
in spring 1986. VHS and Beta copies can be purchased or borrowed through the
Library.
Training Science Communicators
Scientific advances reorder our life-styles at a bewildering rate. Although our
involvement in technology is increasing at an exponential rate, public understand-
ing of the scientific factors that speed us into brave new worlds lags far behind.
This widening "knowledge gap' breeds individual anxiety and, in a real sense,
threatens the informed decision-making essential to democratic politics. Thus, in a
society increasingly dominated by science-related issues, we need more people
who can translate the specialized jargon of science into language understandable
to nonscientists. Their job is essential: to narrow the "knowledge gap."
In 1985 we instituted an internship to give promising journalism students the
practical training to become effective science communicators. While at Cold
Spring Harbor, an intern interacts directly with our scientists, having the dual
challenge of learning firsthand about the process of discovery and of distilling that
experience for a lay audience.
Our first intern, Laurel Vanderkleed, came to us from the graduate science-
writing program at Miami University (Ohio). Laurel played a critical role in the
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development of the Cold Spring Harbor Curriculum Study, testing laboratory
procedures, assisting with workshops, and writing reference appendices. She also
was key to the conversion of the Harbor Transcript to an attractive external
newsletter. After a nine-month stay, Laurel left in the fall to become associate editor
at Technical Insights, Inc., which publishes technically oriented newsletters.
We were also sorry to bid goodbye in December to Jenny Flanagan, who, for
the past year, had performed with good grace the many hectic chores required of
a public affairs assistant. Standing behind the scenes with lists in hand, she was
the organizing factor of many public events, including the annual LIBA dinner
parties. She was key to the development of the Corporate Sponsor Program and
computerization of our development and public affairs efforts.
David Mick los
LIBRARY SERVICES
Neurobiology Library Moved, Storage Facility
Established
Space needs dictated the integration of the McClintock labs neurobiology library
into the main library collection. The neurobiology library was established in 1971 to
support the receipt of a Sloan Foundation grant that funded the summer-long
neurobiology program for ten years. In 1981, our year-round neurobiology
program was established in Jones lab. The limited space in Jones did not
accommodate the 1800-volume collection, and it remained in McClintock until this
year, when the space it occupied was badly needed for scientific offices.
To provide space in the main library, which reached its capacity in late 1984, we
arranged to share that portion of East Side School in Cold Spring Harbor leased
by the Publications Department for its book shipping and warehouse operations.
About 7700 older bound volumes from the library's journal collection were
relocated to 1600 linear feet of shelving in remote storage. The move was
completed over a weekend in August by the library staff in conjunction with a
specialized moving company; the library remained open throughout. This arrange-
ment eased the overcrowded conditions while still providing for retrieval within
24 hours.
Reference Service and Archives Use Increases
In 1985, patron/reference services increased by another 12%. Our continued effort
to provide faster information service for the Laboratory's scientific staff is seen in a
two-year growth of 535/o in reference service with an over-all decrease in staff of
0.5. The continued excellence of a well-trained staff accounts for this sustained
savings. Genemary Falvey, Librarian, has developed a variety of processes to
accommodate this continued growth.
An ever-increasing demand has been placed on the Archives Department,
which loaned 538 photographs in 1985. Requests came from 38 outside organiza-
tions representing 12 countries and a variety of institutions. Largest among our on-
grounds consumers are the Public Affairs Office and the Publications Department.
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Cathy Garg, Archives secretary, was actively involved in the research for the
Laboratory's Centennial film, the Sambrook dedication brochure, and the exhibit
for the 50th anniversary of the Symposium. Organization of the 470 entries in the
portrait collection, which includes files on such notables as Darwin and Mendel as
well as a total file of staff and alumni, was completed. Additionally, all scrapbooks,
ledgers, and photo albums have been preserved in acetate sheets and acid-free
boxes to ensure the greatest shelf life.
Annual Growth of Permanent Collection
In 1985, the book collection grew by a net total of 1799 bound volumes, bringing
the total number of volumes to 29,098. This 22% increase is due in part to the
large number of advanced textbooks and reference tools that were added to the
collection this year. The journal collection remained stable at 434. This year, 15
titles were added and 14 were withdrawn.
Staff Member Celebrates 12th Year
Laura Hyman celebrated her 12th year at the Laboratory. Along with handling
myriad details for the entire staff, Laura functions as my administrative assistant for
budgets, personnel, and scheduling, in addition to her library job as binder and
interlibrary loan expert. An invaluable asset, she has managed to streamline the
binding of our 434 current titles; bindery turnaround has been reduced to one
month and rush materials can be readied in two weeks. Laura also recommended
renegotiation of our subscription service contract, managing to secure a reduction
from 6% to 4%, a savings of $1200.
There are three new faces on the Library staff. Wanda Felker, Library Clerk,
replaced Michaela McBride, who transferred to the Meetings Office. Carol O'Shea,
Library Assistant, stepped in for Margaret (Peggy) Main, who entered library
school in September. Cathy Garg was hired as Archives Assistant in May to fill the
vacancy left by Caroline Albinson.
Susan Gensel Cooper
PUBLICATIONS
Expanding Our Audience with Paperback Editions of Monographs
With the aim of easing the financial burden on students, we began 1985 by
issuing paperback editions of two of our previously published monographs:
Lambda ll and Gene Function in Prokaryotes. This trend was continued later in
the year with the release in paperback of the two-volume monograph The
Molecular Biology of the Yeast Saccharomyces: Life Cycle and Inheritance and
Metabolism and Gene Expression, which was followed by the publication of an
updated paperback edition of our Nucleases monograph.
With a sigh of relief and a publication dinner held for the editors and principal
contributors who were attending the RNA Tumor Virus meeting in May, we
celebrated the completion of the second volume, Supplements and Appendixes,
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of the paperback edition of the RNA Tumor Virus monograph. Conceived two
years earlier, at a previous RNA Tumor Virus meeting, this massive 2525-page
work stands as a tribute to the unselfish dedication of all who persevered through
numerous rewrites and burgeoning sequence additions as we strove to keep
current with a field that was exploding with new data almost daily.
By the close of 1985, combined unit sales of these paperbacks equaled almost
40% of the total units sold of their hardcover predecessors, a strong indication
that there is a potentially substantial market for these lower-priced editions.
Although release of the paperback editions expanded the audience for our
existing monographs, we note that for the second year in a row, no new
monograph was added to our list. Two new monographs are, however, planned for
publication in 1986, and a major effort is being made to revitalize this series,
which has been highly regarded by the scientific community since it began in
1971 with the publication of The Bacteriophage Lambda.
Strong Comeback for Current Communications Series
After a hiatus in 1984, the Current Communications in Molecular Biology series,
which was begun in 1983 with two titles, came back strongly in 1985 with four
new titles: Eukaryotic Transcription: The Role of cis- and trans-acting Elements in
Initiation, Protein Transport and Secretion, Immune Recognition of Protein
Antigens, and Plant Cell/Cell Interactions. With the publication of these volumes,
we feel we are well under way to achieving our goal of producing a minimum of
six titles in this series annually. Priced attractively between $27 and $30,
cumulative sales of all volumes in this series exceeded the $150,000 mark by the
close of 1985.
Cancer Cells Gains Acceptance and Series on Vaccines Launched
New in our just one-year-old Cancer Cells series was volume 3 Growth Factors
and Transformation. With first-year sales of this title 29% higher than the averaged
sales of the two inaugural issues in 1984, it is clear that the series has gained the
confidence of our customers, and we look forward to its continuation for many
years to come.
We are optimistic that our new series on vaccine development, launched in
1985, will achieve the same acceptance. The inaugural issue, Vaccines 85,
addressed the molecular and chemical basis of resistance to parasitic, bacterial,
and viral diseases. Future issues will incorporate immunological approaches and
chart the potential, and hopefully the success, of developing a vaccine against
AIDS.
Neuroscience and Plant Molecular Biology Are
Featured in Two New Volumes
Topics currently of interest in the neurosciences and plant molecular biology were
also featured in our 1985 publications, the former in Gap Junctions and the latter
in Molecular Biology of the Photosynthetic Apparatus. Responding to the many
requests from our customers for a copy of the manual used in the Molecular
Biology of Plants course here at CSH, we decided to publish this interim manual
as a service to the scientific community while work continues on producing a
comprehensive lab manual in 1986. The Laboratory's summer courses have always
been fertile ground for the development, refinement, and testing of the latest
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techniques, and we look forward to harvesting the best that these courses yield to
continue our highly successful program of lab manuals.
In conjunction with our manual program, we will continue to offer, when
needed, a complete kit of strains to facilitate the use of a manual. In keeping with
this, a fully tested Strain Kit to accompany our Experiments with Gene Fusions
manual became available in 1985.
50 Years of Publishing: The Symposia on Quantitative Biology
The opening days of 1985 found us firmly pushing volume 49 of the Symposia,
Recombination at the DNA Level, out of the printer and into the hands of our
customers while busily preparing for the 50th Anniversary of the Cold Spring
Harbor Symposia on Quantitative Biology, soon to be upon us in May. As we
closed 1985 we found ourselves in a not much different situation, putting to bed
the last issue of our 50 years of publishing history while reaching ahead to May
and the start of our second half-century, our aim unaltered from that expressed by
Reginald G. Harris when he ushered in this publishing program in 1933: "to make
available to all workers the methods and ideas which will be set forth in the group
meetings."
Production Stabilized at 1984 Level while Expenses Declined
With a total in 1985 of 11 new titles, 5 new editions, and 7 reprintings of existing
titles, the production output of the publications program remained approximately
equal to that of 1984. Since 73% of our new titles, however, were issued in the
lower-priced paperback format (as compared with 40% of our 1984 titles), it is not
surprising that dollar sales declined by approximately 5% in 1985. This decline in
income was more than offset by an almost 20% decrease in total expenditures,
which resulted in a net increase in revenues after expenses from 1984 to 1985 of
$166,815. Several significant factors contributed to this savings, including the
almost total use of in-house computers for typesetting, lower binding costs for
paperbacks, and staff reductions through attrition.
Although 1985 was a year of consolidation and evaluation, the prospects for a
sustained period of growth over the next several years seem bright. Cancer Cells
and Current Communications show every indication of having established
consistent sales records, several high-quality lab manuals long in development
now appear to be likely candidates for publication over the next two years, and
efforts already under way to develop several definitive monographs within the
same time frame all contribute to this optimistic outlook.
Publications Services to the Laboratory
As we draw from the vast resources of the Laboratory's meetings, course, and
research programs to provide the seeds for our growing publications program, we
in turn provided our services to the Laboratory in 1985 by producing the abstracts
booklets for the meetings program (10 in 1985), the program booklet for the
dedication of the Joseph Sambrook Laboratory, and the 1984 Annual Report, as
well as the Annual Reports for LIBA and Banbury Center. Last year's CSH Annual
Report was a particularly complex undertaking as the entire design and
production were revamped to achieve a more contemporary look while highlight-
ing the unique character of CSH through the use of numerous informal
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photographs in conjunction with striking photographs of details of the rich
architectural heritage of our grounds.
A New Vehicle for Disseminating Information
We undertake the task given to the Publications Department by Dr. Harris to be
the conduit for the dissemination of information not only in the books we produce,
but also in our marketing efforts. In 1985 the Marketing Department developed the
CSHL Notebook, a triennial newsletter designed to bridge the gap between direct
mail campaigns and to inform students and researchers the world over about our
meetings and course programs. That such information was clearly needed was
reflected in the responses to a detailed questionnaire included in the first issue:
93% of the respondents endorsed the newsletter as a welcome addition. We also
learned from the 82% of the respondents who have the responsibility of buying
textbooks for their institutions that there are many courses for which no textbook is
available. We are presently analyzing these responses with a view to how we
might develop materials to meet these needs.
The Pace of Science Demands Rapid Order Processing
Over the last five years, we have taken several steps to decrease the turnaround
time for filling an order. The first step was the introduction of a new computer
system that generates packing slips within 24 hours. This year, we have taken the
final step by bringing our shipping and warehousing totally in-house. Depending
on the type of shipping requested by a customer, this allows us to get a book to
our domestic customers in as little as 48 hours and to our foreign customers
within two weeks.
Foreign Marketing and Distribution Agreements
Supplying timely information and making our titles available worldwide are
constant goals. Accordingly, we completed negotiations for an exclusive
distributorship in Japan with Maruzen Co., Ltd., in Tokyo. Through their extensive
advertising program and excellent distribution channels, Maruzen is well-equipped
to serve our Japanese customers efficiently.
Our own marketing capabilities have been made available to the John Innes
Institute under an agreement with them to market and distribute in North America
their new lab manual Genetic Manipulation of Streptomyces.
Marketing Techniques Reduce Costs and Increase Sales
Two steps were taken in 1985 to make the most effective use of our marketing
dollar. Our house mailing list was meticulously pruned by 23%, from 57,000 to
44,000 entries, by eliminating addresses inactive since January 1982. In addition,
to lessen the impact of the escalating cost of journal ads, each ad now features
several titles, with the exception of ads for the Symposium.
With these economies, we were able to reallocate funds to produce our first
four-color flyer, which featured volume 3 in our Cancer Cells series, Growth
Factors and Transformation, and highlighted the previous volumes The
Transformed Phenotype and Oncogenes and Viral Genes. The result was a
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marked upswing in sales of the earlier volumes and a quickening in the pace of
sales of volume 3.
Video Becomes Part of Our Book Exhibits
In the process of displaying our books at key professional meetings throughout the
year, the Marketing Department disseminates much useful information about the
Laboratory's overall program of research and education. Following the completion
in 1985 of a video documentary of the history of CSH, it was decided that this
video will become an integral part of all our book exhibits in 1986. Prepared in
anticipation of the centennial of the Laboratory in 1990, The Biological Revolution:
100 years of Science at Cold Spring Harbor traces, through events that
happened at CSH, the development of the biotechnology revolution. It is thus a
fitting backdrop for the display of our books, which have chronicled those events
for the last 50 years.
Nancy Ford
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Recto: Corn thrives during the winter months in the newly completed greenhouse at
Uplands Farm. Construction of the facility is part of a $3-million capital program to
reestablish plant genetics as a major concern at Cold Spring Harbor.
TUMOR VIRUSES
In the field of eukaryotic gene regulation, the DNA tumor viruses remain a main-
spring. Study of adenovirus and simian virus 40 (SV40) has illuminated areas of
molecular biology ranging from DNA replication to translational control and from
cellular transformation to messenger RNA synthesis and maturation. From its
origins nearly 15 years ago, the Tumor Virus group has played a seminal part in
the development of the pattern and style of research at Cold Spring Harbor. The
following pages record the continued progress of this highly interactive group of
investigators.
MOLECULAR BIOLOGY OF TUMOR VIRUSES
Y. Gluzman T Adams B. Ondek R. Chisum
T. Grodzicker K. Buchkovitch M. Quinlan J. Clarke
E. Harlow M. Chapman M. Romani J. Cosset
W. Herr R. Cone A. Shepard R. Gensel
M. Siniscalco D. Esposito C. Stephens M. Goodwin
H. Fox K. Van Doren K. Marcinczak
R. Gerard P Whyte R. McGuirk
J. Harper M. Yamada C. Schley
D. McVey C. Bautista L. Vanderwal
I. Mohr D. Chao J. Wiggins
The major focus of research in the Tumor Virus
Section continues to be the analysis of the trans-
forming genes and proteins of SV40 and adenovi-
ruses as well as studies on regulation of viral gene
expression. Many projects are concerned with the
role of transforming proteins in cell proliferation,
growth control, and transformation; with the inter-
action of transforming proteins with other cellular
proteins; with modifications and cell localization
of transforming proteins and their role in protein
function; and with comparisons of viral and cellu-
lar transforming proteins. The properties of wild-
type and mutant T antigens in in vitro replication
systems are also being actively explored. Many ex-
periments are concerned with the dissection of con-
trolling elements, such as viral promoters and en-
hancers, their interaction with viral and cellular
proteins, and the effects of these interactions on
transcription and replication. Yeast cells, as well as
a variety of mammalian cells, are being explored as
host systems to study the effects of viral regulatory
proteins. Viral vectors that can be used to over-
produce transforming proteins, new monoclonal
antibodies directed against transforming proteins,
new mutants in viral transforming proteins and
controlling elements have been produced and are
valuable reagents for many of the genetic and bio-
chemical studies.
Production of a Cell Proliferation
Factor by Baby Rat Kidney Cells
Infected with Ad5 12S Virus
M. Quinlan, T Grodzicker
Primary cultures of cells isolated from baby rat kid-
ney (BRK) consist of fibroblast and epithelial cells.
Within 1 week after plating, the epithelial cells die
and the fibroblasts remain viable for about 2 weeks.
However, when these cultures are infected with the
adenovirus 5 (Ad5) 12S virus, the epithelial cells un-
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dergo rapid proliferation and dominate the cul-
tures. This effect is detectable within the first 24
hours after infection and results in an eight- to ten-
fold increase in the level of [3H]thymidine incor-
porated. The proliferation of epithelial cells con-
tinues for up to at least 1 month after infection.
Ad5 12S is a mutant that only encodes the 12S gene
product of early region lA (E1A) in the form of a
cDNA copy of the 12S mRNA. The 12S gene prod-
uct has been shown to immortalize primary cells
but not to activate gene expression from the viral
genome. The 12S sequence is transcribed and trans-
lated by these cells between 9 and 18 hours after in-
fection. Cells infected by the Ad 5d1312 mutant vi-
rus, which has a deleted E1A region, resemble
mock-infected cultures. Infection by Ad 5d1309,
which contains a wild-type E1A region, or by Ad5
13S, which only encodes the 13S gene product
within the E1A region, results in the death of the
majority of the cells within 48 hours.
The conditioned medium from Ad5-12S-infected
cells is able to produce a similar proliferative effect
on epithelial cells when added to uninfected pri-
mary BRK cultures. Pure populations of epithelial
cells can be produced when BRK cells are plated in
serum-free, hormonally defined media. The infec-
tion of such a population with Ad5 12S results in
rapid cellular proliferation, even in the absence of
serum or growth factors. The conditioned medium
from Ad5-12S-infected BRK cells (maintained in
media containing a variety of different growth fac-
tors, or none) induces the proliferation of unin-
fected epithelial cells; conditioned medium from
cultures infected with Ad 5d1312 or mock-infected
does not. The conditioned medium is also able to
extend the life of the primary cultures for several
weeks. This and other data suggest that some factor
is produced by BRK cells infected with Ad5 12S.
The continued presence of this factor seems to be
necessary for the continuous proliferation of the
epithelial cells. However, the conditioned medium
is unable to complement Ha-ras to produce trans-
formed foci, which are produced when the 12S and
Ha-ras genes are cotransfected. At present, we are
analyzing the nature of the growth factor(s) pro-
duced, by analyzing both proteins and RNAs in-
duced in 12S-infected cells; we are also investigating
the range of cell types that can be stimulated by the
12S product. We are also studying E1A mutants to
determine what region of the 12S protein is neces-
sary to stimulate cell growth and to correlate this
property with other parameters of transformation.
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Adenovirus Vectors: Downstream
Sequences That Affect Transcription
Initiation from the Adenovirus 2
Major Late Promoter
T Grodzicker [in collaboration with S. Mansour and
R. Tjian, University of California, Berkeley]
We have used in vitro and in vivo recombination to
position the coding sequences for SV40 T antigen
at various locations downstream from the adenovi-
rus major late promoter. Previously, we had con-
structed hybrid viruses that had T-coding sequences
in the middle of the third segment of the tripartite
leader, in the intron between the first and second
leaders, in the auxiliary i leader segment (located in
the intron between the second and third leader),
and in the intron between the second and third
leader but not within the i leader. All viruses made
equal and very high levels of SV40 mRNAs that
carried various amounts of the tripartite leader at
their 5' ends, depending on where the T-antigen-
coding sequences were located. The SV40 mRNA
from one recombinant virus, Ad-SVR284, which
carried a nearly complete tripartite leader, was
translated ten times more efficiently than hybrid
SV40 mRNAs from the other viruses. The poorly
translated SV40 mRNAs, which carried only one or
two segments of the tripartite leader, also lacked
the normal T-antigen initiation codon as a conse-
quence of splicing from unpaired 5' splice sites to
a cryptic 3' site within the T-antigen-coding se-
quences. The 3' splice removed 48 nucleotides of
SV40 RNA, including the normal AUG, so that
translation initiated at an in-frame initiator AUG
13 codons downstream from the normal translation
start site. Therefore, we could not determine
whether their translational defect was due to the
leader structure at the 5' ends of these mRNAs or
to the use of an AUG triplet downstream from, but
in-frame with, the normal T-antigen initiation
codon.
To distinguish between these possibilities, we
constructed two new adenovirus-SV40 hybrid
viruses in which the T-antigen-coding region is
fused to either the first leader segment or the sec-
ond leader segment to eliminate the possibility of
cryptic splicing events. Together with Ad-SVR284,
these new viruses form a matched set encoding hy-
brid SV40 mRNAs that differ only in the number
of tripartite leader segments attached to their 5'
ends. Moreover, one of these viruses contains the
most extensive deletion of DNA sequences 3' to the
late promoter that we have yet tested. We have mea-
sured the transcription and translation of the SV40
sequences carried by these hybrid viruses. To our
surprise, we found that there was no detectable ef-
fect of altering the 5' leader sequences on the trans-
lation of hybrid SV40 mRNAs. However, DNA se-
quences that lie downstream from the major late
promoter (starting at + 33 relative to the 5' end of
the mRNA) and extend into the intron following
the first leader (to nucleotide +190) contain an ele-
ment that increases, by about tenfold, the fre-
quency of initiation from the adenovirus major late
promoter. In addition, we have used a transient ex-
pression assay to demonstrate that the effect of
these downstream sequences is mediated by a virus-
encoded or virally induced trans-acting factor. We
plan to map these downstream sequences further
and to investigate what viral products mediate tran-
scription stimulation.
Analysis of the Adenovirus E1A
Proteins Using Monoclonal Antibodies
E. Harlow, C. Stephens, P Whyte, C. Schley
The proteins encoded by the E1A region of Ad5
have been analyzed using a series of monoclonal
antibodies. These antibodies bind to at least six dis-
tinct epitopes located in both the first and second
exons of the 13S polypeptide. Immunoprecipita-
tions from adenovirus-infected HeLa cells using
these antibodies have shown that the E1A products
are heterogeneous in size and charge. When the
E1A proteins are analyzed by two-dimensional
isoelectric focusing, approximately 80 polypeptide
species can be resolved. About half of these poly-
peptides are products of the 12S and 13S mRNAs.
The patterns of 12S and 13S proteins on two-
dimensional gels are similar, although the 12S
products have more acidic isoelectric focusing
points and migrate somewhat faster in the second
dimension. Pulse-chase experiments have shown
that these spots are normal intermediates in E1A
synthesis. Using short labeling times, we have been
able to identify the primary translation product for
both the 12S and 13S mRNAs. The modification
pathway for these proteins moves the polypeptides
to a more acidic pI and a higher molecular weight.
In addition to the 12S and 13S polypeptides, a num-
ber of other E1A-related protein species can be seen
using two-dimensional analyses. These include
polypeptides with relative molecular weights of
35,000, 30,000, 25,000, 20,000, and 15,000. The
30,000-molecular-weight polypeptide appears to be
encoded by an E1A-specific mRNA. The origin of
the other polypeptides is at present unknown.
The monoclonal antibodies also coprecipitate a
series of bands with relative molecular weights of
approximately 300,000, 130,000, 110,000, 80,000,
and 60,000. Several lines of evidence suggest that
these proteins are host polypeptides that are com-
plexed to the E1A products. (1) These bands are not
precipitated from cells that do not contain E1A
polypeptides. (2) The bands are still seen when anti-
bodies that bind to separate epitopes on E1A are
used. (3) After denaturation, the E1A proteins, but
not the other polypeptides, are specifically recog-
nized by the monoclonal antibodies. (4) The
300,000- and 110,000-molecular-weight proteins are
precipitated when lysates of labeled HeLa cells and
unlabeled 293 cells are mixed together and precipi-
tated with an E1A-specific antibody.
Overexpression of the Human Cellular
Tumor Antigen p53
T. Adams, K. Buchkovich, E. Harlow
A full-length cDNA clone for the human tumor
antigen p53 has been isolated. This clone has been
inserted behind several different mammalian pro-
moters, including the SV40 early promoter, the
metallothionein promoter, and the mouse mam-
mary tumor virus promoter to begin studies of the
function of the p53 protein. Transient expression
studies have shown that these constructs are correct
and that they synthesize an authentic p53 protein.
However, attempts to obtain stable high-expressing
cell lines have failed to date. We have also compared
the ability of these clones to collaborate with an ac-
tivated ras gene to transform normal rat primary
cells. All three of these p53 expression plasmids fail
to cooperate in this assay under conditions where
the adenovirus E1A gene will complement the ras
gene. In an attempt to circumvent these problems,
the cDNA has been cloned into an adenovirus ex-
pression vector provided by Y. Gluzman (this sec-
tion). We have assayed the level of transcription
from this vector and have found that this construct
produces approximately 50 times more RNA than
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the highest expressing cell line we have analyzed.
We are currently checking for the expression of the
p53 protein itself.
SV40 DNA Replication
R. Gerard, Y. Gluzman
Development of an in vitro SV40 DNA replication
system (see B. Stillman, this section) allowed us to
assess the effect of mutations in the origin of DNA
replication and in a variety of mutant SV40 T anti-
gen proteins.
T-antigen mutants. Five mutant T antigens
containing amino acid substitutions known to af-
fect SV40 replication in vivo have been purified.
Human cells were infected with helper-independent
adenovirus vectors carrying different mutant SV40
early genes, the mutant T antigens were purified by
immunoaffinity chromatography, and their in vitro
properties were compared with those of the puri-
fied wild-type protein. One mutant protein (C11) is
completely defective in T-antigen ATPase activity
but still binds to the origin sequences. Three other
T-antigen proteins (C2, C6-2, and T22) are de-
fective in their ability to bind to origin DNA but re-
tain ATPase activity. Finally, the fifth altered T
antigen (C8A) binds to origin sequences and retains
ATPase activity. All five proteins fail to support
SV40 DNA replication in vitro. However, in mixing
experiments, all five proteins efficiently compete
with the wild-type protein and reduce the amount
of DNA replication. These data suggest that an ad-
ditional function of T antigen other than origin
binding or ATPase activity is required for initiation
of DNA replication, and this hypothesis is cur-
rently under investigation.
Origin mutants. Plasmid DNAs containing the
SV40 origin of DNA replication support efficient
DNA synthesis in vitro and in vivo. Deletion of
DNA sequences that had been previously defined
by studies in vivo to constitute the minimal core ori-
gin sequence is also necessary for DNA synthesis in
vitro. In the process of this investigation, the im-
portance of the AT-rich region (n.p. 15-31) on the
late side of SV40 origin became obvious: removal
of 4-6 AT nucleotides (n.p. 25-31) renders the ori-
gin defective. We constructed SV40 viral genomes
that contain these lesions and confirmed that these
constructs are defective for replication and did not
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produce any plaque, although T-antigen synthesis
was not affected by the mutations in the AT region.
We were able to isolate revertants and found that
they always contain an increase in the length of the
AT region. This was due either to insertions or to
point mutations. We are going to isolate and ana-
lyze a large number of revertants to draw firm con-
clusions about the role of the AT-rich region in
SV40 origin function.
Properties of the SV40 T Antigen
Produced in Mouse Cells
R. Gerard, Y. Gluzman
To address the question of why SV40 DNA fails to
replicate in mouse cells (nonpermissivity), wild-
type SV40 T antigen was expressed from the mouse
metallothionein-I promoter in C127 mouse cells
using a bovine papilloma virus (BPV)-based vector
system. Induction of the transformed mouse cells
with heavy metals resulted in the production of
three times more SV40 T antigen than is found in
COS monkey cells. Nevertheless, after adding a va-
riety of exogenous templates containing an SV40
origin, no SV40 DNA replication was observed in
the mouse cells; however, abundant replication was
obtained in COS cells. Fusion of T-antigen-produc-
ing mouse cells with C6 cells (permissive monkey
cells transformed by UV-irradiated SV40 that make
a T antigen that is defective for viral replication but
contain a functional origin) demonstrated that the
T antigen produced in mouse cells was capable of
replication of SV40 DNA in monkey cells. Further-
more, T antigen purified from mouse cells was ac-
tive in an in vitro SV40 DNA replication system (in
collaboration with R. Guggenheimer, this section).
From this, we conclude that mouse cells trans-
formed with a BPV vector carrying SV40 T antigen
are deficient in replicating SV40 DNA because they
are missing some positive factor(s) present in per-
missive cells.
Properties of Saccharomyces cerevisiae
Cells Expressing SV40 T Antigen
D. McVey, Y. Gluzman [in collaboration with J. Hicks]
The possibility that SV40 T antigen expressed in
yeast cells would interact with yeast components
(proteins?) and would affect some metabolic
processes prompted us to undertake these experi-
ments. Expression of T antigen in yeast cells was
done to determine whether T antigen could pro-
duce any phenotype, particularly one affecting the
life cycle and replication of Saccharomyces cere-
visiae.
T-antigen cDNA was cloned into the YEp51 vec-
tor, and its expression was driven by the regulated
GALIO promoter. No morphological changes were
observed when yeast transformants were grown on
glucose-containing medium (repressed conditions).
However, when the yeast transformants were grown
on galactose-containing medium (induced condi-
tions), 5-15% of the cells exhibited a "shmooing"
phenotype, reminiscent of the behavior of some
cell-division-cycle mutants (e.g., cdc28). This pheno-
type was not exhibited by cells expressing truncated
(aminoterminal 272 amino acids) T antigen, al-
though much larger quantities of the truncated
polypeptide were produced, as detected by immu-
noprecipitation.
The major problem with this system is the low
frequency (5-15%) with which T-antigen-produc-
ing yeast manifests the shmooing phenotype. This
makes genetic analysis very difficult. To overcome
this problem, we are trying to express larger quanti-
ties of T antigen using a variety of yeast vectors and
strains.
Further Modifications of
Helper-independent
Adenovirus Vectors
K. Van Doren, Y. Gluzman
CONSTRUCTION OF A DOUBLE REPLACEMENT
VECTOR
The helper-independent double replacement vector
allows the propagation of two different genes (usu-
ally one selectable marker and one gene of interest)
inserted into two different areas of the adenovirus
genome (early regions 1 and 3). This vector makes
it possible to introduce both genes into the host ge-
nome by isolating drug-resistant cells after infec-
tion: Because the defective adenovirus genome usu-
ally integrates in toto, the second gene will also be
present with high frequency. We constructed dou-
ble recombinant viruses containing the human p-
globin gene or a human y-D chimeric globin gene
in place of the El region and a neomycin resistance
gene in place of the E3 region. The human D-
globin/neor virus was used to transform human
(K562) or mouse (MEL) erythroleukemia cells, and
approximately 25% of the two' cells also con-
tained the complete human (3- globin gene. In col-
laboration with D.S. Carlsson (National Institutes
of Health), we are investigating the regulation of
expression of the (3- globin gene in these cells.
EXPRESSION OF GENES INSERTED IN THE
ADENOVIRUS E3 REGION
Previously, we demonstrated that recombinant
viruses that carry insertions in the E3 region can be
efficiently propagated. The inserted gene was a
neomycin resistance marker driven by the SV40
promoter. Viruses with inserts in either orientation
were equally viable and could convert recipient cells
to the neomycin-resistant state with equal effi-
ciency. However, we obtained a different result
when we inserted the SV40 T antigen gene driven
by the major late adenovirus promoter into the E3
region. The only viruses we obtained contained the
insert oriented so that transcription proceeded
from right to left relative to the adenovirus genome
(anti-E3 orientation). There are a few possible ex-
planations for this discrepancy and they are now
under investigation.
Pre-mRNA Splice-site Selection:
In Vitro Splicing of Adenovirus
E1A Precursor RNA
J. Harper, W. Herr
Maturation of many eukaryotic mRNAs involves
removal of intervening sequences by RNA splicing.
This process must be carried out with precision to
produce mRNAs that encode proteins faithfully.
Major advances in our understanding of the splic-
ing process have resulted from the faithful
reproduction of mRNA splicing in vitro (for review,
see Keller, Cell 39: 423 [1984]). Analysis of the
products and intermediates generated by in vitro
splicing reactions has defined a pathway for the
removal of intervening sequences and exon liga-
tion. The first step is cleavage of the precursor at
the 5' splice site and attachment of the 5' end of the
intron to an adenosine residue near the 3' end of the
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intron, generating a free 5' exon and a branched cir-
cular molecule, referred to as a lariat. The second
step is cleavage at the 3' splice site and ligation of
the two exons, producing spliced RNA and the in-
tron sequences in a shortened lariat structure. De-
spite this elucidation of the mechanism of splicing,
the signals that direct accurate excision of introns
are not fully understood. Much of the specificity re-
sides in conserved sequence elements found at the
5' and 3' splice sites, but this is not sufficient to di-
rect accurate splicing because many pre-mRNAs
contain similar sequences that are not normally
used as splice sites. Some other factors must modu-
late the accuracy and efficiency of splice-site selec-
tion.
We are addressing this question by examining
splice-site selection during in vitro splicing of
precursor RNA containing multiple functional
splice sites. For our initial studies, we have chosen
the adenovirus E1A gene, which encodes three over-
lapping mRNAs that are produced by splicing from
different 5' splice sites to a common 3' splice site.
The accumulation of these RNAs is differentially
regulated during the course of lytic infection by
adenovirus. Two of these RNAs, the 12S and 13S
species, are expressed throughout the lytic cycle,
whereas the 9S species is not expressed until inter-
mediate and late times after infection.
We have examined the relative efficiency with
which the 13S, 12S, and 9S 5' splice sites are utilized
in an in vitro splicing reaction. An E1A gene con-
struct was made in which the bacteriophage SP6
promoter replaced the normal adenovirus E1A pro-
moter and enabled precursor RNA to be prepared
in vitro using SP6 RNA polymerase. This precursor
was incubated in nuclear extracts from uninfected
He La cells under conditions shown to be optimal
for pre-mRNA splicing (Krainer et al., Cell 36: 993
[1984]). This reaction generates a large number of
products, including correctly spliced 13S RNA and
the expected intermediates of 13S splicing (i.e., 5'
exon and lariat intermediates), but no detectable
12S or 9S RNAs. The 13S RNA produced in these
reactions can undergo a further processing event.
This reaction involves selection of the 9S 5' splice
site and a cryptic lariat attachment site in the 13S
mRNA, resulting in an accurately excised 9S 5' exon
and a lariat intermediate, but no detectable final
spliced product. This reaction is probably analo-
gous to that observed in cells transfected with a 13S
cDNA plasmid, in which aberrant 12S and 9S
RNAs were produced by processing of the 13S pri-
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mary transcript (see Svensson et al., J. Mol. Biol.
165: 475 [1983]).
These results indicate that the three 5' splice sites
are differentially recognized during the in vitro
splicing reactions; the 13S splice site is recognized
in the E1A precursor, resulting in correct 13S RNA
splicing, the 9S splice site is recognized in a 13S pre-
cursor, resulting in an incomplete splicing reaction,
and the 12S does not appear to be recognized in
these reactions. These differences could be the re-
sult of competition between the three 5' splice sites
for common splicing factors or for the 3' splice site,
lack of specific splicing factors (e.g., 12S specific
factors) from the splicing extracts, or a combina-
tion of the two. We are currently testing the idea of
splice-site competition using a mutant E1A precur-
sor that contains a deletion of the 13S 5' splice site.
Future experiments will examine the possible role
of precursor modification (e.g., adenine methyla-
tion) in splice-site selection and will explore differ-
ent cells and extraction methods for making splic-
ing extracts.
The SV40 Enhancer Is Composed of
Multiple Functional Elements That
Can Compensate for One Another
W. Herr, J. Clarke, H. Fox, B. Ondek, A. Shepard
We are studying the structure and function of ele-
ments within the SV40 enhancer that are respon-
sible for activation of transcription. Our strategy
has been to make point mutations within specific
regions of the enhancer that weaken enhancer func-
tion and growth of SV40. We then select for and
analyze the structure of SV40 growth revertants in
which enhancer function has been restored. Last
year, we described the structure of 18 revertants of
the enhancer mutant dpm12. This mutant contains
one copy of the 72-bp element and two point mu-
tations within each of two different 8-bp stretches
of alternating purines and pyrimidines (PU/PY);
each revertant contains a tandem duplication rang-
ing in size from 45 by to 135 by within the mu-
tated enhancer region. A 15-bp region, called ele-
ment C, that spans the "core" consensus sequence,
GTGGAAAG, was present in all the duplications,
suggesting that this region plays a critical role in
restoring activity to the dpm12 mutant.
To identify sequences that can compensate for
point mutations within the C element, we selected
growth revertants of the mutant dpm6, which con-
tains a mutated core element (GTGGAAAG to
GTCCAAAG). Revertants of this mutant likewise
contain tandem duplications. As shown in Figure 1,
the duplications span either one or both of two sep-
arate regions that we refer to as elements A and B.
Each of these elements contains one of the PU/PY
sequences that is mutated in the dpm12 mutant.
These results suggest that the SV40 enhancer con-
tains multiple elements capable of functioning in-
dependently and compensating for one another.
Consistent with this hypothesis, revertants of the
double mutants dpm16 and dpm26 containing mu-
tated A and C and B and C elements, respectively,
consistently duplicate the unmutated B or A do-
mains.
When all three elements are mutated as in the
mutant dpm126, no new element appears to com-
pensate for loss of function; instead, enhancer
function is effectively restored by "double duplica-
tions," in which the first duplication event recreates
one of the sequences destroyed by the point muta-
tions and the second event then duplicates this
newly created sequence. This result illustrates one
mechanism by which a strong enhancer can be
created, i.e., by apparent creation of functional se-
quences at duplication junctions.
To determine whether or not the C element can
activate transcription in the complete absence of
the A and B domains, we synthesized a 17-bp-long
SV40 fragment (GGGTGTGGAAAGTCCCC) con-
taining 14 by (underlined) of the 15-bp C element.
Four and seven tandem copies of this element effi-
ciently stimulate transcription of the 13-globin gene
in both CV-1 and He La cell transient expression as-
says. These results show that at least one of the
three elements we have described can function inde-
pendently of the other two. We plan to use these
synthetic enhancers as probes to isolate and iden-
tify trans-acting cellular factors.
Transcriptional activation by the three elements
(A, B, and C) may involve interactions with differ-
ent cellular trans-activating factors. If this is the
case, the revertant enhancers that contain duplica-
tions of different active elements may display
different host-cell preferences, depending on the
relative concentration of the trans-acting factors
present in the cell. To date, we have examined the
relative efficiency of the various mutants and rever-
tants to activate (3-globin gene expression in the
simian cell line CV-1 and in HeLa cells. We find that
both the dpm6 and dpm12 mutant enhancers yield
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FIGURE 1 Tandemly duplicated sequences in 13 revertants of
the SV40 enhancer mutant, dpm6. The diagram at the top of the
figure illustrates the structure of the SV40 early promoter. Shown
from right to left are the major early transcription start site (zig-
zag arrow), the origin of replication (ori), the AT-rich TATA-like
element (A/T), the two perfect 21-bp repeats, and a single copy
of the 72-bp element. Numbers below the diagram refer to the
nucleotide positions in the SV40 sequence. The positions of the
two 8-bp PU/PY sequences (hatched boxes a and b) and the
8-bp core sequence (box c) are indicated with the respective
nucleotide sequences shown above each box. The two dpm6
point mutations are shown above the sequence of the SV40 core
element. The regions that are tandemly duplicated in the dpm6
revertants are shown in order of size by the rectangular boxes.
The series of double Xs show the location of the two "cord' point
mutations when included in the duplication. The two stippled
areas show the location within the duplicated sequences of the
two elements A and B, the sequences of which are shown at the
bottom of the figure with brackets identifying the PU/PY se-
quences corresponding to the a and b hatched boxes at the top
of the figure.
similar levels of fl-globin RNA after transient ex-
pression in either cell line. Revertants of these two
mutants exhibit two- to sixfold higher activity in
CV-1 cells. In HeLa cells, the dpm12 revertants are
also two- to sixfold more active, but revertants of
the dpm6 mutant are scarcely more active than the
parent mutant. These results indicate that the re-
vertant enhancers are differentially selective with
respect to the cell lines in which they will function
effectively. By examining the behavior of the rever-
tant enhancers in a variety of different cell lines, we
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hope to identify cells that are likely to be rich
sources of particular trans-acting enhancer factors.
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B. Stillman R. Guggenheimer E. White J. Brody
P Cotton G. Prelich P Newman
J. Diftley B. Faha S. Penzi
N. Byrne
Research in this laboratory is aimed at elucidating
(1) the mechanism and regulation of DNA replica-
tion in eukaryotic cells and (2) the functions of the
adenovirus early region 1B (E1B)-encoded tumor
antigens. In previous years, we have concentrated
on understanding the mechanism of replication of
one DNA replicon, the human adenovirus genome.
These studies have now focused on a cellular en-
coded, site-specific, DNA-binding protein (nuclear
factor I), which is required for adenovirus DNA
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replication in vitro by binding to the origin se-
quences. The work on nuclear factor I has stimu-
lated a search for cellular site-specific, DNA-
binding proteins that may initiate DNA replication
at specific origins in cellular chromosomes. To this
end, we have detected a protein that binds to an au-
tonomously replicating sequence (ARS1), which is
present in the genome of yeast and is a candidate
for an origin of chromosomal DNA replication.
In 1984, we began studies on the replication of
SV40 DNA in vitro and progress in this area has
been rapid. We have characterized the kinetics and
products of this cell-free reaction and have ana-
lyzed mutations in both origin sequences and the
SV40 tumor antigen, which is another site-specific,
DNA-binding protein that is required for initiation
of SV40 DNA replication. During the course of
these studies on SV40 DNA replication, we discov-
ered reaction conditions that enabled replicating
DNA to be preferentially assembled into a chroma-
tin structure that resembles the structure of SV40
minichromosomes that are found in infected cells.
This is the first such system described, and it may
have far-reaching consequences for future biochem-
ical studies on chromatin structure and function.
Finally, our studies on the adenovirus E1B-
encoded tumor antigens have continued to yield
surprising results. The E1B 19K protein was previ-
ously shown to localize predominantly in the nu-
clear envelope of infected cells. We have now dem-
onstrated that this protein is a negative regulator of
early gene transcription and controls the expression
of other early gene products during infection of
various human cells. The overproduction of early
gene products in 19K- mutant-infected cells may
cause the wide variety of phenotypes that were de-
scribed in last year's Annual Report.
Sequence-specific DNA-Protein
Interactions at Viral and Cellular
Origins of DNA Replication
J. Diff ley, B. Stillman
The efficient initiation of adenovirus DNA replica-
tion in vitro requires, in addition to the virus-
encoded preterminal protein-DNA polymerase
complex (pTP-pol), a He La cell protein called nu-
clear factor I (NFI). The stimulatory effect of NFI
on the initiation of adenovirus DNA replication is
mediated through the binding of NFI to a specific
sequence within the origin of adenovirus replica-
tion. Although a role for NFI in adenovirus replica-
tion is clear, any role for NFI in cellular DNA me-
tabolism remains obscure. For example, NFI has
been shown by investigators in several laboratories
to bind to other viral DNA sequences, including
transcriptional enhancers and potential cellular
regulatory sequences. To understand its cellular
function, we have set out first to purify NFI. In last
year's Annual Report, we described a sensitive as-
say for NFI based on its ability to bind specifically
to a small DNA fragment containing the origin of
adenovirus DNA replication. We have used this as-
say in the purification of NFI to apparent homo-
geneity. The purified protein exhibits one dominant
band with a molecular weight of 160K on SDS-
polyacrylamide gels and some minor proteins of
lower molecular weight. The stoichiometry of DNA
binding is consistent with two moles of the 160K
polypeptide binding per mole of binding site. We
have raised and are currently characterizing poly-
clonal antibodies directed against the 160K poly-
peptide that will be useful for further characteriza-
tion of this polypeptide and its relationship to NFI
activity.
Since the binding of proteins to specific DNA se-
quences appears to be a common motif in the orga-
nization of DNA replication origins from both
prokaryotes and eukaryotic viruses, we are inves-
tigating whether these observations can be ex-
tended to eukaryotic cells and have thus begun to
look at sequence-specific DNA-protein interactions
at potential cellular origins of DNA replication.
The ability of certain sequences (known as autono-
mously replicating sequences, ARS) to confer, in
cis, upon any DNA the ability to be maintained ex-
trachromosomally in yeast makes these sequences
good candidates for eukaryotic origins of replica-
tion. One well-studied ARS, ARS1, has been shown
to consist of at least three sequence elements im-
portant for full ARS function. Using a variation of
the DNA-binding assay described for NFI, we have
recently identified a factor in whole-cell extracts
from the yeast Saccharomyces cerevisiae, which
binds specifically to ARS1. After partial purifica-
tion, we have shown that the protein protects ap-
proximately 25 by of ARS1 DNA from DNase-I
digestion. This 25-bp sequence is contained entirely
within a 63-bp region previously determined by de-
letion analysis (Celniker et al., Mol. Cell. Biol. 4
2455 [1984]) to be important in ARS function. Our
current efforts involve (1) site-directed mutagenesis
of the protein-binding site to determine if protein
binding is required for ARS activity; (2) the com-
plete purification of this protein; (3) the identifica-
tion of the gene encoding this protein; and (4) eluci-
dation of any role played by this protein in cellular
DNA replication.
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SV40 DNA Replication
R. Guggenheimer, G. Prelich, J. Brody, N. Byrne,
B. Stillman
Recently, we have initiated studies that utilize SV40
as a model system for the replication of eukaryotic
chromosomes. Our work on SV40 DNA replication
in vitro was performed in collaboration with Y.
Gluzman's laboratory and has initially focused on
(1) developing a detailed understanding of the func-
tion of cis-acting DNA sequences that comprise a
functional origin of DNA replication; (2) the char-
acterization of the protein requirements, both viral
and cellular, for in vitro DNA replication of the
SV40 genome; and (3) analysis and characteriza-
tion of the products of the in vitro DNA replication
system.
ESTABLISHMENT OF THE IN VITRO DNA
REPLICATION SYSTEM
We have used an in vitro DNA replication system
that carries out efficient and extensive synthesis of
exogenously supplied plasmid DNAs containing
the entire SV40 genome or fragments of the viral
genome that span the origin of replication as deter-
mined by in vivo studies. The in vitro SV40 DNA
replication system utilizes soluble extracts of
adenovirus-transformed human embryo kidney
cells (293 cells) as a source of replicative enzymes.
SV40 DNA synthesis has been shown to be com-
pletely dependent on an intact SV40 origin of repli-
cation (see below) and requires the virus-encoded
large tumor (T) antigen as well as crude cytoplas-
mic extracts from 293 cells. DNA synthesis also re-
quires Mr, ATP, an ATP regenerating system
(creatine phosphate and creatine phosphokinase),
and the four deoxynucleoside triphosphates. Addi-
tion of the ribonucleoside triphosphates other than
ATP only marginally stimulates DNA synthesis in
vitro.
DNA synthesis has been shown to initiate at or
near the origin of replication and proceeds bidirec-
tionally. Density gradient centrifugation analysis
of products of in vitro reactions synthesized in the
presence of bromodeoxyuridine has demonstrated
that replication proceeds semi-conservatively, with
multiple rounds of replication occurring.
CHROMATIN ASSEMBLY IN VITRO
Initial analyses of the products of in vitro replica-
42
tion reactions by high-resolution agarose gel elec-
trophoresis indicated that the products of these
reactions were covalently closed, relaxed circular
DNA molecules and topoisomers migrating be-
tween form I and form II DNA markers. These
results were confirmed by agarose gel electrophore-
sis performed in the presence of the intercalating
agent chloroquine. Furthermore, we have demon-
strated that these intermediates of the replication
process can be converted to negatively supercoiled
(form I) DNA molecules upon the addition of a nu-
clear extract prepared from 293 cells. The supercoil-
ing reaction requires the SV40 T antigen, and vary-
ing the amount of T antigen can modulate the level
of supercoiling. Electron microscopic (Fig. 1) and
biochemical analyses have revealed that the nega-
tive supercoiling of newly replicated DNA is due to
the formation of stable nucleoprotein complexes in
vitro and that these nucleoprotein complexes are in-
distinguishable from SV40 minichromosomes. In-
terestingly, formation of chromatin in vitro occurs
concomitantly with replication and requires host-
cell factors derived from the cytoplasmic and the
nuclear extracts of 293 cells. The ability to synthe-
size chromatin during DNA replication in vitro
should advance future studies on the structure and
assembly of chromatin and its role in cell replica-
tion and transcription.
CIS-ACTING DNA SEQUENCES
The DNA sequences that comprise the origin of
SV40 replication have been defined by studies in
vivo, and we have demonstrated that the origin se-
quences required for efficient DNA synthesis in
vitro are essentially the same as these. A 65-bp re-
gion of the SV40 genome has been defined as the
minimal origin of replication by analysis of the
ability of deletion mutants of SV40 DNA to func-
tion as templates in the DNA replication reaction.
Within this minimal origin, four subregions have
been defined. The first consists of a portion of the
early side of T-antigen binding-site I. The second,
a region between T-antigen binding-sites I and II,
is essential and overlaps with a region that is the
transition point between leading- and lagging-
strand synthesis in vivo. A third region essential for
template function consists of T-antigen binding-
site II that is centered in a 27-bp palindrome. Fi-
nally, a stretch of 17 AT base pairs that lie on the
late side of the palindromic sequence is required.
These results are summarized in Figure 2.
FIGURE 1 Electron microscopy of SV40 DNA replication products. Reactions were done with a nuclear extract
that promotes the assembly of replicated DNA into a chromatin structure. The products were isolated by sucrose
gradient centrifugation, and the peak fractions were pooled, dialyzed, and then fixed directly (A) or after sitting
on ice for 48 hr, followed by heating at 30°C for 15-30 min (B-E). After fixation and staining, the samples were
viewed in the electron microscope. The figure shows the image of the negative. Bar, 0.1
T-ANTIGEN FUNCTION
We have also analyzed the effect of mutations in the
T-antigen coding region on the ability of the resul-
tant altered proteins to (1) support DNA synthesis
in vitro, (2) bind to the origin sequences, and (3)
hydrolyze ATP to ADP and P. All three activities
are known to be intrinsic to wild-type T antigen.
The results of studies on five such mutants suggest
that both ATPase and origin binding activities are
necessary but not sufficient for the replication ac-
tivity of T antigen. One mutant, C8A, which con-
tains a lysine to glutamic acid change at residue
224, retains wild-type levels of origin binding and
ATPase activities but is replication-defective. Ad-
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FIGURE 2 Definition of the SV40 DNA replication origin. The nucleotide sequence surrounding the SV40 origin region is shown. Above the sequence, the three T-antigen binding
sites (I, II, and ill) are indicated, together with the start site for early gene transcription (open box) and the transition point between leading- and lagging-strand synthesis (vertical
hatched box). Below the line are the deletion endpoints for plasmids in the pSVO and pS1 series, together with plasmids pSVO- and pRG53. The construction and analysis of these
plasmids were described previously (Stillman et al., EMBO J. 4: 2933 [1985]). The solid line represents sequences present in the plasmid DNAs. The ability of these plasmids to
support SV40 DNA replication in vitro is indicated at the right: ++ indicates 100% of wild-type activity; + indicates 40-50% of wild-type activity; - indicates no detectable activity.
ditionally, we have demonstrated that several repli-
cation-defective mutant T antigens compete effi-
ciently with wild-type T antigen in DNA replication
reactions. On the basis of these results, we suggest
that an additional function of T antigen, possibly
involving a protein-protein interaction, is an essen-
tial feature of this multifunctional protein with re-
spect to its replication activity.
GENETICS OF DNA REPLICATION IN VITRO
An interesting feature of the SV40 DNA replication
system is that DNA synthesis only commences after
a 10-15-minute lag but then remains linear for 90
minutes at 37°C. Experiments have demonstrated
that this lag period could be abolished by preincu-
bation of the template DNA, T antigen, and 293 -
cell cytoplasmic extracts for 15 minutes at 37°C in
the absence of deoxynucleoside triphosphates.
Omission of any of the aforementioned compo-
nents during the preincubation, or preincubation
of all required components at 4°C, 23°C, or 30°C,
resulted in the reappearance of the lag in DNA syn-
thesis. By ammonium sulfate fractionation of the
293-cell cytoplasmic extract, we have been able to
demonstrate that a fraction, devoid of both DNA
polymerase a and DNA primase activities, is com-
petent in abolishing the kinetic lag in DNA syn-
thesis.
Similar kinetic lags in DNA synthesis have been
observed in a variety of DNA replication systems in
vitro, most notably the Escherichia coli oriC and
the phage (pX SS->RF systems. In both cases, it has
been demonstrated that this lag period corresponds
to the time required for the assembly of a multi-
enzyme prepriming complex required for genera-
tion of DNA primers used to initiate synthesis of
nascent DNA chains. Because we have not yet been
able to determine the nature of the primers synthe-
sized in the SV40 replication system, we refer to the
kinetic lag as a "presynthesis" stage. This presyn-
thesis stage does not require the function of either
DNA polymerase a or DNA primase and may rep-
resent the formation of a multi-enzyme complex
functionally similar to the preprimosome of E. coli.
Alternatively, the lag may reflect the time required
to alter and prepare the template DNA for efficient
use in the replication system. With respect to the
latter possibility, we have demonstrated that the
topological state of the input DNA is crucial in de-
termining the efficiency with which this DNA is
utilized as a template in the in vitro reactions. Spe-
cifically, covalently closed, negatively supercoiled
DNA (form I) is at least 20-fold more efficient as
a template than linear duplex (form III) DNA
molecules.
It is our intention to pursue these studies on the
in vitro replication of SV40 DNA. Our approach at
the present time is to fractionate the 293-cell
cytoplasmic extract and then purify and character-
ize the required activities, with a long-term goal to
reconstitute SV40 DNA replication in vitro with
purified components. Due to the lack of suitable
eukaryotic cell replication-defective mutants, it is
only through this biochemical approach that we
may ask questions concerning the functional,
mechanistic, and regulatory aspects of DNA repli-
cation in higher organisms.
Adenovirus E1l3 Tumor Antigens
E. White, B. Faha, P Cotton, P. Newman, B. Stillman
The main focus of our work on adenovirus during
the last year has been to determine the function of
the E1B 19K tumor antigen in transformation and
productive infection. It is clear that this protein has
a pivotal role in oncogenic transformation by
adenovirus; however, the precise mechanism be-
hind this phenomenon is not known. We have
approached this problem (1) by determining the
intracellular localization of the 19K protein in
adenovirus-transformed and lytically infected cells,
(2) through the characterization of adenovirus mu-
tants carrying defined genetic lesions within the
coding region for this protein, (3) by investigating
the interaction of the 19K protein with the other vi-
ral early region gene products through the con-
struction of double-mutant viruses, and (4) by ex-
amining the effect of E1B 19K gene mutations on
viral gene expression in different human host-cell
lines.
INTRACELLULAR LOCALIZATION OF THE
E1B 19K PROTEIN
Biochemical fractionation, indirect immunofluo-
rescence, and immunoelectron microscopy of ade-
novirus-infected and -transformed cells has estab-
lished that the E1B 19K tumor antigen is associated
with the nuclear envelope and cytoplasmic mem-
branes, probably those of the endoplasmic reticu-
lum (see last year's Annual Report). The 19K pro-
tein is found in both the inner and outer nuclear
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membranes of the nuclear envelope and the nuclear
lamina, and this association with the nuclear enve-
lope appears to be required for preserving the in-
tegrity of the host-cell chromosomal DNA during
productive infection (see below). We have detected
a small fraction of the 19K tumor antigen on the
cell surface of adenovirus-transformed cells and are
currently investigating its possible functional sig-
nificance.
E1B 19K GENE MUTANTS
Adenovirus mutants have been isolated and have
been shown to contain either point mutations or a
deletion within the coding region for the E1B 19K
tumor antigen. Infection of He La or KB cells with
these mutant viruses causes the degradation of
host-cell chromosomal DNA and enhanced and
unusual cytopathic effects, the deg and cyt pheno-
types, respectively. DNA degradation directly corre-
lates with the absence of 19K protein in the nuclear
envelope, indicating that its proper intracellular lo-
calization is required to prevent the DNA degrada-
tion in infected cells. The initial characterization of
these mutants has formed the foundation for our
current work on the interaction of the 19K protein
with the other adenovirus early proteins and the
role of the 19K protein in the control of early gene
expression.
INTERACTIONS BETWEEN THE E1B 19K GENE
PRODUCT AND OTHER VIRAL PROTEINS
DNA degradation is the result of early gene func-
tion, since it occurs in the absence of DNA replica-
tion and late gene expression. A viral mutant that
does not synthesize a 19K gene product due to an
out-of-frame deletion has the deg phenotype. This
suggests that the DNA degradation, which occurs
after infection with an E1B 19K gene mutant virus,
is caused directly or indirectly by the action of an-
other viral early gene product. We have postulated
that the functional 19K protein in the nuclear enve-
lope prevents the host-cell chromosomal DNA
from becoming degraded by modulating the activ-
ity of this other early viral gene product(s) during
the course of a normal infection. To this end, we
have constructed double-mutant viruses that con-
tain alterations in the 19K coding region as well as
in other early viral genes. These double-mutant
viruses have been assayed for their ability to induce
the deg and cyt phenotypes in infected He La cells.
An involvement of the E1A proteins has been
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tested by constructing viruses that express only the
12S (243R) or 13S (289R) E1A gene products in
conjuction with an E1B 19K gene mutation. Both
viruses are capable of causing the deg and cyt
phenotypes, precluding the individual involvement
of the 243R or 289R proteins. However, a double
mutant that deletes both E1A proteins remains to
be tested. Another virus that has been constructed
contains the temperature-sensitive mutation in the
E2A 72K DNA-binding protein from Ad5ts125 in
conjunction with an altered E1B 19K gene. Infec-
tion with this virus also induces DNA degradation
at the restrictive temperature where the DNA-
binding protein is not functional. Experiments to
test the effects of expression of the remaining early
region gene products on DNA degradation are cur-
rently under way.
HOST-RANGE PHENOTYPE OF THE E1B 19K
GENE MUTANTS
We have identified three classes of human cell lines
that respond differentially to E1B 19K gene muta-
tions. The first class is represented by HeLa cells,
where the growth of E1B 19K mutant viruses is not
much different from that of the wild-type adenovi-
rus 2 (Ad2). Infection of HeLa cells with the mu-
tant viruses causes the deg and cyt phenotypes (see
above). The second class is represented by KB cells,
where the mutant viruses grow substantially poorer
than the wild-type virus (>100-fold reduction in vi-
rus yield). The DNA degradation is even more se-
vere, and the cytopathic effect is more pronounced
than in HeLa cells. The third class is represented by
WI38 and human embryo kidney (HEK) cells,
where there is no DNA degradation after infection
with mutant E1B 19K viruses, and in fact the mu-
tant viruses possess a substantial growth advantage
over that of the wild-type Ad2. In virus-yield ex-
periments, the E1B 19K gene mutant viruses grow
to 500-fold higher titers than the wild-type virus.
We have sought to determine the nature of the re-
duced ability of the wild-type virus to grow in these
cells by examining viral DNA, RNA, and protein
synthesis in infected WI38 cells.
Viral DNA replication is reduced in Ad2 but not
E1B 19K mutant-infected WI38 and HEK cells. The
levels of viral DNA synthesized after infection with
Ad2 have been quantitated by hybridization to a la-
beled adenovirus DNA probe and are tenfold lower,
when compared to mutant-infected cells. This ef-
fect can be overcome, however, by infecting the
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FIGURE 3 Northern analysis of cytoplasmic poly(A)* mRNA isolated from mock wild-type (Ad2)-infected and mutant
(1p5)-infected WI38 cells. Filters were hybridized to SP6-generated RNA probes for E1A, E1B, and E2A region tran-
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wild-type virus at high multiplicities of infection
(>50 pfu/cell). Synthesis of early and late viral pro-
teins has been examined by Western blotting pro-
teins from wild-type and mutant-infected cell ex-
tracts using antibodies directed against E1A, E1B
19K, E2A DNA-binding protein, and hexon. Both
late protein synthesis and early protein synthesis
are reduced. Similar results were obtained when in-
fected cells were labeled in vivo with [35S]methio-
nine and labeled extracts were examined for early
and late viral protein synthesis.
The reduced synthesis of early proteins in Ad2 -
infected WI38 cells was further investigated at the
RNA level. Cytoplasmic mRNA was isolated from
mutant- and wild-type-infected WI38 and HEK
cells and translated in vitro. The levels of translat-
able mRNA for viral polypeptides are tremen-
dously reduced in Ad2-infected cells when com-
pared to mutant-infected cells. Northern analysis
of poly(A)* mRNA from these cells has revealed
that the reduced levels of early viral gene expression
in Ad2-infected WI38 cells are the result of reduced
levels of cytoplasmic message encoding these pro-
teins (Fig. 3). To establish whether the effects on
early viral gene expression occur at the level of
mRNA processing, transport, or transcription,
nuclei from wild-type- and mutant-infected WI38
cells were assayed in run-on transcription reactions
in vitro, and the RNA was analyzed by hybridiza-
tion to adenovirus DNA probes for each of the
early region genes. We conclude from these experi-
ments that the reduced level of early viral gene ex-
pression in WI38 cells infected with the wild-type
adenovirus is due to reduced levels of transcription
of the viral genes.
The E1B 19K tumor antigen must therefore be
acting as a negative regulator of early viral gene ex-
pression in human WI38 cells, thereby accounting
for viral gene expression only in the absence of
functional 19K protein. Experiments to define the
molecular mechanism behind this important phe-
nomenon are being persued.
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Cloned Restriction-Modification
Genes from Bacilli
A Kiss
We have completed the sequence of the gene coding
for the BsuRI endonuclease and have determined,
by Sl-nuclease mapping, the initiation sites of the
BsuRI endonuclease and methylase transcripts.
The predicted amino acid sequences of the BsuRI
enzymes were compared, in a computer search,
with each other and with other type II restriction
and modification enzymes for which sequence in-
formation is available. The following are the main
conclusions of this search: (1) There is no homology
between the BsuRI endonuclease and methylase,
suggesting that these two enzymes recognize their
common target sequence (GGCC) by different
mechanisms. (2) Extensive homology was found
between the BsuRI methylase and the BspRI
methylase, another enzyme recognizing GGCC.
Parts of this homology are shared by two other
modification enzymes: the SPR methylase (speci-
ficity: GGCC, CCGG, and CCA/TGG) and the
Mspl methylase (CCGG). (3) Regions of partial ho-
mology were found between the Eco dam (GATC),
T4 dam (GATC), Dpnll (GATC), and EcoRV
(GATATC) methylases. The correlation between the
sequence similarities and the recognition specifici-
ties suggests that the conserved regions may play a
role in the recognition process.
Comparison at the amino acid sequence level of
different modification methylases recognizing the
same or related sequences provided information
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that hopefully will guide further experiments (e.g.,
site-directed mutagenesis) to determine how these
proteins recognize the specific DNA sequence. Un-
fortunately, due to the lack of cloned genes, no
such comparison between restriction enzymes of
identical specificity was possible. Therefore, we
started experiments to clone the gene coding for the
BspRI endonuclease, an isoschizomer of BsuRI.
We tried several cloning strategies using selection
either for the methylase or for the endonuclease,
but so far we have not been successful in cloning
this gene. These experiments yielded an unexpected
clone that exhibits in vivo restriction and modifica-
tion but with a specificity different from that of
BspRI. In vivo, the clone restricts nonmodified
bacteriophage X. However, in vitro, using cell-free
extracts of the clone under assay conditions gener-
ally used for type II restriction enzymes, we failed
to detect specific cleavage of X, DNA. Thus, we con-
clude that this clone probably codes for a previ-
ously undetected type I or type III restriction-
modification system of Bacillus sphaericus.
Experiments are in progress to isolate mutations
that alter the recognition specificity of the cloned
restriction and modification enzymes.
5-Azacytidine Sensitivity
of Escherichia coil
A.S. Bhagwat
5-Azacytidine (5-azaC) is an analog of cytidine in
which the C -H group at the 5-position of cytidine
is replaced by an azide group. It is an inhibitor of
growth for both prokaryotes and eukaryotes. Its ac-
tion depends on the presence of a deoxycytidine
methylase in the cell. In Escherichia coli, the analog
is taken up by the cells, phosphorylated, and incor-
porated into RNA. It is also converted to its deoxy-
nucleotide form by the enzyme ribonucleotide re-
ductase and incorporated into DNA. Such incor-
poration into DNA or RNA is not toxic by itself;
however, it is highly toxic when a deoxycytidine
methylase is present in the cell. It has been shown
that a deoxycytidine methylase, in trying to methy-
late the 5-azadC residue in DNA, covalently at-
taches itself to DNA. This presents a block in DNA
replication, leading to cell death.
I have found that the sensitivity of E. coli to 5-
azaC depends on two factors -the amount of deoxy-
cytidine methylase present in the cell and the state
of DNA repair in the cell. E. coli K-12 strains carry
a DNA methylase, dcm, that methylates the second
C within the sequence 5'-CC(A/T)GG-3; but most
dcm* E. coli strains are not sensitive to 5-azaC.
They become sensitive to the drug either when a
plasmid carrying the dcm gene is introduced in the
cell or when the chromosome carries a mutation in
recA, the gene central to inducible DNA repair in
E. coli. The plasmid carrying the dcm gene is
known to produce 30-fold more methylase than the
chromosomal dcm. The current hypothesis is that
when the cell is recA*, a small number of enzyme-
DNA complexes are repaired by a recA-dependent
system. If this hypothesis is verified by further
studies, it would constitute the only known repair
system for DNA damage involving covalently
linked DNA-protein complexes.
Regulation of Transposon Tn3:
Choice between Intermolecular and
Intramolecular Transposition
A.S. Bhagwat
Tn3, a bacterial transposon that carries the ampicil-
lin resistance gene, undergoes a replicative mode of
transposition. Its transposition to another replicon
(intermolecular transposition) results in two repli-
cons, each carrying one copy of Tn3. Alternatively,
it can transpose within its host replicon (intra-
molecular transposition), resulting in either a dele-
tion of part of the replicon or the insertion of a sec-
ond, inversely repeated, copy of Tn3 within the
same replicon. Although the intermolecular trans-
position is expected to aid the survival of the trans-
poson and the spread of the ampicillin resistance
gene, the intramolecular transpositions are ex-
pected to cause deleterious rearrangements within
the host replicon.
I have determined the relative frequencies of the
two modes of Tn3 transposition using a system in
which both types of events take place in the same
cell and have the same DNA sequence as target. I
have found that the intermolecular mode is 15 times
more frequent than the intramolecular mode. Fur-
thermore, eliminating much of the intermolecular
transposition in the cell does not increase the fre-
quency of intramolecular transposition.
The experiment involves "mating-out" Tn3 inser-
tions that are conditionally lethal to the recipient.
These are Tn3 insertions in the EcoRII methylase
gene on a plasmid that also carries an active EcoRII
endonuclease gene. Cells that carry, or receive
through conjugation, such plasmids are killed by
the endonuclease unless the cell also carries the
methylase gene. In the donor, cell death is avoided
by maintaining the plasmid carrying the EcoRII en-
donuclease and methylase genes (pR209), along
with the plasmid carrying Tn3 (pR209::Tn3). When
such a donor is mated with a recipient lacking the
EcoRII methylase, and transconjugants are selected
for Tn3 (AmpR) as well as for the outside marker
on pR209 (TetR), two major types of transconju-
gants are expected. One type involves two inter-
molecular transpositions -pR209::Tn3 to pR209,
followed by cointegrate formation with the F-
factor, and pR209::Tn3 to the F-factor, followed by
cointegrate formation with pR209. These cointe-
grates are transferred to the recipient during mating
and resolved. They have the phenotype of either
restriction' (R *) modification' (M.) or R- M. Al-
ternatively, the transconjugants can arise through
one intramolecular transposition and one inter-
molecular transposition of Tn3; an intramolecular
transposition within pR209::Tn3 making it R-, fol-
lowed by cointegrate formation with the F-factor.
The cointegrates are then transferred to the re-
cipients during mating and resolved, resulting in
an R- M- phenotype. Therefore, the two pathways
are expected to result in transconjugants with plas-
mids that have different phenotypes and different
structures. Thus, a restriction enzyme analysis of
plasmids in the transconjugants can ascertain the
pathway by which each has arisen.
When such an analysis was carried out on 110
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transconjugants, 94 were found to have arisen by
the first pathway (2 intermolecular transpositions),
whereas only 3 were found to have arisen by the sec-
ond pathway (1 intramoleuclar and 1 intermolecu-
lar transposition). At least half of the transposi-
tions in the first pathway could be shown to have
been mutually independent. Thus, the first pathway
was used by Tn3 15- to 30-fold more frequently than
the second pathway. As both pathways involve one
transposition to the F-factor, the preference for the
first pathway must reflect a preference for inter-
molecular transposition to pR209 as opposed to
intramolecular transpositions within pR209. This
result has been found to be independent of the
orientation of the donor Tn3. When the plasmid
carrying the active methylase gene in the donor
(pR209) is replaced by a plasmid carrying the right
end of Tn3 in addition to the methylase gene
(pR222), no transposition can take place to pR222
because of the "transposition immunity" property
of Tn3. Thus, much of the intermolecular transpo-
sition within the cell is inhibited. Under these con-
ditions, the choice between the pathways described
above is reversed. In this case, no transconjugants
arise by the first pathway, whereas most of the
transconjugants arise by the second pathway. More
interestingly, the overall frequency at which Tn3
undergoes intramolecular transposition remains
unchanged. It appears that intramolecular trans-
position of Tn3 is maintained at a low frequency,
regardless of the state of intermolecular transposi-
tion within the cell.
Restriction Endonucleases
P.A. Myers, A. Sohail, R.J. Roberts
The collection of restriction enzymes continues to
grow, and more than 600 such enzymes are now
known; 137 different specificities have been char-
acterized, including 21 new ones within the last
year. Among these new specificities, the recognition
sequences for BspMI (ACCTGC[4/8]), BspMII
(T t CCGGA), EagI (C f GGCCG), PpuMI
(PuG t G[A/T]CCPy), Pf1MI (CCAN[N]5TGG),
and PpaI (GAGACC) have been characterized as
part of a collaborative program with I. Schildkraut
and D. Comb (New England BioLabs). In addition,
more than 20 other enzymes have been character-
ized that are isoschizomers of previously known re-
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TABLE 1 Simple Hexanucleotide Palindromes
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striction enzymes. As shown in Table 1, 47 of the
possible 64 enzymes that could recognize hexanu-
cleotide palindromes have now been discovered.
In Vitro Splicing of Adenovirus 2
Late RNA
G.A. Freyer, E. Grubman
We have continued our studies of RNA splicing in
vitro using extracts from He La cell nuclei. The sub-
strate that contains the first and second exons and
first intron of the tripartite leader of adenovirus 2
(Ad2) major late RNA is synthesized in vitro using
the Salmonella phage RNA polymerase, SP6. The
transcripts contain a modified version of the first
intron that contains only 86 nucleotides (6 nucleo-
tides from the 5' end of the intron and 18 nucleo-
tides from the 3' end of intron). The products of
splicing of this RNA have been completely ana-
lyzed and all intermediates have been character-
ized, including both intron lariats and intron/exon
lariats. Analysis has been performed by hybridizing
the products to appropriate cDNA, trimming with
ribonuclease Tl, and fingerprinting the oligonu-
cleotides. It has been possible to identify unambig-
uously each of the products of the reaction. The
lariat attachment site has been shown to involve an
A residue 24 nucleotides upstream of the 3' splice
site, in agreement with the results of Konarska et al.
(Nature 313: 552 [1985]).
One interesting mutant version of the substrate
has been prepared in which two A residues, one of
which is the normal lariat attachment site, have
been converted into G residues. This mutant clone
was prepared by oligonucleotide-directed, site-
specific mutagenesis. When RNA is transcribed
from this clone in vitro and used in the splicing
reaction, all of the usual intermediates are found,
including the final splice product. However, the ef-
ficiency with which the final splice is produced is
reduced at least 40-fold as compared with wild type.
As with the wild type, all intermediates of this reac-
tion have been characterized. The lariat intermedi-
ates are present in quantities similar to those ob-
served with the wild-type precursor. We have shown
that the nucleotide used for the lariat attachment
site is now the G residue that replaced the wild-type
A at the normal site. Analysis of the lariat attach-
ment by Ti fingerprinting and by redigestion with
RNase P1 shows unambiguously that the lariat
forms through one of the newly introduced G resi-
dues. Primer-extension experiments using oligonu-
cleotides that hybridize to the handle of the lariat
also confirm the position of the lariat attachment
site. This is in contrast to other lariat attachment
sites that have been characterized in other systems
in which the branch point has always been found to
involve an A residue. It is of interest that the de-
branching enzyme (Ruskin and Green, Science 229:
135 [1985]), which is able to cleave the lariat specif-
ically at the branch point when an A residue is pres-
ent, also works successfully when a G residue is
present.
Fate of Adenovirus 2 Introns In Vivo
G.A. Freyer, K. O'Neill, R.J. Roberts
The main thrust of our work in this area has been
to examine extracts of adenovirus 2 (Ad2)-infected
He La cells at late stages of infection to discover
whether any RNA species are present that contain
sequences corresponding to the first two interven-
ing sequences removed during the processing of the
late mRNA leader sequences. A number of oligo-
nucleotide probes were designed that would be able
to detect possible lariat intermediates or their prod-
ucts. The probes were made specifically against the
first intron of the Ad2 major late transcript, and
their locations are indicated schematically in Figure
1. They were 32P-labeled at their 5' ends and used
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FIGURE 1 Position of oligonucleotides used to probe for the
first intron of the Ad2 major late transcript.
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either as hybridization probes on Northern blots or
as sequencing primers for reverse transcriptase.
When oligonucleotides 6, 9, 10, or 13 were used
to probe Northern blots, strong signals were ob-
tained from two RNA species with apparent sizes
around 1000 nucleotides. The slower moving of
these two species shows abnormal mobility on
different concentration agarose gels and is believed
to be a circular version of the faster-moving mole-
cule. Neither of these two molecules can be detected
when oligonucleotide 12 is used as probe. These two
RNA species are not polyadenylated and are de-
tected in cytoplasmic extracts from infected cells.
Time course experiments show that these sequences
accumulate early during infection and reach
steady-state levels by about 12 hours postinfection.
Since late mRNA continues to be synthesized and
processed at that time, these intron sequences
clearly must turn over. Experiments are now in
progress to discover whether these intron sequences
are associated with specific proteins.
Adenovirus 2 E1A Gene Products
B. Zerler
In collaboration with E. Moran and M. Mathews
(Protein Synthesis section), we are continuing to ex-
amine the transforming and gene-regulating prop-
erties of the adenovirus E1A gene. Previously, to
distinguish the roles of individual E1A gene prod-
ucts, we made plasmids and viruses containing 9S,
12S, and 13S ElA cDNAs.
Virus isolates containing the 13S cDNA in place
of E1A are competent for lytic functions in He La
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cells, whereas the 12S viruses are defective. North-
ern and Western analyses of virus-infected He La
cells indicate that the adenovirus E2 gene product,
the DNA-binding protein, is made in He La cells
during 13S virus infection but is not detectable dur-
ing infection with 12S virus, although expression of
both the 12S and 13S products is detectable by
Northern and Western analyses. Although defec-
tive for lytic functions in human cells, the 12S virus
transforms primary baby rat kidney cells in culture
at very high efficiency. Infection of these cells with
13S or wild-type E1A viruses is cytotoxic. Only the
13S plasmid stimulates expression of the heterolo-
gous cat gene from the adenovirus E3 promoter in
a transient expression assay, whereas both the 12S
and 13S plasmids establish primary baby rat kidney
cells in culture or cooperate with the ras oncogene
to transform these cells fully. Thus, it appears that
both the 12S and 13S products have transforming
functions. However, the transformation function
of the 12S product is not dependent on the ability
to turn on other adenovirus genes and does not ap-
pear to be required for virus lytic growth in He La
cells. It is not clear whether the lytic functions re-
quire the establishment activity of the 13S product.
The kinetics of expression of the 9S mRNA in 9S
cDNA virus-infected He La cells are interesting,
since the 9S mRNA normally does not appear at
appreciable levels until late in wild-type infection.
It is noteworthy that the level of 9S mRNA in He La
cells is increased when the 9S virus is coinfected
with the 13S virus, suggesting a possible role for the
13S RNA or protein products in 9S expression. The
enhancement of the 9S mRNA level occurs even in
the presence of cycloheximide, but the mechanism
of action of cycloheximide on mRNA levels in
virus-infected cells is not certain. Transcription of
other early genes dependent on E1A is readily de-
tectable in cycloheximide-treated cells and may de-
pend on residual protein synthesis. It is also in-
teresting that 293 cells do not normally express 9S
mRNA from the endogenous E1A sequences they
contain, but 9S mRNA is expressed during adeno-
virus infection of 293 cells. We have observed the
production of 9S mRNA during infection of 293
cells with the 9S cDNA virus and are continuing to
investigate the regulation of 9S mRNA expression.
In addition to the above studies, we have ex-
pressed the 12S and 13S E1A cDNA products in
Saccharomyces cerevisiae. The cDNAs were cloned
into a yeast expression vector under transcriptional
control of the inducible GAL10 promoter. Western
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blot analysis shows the presence of two 13S proteins
and three 12S proteins. The largest of the 13S and
12S proteins made in S. cerevisiae have the same ap-
parent molecular weight as the largest of the 13S
and 12S proteins present in adenovirus-infected
HeLa cells. There is also a major lower-molecular-
weight 12S protein made in S. cerevisiae that is not
detected in virus-infected HeLa cells. In addition,
there is a protein of the same apparent molecular
weight made in both 12S- and 13S-containing S.
cerevisiae that is not detected in virus-infected
HeLa cells. The 12S protein is found in the soluble
fraction when yeast are lysed by either glass-bead
homogenization or French Press, whereas only
50% of the 13S protein is found in the soluble frac-
tion using either method of cell lysis. Western anal-
ysis shows that the amount of I2S or 13S protein
made in 107 cells of S. cerevisiae in mid-log growth
is about equal to the amount of 12S and 13S protein
made in 10' HeLa cells infected with adenovirus at
a multiplicity of infection of 10.
When grown under inducing conditions, the S.
cerevisiae containing either the 13S or 12S E1A
cDNAs do not exhibit any observable phenotype.
Generation time and morphology appear to be
similar to those of the controls. We have also found
that mating-type a (M ATa) cells expressing E1A
proteins are not altered in their susceptibility to the
cell-cycle-arrest effect of a-factor. In other experi-
ments, it was found that adenovirus E1A proteins
do not alter the ability of S. cerevisiae to sporulate,
and diploid strains expressing E1A do not exhibit
any differences in growth and morphology from
diploids not expressing E1A.
We are currently purifying the E1A proteins from
yeast based on an isolation protocol applied to
adenovirus E1A proteins obtained from Esche-
richia coli. Purified E1A protein from yeast will be
assayed for function by microinjection into mam-
malian cells and will be used to screen mammalian
cell extracts for factors that interact with E1A.
Besides expressing the adenovirus E1A proteins
in S. cerevisiae, the E1A proteins have also been
successfully expressed in DHFR- CHO cells follow-
ing transfection of a plasmid containing E1A and
the amplifiable dhfr gene. By stepwise amplifica-
tion with methotrexate, we hope to establish a
mammalian cell line that expresses large amounts
of E1A protein.
We have also recently expressed E1A 13S protein
in E. coli. The 13S cDNA was cloned into a bac-
terial expression vector under transcriptional con-
trol of the T7 promoter. From earlier studies in
other laboratories, it is known that E1A protein
produced in E. coli is not properly modified and is
inactive. Therefore, the bacterially made E1A pro-
tein provides a good substrate to analyze the
modifications necessary for activity. The bacterial
system also provides a large amount of protein that,
in combination with E1A protein isolated from S.
cerevisiae, can be used to screen mammalian cell
extracts for factors that interact with E1A.
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Research in the Protein Synthesis laboratory con-
tinued along the lines described in last year's An-
nual Report. The main themes are the regulation of
gene expression in adenovirus-infected human cells
both at the translational level and at the transcrip-
tional level, autoantibodies and autoimmunity, and
the heat-shock (stress) response of human cells.
VA RNA and Translational Control
R.P. O'Malley, K. Mellits, A.P. Rice, P.A. Reichel,
M.B. Mathews
Last year, we reported that the VA RNAs are essen-
tial in adenovirus-infected HeLa (human) cells to
preserve the activity of certain protein synthesis ini-
tiation factors. Eukaryotic initiation factor 2 (eIF-
2) ferries the initiator tRNA, methionyl- tRNAF, to
the ribosome in one of the first steps of protein syn-
thesis. At the completion of the series of initiation
reactions, eIF-2 emerges complexed with GDP, and
the cofactor must be replaced by GTP before eIF-2
can reload with methionyl -tRNAF in preparation
for another initiation event. The cofactor substitu-
tion reaction is itself mediated by an enzyme, the
guanine nucleoside exchange factor (GEF, also
known as eIF -2B), and work in other systems has
shown that the interaction between eIF-2 and GEF
constitutes an important site for the regulation of
polypeptide chain initiation. Phosphorylation of
eIF-2 on its a-subunit (it contains three different
polypeptide chains) results in formation of a tight
complex between the two enzymes, preventing GEF
from fulfilling its role.
Adenovirus encodes two small RNAs, the virus-
associated (VA) RNAs, transcribed by RNA poly-
merase III. These RNAs ("160 nucleotides long)
53
are produced abundantly at late times of infection
and accumulate in the cytoplasm. The deletion mu-
tant Ad 5d1331 described by Thimmappaya et al.
(Cell 31: 543 [1982]) fails to make the major species
of VA RNA, VA RNA,, and protein synthesis is
severely depressed during the late phase of infec-
tion with this virus. Work in cell-free translation
systems from d1331-infected cells indicated that a
mechanism of the kind outlined above must be at
play. In extracts of d1331-infected cells, (1) initiation
of protein synthesis is restored by addition of either
eIF-2 or GEF; (2) GEF activity is lacking; and (3)
a kinase capable of phosphorylating eIF-2 on its a-
subunit is present.
This kinase phosphorylates the serine residue
that comprises the regulatory site on the a-subunit
of eIF-2. Identification of the protein kinase was a
vital step in elucidating the mechanism of VA RNA
action. Of the two enzymes known to share this
substrate specificity, one (known as the heme-
controlled inhibitor, HCI) is activated by the ab-
sence of heme and the other (known as the double-
stranded RNA-activated inhibitor, DAI) is acti-
vated by the presence of double-stranded RNA
(dsRNA). The enzyme present in d1331-infected
He La cells resembles DAI in several diagnostic
ways: sensitivity to a sulfhydryl reagent; binding to
a dsRNA affinity matrix; and association with a
phosphoprotein of approximately 70 kD, which is
thought to be a subunit of DAI. Furthermore, when
infected with d1331, cells deficient in DAI were per-
missive for protein synthesis. This evidence left no
doubt that DAI is the kinase responsible for the in-
hibition of protein synthesis and immediately sug-
gested how VA RNA might function. VA RNA, is
highly structured and contains several duplex
regions, although these are not sufficiently exten-
sive or unbroken to activate the enzyme as long,
perfect dsRNA molecules do. Short duplexes, how-
ever, block activation of DAI by long dsRNA
molecules, and we have shown that VA RNA, can
indeed interfere with the activation of DAI by
authentic dsRNA in a model system. Indirect evi-
dence suggests that the activator of DAI found in
virus-infected cells is probably dsRNA produced by
symmetrical transcription of both viral DNA
strands.
As illustrated in Figure 1, it appears that VA
RNA protects against activation of DAI and the
consequent cessation of all protein synthesis in the
infected cell. But it is also possible that VA RNA
subserves additional functions in the infected cell;
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FIGURE 1 The role of VA RNA, in maintaining protein synthe-
sis in adenovirus cells. (Reprinted, with permission, from O'Mal-
ley et al., Cell 44: [1986] in press.)
for example, it may counter the antiviral action of
induces synthesis of DAI to
higher levels, or perhaps it may participate in the
process that favors the translation of viral mRNAs
relative to cellular species at late times of infection.
Investigation of these possibilities is under way.
Functions of the E1A Gene
E. Moran, C.V. Dery, C. Herrmann, J.M. Langstaff,
M.B. Mathews
The E1A gene occupies the extreme left end of the
viral chromosome and plays a key role in regulating
viral transcription (a process known as trans-
activation) and in cellular transformation by ade-
novirus. The extent to which these functions are in-
terrelated and the mechanism whereby they are
achieved by the E1A proteins are issues that con-
tinue to attract intensive research in many laborato-
ries. Our work in this field has been pursued par-
tially in collaboration with B. Zerler, R. Roberts,
and T. Grodzicker (see Nucleic Acid Chemistry and
Molecular Biology of Tumor Viruses) and has
taken a genetic approach. We have made and ana-
lyzed E1A mutants of three classes: (1) variants in
which the intact genomic ElA sequence is replaced
by cDNAs equivalent to the three differently
spliced ElA mRNAs (9S, 12S, and 13S), (2) dele-
tions removing portions of the E1A sequence bor-
dered by convenient restriction sites, and (3) point
mutants altering selected individual amino acids.
In last year's Annual Report, we discussed the
roles of the products of the 9S, 12S, and 13S EIA
mRNAs and described the properties of a mutant
that lacks amino acids 121-150 of the 13S product.
We have now constructed an additional deletion
mutant that lacks residues 86-120. A virus carrying
this deletion grew as well in He La cells as in 293
cells, indicating that it is competent in trans-
activation. The corresponding E1A plasmid was, as
expected, able to stimulate E3-cat expression in
He La cells and was able to cooperate with ras in
transforming baby rat kidney (BRK) cells. Taken
together with earlier findings, these data suggest
that amino acids following position 140 are not re-
quired for transformation, residues 140-187 are re-
quired for trans-activation, residues 86-120 are not
essential for either the trans-activation or transfor-
mation functions, and residues 121-150 are impor-
tant for both. This region is highly conserved be-
tween adenovirus serotypes, shows homology with
the myc oncogene product, and includes a string of
acidic amino acids between residues 133 and 138.
We are studying this region in more detail through
the use of oligonucleotide-directed mutagenesis to
generate specific point mutations in conserved
amino acids. Specific point mutations have been in-
troduced at base pair 928 (to change the amino acid
from cysteine to glycine at position 124), base pair
946 (proline to alanine at position 130), base pair
952 (serine to glycine at position 132), and base pair
961 (glutamic acid to lysine at position 135).
In addition, because the sequence Cys-X-X-Cys,
which occurs twice within the 13S unique region
(from amino acid positions 154-157 and 171-174),
has been proposed to be an active site in some pro-
teins, we have introduced a single base change at
nucleotide 1072 to change the serine residue at posi-
tion 172 to alanine. This mutation did not impair
the trans-activation of E3-cat in He La cells or the
ability to cooperate with ras in transformation of
BRK cells, although changes at nearby amino acid
positions 173 and 176 have been reported to impair
the trans-activation function severely (Glenn and
Ricciardi, J. Virol. 56: 66 [1985]).
Analysis of the amino acid changes in the region
between residues 121 and 150 is in progress. Results
obtained so far indicate that the 946 and 952 muta-
tions retain the trans-activation function. The 961
and 928 mutations also retain the trans-activation
function but are impaired for transformation. Both
of the latter have been transferred to 12S cDNA vi-
rus constructs to study the transformation defect in
more detail. The mutant proteins are expressed at
about the same levels as wild-type 12S protein;
however, immortalization activity of the 12S/961
virus was about 40-fold less than that of wild-type
12S virus on primary BRK cells, whereas immortal-
ization activity of the 12S/928 virus was at least
100-fold reduced. The E1A/928 mutation was also
transferred to virus to analyze its growth properties
in more detail. This virus formed plaques as effi-
ciently on He La cells as on 293 cells, and the time
course of infection was the same as that of wild-
type virus. Thus, we have detected no impairment
of the lytic functions in the E1A/928 virus, but the
plasmid pE1A/928 was reduced more than 50-fold
compared with wild-type in its ability to cooperate
with ras to transform BRK cells. Since both the 12S
and 13S plasmids were active in the transformation
assay, this defect in the pE1A/928 plasmid suggests
that the 13S product has lost its establishment ac-
tivity while retaining trans-activation function. We
are presently making a 13S/928 construct to test
directly the implication that the early adenovirus
gene trans-activation functions of the 13S product
do not require an intact establishment activity.
To expand our study of trans-activation and to
explore the mechanisms involved in regulating ex-
pression of early and late genes, we have placed the
bacterial chloramphenicol acetyltransferase (cat)
gene under the control of individual adenovirus
promoters. The E2 and E3 constructs were already
available from Weeks and Jones (Mol. Cell. Biol.
3: 1222 [1983]); we completed the early set (E1A,
E1B, and E4) and generated constructs carrying the
major late promoter (MLP) and other late promot-
ers (IX, IVa2, and E2L). The constructs are being
checked by sequence analysis and assayed by trans-
fection into a variety of mammalian cell lines. In
He La cells, only the early promoters were active.
With the exception of the ElA promoter itself, all
of the early promoters were stimulated by cotrans-
fection of the ElA gene or its derivative containing
the 13S cDNA; the 12S cDNA repressed their ex-
pression, and the 9S cDNA either repressed slightly
or was ineffective. In He La cells, the late promoters
were not active either in the presence or in the ab-
sence of E1A products. In 293 cells, which express
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both E1A and E1B products, the early promoters
and the MLP were active, but the other late pro-
moters (IX, IVa2, and E2L) were inactive or active
only to a small or variable extent. The E1A pro-
moter itself was active in both cell lines and was
repressed by the 12S and 9S products but not by the
13S product. These results indicate that the early
promoters are autonomously active and are E1A-
sensitive, whereas the late promoters apparently re-
quire additional factors (possibly including E1A
but not limited to ElA) for their activity. The na-
ture of these additional factors is currently under
investigation.
None of the promoters tested to the present time
is stimulated by the E1A 12S product, but it seems
likely that this protein activates some host-cell
products during transformation. Although we have
not yet succeeded in cloning the cDNA for the
proliferating cell nuclear antigen (PCNA), we have
obtained preliminary evidence that this cell-cycle-
linked protein may represent such a 12S-sensitive
product. The synthesis of PCNA occurred at a very
low level in uninfected BRK cells but increased rap-
idly after infection with 12S virus. PCNA synthesis
was first detected at about the same time as E1A
protein, and it also increased in cells infected with
wild-type virus or 13S virus but not with the E1A
deletion mutant d1312. We are presently extending
our analysis to viruses mutant in the ElA gene to
elucidate the relationship of this effect with trans-
formation and trans-activation.
Ribonucleoprotein Particles and
Autoimmunity
C.C. Bunn, L. Manche, M.B. Mathews
Stemming from our work on the cellular protein
known as the La antigen, which complexes with the
VA RNAs, we have become increasingly interested
in problems of autoimmunity. In several diseases,
antibodies are generated against "self" (the body's
own constituents), and such autoantibodies may in
turn contribute to the disease process. Antibodies
against the La antigen are often found in diseases
such as systemic lupus erythematosus and Sjogren's
syndrome, whereas antibodies against tRNA-related
proteins are common in muscle-wasting diseases
such as polymyositis and dermatomyositis. During
the past year, we have concentrated our attention
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on the latter group of antibodies, which seem to
pick out a subset of myositis patients who are prone
to severe lung complications.
As discussed in last year's Annual Report, there
are three well-characterized antibody specificities
in this group, of which Jo-1, reacting with the
charging enzyme histidyl-tRNA synthetase, is the
most frequent. The PL-7 and PL-12 specificities,
reacting with threonyl-tRNA and alanyl-tRNA syn-
thetases, respectively, are less common, but through
screening over 100 new sera, we now have over a
dozen examples of these sera. Only one other seem-
ingly distinct tRNA-related antibody specificity
emerged from our screening, implying that there
may perhaps be few such specificities awaiting dis-
covery. It is intriguing to note that the aminoacyl-
tRNA synthetases, which are known targets of au-
toimmune responses, are distinguished from most
other synthetases in that they do not appear to par-
ticipate in the large macromolecular synthetase
complex that has been studied in several labora-
tories.
The PL-12 system differs from both the Jo-1 and
PL-7 systems in that PL-12 antisera contain two
distinct sets of antibodies, directed against the
charging enzyme, alanyl-tRNA synthetase, and its
cognate tRNA, tRNAma. To understand in detail
the molecular features of an antigen that excite an
autoimmune response, we have begun to character-
ize the tRNAs recognized by PL-12 antibodies at
the sequence level. To date, we have fractionated the
mixture of tRNA species into three major families
and have derived a considerable amount of se-
quence information. The sequence of two of the
tRNAA'a species is nearing completion, and we
have begun to explore the antibody-reactive sites on
the tRNA. We will compare sera from different pa-
tients to discover whether there is a unique anti-
genic epitope. To shed light on one of the theories
of autoimmunity (the anti-idiotype hypothesis), we
will also determine the synthetase-binding site on
the tRNA to see if the antibody and synthetase in-
teract with the same site on the RNA molecule.
Human Stress Protein Genes
D.D. Pascucci, G.P. Thomas
Our work on the human stress response (heat-
shock) genes has continued to focus on the genes
encoding two of these proteins, the 90K and 70K
proteins. Last year we reported the characterization
of a 90K gene isolated from a human DNA library
in bacteriophage 3.. The sequence of a 4.2-kb region
was determined from the phage X2/59 and com-
pared with published sequences of the whole of one
of the yeast 90K genes and half of the D,osophila
90K gene. Considerable homology was detected
throughout the entire coding regions, with little ho-
mology in the untranslated regions. However, we
were not able to express polypeptides of approxi-
mately 90K from the putative coding regions, and
further examination of the gels revealed a number
of frameshifts in the "coding region," leading us to
suspect that X2/59 contained a pseudogene. Com-
parison with the complete Genbank compendium
of sequences revealed two regions of extremely
good homology (,,95%) with the Ll repeat, the so-
called Kpnl family of repeated sequences, and it be-
came clear that this isolate represented a processed
pseudogene embedded in an Ll repeat, with a 15-bp
direct repeat at the site of insertion. Restriction,
fragments predicted from this clone are present in
genomic blots, and thus the phage is unlikely to
have undergone gross rearrangements.
Two other clones isolated from the same DNA li-
brary appeared identical with the X2/59 clone that
was sequenced, and thus we resorted to two differ-
ent DNA libraries in an effort to obtain the authen-
tic gene. These libraries were screened with frag-
ments subcloned from 72/59. Among the products
was phage XE9, which was distinct from the origi-
nal clone by restriction mapping and lacked detect-
able interruptions of coding sequence. Upon se-
quence determination, this clone also proved to
contain at least two frameshifts, and we are forced
to conclude that it probably represents another
processed pseudogene. This view is reinforced by
the discovery of Ll sequences to the 5' side of the
putative coding sequences. The presence of such
repeats in close proximity to one end of the XE9 se-
quence need not imply that it is embedded in such
a repeat, since no LI sequences have been found to
the 3' side, at a distance that, in the pseudogene,
would be expected to extend past the poly(A) tail
of the 90K mRNA. However, expression studies
have yet to be undertaken to determine whether this
sequence can be expressed or whether the frame-
shifts are errors.
Both clones are nevertheless sufficiently close to
the 90K mRNA to generate St- protected hybrids
under very stringent conditions and to generate the
same-sized bands in both Sl protection and North-
ern analyses, using RNA from normal or stressed
cells. From this, we assume that the inducible 90K
mRNA is practically indistinguishable from its nor-
mally expressed counterpart, since other than a
mass increase, no difference is observed. It is also
possible to derive probable amino acid sequences
from these clones based on the most likely initia-
tion and termination codons. These predicted se-
quences are approximately 95% identical, given
that some assignments remain tentative because of
the frameshifts. This homology is much greater
than the homology of these clones with the yeast or
Drosophila 90K sequences. In comparisons with
the yeast sequence, it appears that the region of
greatest divergence lies toward the carboxyl termi-
nus, although even here amino acid homology ap-
proaches 70-75%. Thus, in common with the 70K
gene family (see below), the stress proteins as a
whole rank among the most highly conserved pro-
teins throughout nature, even though as yet there is
little indication of their real function under normal
growth circumstances or under stress.
Protein studies suggest the existence of at least
three families of approximately 70K polypeptides
that may be related to one another. One way to re-
solve this issue is to isolate and characterize the
cDNAs corresponding to the 70K proteins. We have
completed the sequence of one such cDNA of
about 1750 bp. It contains sequences from amino
acid 100 to the carboxyl terminus of the protein and
into the untranslated region, but it does not contain
the poly(A) tail. With the exception of a single base
difference, which causes a conserved substitution at
residue 148, it is identical with the sequence pub-
lished last year by Hunt and Morimoto (Proc. Natl.
Acad. Sci. 82: 6455 [1985]).
Using this clone as a probe, we have detected two
differently spliced transcripts in stressed cells. This
observation suggests that there may be two genes
encoding the 70K sequence that generate tran-
scripts differing at their 3'-untranslated region; al-
ternatively, the primary transcript of one gene is
subject to differential processing at a site located
near the end of the coding sequence. Screening the
cDNA library with this clone as probe indeed led
to the isolation of an additional cDNA clone,
pDDP1. However, the mRNA product of this gene
differs in size from mRNAs hybridizing to the
original pDP8 clone. It is likely that pDDP1 corre-
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sponds to another member of the 70K family that
(unlike the original) is relatively uninducible and is
expressed under normal circumstances.
In cultured rat cells, the 70K protein family is
seemingly less heterogeneous than in He La cells
and apparently contains one constitutive and one
induced species. We have also isolated cDNA
clones for the 70K family from a library from rat
REF52 cells. The largest clone, REF19, contains se-
quences from residue 180 to the untranslated se-
quence at the 3' end and including some of the
poly(A) tail. As judged from RNA analysis, this
clone apparently corresponds to a major, induced
species in rat cells. Curiously, the rat sequence ex-
hibits better homology with the Drosophila gene
than with the human pDP8 sequence. With this in
mind, we examined interrelationships between the
different 70K clones using a combination of North-
ern blots, SI protection, and hybridization. It ap-
pears that the pDP8 gene, which corresponds to the
major induced species in He La cells, is the odd man
out; the uninducible human gene (pDDP1), the in-
ducible rat gene (REF19), and the Drosophila 70K
gene are more closely related to one another than
to the major induced human gene (pDP8). The sig-
nificance of this observation is not clear at the
moment.
Progress has also been made toward understand-
ing the mechanism of the unusual translational
control that operates in stressed cells. Although
preexisting normal mRNAs remain intact and func-
tional and are associated with polysomes, they
either are not utilized for protein synthesis or are
used at a greatly reduced rate. We have isolated
from the polysomes of stressed cells a novel popula-
tion of mRNP particles that contain little or no
normal mRNA but a good proportion of newly
synthesized mRNA (largely stress-protein mRNAs).
These particles are isolated from density gradients
after fixation and contain no detectable amounts of
the mRNAs for tropomyosin, myosin, actin, or
tubulin. The particles are lighter than mRNA parti-
cles from polysomes of untreated cells, and they
contain ribosomal RNA in addition to mRNA and
considerable amounts of protein, but their compo-
sition remains to be fully defined.
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PROTEIN CHEMISTRY
C. Slaughter T. Fischer
C.R. Moomaw
The alkaline phosphatases (APs) are a family of
cell-surface enzymes that have become very impor-
tant in clinical chemistry for the diagnosis of cer-
tain cancers. Like other ectoenzymes (enzymes with
active sites oriented toward the outside of the cell),
the role of AP in the physiology of the normal cell
is not understood, although the presence of AP in
large amounts on epithelial cells with absorbtive
functions has suggested some direct or indirect role
in a transport process yet to be identified. Several
tissue-specific forms of AP have been described,
and the existence of several differentially expressed
AP genes has been inferred. Broadly, the family can
be divided into two parts, the heat-stable APs, in-
cluding placental, testicular, and intestinal APs,
and the heat-labile APs, including bone, liver, and
kidney APs. (The usefulness of the distinction be-
tween heat-stable and heat-labile APs is also sup-
ported by a variety of other biochemical and im-
munochemical studies.) A basis for oncologic
testing is that "ectopic" APs similar to one or an-
other of the normal heat-stable APs are frequently
expressed in tumors arising from tissues that nor-
mally only express heat-labile APs in appreciable
amounts. These ectopic APs are shed into the se-
rum, where they can be detected by biochemical
means. They have also been used as the basis for di-
rect tumor-imaging studies using immunochemical
methods. The genetic basis for normal tissue-
specific control of these proteins, the mechanism
for their ectopic expression, the structural relation-
ship between ectopic and normal APs, the mecha-
nism of shedding into the serum, and the normal
function of these ectoenzymes are all questions
predicated upon the detailed knowledge of the
complexity of the AP gene family and the struc-
tures of the expressed proteins.
AMINOTERMINAL AMINO ACID SEQUENCES
Using monoclonal antibodies specific for placen-
tal, intestinal, and liver APs, we isolated small sam-
ples of APs from these organs by immunoaffinity
chromatography. The proteins were subjected to
aminoterminal amino acid sequence analysis, and
the first 42 residues of each were identified. All
three sequences were different, confirming that
different genes are involved in coding for all three
forms of APs as previously inferred. Furthermore,
the two relatively heat-stable APs, placental and in-
testinal, were more closely related to one another
than either was to the heat-labile liver AP, reflect-
ing the degree of immunochemical relatedness be-
tween these proteins. Comparison of the sequences
with the known amino acid sequence of AP from
Escherichia coli revealed little similarity in the first
35 residues, but the remainder showed homology
with an aminoterminal region of E. coli AP that
forms a 0-sheet structure, at one end of which the
active site of the enzyme is located. An aspartic acid
residue believed to play a role in catalysis is present
in the human and the bacterial sequence in this lo-
cation. This suggests that mammalian and bacterial
APs are related functionally and genetically. Two
different molecular forms of APs are found in
adult and fetal intestine, respectively. These differ
in their sensitivity to neuraminidase, reflecting a
difference in glycosylation, but were found to show
the same aminoterminal amino acid sequences.
CLONING OF THE PLACENTAL AP GENE
Cyanogen bromide digestion and isolation of frag-
ments from a sample of placental AP permitted the
sequence analysis of a number of peptides from
which oligonucleotide probes could be constructed.
In collaboration with H. Harris at the University of
Pennsylvania, these have been used to identify a
clone containing the gene for human placental AP
from a placental cDNA library. This has been ana-
lyzed to obtain the complete coding region se-
quence. A similar series of experiments on liver AP
is presently under way.
LARGE-SCALE ISOLATION OF PLACENTAL AP
A convenient procedure for the large-scale isolation
of placental AP has been worked out for use in
crystallographic studies to be undertaken in collab-
oration with G. Wykoff at Yale University. The
purification procedure involves butanol extraction,
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anion exchange chromatography, hydrophobic in-
teraction chromatography, and gel filtration.
MEMBRANE INSERTION OF AP
The structural basis for membrane insertion of AP,
and hence the mechanism for its release into the se-
rum, is being approached through studies of certain
isozymes of AP found in tissue extracts. From all
tissues, native gel electrophoresis resolves two sets
of isozymes, one with rapid anodal mobility and
the other with very slow anodal mobility. Two sets
of isozymes have also been described by other in-
vestigators. These are believed to represent dimers
and high-molecular-weight aggregates, respectively.
We have determined that although the fast elec-
trophoretic components we observe correspond to
the simple dimeric species, the slow electrophoretic
components have properties different from those of
the aggregated form. The slow components there-
fore represent a third molecular form of the en-
zyme. This species behaves as though it were more
hydrophobic than the fast components, but it has
a similar apparent molecular weight. Our working
hypothesis is that it may contain a chemical group-
ing of importance for membrane attachment. A
method for large-scale purification of the slow
components has therefore been developed for prep-
aration of both slow and fast isozymes from the
same placenta. The purified material is currently
being used in comparative peptide-mapping studies
in an effort to identify the structural differences
and hence the mechanism for membrane attach-
ment.
PLACENTAL AP POLYMORPHISM
Human placental AP is an extraordinarily poly-
morphic enzyme. By native gel electrophoresis, 3
common alleles and more than 20 rare alleles have
been identified. By analogy with the major
histocompatibility antigens (another family of
polymorphic cell-surface glycoproteins that are
coded by a multigene family), it is possible that this
variation is in part the result of gene conversion
events. Studies have therefore been initiated to de-
termine the extent and origin of the allelic diversity;
260 placentas have been collected from a local hos-
pital and their AP electrophoretic phenotypes have
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been determined. Selected placentas have also been
examined by hydrophobic interaction chromatog-
raphy, and it has been found that some allelic types
differ with respect to their hydrophobicity as well
as their net surface charge. Taken together with the
extensive antigenic differences revealed in previous
studies using monoclonal antibodies, this result un-
derscores the probably complex nature of the allelic
differences. The AP from selected placentas will be
purified for peptide-mapping studies which, along
with sequence analysis of the peptides found to dif-
fer from type to type, should localize the areas sub-
ject to allelic structural variation.
STRUCTURAL ANALYSIS OF MINOR
HEAT-STABLE AP
It has long been a goal of protein chemistry to de-
velop the sensitivity of its methods to the point that
the spots generated by two-dimensional gel elec-
trophoresis can be analyzed directly for aminoter-
minal amino acid sequence. In this way, advantage
would be taken of the tremendous discriminative
power of two-dimensional gels for isolating pure
proteins from very complex mixtures in a single
step. Two recent technical developments appear to
make this goal a practical possibility.
commercial production of an on-line PTH amino
acid analyzer for the Applied Biosystems Gas
Phase Sequencer. This instrument allows the iden-
tification of phenylthiohydantoin (PTH) amino
acids at the level of 1 pmole or less, approximately
one order of magnitude improvement in sensitivity
compared with this laboratory's present capabili-
ties. The second development is the introduction
of procedures for trans-blotting proteins on gels
onto glass-fiber filter paper compatible with se-
quencing chemistry. This allows sequence analysis
of proteins immobilized on such filters without fur-
ther processing. Experiments in collaboration with
R. Franza (Cell Biology Section) are now being un-
dertaken in this laboratory to realize the goal of se-
quencing spots from two-dimensional gels using
these developments. The first fruits of this effort
will be the structural analysis of heat-stable APs ex-
pressed in very minor amounts in tissues that con-
tain predominantly heat-labile AP. These minor
AP species may be similar to, or identical with, the
ectopic APs that are expressed when tumors arise
in such tissues.
MOLECULAR GENETICS OF EUKARYOTIC CELLS
This section includes four laboratories that use molecular approaches to under-
standing aspects of the cellular and organismal biology of eukaryotes. The control
of the expression of the cit,u globulins (Hormonal and Developmental Control of
Gene Expression) is the focus of D. Kurtz's laboratory. The 02, globulins are prod-
ucts of a multigene family in rats; they are of unknown function. Their expression is
under the control of multiple hormones that act at multiple levels and also under
complex developmental control. The control of cell growth (Genetics of Cell
Proliferation) is the focus of M. Wigler's laboratory. Cellular oncogenes that can
positively alter the proliferative capacity of cells are being characterized. A human
oncogene encoding a product of novel structure has recently been discovered.
Particular attention is given to the function of the ras oncogenes that are impli-
cated in a wide variety of human neoplasia. The ras oncogenes have structural
and functional homologs in the yeast Saccharomyces cerevisiae, and the power-
ful genetics of yeast is being applied to understanding ras function. F. Tamanoi's
laboratory (Biochemistry of Yeast RAS proteins) is characterizing the covalent
modifications of RAS proteins and the role of such modifications in RAS function.
Finally, the laboratory of D. Hanahan (Molecular Biology of Mouse Development) is
using the extremely powerful method of germ-line genetic manipulation to study
several aspects of gene expression and tumor formation in mice. Introduction into
the germ line of the SV40 T antigen gene under the control of the insulin gene
promoter/enhancer leads to the heritable development of pancreatic 0-cell tumors.
Introduction of a papilloma genome leads to the development of dermal fibrosar-
comas. This type of approach should lead to deep insights into the neoplastic
process.
HORMONAL AND DEVELOPMENTAL CONTROL
OF GENE EXPRESSION
D.T. Kurtz W. Addison A. Louis
J. Maclnnes B. McDonald
D. Danna
Our laboratory has been studying the hormonal
control of gene expression in higher eukaryotes.
The model system we have been using for the most
part is the regulation of the expression of a rat gene
family that codes for a protein called a2 globulin.
This protein is synthesized in several rat tissues un-
der complex developmental and hormonal control.
Sex steroids, glucocorticoids, growth hormone, and
insulin all interact to regulate a2 globulin synthe-
sis in vivo.
DNA SEQUENCES REQUIRED FOR GLUCOCORTICOID
INDUCTION OF a2, GLOBULIN
ct2 globulin transcription can be induced by glu-
cocorticoids. This response is "secondary" or in-
direct; i.e., protein synthesis is absolutely required
for the hormone to exert its effect on a2 tran-
scription. This is in contrast to most of the other
well-studied glucocorticoid-inducible systems (e.g.,
mouse mammary tumor virus [MMTV]) in which
the response is primary. A primary response to ste-
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roid hormones is believed to occur by a mechanism
in which the hormone binds to its receptor, result-
ing in its "activation." The activated receptor then
binds to specific DNA sequences in or near a set of
target genes and, by an unknown mechanism, in-
duces transcription. Very little is known about the
molecular mechanism of a secondary response to
steroid hormones. The most reasonable model
postulates that the steroid hormone induces a
regulatory protein(s) that is required for the tran-
scriptional activation of the secondary response
genes.
We had previously shown that cloned an globu-
lin genes retain their responsiveness to glucocorti-
coids when transfected into mouse L cells in tissue
culture. These studies showed that 235 by of 5'-
flanking DNA, relative to the an transcription
start site, were sufficient to maintain glucocorticoid
inducibility. We have saturated this 235-bp region
with clustered point mutations using the "linker-
scanning" mutagenesis procedure. These mutant
a2u genes were then introduced into L cells, and
their response to glucocorticoids was assayed (Fig.
1). Mutations between approximately -125 and
-160 were found to reduce greatly or abolish azu
induction by glucocorticoids, although they had no
effect on basal transcription. One mutant, LS-
137/125, was found to be virtually unresponsive to
hormones, and several others more distal to this
position showed greatly reduced induction. The
phenotype of the mutant LS-137/-125, in which in-
duction is completely abolished, indicates that the
hormone-responsive region of the an promoter is
organized very differently from that of MMTV and
several other primary response genes, which seem
to contain multiple binding sites for the hormone
receptor. Mutations in any one of these sites do not
abolish induction but only slightly reduce it. The
glucocorticoid response region of the an promoter
seems to be much more compact.
A series of mutations in the a2u promoter fur-
ther upstream of the glucocorticoid response re-
gion, between approximately -165 and -185, were
found to increase induction two- to fourfold (Fig.
1) without affecting the basal level of expression.
As yet, we have no explanation for this class of
"hyperinducible" mutants, nor can we assess their
biological relevance, if any.
In the glucocorticoid regulatory region of the
a2u promoter, at position -136 to -131, is the
hexanucleotide -GGAACA-, which is found at a
very similar position in the promoter of the rat a-1
acid glycoprotein gene, another glucocorticoid-
inducible gene whose response, like a2u, is second-
ary. It is obviously premature to attempt to define
a "consensus sequence" for secondary hormonal re-
sponse until more genes of this type have been
characterized.
ALTERED REGULATION OF a, SYNTHESIS IN
STRAIN NBR RATS
a2u is synthesized in five tissues in rats: liver, sub-
maxillary gland, lachrymal gland, preputial gland,
and mammary gland. Different protein isoforms
are produced in the various organs, the result of
different an globulin gene sets being active in the
different tissues (Fig. 2). The mouse analog of an,
called MUP, is synthesized in these same tissues in
mice (with the exception of the preputial gland).
The isoforms of MUP that are synthesized in the
livers of mice of different strains can vary greatly,
and it has been shown that this variation is con-
trolled by an unliked regulatory locus termed
mupA. We have screened several rat strains to look
for possible differences in an globulin synthesis or
regulation. Most rat strains showed identical a2u
synthesis patterns in all tissues; however, strain
NBR rats showed a marked alteration in an syn-
thesis: (1) The level of an in the liver of NBR rats
was approximately 100-fold lower than the level
found in Sprague-Dawley (SD) rats (in which it
represents 1-2% of total hepatic protein synthesis).
(2) In prepubescent animals, the level of a2u in the
submaxillary gland of NBR rats is comparable to
the level found in SD rats (,,0.3070 of protein syn-
thesis). In SD rats, this level drops three- to fivefold
LIV LACH PREP SUB MG
I II II 11
c? e ?. 18d
- 8.3
-6 9
- 5.9
Awe.
- 4.7
am. 41111111111-"--
- 3.5
FIGURE 2 02, globulin protein isoforms produced in rat
tissues.
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at puberty, and this lower level of synthesis is main-
tained in adult animals. In NBR rats, ct,,, synthesis
in the submaxillary drops at puberty and becomes
undetectable in adult animals. (3) The level of syn-
thesis of 02,1 in the lachrymal gland in NBR rats is
comparable to the level found in SD; however, the
protein isoform pattern is "reversed." That is, in SD
rats, lachrymal gland 02,, is characterized by four
isoforms: two major forms with pI values of 4.5
and 4.3 and two minor forms with pI values of 4.7
and 4.1 (Fig. 2). In NBR rats, the pI 4.1 isoform is
predominant, and the 4.3 and 4.5 forms are minor
species.
We performed crosses between NBR and SD rats
and found that the a, synthesis phenotypes were
codominant: Levels of 02, globulin synthesis in the
liver and adult submaxillary gland in F, animals
were approximately 50% of the levels in SD rats,
and all lachrymal gland isoforms were found at ap-
proximately equal levels in the F, animals. This in-
dicates that the altered expression in NBR rats is
probably not Controlled by an unlinked regulatory
locus such as mupA. Southern blot analysis of
DNA from NBR rats showed that these animals
possess the full complement of 02 genes (20-25
copies per haploid genome). However, the a2,
genes in NBR rats were found to be highly
methylated compared to the genes with SD rats. In
the F, animals, the level of methylation of the CE2u
genes was intermediate, indicating an allelic main-
tenance of the methylation pattern. Further studies
are necessary to determine whether hypermethyla-
tion is the cause of the altered expression of the
a2,, globulin gene family in NBR animals.
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GENETICS OF CELL PROLIFERATION
M. Wigler D. Birnbaum D. Broek
0. Fasano S. Efrat
T. Kataoka J. Field
C. Birchmeier S. Powers
G. Bolger J. Nikawa
P. Sass
T. Toda
D. Young
S. Cameron
L. Edlund
G. Waitches
Our laboratory is concerned with the genetic and
functional analysis of growth control in eukaryotic
cells. We have stressed studies on the function of
the ras oncogenes, a family of genes found to be ac-
tivated in perhaps 10-20% of human cancers and
which have been highly conserved in evolution.
Homologs of the mammalian ras exist in the yeast
Saccharomyces cerevisiae (RASI and RAS2), and
we have been studying the function of these genes
in this species. We have shown that human ras pro-
teins can complement the loss of RASI and RAS2
proteins in yeast and hence are functionally homol-
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ogous. Both human and yeast ras proteins can
stimulate the magnesium and guanine nucleotide-
dependent adenylate cyclase activity present in
yeast membranes, and hence we also have been
studying the adenylate cyclase pathway of yeast.
Our studies have led to the important conclusion
that although ras is an essential controlling element
of adenylate cyclase in yeast, it has other essential
functions in that organism. Moreover, there may be
multiple pathways controlling the growth of yeast
that are independently regulated but can have over-
lapping functions. In this respect, growth control in
yeast may be fundamentally as complex as growth
control in mammalian cells and may prove to be a
useful model system for studying the latter.
In addition to our studies of yeast, we are contin-
uing studies on oncogenes in mammals. We have
developed a useful in vivo assay system for the hu-
man ras proteins: induction of maturation in
microinjected frog oocytes. From these studies, we
conclude that ras proteins do not stimulate the
adenylate cyclase of frog oocytes but have powerful
biological effects through another pathway. We are
studying two other human oncogenes: the human
rosl gene, which may be a growth-factor receptor,
and the human masl gene, which is a new oncogene
we discovered that encodes a protein of novel
structure.
Studies in Saccharomyces cerevisiae
M. Wig ler, T. Kataoka, S. Powers, 0. Fasano,
T. Toda, C. Birchmeier, D. Broek, P Sass,
J. Nikawa, J. Field, S. Cameron
We have previously demonstrated the existence of
two ras genes in the yeast Saccharomyces cerevisiae,
RAS1 and RAS2, which encode proteins that are
structurally homologous to the mammalian ras
proteins (Powers et al., Cell 36: 607 [1984]). The
studies described below demonstrated that ras
genes are essential for S. cerevisiae, that they are es-
sential controlling elements of adenylate cyclase in
S. cerevisiae, that the mammalian ras can perform
this biochemical function, and that yeast RAS
genes have at least one other essential function in
S. cerevisiae. The latter result derives from two ex-
perimental sources: studies of suppressors of ras
function and careful genetic analysis of the adeny-
late cyclase pathway in yeast. We have isolated and
characterized several of the genes of the ras/ade-
nylate cyclase pathway, some of still unknown
function.
EARLY STUDIES OF YEAST RAS GENES
We and other investigators have previously shown
that at least one functional ras gene is essential for
the germination of haploid yeast spores (Kataoka
et al., Cell 3Z. 437 [1984]; Tatchell et al., Nature 309:
523 [1984]). This was demonstrated by constructing
doubly heterozygous diploid yeast cells containing
wild-type RASI and RAS2 alleles and RASI and
RAS2 alleles each disrupted by a different auxo-
trophic marker. These diploid cells were then
sporulated, and the resulting tetrads were analyzed.
Only spores containing at least one functional ras
gene could germinate. We then introduced into
these doubly heterozygous diploid cells a RAS2
gene under the transcriptional control of the
galactose-inducible GALIO promoter (Kataoka et
al., Cell 40: 19 [1985b]), linked to a third auxo-
trophic marker. These diploid cells were then
sporulated, and tetrads germinated on either
glucose-containing medium (YPD) or galactose-
containing medium (YPGa1). The results confirm
that at least one functional ras gene is required for
germination. rasl- ras2- GALIO-RAS2 spores ger-
minate only in the presence of galactose, the in-
ducer of the GALIO promoter. Cells with the geno-
type rasl- ras2- GALIO-RAS2 were grown in YPGa1
and then shifted to YPD. Within several cell genera-
tions, cell growth ceased and cells lost viability.
These experiments indicated that the ras genes are
needed not only for spore germination, but also for
the continued growth and viability of yeast cells
(Kataoka et al., Cell 40: 19 [1985b]).
Using the approach described above, we have
been able to test if expression of the normal human
Ha-ras protein is sufficient for viability in yeast
cells lacking their own endogenous ras genes. To
this end, we constructed a GAL10-Ha-ras transcrip-
tion unit that utilized a full-length cDNA clone of
the human Ha-ras mRNA under the control of the
galactose-inducible GALIO promoter. This unit,
closely linked to a LEU2 marker, was inserted into
diploid yeast cells that were doubly heterozygous
for their endogenous ras genes. Cells were induced
to sporulate, and tetrads were examined after ger-
mination on YPD or YPGa1 plates. Approximately
40% of spores with the genotype rasl- ras2-
GAL10-Ha-ras were capable of germination when
plated on YPGa1, from which we conclude that the
human Ha-ras protein can supply essential ras
function to yeast.
Certain missense mutations drastically alter the
biological activity of mammalian ras genes. In par-
ticular, the human Ha-ras"12 gene, which encodes
valine instead of glycine at the 12th codon of the
Ha-ras gene, can induce the tumorigenic transfor-
mation of NIH-3T3 cells. To test the consequences
of a similar mutation of RAS2 on the properties of
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yeast cells, we constructed the RASP." gene
using site-directed mutagenesis (Kataoka et al., Cell
37: 437 [1984]). RAS2v." thus encodes valine in-
stead of glycine at the 19th codon, which corre-
sponds to the 12th codon of the mammalian Ha-ras
gene. We then examined the effects of introducing
this gene into yeast cells. Our first observation was
that diploid cells containing RA S2va"9 could not
be induced to sporulate by incubation under condi-
tions of nutritional deprivation (Kataoka et al.,
Ce1137: 437 [1984]). Next, we observed that haploid
cells carrying RAS2v." lost viability if starved for
nitrogen, sulfur, or phosphorus and failed to arrest
in G, under those conditions (Toda et al., Cell 40:
27 [1985]). Wild-type cells normally arrest in G,
and retain viability for long periods if nutritionally
deprived. In addition to these phenotypes, we also
noted that cells carrying RAS2va19 failed to accu-
mulate carbohydrate stores as cells entered the sta-
tionary growth phase. Thus, in general, RAS2va"9
cells appeared to show a defective response to nutri-
tional stress (Toda et al., Cell 40: 27 [1985]).
The cluster of cellular properties just described
closely resembles the phenotype of cells carrying
the bcyl mutation (Matsumoto et al., Proc. Natl.
Acad. Sci. 79: 2355 [1982], Cell 32: 417 [1983], Exp.
Cell Res. 146: 151 [1983]; Uno et al., J. Biol. Chem.
257: 14110 [1982]). The bcyl mutation was first iso-
lated by Matsumoto and co-workers as a mutation
that suppresses the growth defect that otherwise
results from the disruption of adenylate cyclase
(Matsumoto et al., Proc. Natl. Acad. Sci. 79: 2355
[1982]). Cells carrying bcyl appear to lack the
regulatory subunit of the cAMP-dependent protein
kinase and hence have lost the requirement for
cAMP (Uno et al., J. Biol. Chem. 257: 14110
[1982]). These observations suggested that the ras
genes might be participating in the cAMP pathway.
In support of this idea, we found that bcyl sup-
pressed the lethality that otherwise results from dis-
ruption of both ras genes.
The adenylate cyclase activity of the yeast S.
cerevisiae is stimulated by guanine nucleotides in
the presence of magnesium (Casperson et al., J.
Biol. Chem. 258: 791 [1983]). In this respect, yeast
adenylate cyclase resembles the adenylate cyclase of
mammalian cells, which can be stimulated by a
guanine-nucleotide-binding complex called Gs (Gil-
man, Cell 36: 577 [1984]). Since the yeast ras pro-
teins also bind guanine nucleotides (Tamanoi et al.,
Proc. Natl. Acad. Sci. 81: 6924 [1984]), we reasoned
that they might also modulate adenylate cyclase.
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This was tested directly by the assay of membranes
from wild-type yeast cells and rasl- ras2- cells.
Membranes from wild-type or rasl- ras2- strains
contained appreciable adenylate cyclase activity
when assayed in the presence of manganese ion, but
rasl- ras2- membranes displayed negligible levels of
activity when assayed in the presence of magnesium
and a nonhydrolyzable guanine nucleotide analog
(Toda et al., Cell 40: 27 [1985]). These results were
confirmed in a striking manner by membrane-
mixing experiments. We prepared membranes from
RAS1 RAS2 yeast carrying the cyrl -1 mutation and
membranes from rasl- ras2- yeast. The cyrl-1 muta-
tion disrupts the catalytic subunit of adenylate cy-
clase. Membranes from these two sources were as-
sayed separately and together after membrane
mixing and fusion. The data indicate that mem-
brane mixing and fusion regenerate a guanine-
nucleotide-stimulated adenylate cyclase activity
(Toda et al., Cell 40: 27 [1985]).
These studies suggested that it would be possible
to develop an in vitro assay for ras protein function.
The addition of purified yeast RAS2 protein to
membranes from bcyl rasl- ras2- cells indeed in-
duces adenylate cyclase activity to about 50-fold
above background level (Broek et al., Cell 41: 763
[1985]). Adenylate cyclase activity in the bcyl rasl-
ras2- membranes can also be increased dramati-
cally by addition of yeast RAS1 protein. Restora-
tion of adenylate cyclase activity by ras proteins is
dependent on the presence of guanine nucleotide,
with the nonhydrolyzable GTP analog, GppNp,
yielding twice the activity of that observed in the
presence of GDP. Incubation of the RAS2 protein
with GTP prior to mixing with the bcyl rasl- ras2-
membranes results in adenylate cyclase activity
comparable to that restored with RAS2 bound to
GDP. In contrast, preincubation of RASP." with
GTP results in activation of adenylate cyclase to
levels identical with those induced by RAS2 pro-
teins bound to GppNp. These results confirm our
genetic studies and indicate that there are proteins
in membranes which can distinguish between ras
proteins complexed with GTP and ras proteins
complexed with GDP; furthermore, they provide
for the first time an in vitro bioassay for the effec-
tor function of ras (Broek et al., Cell 41: 763 [1985]).
Using this approach, we tested whether the hu-
man ras protein could stimulate yeast adenylate cy-
clase. For this purpose, we used a bacterial expres-
sion system as our source of human Ha-ras protein
(Gross et al., Mol. Cell. Biol. 5: 1015 [1985]). Adeny-
late cyclase activity in bcyl rasl- ras2- membranes
was dramatically increased by the addition of puri-
fied human Ha-ras protein. These results indicate
that the effector domain of yeast and mammalian
ras proteins has been conserved in evolution (Broek
et al., Cell 41: 763 [1985]). In particular, these
results urged us to test whether ras proteins may be
involved in regulating adenylate cyclase in ver-
tebrates. However, these experiments, conducted
with ras-injected frog oocytes, indicated that ras
was not acting upon adenylate cyclase but upon
some other effector system (Birchmeier et al., Cell
43: 615 [1985]; and see below).
The results of our studies in yeast and frog oo-
cytes have left us with an apparent paradox: ras
stimulates adenylate cyclase in one but not in the
other. Several models are consistent with these
results. In the first model, ras proteins interact
directly with a domain of yeast adenylate cyclase. In
the course of evolution, the interaction with this
domain has been conserved, but the function of
adenylate cyclase has changed. In a second model,
ras interacts directly with another component (X)
that directly or indirectly interacts with adenylate
cyclase in yeast. In the course of evolution, the in-
teraction of ras with X has been conserved, but X
interacts with a different effector system in ver-
tebrates. In a third model, ras interacts directly or
indirectly through more than one effector system,
and in evolution, one or more of these interactions
have been conserved and/or are operant in different
cell types. To decide among these possibilities, we
have initiated more detailed studies in yeast. The
first major approach has been a detailed genetic
analysis of the adenylate cyclase pathway (de-
scribed in the next section). The second major ap-
proach has been an examination of ras function by
"suppressor" analysis (described in the section fol-
lowing the next).
THE YEAST ADENYLATE CYCLASE PATHWAY
Adenylate Cyclase (CYR1). Mutants in the ade-
nylate cyclase locus, CYR1, were obtained from
K. Matsumoto. The wild-type gene for CYR1 was
cloned by complementation screening and then se-
quenced. It contains an open reading frame of
greater than 6000 bp, which can encode a protein
of 2026 amino acids (Kataoka et al., Cell 43: 493
[1985a]). Northern analysis indicates that the entire
open reading frame is used. The structure of this
large protein is interesting. Centrally located is a 23-
amino-acid unit repeated 25 times. The consensus
sequence of this repeat is leucine-rich, and, amaz-
ingly, a protein with a similar consensus sequence
and periodic structure is found in human serum.
Deletion analysis indicates that the catalytic activ-
ity is located in the carboxyterminal portion of the
molecule, and the aminoterminal portion contains
the ras responsive domain.
High-level expression of the catalytic portion of
adenylate cyclase in yeast is sufficient to suppress
the lethality that results from loss of ras function.
Thus, if ras has other essential functions in yeast
besides stimulating adenylating cyclase, these func-
tions can be compensated by overexpression of the
CAMP effector pathway. Biochemical analysis indi-
cates that only one gene for adenylate cyclase must
exist in yeast, since cells containing deletions of this
gene do not produce CAMP. Surprisingly, however,
complete deletions of the CYR1 gene are not lethal.
By tetrad analysis, approximately half of the spores
without cyclase can germinate and give rise to very
slow growing colonies (T. Toda et al., in prep.). We
estimate that the doubling time of such cells is ini-
tially approximately 24 hours, which is in marked
contrast to spores lacking ras function. These rarely
germinate and, if they do, cease division soon after.
from this that ras is likely to have a
second function essential for yeast cells besides the
stimulation of adenylate cyclase. Another line of
experiments is consistent with this idea. Cell strains
lacking the adenylate cyclase gene have been grown
and transformed with a high-copy extrachromo-
somal plasmid containing the RAS2va19 gene. Such
strains now evince a heat-shock phenotype and sen-
sitivity to starvation.
The Regulatory Subunit of the cAMP-dependent
Protein Kinase (BCY1). bcyl cells were first ob-
tained as bypass mutants of cells with defective
adenylate cyclase (Uno et al., J. Biol. Chem. 257.:
14110 [1982]). Biochemically, bcyl cells appear
to lack the regulatory subunit of the cAMP-depen-
dent protein kinase. Phenotypically, bcyl cells, like
RAS2""9 cells, are sensitive to nitrogen starvation
and heat shock, presumably because they cannot
arrest in G,. BCYI was cloned from a centromere-
linked library (constructed and generously supplied
by M. Rose, Massachusetts Institute of Technology)
by transforming bcyl cells with the library and
selecting cells capable of resistance to nitrogen star-
vation and heat shock. We obtained one clone that
displays all of the genetic features expected of a
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BCY1 clone. Gene disruptions of BCY1 were con-
structed and used to transform haploid yeast cells
by gene replacement. The transformants display a
phenotype similar to that of cells containing the
spontaneously occurring bcyl mutation. In addi-
tion to the heat-shock phenotype, such cells do not
grow at all on nonfermentable carbon sources or on
galactose and grow poorly on glucose.
Sequence analysis confirms that BCY1 encodes
the regulatory subunit of the cAMP-dependent pro-
tein kinase. The primary amino acid sequence of
the encoded protein is virtually identical with the
primary amino acid sequence of the protein puri-
fied by E. Krebs and co-workers, which has been
demonstrated to be the cAMP-dependent protein
kinase of yeast. Moreover, M. Zoller (Genetics Sec-
tion) has demonstrated that the BCY1 protein ex-
pressed in E. coli can act as a CAMP regulatory
subunit when combined with the bovine heart cata-
lytic subunit of the cAMP-dependent protein
kinase.
Catalytic Subunits of the cAMP-dependent Protein
Kinase (TPK1, 2, and 3). While cloning genes that
in high copy were able to suppress a temperature-
sensitive, cell-division-cycle mutant called cdc25,
we found a gene with the potential to encode a pro-
tein with great sequence similarity to the bovine
heart cAMP-dependent protein kinase catalytic
subunit. Originally called CAKI, in last year's An-
nual Report, we renamed this gene TPKI. Hybrid-
ization analysis indicated that TPKI was homolo-
gous to two related genes that we cloned and called
TPK2 and TPK3. Sequence analysis indicated that
the three encode proteins that are nearly 90% ho-
mologous to each other and show greater than 50%
homology with the bovine cAMP protein kinase.
Biochemical analysis indicated that TPKI indeed
encodes a catalytic subunit of the yeast cAMP-
dependent protein kinase. TPK2 and TPK3 pre-
sumably also encode catalytic subunits, although
we have not yet proved this. Consistent with this
idea, when any of the three genes are present in high
copy, they suppress the growth defect that other-
wise results from disruption of the gene for adeny-
late cyclase.
The three TPK genes form a complementary
triplet. Disruption of any pair has no readily dis-
cernible phenotype. Disruption of all three leads to
cells that grow very slowly, with a doubling time
that we estimate to be 24 hours. This phenotype is
consistent with the phenotype of very slow growth
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that results from the disruption of the adenylate cy-
clase gene and differs from the phenotype of ras-
disrupted cells that cannot grow at all. These results
also suggest that ras has more effects on yeast than
are mediated through the cAMP effector pathway.
High-affinity cAMP Phosphodiesterase (PDE2).
A gene encoding a high-affinity CAMP phospho-
diesterase, PDE2, was cloned by searching for
genes that, in high copy, can reverse the heat-shock
phenotypes of cells containing the RA S2 van' gene
(see below). Sequence analysis of this gene showed
that it encoded a protein with an amino acid com-
position similar to that of the high-affinity CAMP
phosphodiesterase of bakers' yeast. Biochemical
analysis of yeast cells containing disruptions of
PDEI or expressing high levels of PDEI confirmed
this conclusion. Comparison of the sequence of
yeast PDEI protein with unpublished amino acid
sequences of Drosophila and bovine cAMP phos-
phodiesterases indicated that there is a conserved
12-amino-acid sequence in all three.
SUPPRESSORS OF RAS FUNCTION IN S. CEREVISIAE
One fruitful approach to the genetics of ras is to ex-
amine genes that function either to bypass or to
diminish ras function. lino different approaches
can be taken. First, since ras genes are essential for
growth in yeast cells, we can look for genes or muta-
tions that relieve this requirement. Second, since
yeast strains containing the RAS2"19 mutation are
heat-shock-sensitive, we can look for genes or mu-
tations that restore normal heat-shock sensitivity in
such strains.
Genes That Do and Genes That Do Not Suppress
Effects of the Loss of ras Function. We previously
demonstrated that the loss of the functional BCY
gene, encoding the regulatory subunit of the cAMP-
dependent protein kinase, renders cells resistant to
the loss of adenylate cyclase or ras function. This
result initially suggested that all the essential effects
of ras are mediated through the adenylate cyclase
system, a conclusion that we now know is wrong.
To pursue this observation further, we conducted
studies with the individual TPK genes, by trans-
forming yeast cells with these genes on high-copy
extrachromosomal replicating plasmids. We then
examined the ability of such cells to lose adenylate
cyclase or ras function. Although cells containing
any of the TPK genes in high copy could grow read-
ily when they lose adenylate cyclase, the same is not
true when they lose ras. These results suggested
that, in addition to stimulating adenylate cyclase,
ras proteins have other essential functions in yeast.
We have since isolated two other genes (which we
have provisionally named SCH1 and SCH9) that
can partially suppress the growth retardation that
results from the loss of adenylate cyclase, but they
do not suppress the lethality resulting from the loss
of ras. These genes were obtained initially as sup-
pressors of cdc25 (see below).
Genes and Mutations That Suppress the RAS2""9
Phenotype. Strains containing the RAS2va19 mu-
tation are sensitive to heat shock. We therefore
sought genes in high-copy yeast libraries that could
suppress the heat-shock phenotype of RAS2"19
strains. Two were found. One encoded the high-
affinity cAMP phosphodiesterase, PDE2, which
was described in a previous section. The other,
which has been provisionally called JUNI, is of un-
known function. JUNI has been sequenced but
shows no homology with phosphodiesterases or
other genes of known function. It encodes a 45,000-
dalton protein, with two homologous domains of
10,000 daltons at its carboxyl terminus.
We also sought "suppressor" mutations in other
genes that would render these cells heat-shock-
resistant. Mutations in the RASP."' gene and mu-
tations in the CYRI gene were encountered along
with many others. One suppressor, supC, has been
cloned and shown to be distinct from previously
identified genes. Another of these suppressor mu-
tations, called supH, is of particular interest. Cells
with supH were found to be temperature-sensitive.
Moreover, they were a-specific steriles. In a collabo-
ration with the Laboratory, I. Herskowitz and co-
workers (University of California at San Francisco)
confirmed that supH was an a-specific-sterile and
furthermore that it failed to make biologically ac-
tive a-factor, although a-factor mRNA was made.
Meantime, we showed that supH cells made RAS2
proteins, but the adenylate cyclase of such cells be-
haved as though they lacked ras protein. It therefore
seems likely that supHencodes a protein needed for
processing both ras and a-factor. Sequence com-
parisons show that the a-factor gene encodes a pro-
tein with the terminal sequence Cys-A-A-X, where
A is any aliphatic amino acid and Xis the terminal
amino acid. This site is probably the site for fatty
acid acylation and is required for the proper func-
tioning of ras proteins. It is therefore possible that
supH encodes the enzyme that performs this acyla-
tion.
SUPH has been cloned and is now being char-
acterized. The genetic properties of supH are
themselves of great interest. Although high-copy
plasmids expressing RAS2 will suppress the tem-
perature-sensitive defect of supH, high-copy plas-
mids of TPKI will not. Since high-copy plasmids of
TPKI will suppress the growth defect of ras cells
in an otherwise wild-type background, supH must
cause defects in yet other pathways not controlled
by ras but which nevertheless interact with ras-
controlled pathways. From our studies, we infer
that there are at least three essential pathways con-
trolling growth in S. cerevisiae. The first, the CAMP
pathway, is regulated by ras proteins. A second,
which we are provisionally calling the "ras alterna-
tive" pathway, is also controlled by ras. It is clear
that under certain conditions, the first pathway can
subsume the essential functions of the second.
Genetic data, not presented here, suggest that these
two pathways may coordinately control certain cel-
lular phenotypes. A third pathway is not regulated
by ras but must cooperate with the ras alternate
pathway in some manner. All three pathways are de-
pendent on a functional SUPH gene.
Since supH is likely to cause defects in the
modification of proteins with the Cys-A-A-X termi-
nal sequence, some proteins of that class are likely
to be regulatory proteins in yeast. supH may pro-
vide a genetic and biochemical entree to such pro-
teins. Moreover, we have not excluded the possibil-
ity that SUPH itself encodes a regulatory protein,
controlling the activity of ras and other proteins.
OTHER RELATED STUDIES
In addition to the above studies, which have mainly
centered on the ras/adenylate cyclase pathways, our
laboratory has been studying the cell-division-cycle
mutant cdc25 in collaboration with M. Zoller and
L. Levin. cdc35 (which is allelic to CYRI) and cdc25
are the two temperature-sensitive mutants that
comprise the first group of start mutants, i.e., mu-
tants that arrest in G, prior to the sex factor G, ar-
rest point. We began by isolating genes that in high
copy could suppress the growth arrest of cdc25.
Two genes were initially isolated. The TPKI gene,
formerly called CAK1, was one. It turned out to be
one of the cAMP-dependent protein kinase cata-
lytic subunits and has been described in a previous
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section. TPK1 is not allelic to cdc25. The second
suppressor gene was shown to be allelic and com-
plementary to cdc25 and was therefore the CDC25
gene itself. The nucleotide sequence of CDC25,
completed by L. Levin, indicates a potential to en-
code a large protein of 185,000 daltons, with no
similarity to other known proteins.
We have investigated genes that in high copy sup-
press the cdc25 temperature-sensitive allele or more
severely disrupted CDC25 alleles. Most genes of the
known ras/adenylate cyclase pathway appear to be
capable of suppressing both: high-copy RAS2vall9,
CYR1, TPK1, TPK2, and TPK3. High-copy RAS2
wild type will suppress the cdc25 temperature-
sensitive allele but not the more severely disrupted
alleles of CDC25. In addition, we have isolated
two new genes, SCHI and SCH9, by screening
high-copy libraries that suppress the temperature-
sensitive allele. These genes do not suppress the
more severely disrupted alleles. More will be said
about these genes below.
These data suggest that the CDC25 pathway and
adenylate cyclase overlap in some manner. One
possibility is that CDC25 is a component of the
adenylate cyclase pathway. However, biochemical
experiments indicate that cells with the CDC25
disruption have normal adenylate cyclase. These
results argue, but do not prove, that the CDC25
pathway and the CYR1 pathway are distinct and
that high-level expression of the cAMP effector
pathway can suppress the need for the CDC25
pathway, perhaps in a manner analogous to its
suppression of the need for the ras alternate path-
way. Thus, we should seriously consider whether
CDC25 is part of the ras alternate pathway.
The genes SCHI and SCH9, initially isolated be-
cause they suppressed the temperature-sensitive de-
fect of cdc25 cells, are each of considerable interest.
Both genes can suppress the growth defects of cells
that lack adenylate cyclase. Therefore, they may be
parts of pathways with the capacity to assume the
functions of the cAMP effector pathway. The strik-
ing picture that emerges is that there are multiple
pathways in S. cerevisiae with potentially overlap-
ping domains of command.
CONCLUSIONS
Table 1 summarizes the genes we have cloned and
characterized that interact with the yeast ras/cy-
clase pathways. The overwhelming impression from
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TABLE 1 Genes of S. cerevisiae That Interact with
the ras/cyclase Pathway
Gene
RAS1
RAS2
CYR1
BCY1
TPK1
TPK2
TPK3
PDE1
JUN1
SUPH
CDC25
SCH1
SCH9
Identity or identifying properties
activates adenylate cyclase
activates adenylate cyclase
adenylate cyclase
regulatory subunit of CAMP- dependent protein
kinase
catalytic subunit of cAMP-dependent protein
kinase
catalytic subunit of CAMP- dependent protein
kinase
catalytic subunit of CAMP- dependent protein
kinase
high-affinity CAMP phosphodiesterase
suppressor of the RAS2." phenotype
involved in functional modification of
ras proteins and a-factor
mutants in CDC25 are suppressed by genes
of the ras/cAMP effector pathway
suppressor of cdc25 and cyrl
suppressor of cdc25 and cyrl
our studies is that control of growth in S. cerevisiae
is complex. There are probably multiple regulatory
pathways that in some cases not only can act coor-
dinately, but also can compensate for each other.
The complexity of growth control in S. cerevisiae
will probably rival the complexity now being seen
in animal cells and may provide a good model for
the latter. What is the need for this complexity?
One simple answer is possible. The growth phase of
any cell requires the production of cellular constitu-
ents in proper proportions and at rates compatible
with available nutrients. Some of this control can
of course be accomplished by "short" feedback
loops. For example, attaining the proper propor-
tion of membrane phospholipids could easily be
regulated by such short feedback loops. But how
are overall rates of membrane synthesis determined
and coordinated, for example, with rates of protein
synthesis? Surely, these larger lines of production
must be as closely regulated as, say, the decision to
begin DNA replication. The growth effector path-
ways may therefore control such lines of production
and be integrated by feedback control from critical
substrates of these production lines. Perturbations
of any one pathway, for example, by mutating or
overexpressing critical controlling proteins, may
therefore perturb the level of activity of the other
pathways.
Mammalian Oncogenes
M. Wig ler, 0. Fasano, C. Birchmeier, D. Broek,
D. Young, J. Nikawa, G. Bolger, S. Efrat,
D. Birnbaum, L. Edlund, G. Waitches
We have maintained our interest in the growth con-
trol of mammalian cells by studying mammalian
oncogenes. Our studies on mammalian ras have
taken clues from the study of ras in yeast. We have
developed a sensitive in vivo bioassay for ras pro-
teins: the induction of frog oocyte maturation. We
have shown that ras proteins probably do not effect
adenylate cyclase in the frog oocyte but rather exert
strong effects through other pathways. In addition,
we are studying two human oncogenes we have re-
cently isolated: the rosl and mast genes. These
genes were isolated using a modification of the
NIH-3T3 transfection assay, which identifies on-
cogenes by their ability to induce tumorigenicity
(Fasano et al., MoL CelL Biol. 4: 1695 [1984]). It is
now clear that this assay identifies normal human
genes that have the potential to act as oncogenes
when amplified, overexpressed, or rearranged as a
secondary consequence of DNA transfer (C. Birch-
meier et al., submitted; D. Young et al., submitted).
MAMMALIAN ras GENES
Our studies of Saccharomyces cerevisiae prompted
us to test whether ras proteins can effect adenylate
cyclase in vertebrate cell systems. For this purpose,
we used a frog oocyte microinjection system. This
system was chosen because it was known that frog
oocyte maturation is dependent on the activity of
its CAMP effector pathway and because it is pos-
sible to perform biochemical experiments on small
numbers of microinjected eggs. We have found that
purified mammalian Ha-ras proteins, prepared
from an Escherichia coli expression system (Gross
et al., MoL Cell. Biol. 5: 1015 [1985]) can induce im-
mature oocytes to progress from prophase to
metaphase (Birchmeier et al., Cell 43: 615 [1985]).
The Ha-rasv" is perhaps 100-fold more potent
than the normal Ha-rase,12 in inducing oocyte mat-
uration. We have observed no significant changes in
cAMP production in oocytes due to injection of
mutant Ha-ras protein. Moreover, the ras-induced
effects are only partly blocked by cholera toxin, an
agent that totally blocks the maturation effects of
progesterone by raising CAMP production. We con-
clude from this that the yeast RAS responsive sys-
tems are not necessarily functionally analogous to
the vertebrate ras responsive systems. Nevertheless,
it is clear that ras-induced frog oocyte maturation
provides an excellent model system for testing ideas
of ras protein function.
THE HUMAN rosl GENE
Last year, we described the isolation of two new hu-
man oncogenes called mcf2 and mcf3, which were
obtained using the DNA cotransfer and tumori-
genicity assay (Fasano et al., CelL Biol. 4: 1695
[1984]). Nucleotide sequence analysis of mcf3
cDNA clones indicated that the mcf3 gene arose by
rearrangement of a human gene homologous to the
viral v-ros gene, which we have called rosl. It is
likely that this rearrangement occurred during or
after DNA transfer and was responsible for activat-
ing the oncogenic potential of rosl. This gene, like
its v-ros counterpart, contains a transmembrane
domain and a carboxyterminal domain that is ho-
mologous to the known tyrosine protein kinases.
The rearrangement creating mcf3 resulted in the
loss of a putative extracellular domain. It is likely
that the normal rosl gene, like the normal counter-
part of the viral v-erb and v-fms genes, is a growth
factor or hormone receptor. We are currently at-
tempting to obtain a full-length cDNA clone to
help us identify the extracellular domain and the
physiologic ligand of this receptor. Expression
studies in progress clearly indicate that the rosl
gene is expressed in a high proportion of human tu-
mor cell lines and hence might be a useful tumor
cell marker.
THE HUMAN mast GENE
We have begun the characterization of another hu-
man oncogene that we have called mast. This gene
was isolated using the same methodology used for
isolating the mcf3 gene described above (D. Young
et al., submitted). Comparison of the transforming
locus with the placental locus, cDNA cloning and
sequencing, and Sl-nuclease protection experi-
ments have led to the following conclusions. Like
mcf3, mast was activated in NIH-3T3 cells during
or after gene transfer by a DNA rearrangement,
and, like mcf3, there is no evidence that mast was
activated in the tumor cells from which it ultimately
derived. Unlike mcf3, the transforming mast gene
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is not rearranged within coding regions. Rather, its
ability to transform cells appears to be entirely
related to its high level of expression, a consequence
of a rearrangement involving DNA 5' to coding se-
quences. The normal masl gene, cloned from a hu-
man placental cosmid library, is only weakly trans-
forming.
Two aspects of the mas1 gene make it of consid-
erable interest as an oncogene. First, NIH-3T3 cells
transformed with masl are highly tumorigenic and
grow to high saturation densities but appear to be
morphologically indistinguishable from normal
NIH-3T3 cells. Second, the protein encoded by
mast is very hydrophobic. In its hydropathy profile,
it closely resembles the visual rhodopsins and is
predicted to have seven transmembrane domains.
In this respect, it is novel among cellular oncogenes.
Our preferred hypothesis is that the masl protein,
like rhodopsin, is a signal-transducing receptor that
activates a GTP-binding protein. An understanding
of the mechanism whereby ma's] transforms cells is
likely to lead to a new insight into growth control
mechanisms.
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BIOCHEMISTRY OF YEAST RAS PROTEINS
F. Tamanoi A. Fujiyama
M. Rao
N. Samiy
As indicated in last year's Annual Report, our in-
terest is in characterizing the RAS proteins of the
yeast Saccharomyces cerevisiae. During the past
year, we have focused increasingly on events taking
place within yeast cells. We have elucidated the
pathway for the biosynthesis of the RAS proteins
and have shown that the mature proteins are local-
ized in plasma membranes.
MODIFICATION OF RAS PROTEINS
The indication that the RAS proteins are modified
within yeast cells was obtained when we compared
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the mobility in SDS-polyacrylamide gels of the pro-
teins isolated from yeast cells with the mobility of
the proteins produced in Escherichia coli. The pro-
teins produced in yeast migrated slightly faster than
the proteins produced in E. coli. The apparent
molecular weights of RASI proteins made in yeast
and in E. coli were 36,000 and 37,000, respectively;
likewise, the apparent molecular weights of RAS2
proteins made in yeast and in E. coli were 40,000
and 41,000, respectively. In addition, RAS proteins
synthesized in a rabbit reticulocyte cell-free transla-
tion system exhibited the same mobility as the pro-
teins produced in E. coli.
RAS H p37
RAS 2: p41
(precursor
form)
p 36
p40
(processed
form )
fp36
> fp40
(fatty acylated
form)
Cytoplasm < Membrane
FIGURE 1 Proposed pathway for the biosynthesis of yeast RAS proteins.
The slow-migrating forms were found to be pre-
cursor forms. By very brief labeling with [35S]me-
thionine and fractionation into soluble and crude
membrane fractions, we were able to detect the
slow-migrating forms within yeast cells. They were
present exclusively in the soluble fractions. The
fast-migrating forms, on the other hand, were pres-
ent in the crude membrane fractions as well as in
the soluble fractions. Chase with cold methionine
established that the slow-migrating forms were con-
verted to the fast-migrating forms and that the fast-
migrating forms accumulated in the crude mem-
brane fractions.
Even though the fast-migrating forms were pres-
ent in both crude membrane and soluble fractions,
there was a physical difference between those in
crude membranes and those in soluble fractions.
The proteins present in crude membranes con-
tained fatty acids as revealed by [3H]palmitic acid
labeling. The label could be released from the pro-
tein by hydrolysis with methanolic KOH, indicating
an alkali-labile ester bond between the fatty acid
and the protein. We identified in the released mate-
rial palmitic acid as well as myristic acid and lauric
acid.
Thus, we have established that the yeast RAS
proteins are first produced as precursor forms that
are converted to fast-migrating forms and that they
are further modified by fatty acylation. Our find-
ings demonstrate that modification in addition to
the fatty acylation is occurring on the RAS pro-
teins. We are currently analyzing the exact nature of
these modification events.
SUBCELLULAR LOCALIZATION OF RAS PROTEINS
To characterize further the RAS proteins within
yeast cells, we have begun to analyze their subcellu-
lar localization. Our first attempt involved bio-
chemical fractionation. Yeast cells were broken and
then fractionated into soluble and crude membrane
fractions by differential centrifugation. Crude
membrane fractions were further separated into
ER, plasma, and mitochondrial membranes by su-
crose density gradient. We have shown that the
majority of the RAS proteins migrate with the
plasma membrane fraction. It is possible that a mi-
nor portion of the RAS proteins are also localized
in other membranes. We intend to investigate fur-
ther the localization of the RAS proteins by carry-
ing out immunofluorescence of yeast cells. On the
basis of these results, we have proposed the pathway
for the biosynthesis of yeast RAS proteins (Fig. 1).
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MOLECULAR BIOLOGY OF MOUSE DEVELOPMENT
D. Hanahan S. Alpert J. Hager
V. Bautch S. Grant
T. Ashley M. Lacey
S. Efrat S. Toda
The work of this group is focused on studies of the
control of gene regulation and the consequences of
oncogene expression in transgenic mice. Currently,
our efforts are centered on targeted oncogenesis in
pancreatic fl cells. The 5'-flanking region of the rat
insulin gene contains the major determinants of tis-
sue specificity and regulation, given its observed
ability to direct the expression of linked protein-
coding information to ft cells following the transfer
of the recombinant genes into the mouse germ line,
which is accomplished by DNA microinjection into
fertilized one-cell mouse embryos. We are examin-
ing the regulatory characteristics of the transferred
genes, as well as the ontogeny of tumor formation
induced by targeted oncogene expression. Other
studies are examining oncogenesis elicited by the
bovine papilloma virus genome in transgenic mice,
the structure of mouse DNA flanking transgene in-
sertions, and the prospects for insertional mutagen-
esis by DNA microinjection or retrovirus infection.
Recombinant Insulin/Oncogenes
in Transgenic Mice
D. Hanahan, S. Alpert, S. Efrat, J. Hager, M. Lacey
Hybrid oncogenes composed of regulatory infor-
mation flanking the rat insulin (II) gene linked to
protein-coding information for SV40 T antigen
have been transferred into the mouse germ line
(Hanahan, Nature 315: 115 [1985]). The rationale
for employing such combinations is threefold: (1) to
identify elements associated with the insulin gene
that mediate its correct tissue-specific expression in
the insulin-producing 13 cells of the endocrine pan-
creas, (2) to examine the consequences of oncogene
expression in Q cells, and (3) to address the prospect
that oncogene expression can be employed to facili-
tate the establishment of [1-cell lines.
Transgenic mice that harbor three different insu-
lin/SV40 T antigen genes have been produced. One
(called RIP1-Tag) carries 660 by of DNA encom-
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passing the insulin gene promoter aligned so as to
transcribe the T-antigen gene. The second (called
RIR-Tag) has the insulin promoter inverted with re-
spect to the SV40 coding information. The third
(RIP2-Tag) is a truncation of the first, which
thereby includes only 410 by of 5'-flanking infor-
mation. All three recombinant genes elicit the
heritable formation of solid 13-cell tumors in trans-
genic mice that harbor them, suggesting that the
tissue specificity element(s) reside within this re-
gion of the insulin gene. Expression of T antigen is
detected only in insulin-producing 13 cells. The hy-
brid genes are expressing in virtually all (3 cells prior
to tumor formation, which occurs in only a few of
the several hundred islets of Langerhans that com-
prise the endocrine pancreas. This indicates that
secondary events are necessary to convert a collec-
tion of islet cells expressing SV40 T antigen into a
solid, well-vascularized tumor.
We are currently transferring a series of hybrid
insulin/oncogenes into mice in order to compare
and contrast the consequences of their expression
in ]3 cells. T antigen has two rather remarkable, and
potentially distinguishable, consequences to mice
which express it in their pancreatic 13 cells. The nor-
mal postnatal development of the islets is dis-
rupted, and solid tumors arise in a few (but not all)
of the islets expressing the oncogene. We hope to
learn something about oncogenesis by examining
the expression of other oncogenes, in view of the
observations with T antigen. The hybrid oncogenes
will include recombinants of the insulin promoter
with Ha-ras, v-fos, ElA, p53, c-myc, v-myc, erb-b,
v-mos, and the trans-activator genes of HTLV-II
and HTLV-III. To date, transgenic mice harboring
insulin-Ha-ras, -E1A, -v-myc, and -v-fos recom-
binant genes have been created, and their analysis
has begun.
In another approach, we will examine the conse-
quences of oncogene expression by performing
complementation or cooperative experiments ge-
netically. Mice harboring separate insulin-onco-
genes (e.g., insulin-myc and insulin-ras) will be
mated, and their progeny will be examined to deter-
mine the effects of coexpression at two oncogenes
in the same cell.
Developmental Regulation of
Insulin/SV40 T-antigen Hybrid
Genes in Transgenic Mice
S. Alpert and D. Hanahan
Transgenic mice containing an insulin/SV40 T-
antigen hybrid gene are being used to investigate
the developmental control of insulin. In mammals,
there are two developmental phases of insulin secre-
tion. The first stage is a low level of insulin produc-
tion detected at about day 14 of the 19 days of
gestation in mice. This correlates with the early de-
velopment of the pancreas. The second phase is a
striking increase in insulin synthesis at approxi-
mately day 16 of embryogenesis; 13 cells are first ap-
parent at this time. During the last 4 days of gesta-
tion, insulin synthesis remains high. The molecular
mechanism controlling this developmental se-
quence has not yet been explained.
Our experimental approach is to compare the de-
velopmental expression of the endogenous insulin
genes with that of the recombinant insulin gene.
This hybrid gene contains 660 by of the 5'-flanking
region of the insulin gene joined to the coding re-
gion for the SV40 large T antigen. Analysis of
transgenic mice carrying this gene has shown that
the sequences required for tissue-specific regulation
are present in the 5'-flanking region of the insulin
gene (see above report by Hanahan et al.).
Immunohistology has been used to analyze
mouse pancreata from embryonic day 16.5 and day
18.5. We have shown that T antigen, like insulin, is
expressed in the developing islets at these stages.
Further immunohistological analyses of the endo-
crine pancreas will be done to examine both T anti-
gen and peptide hormone expression throughout
prenatal and early postnatal development. If the se-
quences that elicit proper developmental expression
of the insulin gene are contained in this recom-
binant gene, we would expect to see T antigen ex-
pressed from embryonic day 14, in the same tem-
poral manner as insulin. Various constructions of
the hybrid gene containing different pieces of the
insulin gene and its flanking regions should allow
us to identify the sequences required for the de-
velopmental regulation of insulin.
Immunohistological Analysis of
Nesidioblastosis and Tumor Formation
in the RIP1-Tag #2 Lineage
S. Alpert, D. Hanahan [in collaboration with G. Teitleman
and J. Lee, Department of Neurobiology,
Cornell University Medical College]
Certain endocrine cells, such as pancreatic 13 cells,
normally have a limited potential for mitotic divi-
sion. Persistent hypoglycemia in human infants has
been attributed to nesidioblastosis, a disease char-
acterized by multifocal abnormal islet-cell hyper-
plasia or abnormal islet-cell distribution. Little in-
formation is available on 13-cell genesis. Theories
on islet histogenesis include (1) division of existing
cells, (2) differentiation of a stem-cell population,
and (3) conversion of exocrine tissue. The RIP1-Tag
#2 transgenic mice all exhibit 13-cell hyperplasia and
thus offer an ideal system to study 13-cell neogenesis
and tumorigenesis. We have recently begun to eval-
uate the process of 13-cell proliferation using im-
munohistology and autoradiography.
Until 4 weeks of age, the RIP1-Tag #2 islets ap-
pear normal. Starting at 6 weeks of age, "holes" ap-
pear in the islets. Histological examination reveals
a duct-like nature of these spaces, which is in accor-
dance with the pattern of proliferation of islets in
obese (ob/ob) mice (Larsson et al., Lab. Invest.
36(6): 593 [1977]). These duct-like structures prolif-
erate as the animals age. Autoradiography clearly
shows that a subset of the (3 cells are dividing.
By 13 weeks of age, most islets are enlarged and
tumors have developed. Both islets and tumors con-
tain a large number of rapidly proliferating insulin-
producing cells; all of the insulin-producing cells
contain T antigen. Additionally, some of the tu-
mors contain a population of pancreatic polypep-
tide (PP)-producing cells. Tumors also contain cells
expressing tyrosine hydroxylase (TH). Although
TH appears during islet formation, it is rarely
found in adult islets. Thus, some "dedifferentia-
tion" is apparently occurring in the RIP I-Tag #2 tu-
mor cells.
We are continuing this analysis to investigate the
changes that occur between 6 and 13 weeks of age.
These analyses will include experiments to inves-
tigate the possibility that these mice represent a
mouse model for human nesidioblastosis. These in-
vestigations will characterize the events that occur
when13 cells are released from the normal divisional
control in the RIP1-Tag #2 lineage. Although we
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have already detected the presence of T antigen in
ducts, double-label experiments with T antigen and
insulin, mucine, and amylase may locate the pro-
duction of new islets to 13 cells, ducts, or exocrine
tissue.
The existence of bidirectional transcription from
the endogenous insulin genes, as well as the pres-
ence of a gene associated with the reversed promot-
ers, is under investigation.
Analysis of Expression of RIR-Tag
Hybrid Genes
S. Efrat, D. Hanahan
Transgenic mice harboring RIR-Tag hybrid genes,
in which an inverted rat insulin II control region is
linked to the SV40 T-antigen structural gene, ex-
press large T protein specifically in the 13 cells of the
endocrine pancreas. Their phenotype of hyperplas-
tic islets, one of which develops to a solid, vascula-
rized tumor of 13 cells at 4-6 months of age, is indis-
tinguishable from that of mice in which the insulin
control region is aligned to promote transcription
of the T-antigen gene (RIP1-Tag). Northern blots of
RNA from pancreatic tumors show comparable
levels of T-antigen mRNAs in RIP1-Tag and in RIR-
Tag mice. The reversed promoter generates mRNAs
about 300 bases longer than the insulin-promoted
version. Riboprobe protection and Si mapping
analyses show that transcription of these mRNAs
is initiated at a specific site, mapping within the
transcriptional enhancer region. Bidirectional tran-
scription is observed with both hybrid gene orienta-
tions; in each case, one transcript represents the T-
antigen gene and the other transcript represents the
opposite strand extending off 5' to the T-antigen
gene. Examination of the sequence of the minus
strand, deduced from the published sequence of the
rat insulin 5'-upstream region, reveals a putative
TAATTA sequence 56 by upstream of the initiation
site, but no open reading frame. These studies in-
volved analyses of two independent lineages of
RIR-Tag transgenic mice, each of which shows the
same phenotypic pattern. Hence, this phenotype
likely reflects a property of the insulin promoter,
rather than a position effect attributable to the site
of integration.
These results demonstrate the existence of two
promoters in the region extending to - 540 up-
stream of the rat insulin gene cap site, operating on
the two strands in opposite directions. Both obey
correct cell-specific regulation in transgenic mice.
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Bovine Papilloma Virus Genome
in Transgenic Mice
M. Lacey, S. Alpert, D. Hanahan
A line of transgenic mice has been established that
harbors the bovine papilloma virus (BPV) genome
as a stable genetic element that is integrated into a
mouse chromosome. BPV DNA was injected into
fertilized mouse eggs as a linearized bacterial plas-
mid in which the BPV genome was reiterated as a
partial tandem duplication. About five copies of
this plasmid are integrated into high-molecular-
weight DNA as a head-to-tail tandem array in the
mice derived from the one live founder mouse that
arose from the injected embryos.
The BPV genome is apparently dormant in
young mice that are healthy and evidence no pheno-
type. However, beginning at approximately 8-9
months of age, these mice begin to develop benign
skin tumors in various locations, primarily around
the face and head, but also on the tail and at multi-
ple locations on the skin of the body. These tumors
are fibroepithelial in nature, being derived from
dermal fibroblasts and epidermal epithelial cells,
and thus are quite analogous to those produced in
vivo (in cows), except that infectious BPV virus is
not produced. The tumors all harbor episomal BPV
DNAs, which apparently arise from the excision of
the BPV genome from its stable integrated location
in a mouse chromosome. Amplification of inte-
grated BPV DNA is also observed in some tumors.
There is a complete correspondence between tumor
formation and the detection of BPV gene amplifi-
cation (either integrated or as episomes). Episomal
forms of BPV are not detected in normal tissues.
Tumors develop in virtually every transgenic
mouse in this lineage, and multiple tumors usually
arise on individual animals. In all cases, oncogene-
sis is slow, indicating that a secondary event is
necessary to cause tumor formation. These mice
can therefore be considered to be predisposed to de-
veloping cancer, which depends on the occurrence
of this other event. It is notable that normal mice
virtually never develop fibroepithelial tumors, and
as a consequence, these transgenic mice are unique
in terms of their oncogenic phenotype.
Structural Analysis of an Integration
Site in a Transgenic Mouse
S. Grant, D. Hanahan
A hybrid oncogene composed of the promoter ele-
ment and 5'-flanking region of the chicken a2(I)
collagen gene linked to the protein-coding informa-
tion for SV40 T antigen was injected into fertilized
mouse embryos, which were implanted in foster fe-
male mice and allowed to develop. One transgenic
mouse arose (M410) that carried 3-4 copies of the
injected plasmid (pCOP 3 Tag), presumably coin-
tegrated at a single location. This mouse showed
evidence of abnormal behavior at 2 weeks of age,
which continued until its death at 7 weeks of age.
This behavior was characterized by hyperactivity,
frequent circling, and nodding of the head. When
this mouse died, tissues were collected and homog-
enized. Protein-blotting analysis using monoclonal
antibodies to SV40 T antigen demonstrated high-
level expression of T antigen in the brain, and no-
where else. This result was surprising in view of the
expected expression of type-1 collagen in a variety
of tissues such as skin, body wall, lung, and heart.
One explanation for this brain-specific expres-
sion is that the injected DNA integrated into a locus
that allowed expression only in the brain. To test
this hypothesis, we are retrieving mouse DNA that
flanks the integrated plasmid array, using plasmid
rescue. So far, we have rescued over 20 bona fide
rescuants. Of these, one contains 2-3 kb of DNA
that appears to be intercolated between two of the
plasmids in the integrated array. The origin of this
DNA is being examined for the possibility that it
contains sequences from a brain-specific gene. So
far, no flanking DNA has been isolated. We will in-
vestigate the nature of the integration to assess the
extent of deletion and/or rearrangement. Flanking
DNA will be used to probe RNA from the brain to
determine whether this locus is expressed in the
brain. The transgenic locus - composed of flanking
DNA plus the plasmid -may be injected into em-
bryos to produce transgenic mice harboring this
rearranged region, in an attempt to recapitulate the
phenotype and thus evaluate its possible identity as
a brain-specific locus, and the phenotype originally
observed as a dominant consequence of this spe-
cific but inappropriate expression of the hybrid
collagen-T-antigen gene.
Should this integration have disrupted such a
brain-specific locus, the uninterrupted region will
be isolated and studied to learn more about its abil-
ity to specify expression in the brain.
Integration of Retrovirus Sequences
into the DNA of Early Mouse Embryos
V. Bautch, S. Toda
Identification of mutations that disrupt the normal
program of embryogenesis is one way to study
mammalian development. Insertional mutations
also provide a molecular marker for the recovery of
genes disrupted by the mutation. However, to be
able to clone the preintegration site and analyze the
disrupted gene, the integration event must preserve
the linear order of cellular sequences in a recogniz-
able way. Retrovirus genomes are particularly use-
ful as potential agents of insertional mutation be-
cause retroviruses integrate with only a small (4-9
bp) duplication of cellular DNA. We are generating
insertions in mice using a breeding scheme (Jenkins
and Copeland, Cell 43: 811 [1985]) that allows for
de novo integration of endogenous retrovirus ge-
nomes into the DNA of early embryos at a relatively
high frequency. A subset of retrovirus genomes
called ecotropic proviruses has been followed be-
cause most inbred strains of mice contain a few
(0-6) copies that can be easily followed using
molecular techniques.
Mice of the RF/J strain contain three ecotropic
proviruses. Two of these, Emv -16 and Emv-17, are
genetically linked and have been implicated in in-
tegration events in early embryos. We have crossed
male RF/J mice to females of two different strains
(CBA/CaJ and SWR/J) that are negative for en-
dogenous ecotropic proviruses. The F, progeny
were backcrossed to the virus-negative strains. The
proviral sequences of the N2 offspring were ana-
lyzed by hybridizing genomic DNAs prepared from
tail clips to an ecotropic-virus-specific probe. N2 fe-
males carrying Emv-16 and Emv-17 were then back-
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crossed to produce N3 progeny that were analyzed
for newly integrated proviruses.
We have scored a total of 111 integration events.
Analysis of the results led to the following conclu-
sions: (1) New proviral integration events occur
when Emv-16 and Emv -17 are present in female car-
riers (mothers) but not when present in male car-
riers (fathers). (2) Crossing Emv-16 and Emv-17
onto the SWR/J strain for three generations results
in a higher frequency of integration events (0.134
per mouse) than the equivalent crosses onto the
CBA/CaJ strain (0.000 per mouse). (3) Integration
events appear to be distributed randomly with re-
spect to breeding pairs and litters. (4) N4 female
carriers of Emv -16 and Emv -17 that had sustained
at least one new proviral integration produced more
positive progeny (21-26%) than did unselected N2
and N3 female carriers (4-8%). These findings in-
dicate that genetic factors contribute to this
phenomenon and that it might be possible to select
for increased efficiency of integrations. The results
are consistent with a mechanism of reintegration
involving infection of the egg or early embryo by
maternal tissues shedding virus, although other
possibilities exist.
These new loci have been transmitted through the
germ line, and to date, we have established 40 lines
with new proviral integrations. The average trans-
mission frequency of the new loci varies with an av-
erage of approximately 25%. This suggests that
many integration events may have occurred at the
two-cell stage of development, concomitant with
the onset of DNA synthesis. This hypothesis is sup-
ported by progeny testing of one mouse containing
nine new proviral integrations. Analysis indicates
that multiple integrations can occur in the same cell
or in different cells of the same embryo; the com-
bined transmission frequencies of the two different
cell lineages approximate 50%, suggesting that
each cell of the two-cell embryo sustained indepen-
dent integrations.
Mouse lines containing these new proviral loci
are being analyzed for insertional mutations. To
date, no dominant phenotypes have been detected
associated with the 40 loci carried in heterozygotes.
We are currently generating homozygous mice car-
rying each locus in order to score for visible reces-
sive phenotypes and for recessive lethal mutations.
We will detect recessive lethal mutations by using
molecular techniques to score a homozygous class
of offspring, and the absence of this class will be
indicative of such a mutation.
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Analysis of DNA Microinjection
into Mouse Embryos to Create
Insertional Mutants
V. Bautch, D. Hanahan
It is known that insertion of DNA into the mouse
germ line via microinjection can result in inser-
tional mutations. Microinjected DNA is usually
found as 5-50 copies in a head-to-tail tandem array
at a single integration site, and the 5' and 3' ends of
the array are sometimes missing sequences. Limited
analyses by several investigators indicate that ap-
proximately 10% of transgenic mice carry a reces-
sive-lethal mutation that cosegregates with the in-
serted DNA. However, the sequences flanking the
integrated DNA have only been analyzed in one of
these lines, and in this case, a deletion of approxi-
mately 1 kbp was associated with integration (Woy-
chik et al., Nature 318: 36 [1985]). This parameter
is important relative to insertional mutagenesis be-
cause only if integration of DNA preserves the lin-
ear order of cellular sequences or gives rise to small
deletions or rearrangements (e.g., no larger than
cosmid size) will it be possible to clone the prein-
tegration site easily and to analyze the disrupted
gene(s). Therefore, we plan to investigate the in-
tegrity of flanking sequences after the integration
of microinjected DNA.
To this end, we have constructed a plasmid vector
that can be used to rescue, by transformation of
Escherichia colt, the inserted DNA and flanking
cellular sequences. Although this vector is derived
from pBR322, it has been altered so that deletion
of some plasmid sequences from the end of a tan-
dem array by "nibbling" prior to integration should
not affect the ability to rescue this plasmid. It con-
tains three different drug resistance genes, and each
gene contains several restriction enzyme sites
unique to the plasmid. In addition, a suppressor
tRNA gene has been inserted that can complement
bacteriophage A, mutations and provide an addi-
tional selection. A polylinker containing unique re-
striction sites has been inserted between two of the
drug resistance markers in order to linearize the
plasmid prior to microinjection. It is expected that
the DNA will integrate in a head-to-tail tandem re-
peat so that the linear order after integration will
be - kanR-ori-supF-ampR-tetR -
. The genomic
DNA will be digested with a restriction enzyme
whose site is in a drug resistance gene and religated.
Any internal copies of the tandem DNA should
recircularize to yield plasmids resistant to all three
drugs upon transformation; however, each end
should contain some cellular DNA and also be uni-
quely sensitive to the drug whose resistance gene
was originally cleaved. For example, digesting with
an enzyme that cleaves the tetR gene should yield a
DNA fragment containing a truncated tetR gene at
one end and flanking cellular DNA at the other
end. This fragment will ligate to form a plasmid
with cellular DNA that is ampR, kanR, and tets.
Moreover, in this scheme, a second rescue using an
enzyme that cleaves the kanR gene should yield a
plasmid containing cellular DNA from the oppo-
site end of the tandem array. In the event that plas-
mid sequences are altered by the integration so as
to make plasmid rescue impossible, it should be
possible to retrieve the flanking DNA by cloning
into phage containing a nonsense mutation and
selecting for the suppressor tRNA gene. Finally, if
alteration of suppressor tRNA sequences makes
phage rescue impossible, the flanking DNA can be
retrieved by making a library of genomic DNA
from the transgenic mouse and screening with the
plasmid as a probe.
At this time, we have generated three lines of
transgenic mice containing this vector. The lines are
currently being bred, and preliminary results sug-
gest that one of the lines may contain multiple
chromosomal integration sites; separation of these
loci in sublines should increase the total number of
loci available for analysis. The flanking sequences
will be cloned and their colinearity with the prein-
tegration site will be assessed. We will also use
breeding and molecular analysis to determine the
efficiency of generating insertional mutants in mice
using this technique.
Analysis of Transgenic Mouse
Line RIR-Gag #2
M. Lacey, D. Hanahan, T. Ashley
Mouse 95 was one of two transgenic founder mice
for the RIR-gag lineages. RIR-gag is a fusion of the
rat insulin promoter region (700 bp) aligned in the
reversed orientation with respect to the sequences
encoding the gag proteins of Rous sarcoma virus.
Mouse 95, a female, was mated to a C57/BL6 male
and produced two litters. Dot-blot analysis of equal
amounts of DNA extracted from the tails of the
progeny resulted in two groups of transgenic mice.
The first group carried about 15 copies of the insert
and was called RIR-Gag #1, and the second group
showed more than 25 copies of the transgene and
was labeled as RIR-Gag #2. The inheritance pat-
terns of RIR-Gag #1 mice demonstrated that the in-
jected DNA had inserted into the X chromosome
of the founder and was therefore sex-linked. Fe-
males homozygous for the insert, as verified by out-
crosses, were obtained and mated to hemizygous
males to maintain the line.
The two RIR-Gag #2 mice, M140 (female) and
M186 (male), were mated. In addition, M186 was
crossed to a C57/BL6 female. Results of the dot-
blot analysis of the progeny from the second cross
included a transgenic male and a nontransgenic fe-
male among the progeny, suggesting that RIR-Gag
#2 was not sex-linked. Therefore, we continued
mating and analyzing mice to produce homozygous
males and females. Homozygotes are postulated on
the basis of a twofold stronger signal than heterozy-
gotes on dot blots. Potential homozygotes are
mated with nontransgenic mice. When all the prog-
eny of this cross are transgenic, the postulated
mouse is confirmed as a homozygote. By such anal-
ysis, females are readily obtained. The one poten-
tial male did not transmit to all progeny, and there
was a high mortality among his progeny during the
3 weeks after birth.
In an attempt to clarify the inheritance patterns,
all progeny from RIR-Gag #2 litters were pooled
and the numbers of male, female, transgenic, and
nontransgenic mice were compiled. Although the
male:female ratio approached 1:1, the number of
transgenic females was twice that of transgenic
males. In crosses involving heterozygotes, RRG x
C57/BL6 produced litters where 11% of the males
(1/9) and 60% of the females (6/10) were trans-
genic. The reciprocal cross resulted in 45.4% of the
males (5/11) and 80% of the females (8/10) being
transgenic. Thus, females preferentially inherited
the injected gene.
Since the RIR-Gag #2 line was derived from a
mouse with a known insert in the X chromosome,
it is possible that the observed preferential in-
heritance results from the incomplete segregation
of two inserts, one of them RIR-Gag #1. Southern
blotting analysis of 20 mice, including M95, M140,
and M186, and an RIR-Gag #1 transgenic mouse,
was done to detect mice with multiple insertions.
The results confirmed that the injected DNA in-
serted in head-to-tail tandem repeats, since bands
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of high intensity (primary bands) correspond to the
predicted molecular weights of internal repeats for
such a pattern of insertion. Secondary bands of
lower intensity, which represent the flanks of the in-
sert and some mouse DNA, were also apparent. A
second Southern blot under conditions that should
delineate the secondary bands should indicate the
number and type of inserts in each mouse. An anal-
ysis of secondary bands (primary bands corre-
sponding to internal repeats) should indicate the
number and type of inserts in each mouse.
T. Ashley, a visiting scientist who has worked on
meiotic synapsis in mice, reanalyzed the inheritance
information previously compiled noting the par-
entage of specific crosses. Her analysis highlighted
the unique quality of M186 (male); only progeny of
this mouse generated the exceptions to the general
pattern of X-linked inheritance. Mouse 140 (fe-
male) and those progeny that do not result from a
cross with M186 demonstrate a typical pattern of
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sex-linked inheritance. A repeat of the Southern
blot analysis of recently established matings involv-
ing offspring of M186 should enable us to elaborate
on our current theory that RIR-Gag #2 is a distal
insert in the X chromosome and that the abnormal-
ities observed in the progeny of M186 result from
crossovers between the pairing region of the X and
Y chromosomes.
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GENETICS
A strong emphasis on genetics, and lately on molecular genetical studies, has
continued at the Cold Spring Harbor Laboratory. For the last 10 years, the number
of scientists working in this area has nearly quadrupled, with the future still calling
for an increased commitment. In the following section, we describe recent results
obtained within the past year. The areas emphasized are cell-cycle control, as well
as the mating-type studies of both budding (Saccharomyces cerevisiae) and fis-
sion (Schizosaccharomyces pombe) yeasts. Among the prokaryotic systems,
studies with the Rhodopseudomonas capsulata, Clostridium pasteurianum, and
Azotobacter vinelandii have continued. Among the higher-plant systems, molecu-
lar characterization of the transposable elements of maize, as well as the biochem-
istry of polyamine biosynthesis in tobacco tissue culture, is being investigated
vigorously.
YEAST GENETICS
A.J.S. Mar J. Ivy
J. Hicks C.I.P. Lin
G.P. Livi
Molecular Cloning and Characterization
of the SUM1 Gene of
Saccharomyces cerevisiae
G.P. Livi, J. Hicks, A.J.S. Klar
The interconversion of mating type in the yeast Sac-
charomyces cerevisiae involves a genetic rearrange-
ment in which cryptic copies of a or a information
are transposed to and expressed at MAT. The
mating-type information residing at the HML and
HMR loci is negatively regulated by the action of
at least four unlinked MAR (or SIR) loci; a muta-
tion in any one of these loci can permit HM gene
expression. The MAR/SIR gene products act in
trans to prevent the transcription of HML and
HMR, presumably by interacting with cis-acting
regulatory sites (called E and I) that flank each lo-
cus (see Fig. 1).
We have recently identified a new locus that is
somehow involved in the regulation of HMgene ex-
pression (Klar et al., Genetics 111: 745 [1985]). A
cell with the genotype HMLa MATa HMRa marl-1
is unable to mate because of the simultaneous ex-
pression of both a and a information. An extra-
genic suppressor of the marl-1 mutation was identi-
fied by isolating a mutant that exhibits an a mating
type, due to the failure to express HML and HMR.
A new locus, SUM/ (SUppressor of Mar), is de-
fined by the mutation in this strain. The sum/-/ mu-
tation (1) is recessive, (2) is centromere unlinked, (3)
does not correspond genetically to MAT, HML, or
HMR or to any of the known MAR/SIR loci, (4)
affects expression of both a and a information at
the HM loci, (5) has no identifiable phenotype in
a Mar* strain, and (6) suppresses a MARI deletion
mutation as well as mutations in SIR3 and SIR4, in-
dicating that it is neither allele- nor locus-specific.
Furthermore, direct transcript analysis has revealed
that the sum/-/ mutation results in a drastic reduc-
tion in the level of both HML and HMR transcripts
but does not affect the level of MAT transcription.
These data suggest a model in which the MAR/SIR
gene products negatively regulate the SUM1 locus,
whose gene product is required for HM gene ex-
pression.
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FIGURE 1 Structure of the mating-type genes on chromosome III. HML and HMR carry copies of mating-
type information but are normally kept unexpressed by the action of the MAR/SIR gene products that
presumably interact with the cis-acting E and I sites. Interconversion of MARa and MATa involves a
unidirectional transposition-substitution event from HML or HMR to MAT.
We have cloned the SUM/ gene by complementa-
tion. Plasmid DNA from a bank of Sau3A partially
digested genomic S. cerevisiae DNA contained in
the yeast-bacteria shuttle vector YEp13 was intro-
duced by transformation into a strain with the
genotype HMLa MATa HMRa marl-I sum/ -1 leu2
(a phenotype). Lett' transformants were selected
and screened for nonmaters. Sterility was shown to
cosegregate with Leu+, and the plasmids rescued
from these strains were shown again to confer a
nonmating phenotype when reintroduced into the
original a strain. There is no apparent homology
between these seven clones and other yeast se-
quences that, if present in high copy number, could
cause sterility (e.g., MATa, HO, anti-sir). Prelimi-
nary cross-hybridization studies indicate that
among these clones there are at least three unique
sequences able to complement sum/-/, one of
which is represented by three overlapping DNAs.
Work is in progress to distinguish the SUMI gene
clone from other wild-type sequences that also com-
plement the sum/-/ mutation in vivo. RNA blot
analysis will reveal any evidence of transcriptional
regulation of SUMI by the MAR/SIR genes, and
this will be combined with additional molecular and
genetic experiments designed to challenge our cur-
rent models for the control of HM gene expression.
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Identification and Characterization
of the SUM2, SUM3, SUM4, and SUMS
Genes of Saccharomyces cerevisiae
C.I.P. Lin, J. Ivy, A.J.S. Klar
To study the possible interactions among the differ-
ent MAR/SIR gene products and to search for new
loci involved in regulating the expression of HML
and HMR, extragenic suppressors of mar2 muta-
tions were isolated. Strain PL1 (HMLa, MATa,
HMRa mar2-I) has a nonmating phenotype be-
cause the mar2-1 mutation allows the simultaneous
expression of both a and a information. Mutant
strains were isolated that exhibit an a phenotype
and therefore, presumably, fail to express the
HMLa and HMRa loci. The mutations responsible
for the suppression of mar2-1 in these strains define
four complementation groups designated sum2-1,
sum3-I, sum4 -1, and sums -1.
Genetic analysis of the four mar2 -1 suppressors
show that they are recessive single gene mutations,
unlinked to MAT or MAR2. As with sum/-/, the
mar2-1 suppressor mutations do not correspond to
SIR1, MARI, MAR2, or SIR4. The mar2-1 sup-
pressors also suppress a mar2 deletion mutation,
indicating that they are not translational suppres-
sors. Only sums -1, however, is also able to suppress
a marl deletion.
Suppressors of mar2-1 also differ from sum/-/ in
their ability to suppress the information at the HM
loci. For example, HMLa is not suppressed by ei-
ther sum2-1, sum3-1, or sum4-I, indicating that
they, in fact, may be a-specific suppressors. In some
experiments, MATa information in HMLa MATa
HMRa MAR sum strains is also repressed, resulting
in an a mating type. Further genetic and molecular
analyses are under way to provide a clearer under-
standing of how these genes fit into the already
complicated regulatory circuit that controls the ex-
pression of the silent mating-type genes of yeast.
Epigenetic Control of MAT1 Switching
in Schizosaccharomyces pombe
A.J.S. Klar, M. Kelly, L. Miglio
The most fascinating and central question in biol-
ogy today is how different cell types are generated.
The P (plus) and M (minus) mating types (cell
types) of Schizosaccharomyces pombe have been
shown to interchange by a transposition-substitu-
tion reaction in which copies of the donor loci
(MAT2-P and MAT3-M) are transmitted to the ex-
pressed MATI locus (see 1983 Annual Report). A
fascinating property of this system is that between
a pair of sister cells, only one member (in 92% of
the cell divisions) generates a single switched cell in
the next generation (Fig. 2) (Miyata and Miyata,
.1. Gen. Appl. Microbiol. 27: 365 [1981]). Our recent
work has shown that cells that switch have inherited
a MAT allele that carries the potential for switch-
ing; i.e., there seems to be semi-heritable epigenetic
control for switching. This conclusion is based on
the results described below.
We have shown that meiotic crosses involving
strains deleted for MAT2 and MAT3 produce 20%
of tetrads with the 1P:3M and 3P:1M types of
MATI gene conversions (see 1984 Annual Report).
The observed high frequency of meiotic gene con-
version is clearly a manifestation of the MAT
switching system that normally occurs in mitoti-
cally dividing cells. We have used the high meiotic
gene conversion system to ask whether the develop-
mental potential to switch is asymmetrically segre-
gated cytoplasmically or chromosomally. Should
the observed pattern of switching in mitotically.
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FIGURE 2 Miyata and Miyata (J. Gen. Appi. Microbiol. 27:
365 [19811) mating-type switching pedigree analysis.
dividing cells be due to chromosomal "imprinting,"
this event might be catalyzed by the SW// and/or
SWI3 and/or SWI7 gene functions, since muta-
tions in any one of these genes can result in a failure
to create the DS cut (see 1983 Annual Report). To
test this idea, we subjected a MAT1-M swi3 x
MAT1-P SWI3 cross (both strains with deleted
MAT2 and MAT3 cassettes) to meiotic tetrad anal-
ysis. It is important to realize that when S. pombe
cells mate, the zygotic cells immediately undergo
meiotic division. If the SWI3 gene product is in-
volved in chromosomal marking, only the MAT1-P
allele would be expected to gene convert to the
MATI-M allele in this cross. Among the 103 four-
spored tetrads analyzed, 16 were found to have a
conversion event. A fascinating finding is that all of
these conversions are of the 3M:IP type. Thus, only
the MAT1-P allele, which was brought in from the
SW/..3+-containing nucleus, is capable of acting as
a recipient for the meiotic gene conversion event.
By a similar cross, but with the reversed swi3 geno-
type, we have shown imprinting of the MAT1-M al-
lele. Therefore, the potential to gene convert in mei-
osis must be imprinted at the template level and
segregated in cis with the MAT allele. These results
prompted us to suggest that only those cells that in-
herit an imprinted chromosome in mitotic cell lin-
eages are competent to switch.
Is the DS break an imprinted event? The results
involving swil and swi3 crosses are consistent with
the idea that the allele that brings along the MAT
DS break into meiosis acts as the recipient for
meiotic gene conversion. However, the key question
is why some chromosomes get the break and others
do not. Results of the following experiment rule out
the DS break as being the imprinted event. A
MATI -M swi7 x MAT1-P SWI7 cross (both
deleted for MAT2 and MAT3) generated conver-
sions of either type with equal frequency, i.e.,
1P:3M = 3P:1M. Should the DS break strictly con-
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stitute an imprinted event, this cross also should
have generated biased gene conversions as was ob-
served for the swil and swi3 crosses. This expecta-
tion arises since swi7 strains also fail to make the
DS break. This result clearly demonstrates that the
chromosomes grown in a swi7 genotype are im-
printed, even though they do not have the break.
Thus, we propose that the SWI] and SWI3 gene
products epigenetically modify (imprint) the MAT
DNA and that the SWI7 gene product catalyzes a
cut of the imprinted substrate.
These results clearly demonstrate that there is an
epigenetic chromosomal basis for the asymmetric
segregation of the switching potential. We should
now ask how it is decided that only one among four
progenies of a single cell switches in 92% of cell di-
visions. We imagine that the decision must have
been made by the grandparent cell and that it takes
two generations to materialize a switch. We propose
that the SW// and SWI3 gene products alone, or in
combination with other functions, catalyze a
sequence-specific marking in the grandparent cell
such that only one chain (e.g., the Watson Strand)
is modified (Fig. 3). To maintain the asymmetry, we
suggest that the modified Watson Strand serves as
a template for a "modified" Crick Strand at the
time of DNA replication in the grandparent cell.
For example, a nicked template will allow the syn-
thesis of a nicked new strand. The other unmodi-
fied Crick Strand of the grandparent cell serves as
a template for an unmodified Watson Strand, the
latter of which will be modified by the hypothesized
SWI gene products. Thus, at the two-cell stage, one
cell has both strands modified, and the sister cell,
like the parental cell, is only modified on one
strand. We further postulate that the cell contain-
ing both chains modified is imprinted to get cut
and will produce a switched and an unswitched
(or homologously switched) pair of cells. Once
switched, the cycle will start again. This strand-
segregation model (SS model) presumes that all of
the cells have the identical cytoplasmic makeup,
and the asymmetry in cell division is postulated to
be due to the two chains of DNA being nonequiva-
lent in acquiring the developmental potential. Ac-
cording to this model, any given cell division in any
biological system will always generate two none-
quivalent cells because one inherits the "old" Wat-
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FIGURE 3 Strand segregation model.
son Strand and the other inherits the "old" Crick
Strand.
We have designed a genetic test of the model that
involves determining the switching pattern of two
types of MAT1 duplications. Two constructions,
one containing directly oriented cassettes and the
other containing inversely oriented cassettes, will
be made. Our model predicts that a directly ori-
ented duplication will allow switching of both cas-
settes in only one among four cells at the four-cell
stage. In the oppositely oriented arrangement, how-
ever, each of two cells, one from each half of the
pedigree, should switch single (but different) cas-
settes. Such studies are under way, and further ex-
periments will be directed at determining the nature
of the hypothesized DNA modification.
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CELL-CYCLE CONTROL IN YEAST
D. Beach M. McLeod L. Brizuela
J. Potashkin M. Stein
R. Booher S. Allen
During the winter and early spring of 1985, the lab-
oratory previously occupied by Tom Broker and
Louise Chow was completely renovated, and in
May 1985, the research group headed by David
Beach was able to move from Delbrack into the new
laboratory in Demerec. This move reflects a shift in
the emphasis of our work, away from purely genetic
approaches to the cell cycle, toward a combination
of genetic and biochemical studies for which the
Demerec location is more suited. As in previous
years, our research has centered on the fission yeast,
Schizosaccharomyces pombe, which continues to
be an ideal model organism for investigation of the
control of mitotic cell division and meiosis.
Cell-cycle Control
J. Potashkin, R. Booher, L Brizuela, D. Beach
Our work on the cell cycle of fission yeast during
the past year has concentrated on the cdcr gene
and its product. The cdcr gene is unusual because
its activity is required at two independent stages of
the cell cycle: in G, prior to DNA replication and
in G, prior to mitosis.
The sequence of the cdc2* gene shares homolo-
gies with known protein kinases. Much of our ef-
forts have been directed toward raising monoclonal
antibodies against cdcr/ lacZ fusion protein in or-
der to investigate whether cdcr is indeed a protein
kinase. We have also expressed the native cdcr gene
product at very high levels in Escherichia coli. This
protein has turned out to be insoluble and we are
presently attempting to resolubilize the protein in a
biologically active form and to purify it.
A dominant allele of cdcr that does not cause
cell-cycle arrest but instead leads to advancement of
cell-cycle events has been isolated and sequenced.
This activated allele has a single mutation,
cdc2Asp146, instead of the wild-type sequence,
which has G1y146. The way in which this mutation
affects the activity of the cdcr gene product is un-
clear at present.
During the summer, an undergraduate research
visitor, G. Costello, undertook experiments to in-
vestigate the behavior of fission yeast during entry
into stationary phase. It was found that contrary to
popular conception, fission yeast enters the station-
ary phase equally from the G, phase or from the
G2 phase of the cell cycle. The fraction of the cul-
ture entering Go/, or G012 was highly dependent on
the initial growth medium (Fig. 1).
G07, and Go, cells were shown to share several
properties: (1) They are equally resistant to heat
shock; (2) they have equal long-term viability; and
(3) both require the cdcr gene product for cell-
cycle progression after restoration of fresh medium
(Fig. 1, right). These experiments are inconsistent
with the widely held view of the cell cycle in which
it is presumed that cells enter stationary phase only
from the G, phase of the cell cycle.
Control of Meiosis
M. McLeod, M. Stein, D. Beach
Our laboratory continues to be interested in under-
standing the molecular basis of the developmental
switch that underlies the transition from vegetative
growth to sexual differentiation. Ultimately, this
process is controlled by the genes of the mating-
type locus, since a diploid strain that is homozy-
gous at the mating-type locus (e.g., h- /h -) merely
enters stationary phase in response to starvation,
whereas an otherwise identical strain that is hetero-
zygous at the mating-type locus (h. / h-) undergoes
meiosis and sporulation under the same conditions.
The genes of the fission yeast mating-type locus are
being studied by M. Kelly (Delbrtick Laboratory).
Our research has concentrated on investigating the
pathway through which the mating-type genes exert
their effect.
The ran]* gene has a central role in the control
of meiosis. Strains carrying temperature-sensitive
alleles of rani undergo haploid sporulation at the
restrictive temperature. We have proposed that dur-
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FIGURE 1 (Left) Heat-shock resistance of actively dividing cells (U) and those that have reached stationary phase in media con-
taining either 5 mm NH4CI (0), 10 mm NI-14C1(0), 100 mm NH4CI ( +), 100 mm NH4CI and 0.1% yeast extract (S), or 100 mm NH4CI
and 0.5% yeast extract (A). All media contained 2% glucose. (A-E) Frequency histograms of the number of cells in each medium
that reach stationary phase with either a Gi (1N) or G2 (2N) DNA content. (Right) Diagrammatic illustration of the cell cycle of S.
pombe. Cells enter stationary phase from either Gi (Goa) or G2 (0012). Reentry into the cell-division cycle requires the cdc2* gene
product for both DNA synthesis and nuclear division.
ing normal sexual differentiation, the mating-type
genes inhibit the activity of the rani' gene product,
thereby provoking meiosis and sporulation.
The nucleotide sequence of the rani' gene has
been determined. It shows extensive homology with
genes known to encode protein kinases. The closest
homolog of rani' is the cdc2' gene of fission yeast.
The predicted rani* and cdc2' proteins share 20%
amino acid homology. These data suggest that
rant' encodes a protein kinase that is active during
vegetative growth and is presumed to be inhibited
during the initiation of meiosis. We are currently
attempting to raise antibodies against a rani*/ lacZ
fusion protein in order to test whether the rani'
gene product is indeed a protein kinase.
In the meantime, an interesting connection has
been drawn between the activity of the presumed
rani' protein kinase and cAMP-dependent protein
kinase. In the absence of the rani' gene product,
cells cease vegetative growth and sporulate. How-
ever, this phenotype is completely suppressed by
addition of either cAMP or caffeine (a phospho-
diesterase inhibitor) to the culture medium. The
rani* gene product is therefore not essential for
growth if cAMP-dependent protein kinase is over-
stimulated. We have proposed that the presumed
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rani' protein kinase shares certain key substrates
with cAMP-dependent protein kinase.
We are particularly interested in the mechanism
that controls the activity of the rani' product and
have recently identified the product of the mei3.
gene as at least part of the pathway by which the
activity of rani* is brought under the control of the
mating-type locus. mei3- mutant strains suffer no
defect in vegetative growth and under appropriate
conditions undergo sexual conjugation, but the
resulting zygote arrests during meiosis before the
initiation of premeiotic DNA replication. However,
a ranl(ts)mei3- double mutant sporulates at restric-
tive temperature, suggesting that mei3' acts "up-
stream" of rani' in the meiotic pathway.
We have isolated and sequenced the mei3' gene,
which is predicted to encode a small basic protein
of 148 amino acid residues. The mei3* gene is not
expressed in haploid strains under any conditions,
but it is expressed in an h+ / h- diploid strain that is
initiating meiosis as a result of nutritional starva-
tion. The expression of mei3' is therefore controlled
by the genes of mating-type locus.
Although the mei3' transcript is not normally ex-
pressed in haploid cells, we have been able to assess
the consequence of such expression by driving the
mei3+ gene off the strong promoter of the alcohol
dehydrogenase (ADH) gene. Expression of mei3+ in
a haploid cell is lethal. However, it appears that
mei3. expression does not have a nonspecific cyto-
toxic action because strains carrying a mutation in
the mei2 gene survive overexpression of the mei3*
gene. mei2- mutants have a phenotype very similar
to that of mei3- mutants, except that the ranl(ts)-
mei2- double mutant does not sporulate at the re-
strictive temperature and instead continues normal
vegetative growth. In the absence of the mei2' gene
product, ran!' is therefore a nonessential gene.
We suspect that overexpression of the mei3.- gene,
driven by the ADH promoter, results in inhibition
of the activity of rani' and therefore vegetative
growth ceases, except in a mei2- strain in which
rani' is not essential for growth. A prediction of
this model is that expression of mei3' in a wild-type
cell should not merely cause cell death but should
provoke sporulation similar to that observed in
ranl(ts) mutants. Indeed, we have found that in the
microcolonies, which develop after transformation
of a haploid strain with a plasmid carrying mei3'
driven by the ADH promoter, many cells contain
spores. Thus, overexpression of mei3' phenocopies
the ranl(ts) mutation. This suggests that the mei3'
gene product inhibits the activity of the ran!' gene
product. Whether the mei3' gene product interacts
directly with the raid' protein kinase will be a topic
for future investigation.
Function of ras in Fission Yeast
D. Beach
I have undertaken a project in collaboration with
S. Nadin-Davis (NRC Laboratory in Canada) to in-
vestigate the function of the ras gene in fission
yeast. Dr. Nadin-Davis, who has spent several
months at Cold Spring Harbor Laboratory during
the year, had previously isolated the fission yeast
ras gene. The gene is apparently unique, encodes a
protein of 210 amino acid residues, and shares con-
siderable homology with the ras genes of verte-
brates.
We have constructed both null and activated
(rasvall2) alleles of the ras gene and introduced
them into yeast by "gene replacement." ras is not an
essential gene in Schizosaccharomyces pombe.
Strains lacking ras function grew quite normally;
however, the process of sexual differentiation was
disrupted. Haploids normally capable of sexual
conjugation were sterile and diploids were highly
inhibited in meiosis and sporulation.
The rasvall2 "activated" allele of the gene like-
wise had no effect on vegetative growth, no effect
on long-term viability in stationary phase, and no
effect on sporulation or meiosis. However, haploid
strains carrying rasvall2 were incapable of conjuga-
tion.
The research group of M. Wig ler (Molecular
Genetics of Eukaryotic Cells Section) has shown
previously that in the unrelated budding yeast, Sac-
charomyces cerevisiae, ras controls the activity of
adenylate cyclase. However, we have found that fis-
sion yeast strains carrying a null allele of ras do not
lack cAMP and that the rasvall2 mutation does not
cause an increase in cAMP level. Indeed, the
phenotype of rasvall2 is quite different from that
caused by increasing the intracellular level of
cAMP. As in budding yeast, high levels of cAMP
in fission yeast inhibit both entry into stationary
phase and meiosis and sporulation.
These experiments suggest that the use to which
the ras protein is put in different organisms may be
entirely different. This is a little surprising, since we
found that introduction of a mammalian ras pro-
tein into a ras strain of fission yeast could partially
restore ras' function. Although the ras protein is
highly conserved and functions across an enor-
mous evolutionary divide, the role of the rasprotein
in cellular function is apparently not highly con-
served.
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PLANT GENETICS
S.L. Dellaporta J. Chen A.C. Hiatt P. Hinton
J. Hicks P. Chomet B.A. Lowe J. Mclndoo
R.L. Malmberg G. Giuliano C. Mitchell J. Wood
P.A. Scolnik M. Alfenito
Studies on maize controlling elements, particularly
the Ac/Ds system, continue to add to our under-
standing of the mechanism of controlling element
transposition and activation. We have concentrated
our efforts on phase changes of Ac at the waxy lo-
cus. Phase changes are heritable, but reversible,
events that are detected by the loss or gain of Ac
genetic activity. As reported last year, we have been
able to correlate changes in DNA methylation pat-
terns of Ac with genetic activity. This methylation
appears to be specific for Ac DNA sequences.
Transposition studies of Ac from the P locus have
been initiated to obtain molecular data on the
mechanism and chromosomal pattern of Ac move-
ment. Finally, we have continued to analyze the R
locus of maize with molecular R probes obtained
by transposon tagging with Ac.
Changes in Phase of Ac
P. Chomet, S.L. Dellaporta in collaboration with
S. Wessler, University of Georgia]
The Ac element at the wx-m 7 allele has the ability
to undergo cyclical changes in genetic activity. This
activity is assayed by the ability of Ac (1) to trans-
pose autonomously from the waxy locus, (2) to
trans-activate unlinked Ds elements, and (3) to con-
tribute to Ac dosage effects; as the number of Ac
elements increases, transposition is developmen-
tally delayed. The Ac element at wx-m7 can lose
these functions during plant or kernel development
and is believed to enter an inactive phase. Our
studies have shown that a shift from an active phase
to an inactive phase of Ac is associated with modifi-
cation of Ac DNA sequences. This modification
may involve cytosine methylation, as detected by re-
striction enzymes sensitive to this type of modifica-
tion. The modification appears to be specific for
the Ac element, since restriction sites flanking the
Ac element in Wx DNA are unmodified (Fig. 1). At
present, we do not know whether Ac modification
is a cause or an effect of inactivation. We are deter-
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mining whether any nucleotide changes are present
in a genomic clone of the inactive element to help
resolve this issue.
Molecular Analysis of the R
Locus of Maize
S.L. Dellaporta, M. Alfenito fin collaboration with
S. Wessler and I. Greenblatt, University of Connecticut,
and J. Kermicle, University of Wisconsin]
The R locus of maize on chromosome 10 is one of
several epistatic loci required for the production of
anthocyanin pigments in plant and seed tissues.
The pattern of plant pigmentation, i.e., which tis-
sues will ultimately be pigmented in the plant and
seed, is determined by various alleles of the R locus.
Moreover, expression of other epistatic gene prod-
ucts in anthocyanin biosynthesis appears to require
a functional R allele or certain B alleles (an un-
linked locus) capable of substituting for R. For
these reasons, R is thought to be a regulatory locus
rather than a structural locus.
Last year we reported on the characterization of
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FIGURE 1 Restriction map of the cloned wx-m7 inactive-
phase allele. Restriction map of Pvull (P), BstNl /EcoRll (E), and
HindlIl (H) sites in the Ac and Wx sequence of the cloned wx-
m 7 inactive allele. Hatched bars represent the Ac sequence and
solid lines represent the flanking Wx sequence. The solid line
below represents the Sstl fragment of Wx without the Ac se-
quence insertion. (V) Sites that do not cleave in the genomic
DNA sequence of the inactive wx-m7 allele, yet are present in
the cloned allele, indicating the presence of DNA modification
at these sites.
an insertion of Ac at the R locus, isolated by I.
Greenblatt. This past year, we have used Ac DNA
probes to clone this mutant R allele and, with
flanking probes, we have defined regions that are R-
specific. We are presently characterizing the R-
r:standard allele by Southern blot analysis and
genomic cloning. This allele has been genetically
characterized as a compound locus comprising a
tandem chromosomal duplication (Fig. 2A). Each
member carries an R component: The centromere-
proximal region contains a plant (P) component
that conditions pigmentation of tissues in the
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plant, and the distal region contains a seed (S) com-
ponent that conditions aleurone pigmentation in
the kernel. Derivative R-r alleles obtained by dis-
placed synapsis (Fig. 2B) and intralocus recombina-
tion have been recovered in J. Kermicle's laboratory
that retain only one member of the duplication. R-g
derivatives retain only S function and r-r derivatives
retain only P function. We have examined the R-r
and derivative alleles with an R-specific probe and
have found homologous DNA fragments that cor-
respond to the presence of S or P.
A third R component called leaf-color (Lc) has
Lc
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FIGURE 2 Genetic organization of the R locus. (A) Genetic map of the long arm of chromosome 10 of
maize showing the genetic map positions of the R locus and flanking markers: (g) golden; (Isr) inhibitor
of striate; (Lc) leaf color component; (M-st) modifier of stippled. The region that includes R is expanded
to show the genetic fine-structure relationship of the P and S components of the R- r:standard allele. Each
component is carried on a chromosome-duplicated segment (stippled area) and includes the linked
marker Isr as part of the duplication. The position of the R component is calculated from the frequency
of S and P derivatives obtained from R-r homozygotes (see Dooner and Kermicle, Genetics 67: 427 [1971],
Genetics 82: 309 [1976]) derived by recombination events depicted in B. (8) Two possible synaptic configu-
rations (I and II) of R-r homozygotes. Recombination in region 1 or 2 (arrows) will yield R-g (S) or r-r (P)
derivatives, respectively.
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also been examined and has been shown to cor-
respond to a DNA fragment homologous to our R
probe. These results suggest that these components,
although functionally divergent, have retained sig-
nificant DNA homology. They may have originated
from a single progenitor R gene, and through a pro-
cess of chromosomal duplication and DNA se-
quence divergence, these genes may have become
independent tissue-specific regulators of anthocya-
nin production. We are also in the process of "walk-
ing" with each of these cloned component frag-
ments to construct a physical map of the standard
R locus. The reconstruction and characterization
of a complete R locus will afford valuable insights
into the mechanisms of plant gene regulation.
Transposition of Ac from the P
Locus of Maize
J. Chen, S.L. Dellaporta [in collaboration with
I. Greenblatt, University of Connecticut]
Maize offers an ideal system for studying somatic
mutations such as transposition events, because so-
matic mutations can sometimes be recovered in
subsequent progeny for genetic and molecular
analyses. We have been investigating the transposi-
tion mechanism of Ac at the pericarp (P) locus that
conditions red pigment formation in the somatic
pericarp and cob tissues of the ear. Genetic studies
on the transposition of Ac from the P locus indicate
that Ac transposition may occur by excision of Ac
from one chromatid, after replication of the P lo-
cus, to an unreplicated receptor site, usually on the
same chromosome. Frequently observed "twinned"
mutations on variegated pericarp ears (Fig. 3) can
red pericarp
be explained by such a mechanism: subsequent
replication of the receptor site along with the newly
transposed Ac element would result in daughter cell
lineages that differ in their genetic constitution at
the P locus, yet both with a transposed Ac element
at an identical chromosomal position.
We have initiated molecular studies of twinned
mutations to test the current model for Ac transpo-
sition from the P locus. We have generated twinned
mutations, and genomic DNAs have been isolated
from offspring of each sector and subjected to
genomic blot analysis. Analyses of Ac homologous
restriction fragments have allowed us to identify the
Ac element at the P locus and the transposed Ac
element at the receptor site. We are currently clon-
ing transposed Ac elements from this material to
determine the molecular location of these elements.
For molecular analysis of the donor element, we
also have cloned the P locus using the Ac cloning
strategy discussed in last year's Annual Report.
Cell and Developmental Genetics
of Tobacco
A.C. Hiatt, R.L. Malmberg, B.A. Lowe, J. Mclndoo
Mutagenesis and selection protocols for the study
of plant development have recently been optimized
for a variety of species. Tobacco is an especially
useful plant for study because after mutagenesis it
retains the ability to regenerate from cell culture
into a whole plant. We have been interested in
regenerating cells selected for resistance to inhibi-
tors of polyamine synthesis. The regenerated vari-
ants have revealed numerous unusual developmen-
tal defects. Developmental defects in the flower are
medium-variegated
light-variegated
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common among plants that develop to maturity;
however, arrested development at earlier stages is
also common. The whole-plant characteristics of
these polyamine synthesis variants were described
in last year's Annual Report. In general, these vari-
ants have revealed that the precise regulation of in-
tracellular polyamine titer may be a critical compo-
nent in many developmental processes, including
tobacco sexual development. A major drawback in
the analysis of these variants has been the unavail-
ability of meiotic genetic analysis because either the
flowers are sterile or the plants do not develop to
maturity. Therefore, our approach has been to ex-
plore the regulation of polyamine synthesis and
degradation in both wild-type and selected mutant
plants and to isolate genes that control the intracel-
lular polyamine titer in the hope that reintroduc-
tion of these genes into the appropriate plant back-
ground will reveal something about the significance
of polyamine metabolism during development.
REGULATION OF POLYAMINE BIOSYNTHESIS
Polyamine synthesis in plants is mediated by three
enzymes that are all decarboxylases. Production of
putrescine, the first polyamine, can come from
decarboxylation of either arginine or ornithine,
whereas conversion of putrescine to spermidine and
then spermine depends on the decarboxylation of
S-adenosylmethionine (Fig. 4). In cell cultures,
these enzymes are regulated both at the level of syn-
thesis and at the level of protein stability. Specific
activities can vary by 40-fold, depending on the
growth phase of the cells. The abundance of the en-
zymes is also developmentally regulated; where ar-
ginine decarboxylase (ArgDC) activities are high
(in leaves and roots), ornithine decarboxylase
(OrnDC) activities are virtually absent. OrnDC is
only abundant in flowers. Addition of polyamines
to cultures results in differential feedback regula-
tion in that ArgDC activity is absent and OrnDC
activity is unaffected. The kinetics of feedback
regulation of ArgDC suggests that ArgDC synthe-
sis is inhibited by exogenous polyamines. S-adeno-
sylmethionine decarboxylase (SamDC) synthesis is
also inhibited by elevated polyamine levels; how-
ever, addition of a spermidine analog, methylgly-
oxal-bis(guanylhydrazone) (MGBG), results in
stabilization of the protein at the same time that the
enzymatic activity is inhibited. Inhibition of
OrnDC by difluoromethylornithine (DFMO) or
prolonged inhibition of SamDC by MGBG is le-
thal, whereas inhibition of ArgDC (the parallel
pathway to putrescine) is not lethal under ordinary
conditions.
The polyamine variants previously described are
resistant to either MGBG or DFMO (Fig. 5). Most
of these cell lines have not been extensively charac-
terized biochemically but probably represent a vari-
ety of mechanisms of resistance (e.g., insensitive
target enzyme, rapid detoxification, and slowed up-
take of the inhibitor). They invariably have abnor-
mal polyamine titers (either too high or too low).
These observations and others have led us to con-
clude that regulation of the enzyme activities in-
volved in polyamine metabolism occurs at multiple
levels (e.g., protein synthesis, protein stability, and
protein modification) and that coordinated control
of synthesis and degradation of polyamines may be
essential to a variety of developmental processes.
One variant resistant to DFMO has been exam-
ined in detail and has revealed multiple defects pos-
sibly due to aberrant coordinated regulation of en-
zyme levels. Resistance to DFMO in this variant
(Dfrl) is apparently due to a partially DFMO-
insensitive allele of OrnDC. The overall OrnDC
level in the absence of inhibitor, however, is less
than 5% of the wild-type level, suggesting that both
alleles are being affected. At the same time, there
are very high levels of the parallel enzyme, ArgDC,
which is elevated 15-fold. This variant also contains
an excess of intracellular putrescine (>10 times the
wild-type level) and secretes putrescine into the cul-
ture medium. Unfortunately, meiotic genetic analy-
sis in this plant in its present state is not possible
(Fig. 6). This type of analysis is essential to demon-
strate that the variant does in fact contain a single
mutation. We are currently trying techniques to
fuse Dfrl protoplasts (plant cells devoid of cell
walls) to normal protoplasts in the hope that the
resulting tetraploid cells will regenerate normally.
We have found that under ordinary culture con-
ditions, ArgDC is not an essential enzymatic activ-
ity; however, it is regulated by a variety of cellular
stresses, including low pH, osmotic shock, absence
of potassium, and wilting. These types of stresses
that induce ArgDC have been observed in shoots,
whole plants, and cell cultures. We have found that
during stress induction of ArgDC in culture, addi-
tion of its inhibitor (DFMA) is lethal, suggesting
that the primary and essential function of ArgDC
is to produce putrescine in response to these ionic
stresses. We are currently exploring the physiologi-
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FIGURE 5 Cells from wild-type or polyamine variant cultures. (DFR) DFMO-resistant cell line; (MGR)
MGBG-resistant cell line; (285) wild-type.
cal effects of elevated putrescine both in wild-type
cultures and in the polyamine variants.
MOLECULAR CLONING OF THE DECARBOXYLASE
GENES
Our strategy for isolation of genes that control
polyamine biosynthesis has relied heavily on our
understanding of the regulation of the enzymes de-
velopmentally as well as in culture. Isolation of a
putative ArgDC cDNA has been accomplished by
differential hybridization of potassium-stressed
and normal oat-seedling RNAs to a potassium-
stressed oat-seedling cDNA library. Stressed oat
seedlings have very high levels of ArgDC compared
with normal oat seedlings. The isolated popula-
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FIGURE 6 Arrested regeneration of a tobacco cell line resistant to DFMO.
tion of cDNAs (representing potassium-regulated
mRNAs) was then hybridized to RNA dot blots
from In this way, a
cDNA clone was identified that hybridized to an
ionic stress-regulated RNA which was absent when
polyamines were present in culture. Additional ex-
periments have further suggested that the isolated
clone contains an ArgDC cDNA. Using this cDNA,
we have isolated genomic clones to study sequences
responsible for its complex regulation. We have also
purified the ArgDC protein and will soon obtain
the amino acid sequence, which will enable the
positive identification of the ArgDC gene.
We have also isolated putative OrnDC genomic
clones by hybridization to a mouse OrnDC cDNA
and are in the process of obtaining the amino acid
sequence of purified tobacco SamDC to generate
probes for gene isolation. Our primary goal will be
to characterize these genes with an emphasis on un-
derstanding their complex regulation as well as the
significance of this coordinated regulation during
development. Our approach will be to reintroduce
these genes into appropriate plants using recom-
binant Agrobacterium vectors. This will enable us
to assess the developmental impact of additional
copies of the genes and to explore the effects of
aberrant regulation of the genes.
We have recently constructed and introduced
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into tobacco the mouse OrnDC gene under the con-
trol of a constitutive plant promoter derived from
the nopaline The
mouse gene will enable us to distinguish between
the endogenous and introduced transcripts and
protein and to study the stability and developmen-
tal effects of a constitutively expressed foreign
gene.
We have also begun seed mutagenesis and selec-
tion of Arabidopsis thaliana for resistance to
MGBG. Unlike most other plants, Arabidopsis has
a relatively small genome (,,70,000 kb), which
means that cloning by complementation using
DNA from a resistant Arabidopsis plant will be
technically feasible. This will eventually facilitate
isolation of genes that control polyamine levels and
have thus far not been characterized.
Finally, as an approach to studying the direct ef-
fects of polyamines on floral development, we have
been using a recently described procedure that al-
lows flowers to develop directly from thin cell layers
in culture. This system is unique in that, unlike the
situation in whole plants, the contents of the
growth medium (e.g., added polyamine, enzyme in-
hibitors, etc.) will be taken up by the cells in culture
and will directly influence floral development.
Using this technique in conjunction with gene iso-
lation and reintroduction, we hope to determine
how alterations in the regulation of polyamine me-
tabolism can influence sexual development in
plants.
Exploring the Systems of
Communication between Nuclei
and Chloroplasts in Plants
G. Giuliano, P Hinton, P.A. Scolnik
There are three classes of pigments in plants: chlo-
rophylls, carotenoids, and anthocyanins. Carote-
noids are yellow or red hydrophobic pigments that
are intrinsic components of the photosynthetic ap-
paratus. Anthocyanins are water-soluble pigments
ranging from pink to blue, and they are located in
cytoplasmic vacuoles. Chlorophylls, carotenoids,
and hydrophobic proteins are the basic components
of the photosynthetic apparatus.
Carotenoids play an essential photoprotective
role in all photosynthetic and many nonphotosyn-
thetic organisms. This is necessary because light
can react with chlorophyll or any other porphyrin
and generate oxygen singlets, which through a free
radical reaction can start a series of oxidations that
result in the death of the organism. Carotenoids
can prevent this reaction between chlorophyll and
oxygen. These pigments are also synthesized in
nonphotosynthetic tissues and are major contribu-
tors to the color of flowers and fruits.
Plants have a sensing mechanism by which they
regulate the amount of chlorophyll that is formed
when carotenoids are not present. At high light in-
tensity, plants containing mutations in carotenoid
biosynthesis do not accumulate chlorophyll (albino
phenotype). However, at low light intensity, the risk
of photooxidative reactions taking place is mini-
mized and the plants induce chlorophyll biosynthe-
sis and become pale green.
Ultrastructural analysis of the organelles formed
under different light regimes in plant carotenoid
mutants indicates that at high light intensity, pro-
plastids, lacking lamellar structures, are formed,
whereas chloroplasts with some membrane struc-
tures are accumulated at low light intensity. This
conditional formation of photosynthetic mem-
branes is not observed with other albino mutants.
Although the chloroplast contains its own ge-
nome, about 70% of the proteins are encoded by
nuclear genes. We wanted to study the possibility
that these genes are under a common transcrip-
tional control, which is dependent on the state of
the chloroplast. The conditional formation of a
photosynthetically active chloroplast in carotenoid
mutants makes them an ideal system to study
chloroplast-nuclei communication. We chose Lyco-
persicon esculentum (tomato) carotenoid mutants
for the following reasons: (1) The tomato is easily
cultivated under greenhouse or field conditions and
is easily propagated by sexual or asexual means. (2)
The cultivated tomato is self-pollinated, thus ensur-
ing two important genetic properties: homozygos-
ity and isogenicity. (3) Many genes affecting plant,
flower, and fruit characteristics have been de-
scribed and these lines are available for molecular
studies. (4) The tomato has been used as a model
system in biochemical and physiological studies,
and the information obtained is now useful in
designing experiments in molecular biology.
Most carotenoid mutants in tomato affect only
the color of the fruit. However, the pathways of
carotenoid biosynthesis in fruit and vegetative tis-
sue seem to be identical. On the basis of this obser-
vation, we propose that there are at least two copies
of each gene in the pathway affecting plant (P) and
fruit (F) pigments. Since carotenoids are part of the
photosynthetic apparatus, we expect the P compo-
nents to be under light transcriptional control and
the F system to be regulated by ethylene, the main
fruit-ripening hormone.
There is one carotenoid mutation (ghost) that af-
fects both vegetative and fruit tissues. This mutant
was isolated in the 1950s by C. Rick at the Univer-
sity of California, Davis. Although it is generally
mentioned as a mutant that would be interesting for
the study of carotenoid biosynthesis, the fact that
it is difficult to grow has prevented molecular biol-
ogists from using this system.
We obtained heterozygous seeds from the
Tomato Cooperative and planted them in the green-
house at Uplands Farm. Albino (gh/gh) and green
(+/gh and + / +) plants segregated in the propor-
tions expected for a Mendelian recessive gene. The
albino seedlings become pale green under low light,
indicating that this is indeed a carotenoid muta-
tion. White plants are nonphotosynthetic, and, in
general, they die within one month. However, in
most ghost plants, we observed green clonal sectors
that, according to the time of appearance in the
plant, can extend from just a few cells to whole
branches. The lifetime of the homozygous recessive
plants is dependent on the total amount of green
(photosynthetically competent) tissue present, indi-
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cating that the death of the ghost plants is mainly
due to the lack of nutrients and not to an intrinsic
lethal effect of the mutation. Analysis of the pig-
ment content in the green tissue revealed that both
chlorophylls and carotenoids are present at wild-
type levels, indicating that the ghost phenotype is
somatically unstable.
We are interested in using ghost plants to study
the systems of communication between nuclei and
chloroplasts, the synthesis and assembly in the
membrane of carotenoid pigments, and the molec-
ular basis for the somatic instability described.
These two projects require the isolation of rela-
tively large amounts of ghost tissue, which is diffi-
cult to achieve under normal conditions. On the ba-
sis of our observation that the green sectors can
provide nutrients to the albino areas, we decided to
use tissue culture to propagate selectively homozy-
gous recessive plants containing green sectors.
Seeds were germinated under sterile conditions and
white plants were propagated by shoot culture.
Green sectors were also observed under these condi-
tions. By selectively cutting areas containing these
sectors, we were able to obtain chimeric plantlets
enriched on green tissue. These plants were then
transferred to soil and grown in a growth chamber.
Plants over 2 feet tall, containing approximately
60-70% white tissue, are now routinely obtained.
Some branches in these plants are now flowering,
and this should allow us to conduct crosses to deter-
mine whether the phenotypic reversion observed is
due to a nuclear or a cytoplasmic event. In any case,
using tissue culture, we have managed to obtain rel-
atively large amounts of ghost tissue that can be
used in molecular studies.
In our first experiments with these plants, we de-
termined the levels of transcription of two nuclear
genes coding for chloroplast proteins: the small
subunit of ribulose-1,5-bisphosphate carboxylase/
oxygenase (Rubisco) and the chlorophyll-a/b-bind-
ing protein. In both cases, high levels of transcrip-
tion are only obtained in green tissue (Fig. 7). How-
ever, the hybridization signals obtained for two
unrelated nuclear sequences are similar between
green and white tissue (not shown), suggesting that
the transcriptional turn-off affects mostly nuclear
sequences coding for chloroplast proteins. We have
also translated poly(A)* RNA in a rabbit reticulo-
cyte system, and the overall pattern obtained is very
similar in the two types of tissue. Experiments are
now being conducted to determine whether the
differences observed are due to the existence of a
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FIGURE 7 mRNAs for the genes coding for the Rubisco small
subunit and chlorophyll-a/b-binding protein are not detected in
white ghost tissue. Homozygous recessive plants were propa-
gated through tissue culture, and white material and green ma-
terial from the same plant were isolated. Poly(A)' mRNA was ex-
tracted and analyzed in a Northern blot probing with cDNAs
corresponding to both genes. (Lanes 1,3) Green tissue; (lanes
2,4) white tissue. Lanes 1 and 2 were probed with the Rubisco
gene and lanes 3 and 4 were probed with chlorophyll a/b
sequences.
regulatory mechanism by which the chloroplast
and the nucleus communicate.
We have also examined by electron microscopy
the cellular structure of both white and green tis-
sues. In green tissue, normal chloroplasts are
formed, and the general architecture of the cells is
very similar to that of the wild-type material. In
white tissue, however, the cellular vacuole is missing
and proplastids are accumulated. Proplastids are
organelles that have no photosynthetic membranes
but can differentiate into chloroplasts if photosyn-
thetic tissue is formed. Electron microscopy work
was kindly arranged by I. Greenblatt (University of
Connecticut).
From these studies, it is becoming increasingly
clear that the ghost mutation arrests the develop-
ment of chloroplasts by affecting either the synthe-
sis or assembly of carotenoids, and this results in an
albino phenotype and the turning off of most, if
not all, nuclear transcripts for chloroplast proteins.
This mutation either reverts or is suppressed at rela-
tively high frequency, and this results in the pro-
plastids becoming fully developed chloroplasts
and, in general, the white tissue becoming wild
type. The molecular analysis of the ghost locus
should provide a wealth of information about
nuclear-cytoplasm interactions and the role of or-
ganelles in plant development.
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Protein Structure and Function
M. Zoller, K. Johnson, L. Levin, R. Kostriken
Our laboratory is interested in the manner in which
proteins specifically interact with macromolecular
substrates. The study of protein structure and func-
tion has been approached over the past 30 years
using tools such as group-specific modification of
amino acids, affinity-labeling, substrate analogs,
limited proteolysis, synthetic proteins, nuclear
magnetic resonance, and X-ray crystallography.
Molecular biology has added a new dimension to
the study of proteins by providing a means to syn-
thesize and express a protein with any amino acid
sequence desired. Proteins with primary sequences
differing by only a single amino acid at a predeter-
mined position can now be easily constructed by
oligonucleotide-directed mutagenesis. Extremely
sophisticated questions can now be asked about the
structure and function of a protein with regard to
the role of a particular amino acid, the location of
a substrate-binding pocket, and the region of pro-
tein-protein interaction. In addition, these power-
ful techniques have spawned a renaissance in the
field of protein crystallography and structure deter-
mination.
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We are studying two types of protein-macro-
molecule interactions: (1) protein-protein interac-
tions of yeast cAMP-dependent protein kinase and
(2) protein-DNA interactions of yeast HO en-
donuclease. The experimental system of yeast is
perfectly suited to the study of protein structure
and function, since mutated proteins can be exam-
ined in the absence of the wild-type protein, and
nonfunctional proteins can be analyzed using the
power of yeast genetics. During the past year, we
have been examining a number of Escherichia coli
expression systems in order to produce large
amounts of protein for subsequent structural
studies. In addition, we have begun to study one
class of proteins (protein kinases) by site-directed
mutagenesis.
Our approach is to construct site-directed amino
acid substitutions within the protein and to study
their effects in vitro using the E. coli expression
systems and in vivo in yeast. Since none of the pro-
teins we are currently studying have been crystal-
lized, mutagenesis can at best yield general infor-
mation, such as the location of domains for
substrate binding or regions of protein-protein in-
teractions. To obtain a more-detailed understand-
ing of the structure of these proteins, we hope to
produce enough pure protein to collaborate with
the newly formed X-ray crystallography group.
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Protein-Protein Interactions:
cAMP-dependent Protein Kinase
M. Zoller, K. Johnson, L. Levin
cAMP-dependent protein kinase (cAMPdPK) has
been shown to be part of a family of protein kinases
that include cGMP-dependent protein kinase, pro-
tein kinase C, and the tyrosine-specific protein ki-
nases of insulin and EGF receptors, and in a
number of transforming viruses. cAMPdPK is
ubiquitous in eukaryotes. Under conditions of low
cAMP concentrations, cAMPdPK exists as an inac-
tive holoenzyme, composed of two catalytic (C)
subunits and two regulatory (R) subunits. When
cAMP concentrations are increased by some stimu-
lus, cAMP binds to the R subunits, thereby releas-
ing two active C subunits that function to phos-
phorylate protein substrates on either serine or
threonine residues. Substrates show a consensus of
serine or threonine residues preceded by two basic
residues (e.g., Arg-Arg-X-Ser-X). Phosphorylation
serves to regulate the activity of enzymes in the
cAMP control pathway. The best-studied system is
the regulation of glycogen breakdown in muscle
and liver. cAMPdPK activates the enzyme phos-
phorylase kinase, which in turn activates the en-
zyme phosphorylase and results in the breakdown
of glycogen. cAMPdPK also phosphorylates glyco-
gen synthetase, which results in a reduction of its
activity. Little is known about the substrates in
yeast.
The genes for the C and R subunits from yeast
have been cloned and sequenced by T. Toda and S.
Cameron of M. Wigler's group (Molecular Genet-
ics of Eukaryotic Cells Section). There are three
closely related genes for the C subunit and one for
the R subunit (there may be another R subunit
gene). Comparison of the predicted amino acid se-
quences for the yeast proteins and the mammalian
proteins revealed a high degree of sequence similar-
ity, as high as 75% in some regions. Biochemical ex-
periments are under way to demonstrate that the
yeast proteins are functionally homologous to the
mammalian proteins.
CATALYTIC SUBUNIT (TPKI -3 GENES)
The C subunit carries out the specific phosphoryla-
tion of protein substrates. It is important to study
the C subunit to learn how it interacts with its
substrates, to study how it is regulated, and to un-
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derstand the structural differences between the
serine/threonine- and tyrosine-specific protein ki-
nases. We hope to identify the specific contacts be-
tween the C and R units and use this information
to develop an R subunit for a tyrosine kinase.
By using conventional protein-modification tech-
niques, two regions of the primary sequence have
been linked to functional domains. One is the ATP-
binding site. Affinity-labeling studies by M. Zoller
and S. Taylor identified a particular lysine residue
in the mammalian protein that coordinates the ter-
minal phosphate of ATP in the active site. The sec-
ond region is thought to be involved in the binding
of protein substrates. A particular cysteine residue
was protected from alkylation in the presence of a
peptide substrate analog. Both of these residues are
conserved in the yeast TPK proteins.
A second method to identify functional domains
of the protein has been through comparisons with
other protein kinases such as cGMP-dependent
protein kinase and the tyrosine-specific kinases
from transforming viruses (e.g., src, fps, erb-B, fes,
and abl). Such an analysis has revealed limited se-
quence homology throughout the protein. Thus,
these kinases are related both structurally and func-
tionally. The residues in common are thought to de-
fine the basic "kinase" activity, such as ATP and
Mg" binding and transfer of the phosphoryl group
to a specific substrate. Just as important are the
regions of dissimilarity. One region must be in-
volved in the means by which each of these kinases
interacts with and discriminates between its sub-
strates.
RESULTS
Expression of TPKI (Yeast C Subunit) in E. coli.
Using the T7 expression system, we produced TPKI
in E. coli. In crude extracts, the TPKI protein com-
prised about 10% of the cellular protein; however,
over 95% of the protein was insoluble. This is a
common result of expression of heterologous pro-
teins in E. coli. The protein is found in insoluble
aggregates called inclusion bodies. Experiments
aimed at solubilization of the protein revealed that
only urea, guanidine, or SDS would release the pro-
tein in a soluble form. Triton and another detergent
(LDAO) were ineffective in solubilizing TPKI pro-
tein, although these reagents released associated E.
coli proteins. When the urea, guanidine, or SDS
was dialyzed away, the protein precipitated. The
characteristics of a protein responsible for insolu-
bility are not known but have been under intensive
investigation by biotechnology companies.
TPK1 Encodes a Protein Kinase. The soluble
fractions of E. coli extracts were assayed for protein
kinase activity. Initially, we used a standard phos-
photransferase assay in which the y-phosphate
from ATP is incorporated into histone. Extracts
from cells containing the T7 vector alone without
an insert showed a weak phosphotransferase activ-
ity. We then switched to a more specific assay, using
a synthetic peptide as a substrate instead of histone.
This lowered the background significantly. Only
cells in which the TPKI gene was expressed ex-
hibited phosphotransferase activity. No activity
was observed in extracts from the control cells or
from cells in which BCYI (R subunit) was produced
(see below).
Additional evidence that TPKI was responsible
for this activity came from analysis of a site-
directed mutation we constructed in the ATP-
binding site of TPKI (see below). This mutation
has been shown to reduce the kinase activity of a
number of viral oncogene tyrosine kinases. Ex-
tracts from cells containing the mutant protein
showed insignificant phosphotransferase activity.
TPK1 Complexes with the Yeast R Subunit (BCYI)
In Vitro. The purified cAMP-binding subunit
(BCYI) was added to extracts containing TPK1.
Addition of BCYI resulted in the inhibition of
phosphotransferase activity. In the presence of
cAMP, phosphotransferase activity was indistin-
guishable from TPKI activity alone. This result
suggested that the TPKI protein was capable of
forming a functional complex with BCYI.
Probing Functional Domains by Site-directed Muta-
genesis: Lys-116 to Arg-116 Eliminates Catalytic
Activity. We have begun to study the role of spe-
cific amino acids in several regions of the protein,
and we are interested in amino acids that have been
conserved throughout the kinase family. The first
mutation we made was within a region thought to
play a role in ATP binding in all kinases of this
family.
Affinity-labeling experiments localized Lys-72
in the mammalian C subunit near the terminal
phosphate of ATP. The analogous lysine (amino
acid 116) of TPKI was changed to an arginine, thus
maintaining the charge but changing the overall
shape of the side chain at this position. As de-
scribed above, our initial experiments indicated
that the protein was inactive, which is consistent
with the results of similar experiments on the tyro-
sine kinases encoded by v-fps and v-src. We will
now purify this protein and compare its ability to
bind ATP and its ability to complex with the R
subunit in vitro. In addition, we will assess whether
this protein is functional in vivo.
FUTURE EXPERIMENTS
1. Purification of TPKI: Initially, we will try to
purify the soluble TPKI produced in E. coli.
This will not be as easy as the purification of
BCYI (discussed below), but through the use of
conventional column chromatographic proce-
dures as well as ATP-affinity columns, purifica-
tion should be feasible. In addition, we may be
able to construct an affinity column using puri-
fied BCYI. TPKI could be efficiently bound to
the column and specifically released by addition
of cAMP to the column.
2. Production of antibodies to TPKI: The insolu-
ble protein serves as an easy way to purify large
quantities of protein to be used as antigen. We
are using both gel-isolated protein and urea- or
preparations from the insoluble
fraction as antigen.
3. Production of TPK2 and TPK3 in E. coli: We
are interested in determining the difference be-
tween the various TPK gene products. The three
genes differ primarily at their amino terminus.
Antibodies will be produced against TPK2 and
TPK3 as well. It may be possible to obtain spe-
cific monoclonal antibodies for each of the pro-
teins. These proteins may be expressed in a solu-
ble form due to their structural differences.
4. Probing structure-function relationships: We
will continue to locate important regions of the
protein by making amino acid replacements by
both site-directed and random approaches. Each
protein will be analyzed in vitro as well as in
vivo. Through such an approach, it may be pos-
sible to obtain temperature-sensitive proteins to
be used in vivo. Site-directed mutations will be
aimed at regions of sequence identity between
the serine-specific kinases (e.g., cAMPdPK) and
the tyrosine-specific kinases (e.g., src, fps, EGF
receptor, and insulin receptor). We believe that
these conserved regions define general kinase
functions. Just as important are the regions of
nonhomology between these two classes of ki-
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nases. These regions are probably involved in the
interaction with specific substrates and effector
proteins. We will identify important amino acid
residues by a strategy of random mutagenesis.
5. An R subunit for tyrosine kinases? Peptide
substrate analogs of cAMPdPK have been syn-
thesized that inhibit kinase activity. These bind
very tightly to the C subunit. An analogous set
of peptides have been synthesized for tyrosine
kinases; however, these bind with low affinity. It
may be possible to modify the R subunit from
cAMPdPK so that it tightly binds to and inhibits
tyrosine kinases. The R subunit contains a se-
quence that resembles substrates for cAMPdPK.
By replacing these amino acids with analogs of
tyrosine kinase substrate/inhibitors, the activity
of these kinases may be regulated by cAMP.
REGULATORY SUBUNIT (BCY1 GENE)
The function of the R subunit is to regulate (in-
hibit) the action of the C subunit. Upon binding
cAMP, the C subunits are released to phosphory-
late substrates. Once the cAMP concentration of
the cell is reduced, the C and R subunits reassociate
to form the inactive holoenzyme. The mechanism
by which the C subunits are released and then
recaptured is not known. Furthermore, cAMP
binds to the R subunit with a K, of approximately
10' M. It is not clear how cAMP is removed from
the R subunit in order to reassociate with the C
subunit. The R subunit in mammals exists as a
dimer. Each subunit has two binding sites for
cAMP, which can be distinguished using analogs of
cAMP. The role of this apparent gene duplication
is not known. Recently, R. Jungmann and co-
workers reported that the purified R subunit from
mammalian liver demonstrated topoisomerase ac-
tivity. Perhaps the R subunit has some unknown
function such as regulation of gene expression
through this activity.
A gene from yeast encoding a protein with many
regions of sequence identity with the R subunit of
mammalian cAMPdPK was cloned and sequenced
by T. Toda and S. Cameron as a gene that com-
plemented the bcyl mutation. Comparison with the
mammalian protein sequence identified it as the R
subunit, similar to the mammalian "type II" R
subunit. This was confirmed by comparison with
peptide sequence data of the purified yeast R
subunit in collaboration with J. Scott and E. Krebs
(Howard Hughes Medical Research Institute, Seat-
100
tle, Washington). There may be a second R subunit
gene in yeast, since some of the peptides from the
yeast R subunit could not be positioned within the
predicted BCYI sequence.
A general identification of the functional do-
mains of the mammalian R subunit has been made
through the use of affinity labeling, limited pro-
teolysis, and sequence comparisons with CAP pro-
tein from E. coli. The major functional domains
can be characterized as follows:
1. cAMP-binding domain(s): Comparison with
the E. coli CAP protein has revealed regions of
sequence identity. This identified amino acids
that might be responsible for cAMP binding. In
addition, in the eukaryotic cAMP-binding pro-
teins, this putative binding region has been
duplicated. Biochemical analysis supports this
finding, since each monomer binds two mole-
cules of cAMP.
2. C subunit-R subunit interaction sites: It is not
known what parts of the C and R subunits inter-
act to form the inactive holoenzyme. Somehow
this tight interaction is broken upon binding
cAMP.
3. R-R dimerization region: Limited proteolysis
has revealed that the amino terminus is responsi-
ble for dimerization of the R subunits. An
aminoterminal 16,000-dalton fragment of the
mammalian protein still retains a dimeric form.
Nothing is known about the specific amino acids
responsible for this protein-protein interaction.
4. Phosphorylation site: The type II R subunit
and the yeast (BCYI) R subunit contain a se-
quence that is recognized and phosphorylated
by the C subunit. This region bears the substrate
consensus sequence (Arg-Arg-X-Ser-X) for ser-
ine protein kinases. The role of this phosphory-
lation has never been clearly determined. This
sequence may play a role in C-R interaction as
described above in 2.
5. Topoisomerase activity: R. Jungmann and co-
workers have presented data that the type II R
subunit from bovine liver contains a topoiso-
merase activity that is dependent on phos-
phorylation. There is no direct evidence that the
R subunits have a DNA-binding domain.
RESULTS
Expression of BCY1 in E. coli. Using the T7 ex-
pression system, we produced the BCYI protein in
E. coli. The protein was in the soluble fraction, in
contrast to the C subunit (TPK1). The level of the
protein in crude extracts was approximately 5% of
the total protein.
Purification of BCY1 from E. coli Extracts.
Using a standard procedure for purifying cAMP-
binding proteins, we purified BCY1 in a single step
to about 90% purity by means of an agarose-cAMP
affinity column. The protein was released from the
column with CAMP. This procedure yielded ap-
proximately 1 mg of purified R subunit per liter of
E. coli. It should be possible to obtain a slightly bet-
ter yield of 2-3 mg/liter. To characterize the protein
further, the bound cAMP was removed by rapid
treatment with urea.
Characterization of Purified BCY1. Simply by
binding the protein to the agarose-cAMP column
demonstrated that the expressed protein exhibited
a cAMP-binding function, as predicted. Using a
cAMP-binding assay, we determined that the pro-
tein bound 2 moles of cAMP per monomer, with a
K, of 10' M. This is similar to the results obtained
with the mammalian protein. Next, we showed that
the purified protein functioned to inhibit the C
subunit of bovine cAMPdPK in the absence of
cAMP but not in its presence. The purified protein
could be stoichiometrically phosphorylated by the
bovine C subunit. This is found with the so-called
"type II" R subunit in mammals as well. Finally, we
demonstrated that the purified protein could in-
hibit the yeast C subunit (TPKI) from crude E. coli
extracts. This suggested that TPK1 and BCY1 can
interact at least in vitro, and probably in vivo as
well.
FUTURE EXPERIMENTS
1. Topoisomerase activity: R. Jungmann and co-
workers reported that the purified R subunit
from mammalian liver demonstrated a topoiso-
merase activity. Furthermore, the activity re-
quired phosphorylation by the C subunit. We are
interested in testing whether the yeast protein
contains this activity as well.
2. Production of antibodies against the BCY1
protein.
3. Probing structure-function relationships: We
will begin to construct mutations within the
BCY1 protein and to test the effects both in vitro
and in vivo.
4. Large-scale purification: We will try to purify
large quantities of the protein to begin crystalli-
zation experiments.
Cloning the Type II R Subunit
of the cAMP-Dependent Protein
Kinase from Rat Skeletal Muscle
M. Zoller, D. Helfman [in collaboration with J. Scott
and E.G. Krebs, Howard Hughes Medical Research
Institute, Seattle, Washington]
We have cloned a cDNA that encodes the type II
regulatory subunit from rat skeletal muscle. The
cloning was done using a 47-nucleotide-long non-
degenerate oligonucleotide probe based on the pro-
tein sequence from the bovine regulatory subunit
and general codon bias of rat proteins. The use of
long nondegenerate probes appears to reduce the
isolation of "false positives" often found when
using short degenerate oligomers.
Cloning and Sequencing of the CDC25
Gene from Saccharomyces cerevisiae
L. Levin
The role of cAMP in controlling many cellular
metabolic processes has been shown in both eukary-
otes and prokaryotes. The apparent mediator of its
effects, in eukaryotes, is the phosphorylation of
cellular proteins by CAMP- dependent protein ki-
nase (cAMPdPK). The requirement of cAMP for
growth can be seen in the yeast Saccharomyces
cerevisiae, where many cAMP-requiring mutants
have been isolated.
The use of S. cerevisiae in understanding the
specifics of cAMP control of growth has proved
fruitful for two reasons. The first reason is the abil-
ity to isolate and utilize mutants in various steps
along the pathway, and the second is the apparent
similarity of those steps to what is known to exist
in higher eukaryotes. The evidence for the related-
ness of many cellular processes in yeast and in
higher eukaryotes is extensive.
In yeast, cAMP has been postulated to be in-
volved in the mitosis-meiosis decision. The cell-
cycle mutations cdc25 and cdc35 have also been
shown to affect the choice between mitosis and mei-
osis. Among the cell-cycle mutations affecting
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"start," only these two have been shown to be able
to undergo meiosis. In fact, homozygous diploids
for either of these mutations sporulate at the re-
strictive temperature, even in rich media. The corre-
lation of one of these two cell-cycle mutants with
the cAMP pathway has already proved correct,
since CDC35 has been shown to encode the gene
for adenylate cyclase.
In light of the apparent connection between
CDC25 and the cAMP regulatory pathway, we are
attempting to determine the function of the CDC25
gene. In conjunction with M. Wigler's laboratory,
we isolated two distinct genes that were able to
complement the temperature-sensitive cdc25-1 al-
lele. I isolated the gene encoding CDC25 and T.
Toda isolated TPK1, which showed protein se-
quence homology with the catalytic subunit of
mammalian cAMPdPK. The ability of a catalytic-
subunit-like gene to complement cdc25-1 is further
evidence for the association of this gene and the
cAMP growth control pathway.
RESULTS
Cloning CDC25. The wild-type gene was isolated
by complementation of the temperature-sensitive
allele, cdc25-1, from a library of yeast DNA cloned
into a 21-base plasmid. The library was introduced
into the cdc25 strain by transformation of sphero-
plasts, and transformants were selected as leucine
auxotrophs. Clones of cells containing the CDC25
gene were selected by their ability to grow at the re-
strictive temperature of 37°C. Plasmid DNA was
recovered from total yeast DNA by its ability to
transform Escherichia coli to ampicillin resistance.
Restriction enzyme analysis showed there to be two
independent isolates of a single insert. It was shown
to be allelic to the temperature-sensitive allele by in-
tegration mapping (work done by T. Toda). Subse-
quent subcloning experiments showed that a 2-kb
BglII-SphI fragment from the original 6-kb frag-
ment was able to rescue the temperature-sensitive
phenotype.
Sequencing. A 2.6-kb EcoRI-SphI fragment that
contained the 2-kb BglII -SphI complementing
fragment was subcloned into the M13 vectors mpl 8
and mp19. Subfragments were also cloned into M13
using the BglII, PstI, BamHI, and HindIII restric-
tion sites. The complete nucleotide sequence was
determined, in both strands, by dideoxy sequenc-
ing. A large open reading frame extended through-
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out the entire 2.6-kb subcloned region. Adjoining
restriction fragments from the original 6-kb insert
were subcloned and sequenced until the ends of the
open reading frame were reached. At the 5' end,
first the 1.6-kb BglII-BgiII fragment was subcloned
into M13. The nucleotide sequence still showed an
open reading frame; therefore, the overlapping 1.5-
kb SalI -EcoRI fragment was subcloned and par-
tially sequenced. At the 3' end, the 1.3-kb HindIII-
Sall fragment containing the vector-insert border
was subcloned and partially sequenced. Synthetic
oligonucleotide primers (usually 15 nucleotides
long) were synthesized in order to complete the se-
quence through an entire M13 clone. In all, 29
primers were utilized. To determine the sequence of
the second strand for the 5' end of the gene,
unidirectional deletions were constructed in the
M13 clones to allow sequencing through the entire
clone without the aid of a synthetic primer. The
open reading frame covered almost 5 kb and could
code for a protein of 1589 amino acids with a
predicted molecular weight of 179,121.
A computational matching program was used to
compare the deduced amino acid sequence with
data bases of known protein sequences for any pos-
sible homologies. No significant homologies were
found. A hydropathic profile was also constructed,
with no obvious relationship to known protein
structures found.
Characterization of Transcripts. The gene was
shown to code for an RNA of approximately 5.3 kb
by Northern blot analysis. Polyadenylated RNA
was selected from wild-type strains of yeast con-
taining YEpCDC25.56 (one of the original com-
plementing clones) or YEp13 (the vector without
an insert) by passing total RNA over oligo(dT)-
cellulose. The poly(A). RNA was separated on the
basis of size on an agarose gel containing formalde-
hyde and blotted to nitrocellulose. The immobilized
RNA was probed with nick-translated restriction
fragments from the CDC25 gene.
The 5' end of the putative transcript was mapped
using both 51-nuclease and primer-extension anal-
yses. Sl protection was carried out using a 430-bp
Hinfl -Sall fragment labeled at the Hinfl site by
phosphatase treatment, followed by kinasing with
[y- 32P]ATP. This probe was hybridized with either
poly(A)-selected or total RNA isolated from the
cdc25ts strain harboring the complementing plas-
mid. Subsequent digestion with SI nuclease yielded
three major protected fragments. The approximate
sizes of the protected fragments were 240, 260, and
270 nucleotides, corresponding to positions -130,
-150, and -160 from the putative initiation
codon.
Primer-extension analysis was done using two
synthetic oligonucleotides of 24 and 25 nucleotides
each. The oligonucleotides were labeled using T4
polynucleotide kinase and [y- 32P]ATP and an-
nealed to the same RNA isolates as in the SI experi-
ments. Extension of the primers with AMV reverse
transcriptase yielded cDNA that, when run along-
side dideoxy-sequencing reactions using the same
oligonucleotide, corresponded to the same posi-
tions as in the Si data. Both experiments were
repeated using RNA extracted from a number of
CDC25 strains of yeast, and although the signals
were much weaker due to the presence of only the
single genomic copy of the CDC25 gene, the sizes of
the cDNAs and protected fragments corresponded
to those of the overexpressing strains.
FUTURE EXPERIMENTS
Our future experiments will follow a biochemical
approach toward the understanding of the function
of the CDC25 gene product:
1. Subcellular localization: To determine the cel-
lular localization of the gene products, indirect
immunofluorescence will be used. A set of gene
fusions using the lacZ gene will be constructed
and introduced into yeast. Antibodies against
the B-galactosidase portion will be used to
visualize the fused gene in situ. Antibodies
generated against the CDC25 gene product itself
will also be used to substantiate these results.
They will be made by purifying the CDC25 gene
product from a strain of E. coli engineered to
produce it and introducing this pure protein into
mice to make monoclonal-antibody-producing
cell lines.
2. Posttranslational modification: The CDC25
gene product will be examined in vivo for any
posttranslational processing, such as phos-
phorylation, glycosylation, and specific proteo-
lytic cleavages. This will be done by immunopre-
cipitation of the protein from yeast cells labeled
with either [32P]phosphate or [35S]methionine.
Using two-dimensional gel electrophoresis, we
will compare the protein produced in yeast with
the protein synthesized in E. coli.
3. Complexes with other proteins: Immunopre-
cipitation experiments may help to identify
other proteins that interact directly with the
CDC25 gene product. Any other proteins that
are immunoprecipitated with antibodies against
the CDC25 protein may be complexed with it in
vivo.
4. Mammalian homolog: We will use the cloned
CDC25 gene as well as antibodies against the
gene product to search for a mammalian equiva-
lent to the CDC25 gene product.
5. Genetic characterization: We will continue
genetic studies in collaboration with M. Wigler's
laboratory. Specifically, we will randomly mu-
tagenize the CDC25 gene, transfer the mutage-
nized gene into yeast, and screen for new
temperature-sensitive mutants. This will help to
localize functional domains within the CDC25
protein itself and to identify other interacting
proteins.
DNA-Protein Interactions
M. Zoller, K. Johnson, R. Kostriken
The HO endonuclease is a protein that is involved
in the transposition of specific DNA sequences
termed mating-type switching. This enzyme func-
tions at a very early stage of the process by creating
a break in the chromosome in the MAT gene. The
specific phosphodiester bonds that are cleaved were
identifed by R. Kostriken and F. Heffron. Our lab-
oratory has studied the interaction between the HO
endonuclease and its recognition sequence by site-
directed mutagenesis. Such an analysis identified a
core of four nucleotides in this region that could
not be altered for proper recognition by the HO en-
donuclease. In addition, we found seven other
nucleotide positions that affected cleavage but did
not abolish it.
Currently, our attention has turned toward an
understanding of the protein. As in the study of
cAMP-dependent protein kinase, we hope to obtain
a three-dimensional structure for the HO en-
donuclease. Specifically, we would like to deter-
mine how this type of protein recognizes and
cleaves DNA, what regions of the protein are im-
portant for binding and catalysis, and what regions
(if any) play a role in the localization into the nu-
cleus. In addition, we are interested in understand-
ing how the mutants we previously described are
discriminated from wild type. Our efforts this year
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have been focused on overexpression of the protein
in Escherichia coli. Although it has been possible
to produce detectable levels of protein, the ex-
pressed protein represents less than 0.5% of the to-
tal cell protein. At present, we are searching for ex-
pression systems that result in increased yields.
High expression of the HO endonuclease in E. coli
may in fact be lethal.
Site-specific DNA Binding:
Antennapedia Gene Product
R. Kostriken
Homeotic mutants, i.e., mutants in which one part
of an organism is transformed into the semblance
of another part, have been studied extensively in
Drosophila melanogaster. Such mutations demon-
strate that the organization of pattern can be al-
tered by relatively minor genetic changes and that
small changes in regulatory functions may be more
important than small changes in structural compo-
nents in the evolution of an organism. Homeotic
mutants are thought to identify "master-switch"
genes that control the selection of developmental
pathways. An attractive hypothesis based on pre-
liminary experiments in a number of laboratories is
that the protein products of the homeotic genes
function as modulators of gene transcription
through sequence-specific interaction with DNA.
Four of the approximately 15 known Drosophila
homeotic genes reside in the Antennapedia com-
plex. The Antennapedia complex has been studied
extensively using genetic and developmental
methods. One of the genes in this cluster is Anten-
napedia (Antp), a homeotic gene in which domi-
nant mutations have been observed to transform
antennae into legs. Molecular analysis of cDNA
clones has revealed that Antp shares homology
with other homeotic genes, as well as a gene re-
quired for compartmentalization, engrailed, and a
segmentation gene, fushi tarazu. DNA sequence
analysis has shown that these genes share homol-
ogy in a protein-coding region of 60 amino acids.
The 60-amino-acid protein sequence is referred to
as the homeo domain. The homeo domain is also
encoded by genes found in higher vertebrates, in-
cluding humans.
The homeo domain is very basic, which suggests
that it may be involved in nucleic acid interactions.
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Support for this idea comes from the homology of
part of the homeo domain with the DNA-binding
domains of certain bacterial proteins. The struc-
tures of three site-specific DNA-binding proteins
have been determined; in each case, the part of the
protein that contacts the DNA is composed of two
a helices joined together by a sharp turn. Certain
amino acids are required in particular framework
positions in the structure. The homology between
a 20-amino-acid part of the homeo domain and the
bacterial helex-turn-helix motif is in the framework
residues. Additional support for nucleic acid bind-
ing comes from immunolocalization studies of
homeo-domain-containing proteins in embryos
and imaginal disks which show that the antigen is
located exclusively in the nuclei. Recently, it has
been shown that a bacterially produced fusion pro-
tein between E. coli13-galactosidase and the homeo
domain of engrailed exhibits site-specific DNA
binding. Our efforts have focused on elucidating
the mechanism whereby the Antp gene product acts
to control tissue determination.
RESULTS
Expression of the Antp Protein in E. coli. We
have constructed
directs the synthesis of the Antp gene product in E.
coll.
Purification of the Antp Protein. The E. coli
Antp-expressing strain has proved to be an excellent
source of the Antp protein, thereby enabling us to
purify it and to study its biochemical properties in
vitro.
Site-specific DNA Binding. The Antp protein ex-
hibits a substantial affinity for double-stranded
DNA, a characteristic shared by bacterial regula-
tory proteins known to act as transcriptional regu-
lators. There is genetic evidence which suggests that
the Antp gene product is capable of positively
regulating its own expression. We have found high-
affinity binding sites for the Antp protein 5' to the
transcriptional start sites of two Antennapedia
transcription units. We are presently characterizing
these sites in order to determine if they play a part
in the tissue-specific regulation of this gene.
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Cytochrome c2 Is Not Essential
for Photosynthetic Growth of
Rhodopseudomonas capsulate
F. Daldal, S. Cheng
Cytochrome c2 is an electron carrier common to
the photosynthetic and respiratory machinery of
Rhodopseudomonas capsulata. It is structurally
homologous and functionally analogous to the
cytochrome c of mitochondria and to the plasto-
cyanin of chloroplasts. In bacterial photosynthesis,
cytochrome c2 is considered to be the primary elec-
tron donor to the reaction center. Equally, during
respiration, it donates electrons to the cytochrome
oxidase. Thus, this evolutionarily well-conserved
heme protein interacts with the components of the
photosynthetic reaction center, of the ubiquinol:
cytochrome c2 oxidoreductase, and of the cyto-
chrome oxidase. These cytochromes have been well
studied biochemically, spectroscopically, and im-
munologically, but their genetics is still scarce.
Prior to this work, no mutant solely defective in
cytochrome c2 was available from a photosynthetic
organism, and the in vivo role of c2 in photosyn-
thesis remained undefined.
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To isolate a c2 mutant, we first cloned the struc-
tural gene of c2 using synthetic mixed oligonucleo-
tide probes and then determined its nucleotide se-
quence. The deduced amino acid sequence was
found to be in perfect agreement with the known
amino acid sequence obtained from the purified c2
protein. Moreover, the nucleotide sequence showed
the presence of a 21-amino-acid hydrophobic se-
quence, located at the aminoterminal part of c2
and highly analogous to prokaryotic signal se-
quences. Thus, the c2 protein is likely to be synthe-
sized as a precursor which is processed during its
secretion to the periplasm. We have also shown by
appropriate genetic crosses that the cloned c2 gene
is expressed in R. capsulata. The control region of
c2 and the regulation of its expression are now un-
der study using operon fusions between the c2 and
the 13-galactosidase genes.
Insertion and insertion-deletion mutations in the
c2 gene were constructed in vitro. They were then
used to replace the chromosomal wild-type allele
via homologous recombination by genetic crosses
mediated by the "gene-transfer agent." In these mu-
tants, the disruption of the c2 gene was confirmed
by Southern analysis, and the absence of the c2
gene product was proved by immunoprecipitation
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and by reduced-oxidized difference spectrum anal-
ysis. c2 mutants are stable and can grow well by
photosynthesis. Thus, considering that during pho-
tosynthesis, cytochrome c2 is the primary electron
donor to the reaction center, these mutants show
that in the absence of c2, R. capsulata must have
alternative way(s) of reducing the oxidized pho-
tosynthetic reaction center.
Study of a c2 mutant (in collaboration with R.
Prince, Exxon Corporation) by flash spectroscopy
indicated that in the absence of c2, the electron
donor to the reaction center is a membrane-bound
c-type cytochrome with a redox mid-potential of
approximately 350 mV. This electron donation is
very rapid (<100 pec) but only equal to approxi-
mately one fifth of that observed in the wild type.
Comparison of whole cells, spheroplasts, and chro-
matophores of the wild type and the c2 mutants in-
dicates that the rereduction of the reaction center
may well be mediated by the cytochrome c, of the
bc, complex. Even though the amount of the elec-
tron transfer between the bc, complex and the
reaction center seems low in the absence of this
cytochrome, the fact that c2 mutants can grow as
well as a wild-type strain when high light intensity
is available indicates perhaps that the photosyn-
thetic machinery is highly overengineered.
Characterization of MT113, a
Nonphotosynthetic Mutant
of Rhodopseudomonas capsulate
Lacking a Functional Loci
Complex and c-type Cytochromes
E. Davidson, F Daldal
MT113, a nonphotosynthetic mutant of Rhodo-
pseudomonas capsulata, not mapping in the known
cluster of photosynthetic-machinery-related genes,
was isolated by Marrs et al. (FEBS Lett. 113: 289
[1980]) and was shown by spectroscopic analysis to
lack cytochrome c2. With the later establishment
that cytochrome c1, a component of the bc, com-
plex, also absorbs at the same wavelength (550 nm)
as c2, it became clear that MT113 also lacks cyto-
chrome c,. Therefore, we decided to ascertain, in
collaboration with R. Prince (Exxon Corporation)
and B. Marrs (duPont Corporation), whether other
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components of the bc, complex were also missing
in this mutant.
Electron paramagnetic resonance (EPR) spec-
troscopy indicated that membranes derived from
MT113 contained the Rieske Fe-S center at a much
lower amount (<1007o) than the wild-type mem-
branes. This lack of Rieske Fe-S center cannot be
attributed to a general defect in the synthesis of
Fe-S clusters, since the same mutant contains an al-
most normal amount of total Fe-S clusters. Simi-
larly, on the basis of EPR spectroscopy, an anti-
mycin-sensitive signal characteristic of the anionic
semiquinone (K was not detectable in MT113 mem-
branes. Absorption spectroscopy showed that even
though an almost normal amount of b-type cyto-
chromes were present in this mutant, the anti-
mycin-induced red shift of the cytochrome b560 of
the bc, complex was absent.
Analysis of the MT113 membrane proteins by
nondenaturing polyacrylamide gels (LDS-PAGE),
coupled to a heme-specific staining procedure, indi-
cated a general lack of c-type cytochromes. To
determine whether the lack of a functional bc,
complex was related to the absence of specific apo-
proteins corresponding to the bet-complex compo-
nents, cell extracts were submitted to Western anal-
ysis using antibodies raised against purified
cytochrome c2 of R. capsulata and cytochrome b,
cytochrome et, and Rieske Fe-S proteins of Rho-
dopseudomonas sphaeroides. The apoprotein of c2
was not detected, but those of the bet-complex
components were present, although at a lower level,
suggesting that MT113 was able to synthesize the
analyzed bet-complex components but was most
likely not able to assemble them as a functional
complex. Genetic analysis using the gene-transfer
agent of R. capsulata and several plasmids carrying
the structural genes for cytochrome c2 and for bet-
complex components (Rieske Fe-S protein, cyto-
chrome b, and cytochrome c1) indicated that the
single pleiotropic mutation in MT113 is not located
in these genes. The nature of this mutation is still
unknown, but a general lack of c-type (but not b-
type) cytochromes in MT113 suggests that it could
be related to the late steps of c-type cytochrome
biosynthesis.
Interestingly, another c-type cytochrome, c', as
detected by CO difference spectroscopy, seems to
be present at a low level. The possibility that this
mutant synthesizes a b-type c' cytochrome with a
noncovalently bound heme group is now under
study.
Isolation of the Structural Genes for
Rieske Fe-S Protein, Cytochrome b,
and Cytochrome c,, All Components
of the bc, Oxidoreductase of
Rhodopseudomonas capsulate
F. Daldal, E. Davidson, S. Cheng, B. Naiman
The ubiquinol:cytochrome cz oxidoreductase or
the bc, complex is a membrane complex common
to photosynthetic and respiratory electron-transfer
chains of Rhodopseudomonas capsulata. It is
made up of at least a Rieske Fe-S protein, a b-type
cytochrome, and a c-type cytochrome. Models for
electron-transfer pathways between the compo-
nents of this complex (based on spectroscopic,
biochemical, and immunological data) exist, but
the assessment of these pathways by genetic ap-
proaches has not yet been carried out.
To study at the molecular level the electron path-
ways in and around the bc, complex, we sought to
isolate the structural genes for the components of
this complex. A nonphotosynthetic mutant with a
lesion related to the bc, complex, isolated earlier
by Marrs et al. (Biochim. Biophys. Acta 637: 96
[1981]), was used. A cosmid library of R. capsulata,
kindly provided by P. Scolnik (this section), was in-
troduced into this mutant, and colonies that can
grow photosynthetically (Ps') were selected. A plas-
mid, pR14A, carrying approximately 12 kb of R.
capsulate DNA, consisting of five EcoRI fragments
Stu Rsa Rsa Smo Nru Ps
SISES
I I I/ I II /
fbcC fbcB fbcF
Stu
E E
L
of 7, 2.7, 1.5, 1.3, and 0.4 kb, was found to confer
photosynthetic growth to R126 (Fig. 1).
Since the location of the mutation in R126 was
not known, the presence of the structural genes for
the bc,- complex components on plasmid pR14A
was assessed using as probes mixed synthetic
oligonucleotides derived from the conserved amino
acid sequences available from other organisms. The
probe for Rieske Fe-S protein hybridized to the 1.3-
kb EcoRI fragment and those for cytochromes b
and c, recognized the adjacent 2.7-kb EcoRI frag-
ment. Partial nucleotide sequence determination
around the regions detected by hybridization
proved that the structural genes for the Rieske Fe-S
protein, cytochrome b, and cytochrome c, are pres-
ent on pR14A. Moreover, it also indicated that
these genes are clustered to form an operon in this
organism, as also appears to be the case in Rhodo-
pseudomonas sphaeroides.
To determine the role of the bc, complex, inser-
tion mutations localized in the Rieske Fe-S protein,
cytochrome b, and cytochrome c, structural genes
were obtained, and deletions covering part or all of
the bc, genes are being constructed (Fig. 1). These
mutants were found to be impaired in photosynthe-
sis, indicating that a functional bc, complex is ab-
solutely essential for photosynthetic growth of R.
capsulate. However, as expected, they were all able
to grow by respiration. These results not only con-
firmed the presence of an alternate respiratory
pathway independent of the bc, complex, but also
Rsa Rsa Sma Nru Pst
cytC1 cyt5 Fe-S
Sal
S
Sol Pst Sal
S EIS E
I I I I VAA.
Sal Sal Pst Sal
FIGURE 1 Restriction map of the plasmid pR14A carrying the fbc operon containing the fbcF (Rieske Fe-S protein), fbcB
(cytochrome b), and fbcC (cytochrome c1) structural genes. Zigzag arrow indicates direction of the transcription. Straight lines
delineate the deletions, and arrowheads and dots represent the kanamycin cartridge insertions and their orientation in different
genes. + and - indicate the photosynthetic growth phenotype of the obtained insertion mutants.
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indicated that the branching point of these respira-
tory pathways must be before the bc, complex,
and thus, most likely at the quinone pool.
The presence of any other essential gene around
the bc, operon was assessed through the construc-
tion of several insertions localized on the available
12-kb cloned DNA. Mutants carrying these inser-
tions were proficient in photosynthesis, indicating
that they did not interrupt any essential genes. Fur-
thermore, because of their close proximity to the
bc, operon, several of the insertions are very use-
ful for mapping and construction of various muta-
tions located in the bc, structural genes. One of
these insertions, located only a few hundred base
pairs upstream of the Rieske Fe-S protein structural
gene, the first in the bc, cluster, is of special in-
terest. This mutant grows very slowly by pho-
tosynthesis and by respiration, shows aberrant pig-
mentation, and reverts with very high frequency.
The effect of this mutation is unknown, but it is ap-
parently not related to the absence of a functional
bc, complex.
The localization of the mutation in R126, origi-
nally used for the isolation of the bc, operon, is
important because this mutant served as evidence
that discrete catalytic sites for quinone processing
were present in the bc, complex. Various frag-
ments of the R. capsulata DNA present in pR14A
were introduced into this mutant, and it was found
that those not carrying the bc, operon were unable
to rescue this mutation. For a more precise map-
ping, an insertion located at the last codon of the
cytochrome c, gene (and still Ps') was used. By ap-
propriate genetic crosses, it was shown that the mu-
tation aer126 of the mutant R126 is linked to this
insertion at a frequency of approximately 10 %.
This suggested that aer126 might be located either
in the carboxyterminal part of the Rieske Fe-S pro-
tein gene or in the aminoterminal part of the cyto-
chrome b gene. The precise location and the nature
of this mutation are now being determined by direct
DNA sequencing after the cloning of the above-
mentioned region from R126.
Primary Structure of the fbc Operon
of Rhodopseudomonas capsulate
Encoding the Rieske Fe-S, Cytochrome
b, and Cytochrome c, Proteins
E. Davidson, F. Daldal
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The structural genes of the Rieske Fe-S, cytochrome
b, and cytochrome c, proteins, components of the
bc, complex of Rhodopseudomonas capsulata, are
located on two adjacent EcoRI fragments with a to-
tal length of approximately 4.0 kb (Fig. 1). Nucleo-
tide sequence determination of these fragments,
which is now almost completed, suggests that they
are part of an operon (fbc) made up of at least three
genes arranged as follows: fbcF (Rieske Fe-S
protein), fbcB (cytochrome b protein), and fbcC
(cytochrome c1). The intercistronic regions be-
tween fbcF and fbcB and fbcB and fbcC are very
short, 12 by and 17 bp, respectively, and contain
sequences similar to Shine-Dalgarno translation-
initiation sites.
The deduced amino acid sequence from cur-
rently available nucleotide sequences shows that the
Rieske Fe-S protein is 191 amino acids long. It con-
tains a long carboxyterminal hydrophobic stretch
that shows high homology with the Rieske protein
of Neurospora crassa. The four cysteine residues
present among the conserved amino acids of this re-
gion are thought to be involved in the binding of the
2Fe-2S clusters that form the prosthetic group of
this protein. A comparison of hydropathy plots of
the Rieske protein from both organisms suggests
that they have an overall similarity in spatial fold-
ing.
The nucleotide sequences of the fbcB and fbcC
genes are not yet complete; however, the available
data show that the cytochrome b protein is over 400
amino acids long and has several regions of strong
homology with the same protein from such diverse
organisms as yeast, mouse, humans, and Asper-
gillus nidulans. There is less homology with cyto-
chrome b6 and subunit IV (17-kD protein) from
spinach chloroplasts. As with all of these organ-
isms, R. capsulata has conserved its four histidine
residues, which are thought to be ligands of the two
heme groups bound to the cytochrome b protein.
Cytochrome cl appears to be close to 300 amino
acids long and features an aminoterminal well-con-
served heme-binding sequence, and several short
regions of homology with cytochrome c, from
yeast. No strong homology is observed between the
bacterial cytochrome c, and the cytochrome f of
plant chloroplasts. A stretch of amino acids similar
to prokaryotic signal sequences is also present at
the beginning of the fbcC gene.
Once completed, the nucleotide sequence of the
fbc operon will obviously provide important basic
knowledge for future studies on the structure-
function relationship in the bci complex of R.
capsulata.
Spectroscopic Analysis of
Rhodopseudomonas capsulata
Reaction Centers
D.C. Youvan
In collaboration with R. Prince at Exxon Research
and Engineering Company, we have successfully
characterized wild-type reaction centers from
Rhodopseudomonas capsulata, using several spec-
troscopic techniques (R. Prince and D.C. Youvan,
in prep.). All of these measurements have previ-
ously been made in Rhodopseudomonas sphae-
roides, and it has been our goal to repeat the mea-
surements on R. capsulata reaction centers in
preparation for the analysis of site-specific mutants.
Wild-type reaction centers were prepared by a
highly efficient and economical procedure that we
have developed in the last year for R. capsulata.
LHII- deletion backgrounds (Youvan et al., Gene
38: 19 [1985]) are used as a source of protein, since
these strains may be grown photosynthetically in
rich medium without reversion of the LHII- lesion.
Previously used strains such as MW442 (point mu-
tation in LHII) rapidly revert under photosynthetic
growth conditions, and the LHII antenna may con-
taminate the reaction center preparation. Chro-
matophores are prepared, solubilized in LDAO,
and applied to a Bio-Gel DEAE-agarose column.
This column material has a remarkably high bind-
ing capacity for reaction centers: a 5-liter prepara-
tion may be bound to a 20-m1 column, yielding 30
mg of highly purified reaction centers. No con-
taminating proteins are observed in this one-step
purification at moderate levels of protein loaded
for SDS-PAGE. Typical A260:A800 ratios are 1.4.
Some of this material was given to M. Michel, who
is attempting crystallization. Other laboratories are
also using our mutant and procedure for purposes
of crystallography.
An optical absorption spectrum of wild-type R.
capsulata reaction centers reveals three absorption
peaks in the near-infrared very similar to the R.
sphaeroides spectra. An actinic light source was
used to bleach P870; the difference spectrum allows
direct observation of the special pair chlorophylls.
The dark spectrum is recovered after the light is
turned off. These data are almost identical to those
from previous experiments conducted on R. sphae-
roides reaction centers; however, our reaction
centers contain wild-type levels of carotenoids.
The kinetics of electron transfer reactions lead-
ing to the reduction of QA and QB were inferred by
measuring the kinetics of the back reactions lead-
ing to rereduction of the special pair. Rereduction
was monitored by measuring the recovery rate of
photobleaching at 600 nm. Our preparation of
reaction centers shows rereduction of the special
pair with a half-time of 80 msec following a 7007o
saturating single flash. Upon addition of 10 pm ubi-
quinone-10, this half-time increases to about 1 sec-
ond. Further addition of 1 mm ametryne (an atra-
zine derivative) results in the half-time returning to
the 80-msec value. These values are very similar to
what has been measured for R. sphaeroides and
Rhodopseudomonas viridis.
We interpret the flash kinetic data as follows. The
reaction centers as prepared contain QA but not
QB, and thus electron transfer following a single-
turnover flash of light results in the stable genera-
tion of oxidized bacteriochlorophyll dimer (special
pair) and reduced (r,. This state decays by direct
electron transfer from the quinone to the dimer
with a half-time of approximately 80 msec. Addi-
tion of ubiquinone-10, in this case about 3 mole-
cules per reaction center, reconstitutes QB, so that
electron transfer can now proceed from QA to QB.
The back reaction from QB to the dimer is very
much slower than from QA to the dimer, with a
half-time of about 1 second. Addition of ametryne
displaces QB, and the reaction centers then behave
as they did before reconstitution of the QB activity.
This series of measurements will be part of the rou-
tine analysis for reaction centers bearing site-
specific mutations at the QA, QB, and Fe binding
sites.
Wild-type reaction centers have been character-
ized by a series of cryogenic electron paramagnetic
resonance (EPR) measurements that should also be
useful in the routine characterization of site-
specific mutants. A light-induced signal was ob-
served in the g = 2.0 region, which is very similar
to the signal observed in R. sphaeroides assigned to
the photooxidized special pair B. The R. capsu-
lata peak appears to be slightly broader (-,0.5
gauss) than the R. sphaeroides R26 peak. Illumi-
nated reaction centers plus dithionite show a
special-pair triplet signal near g = 2.0 that is very
similar (but less intense) to the R. sphaeroides trip-
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let. Again, the R. capsulata signal appears to be
slightly broader, indicating that the unpaired elec-
tron is confined to a slightly different box than
in R. sphaeroides. Under these conditions, a very
strong signal is observed at g = 1.82 that has been
assigned to the QA semiquinone anion, (see
Fig. 2).
Clearly, the R. capsulata reaction centers are
spectroscopically very similar to the much studied
preparations from R. sphaeroides. This will allow
the application of spectroscopic techniques to the
question of what functional changes occur after
site-specific mutagenesis of the quinone and Fe
binding sites. This greatly facilitates the structure-
function problem, since relatively simple spec-
troscopic analysis may be used to characterize
mutants without resorting to X-ray crystallogra-
phy. Our preliminary spectroscopic measurements
strongly suggest that the vast spectroscopic litera-
ture on R. sphaeroides is directly applicable to
R. capsulata.
Site-specific Mutagenesis of the
Photosynthetic Apparatus
E.J. Bylina, S. Ismail, D.C. Youvan
In vitro mutagenesis has been used to study
structure-function relationships of amino acid
residues of the proteins involved in the light reac-
tions of photosynthesis. In the light reactions,
membrane proteins interact with prosthetic groups
(bacteriochlorophyll, quinones, and carotenoids)
to harvest light energy efficiently and to transduce
this energy into a biologically useful reductant (for
review, including genetics, see Youvan and Marrs,
in Molecular Biology of the Photosynthetic Ap-
paratus, Cold Spring Harbor Laboratory, Cold
Spring Harbor, New York [1985]; Youvan and
Marrs, Sci. Am. [1986] in press).
Unique restriction sites have been introduced
into the plasmid-borne puf operon. This 3000-bp
operon carries the structural genes encoding four
membrane polypeptides: the photochemical core of
the reaction center (L and M subunits) and light-
harvesting I (LHI; a and subunits). These restric-
tion sites divide the operon into three domains: the
LHI subunits, the L subunit, and the M subunit.
Incorporation of restriction sites allows straightfor-
ward cloning of these genes into M13 vectors and
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R. capsulata U34 Reaction Centers
A801 = 80
20 mW, 2.0 mT, 5K
FIGURE 2 EPR signal from R. capsulata reaction centers
showing the semiquinone anion radical QA. Using EPR and
optical spectroscopy, single prosthetic groups within the 100-
kD reaction center may be observed. Spectroscopy expedites
the analysis of site-specific mutations that affect peptide-
prosthetic group interactions, since much information can be
obtained without resorting to X-ray crystallography.
simple shuttling of the mutagenized fragment back
into the plasmid bearing the puf operon (pU21).
This division of the puf operon is especially impor-
tant for the two reaction center subunits. The L and
M subunits are very homologous. Without separa-
tion of these two subunits, results from plaque
hybridizations are difficult to interpret.
Oligonucleotide-directed in vitro mutagenesis of
the LHI (B870) polypeptides of Rhodopseudo-
monas capsulata has been used to study bacterio-
chlorophyll binding (E.J. Bylina, in prep.). The
putative bacteriochlorophyll binding sequence Ala-
X-X-X-His has been extensively mutagenized in
both subunits. Seven alanine mutations have been
constructed in M13 vectors, shuttled back into
pU21, and returned to R. capsulata deletion strains
(Youvan et al., Gene 38: 19 [1985]) for phenotypic
analysis. Six histidine mutations have also been
analyzed in the deletion strains. In the future, simi-
lar experiments may be conducted on theLHII an-
tenna (Youvan and Ismail, Proc. Natl. Acad.
[1985] in press).
The results of our mutagenesis experiments are
as follows: (1) Histidine is absolutely required for
biogenesis of the LHI complex. Substitution at this
position results in the loss of the LHI complex, a
reduced level of reaction centers in the membrane,
and a decreased rate of growth under photosyn-
thetic conditions. (2) Residues with small side
chains can substitute for alanine. Replacement with
glycine or cysteine results in a functional LHI com-
plex, whereas a valine substitution results in a re-
duction of the LHI complex. Larger substitutions
at alanine result in the same phenotype as seen for
the histidine mutations. Similar results were ob-
tained for a reaction center bacteriochlorophyll
binding site. Mutagenesis of the histidine ligand to
the bacteriochlorophyll dimer (special pair) from
the L subunit (HL174) to leucine results in the com-
plete loss of the reaction center from the mem-
brane. However, this mutant does assemble LHI,
breaking the previously observed pleiotropy be-
tween the reaction center and LHI. Hence, LHI
biogenesis is not conditional on the insertion of
the reaction center into the membrane. Chromato-
phores from this mutant serve as a pure source of
the LHI antenna for spectroscopy and purification.
The availability of crystal structure data from
reaction centers of Rhodopseudomonas viridis al-
lows mutagenesis experiments to now be intelli-
gently designed in our system. IL230, in the L
subunit of the reaction center, is found in the QB
pocket of the reaction center. A unique BamHI re-
striction site has been introduced at this position.
Using this BamHI mutation as our "wild-type"
template, we can enrich for mutations at this isoleu-
cine site by cutting the M13 RF (replicative form)
with the BamHI enzyme after performing oligonu-
cleotide-directed mutagenesis on the template. Any
changes in the isoleucine codon will result in a
BamHI-resistant template, whereas wild-type tem-
plates remain BamHI-sensitive. RFs linearized with
BamHI are taken up poorly by recipient cells. This
method will be used at other residues that play im-
FIGURE 3 Isolation of two R. capsulata mutants
defective in phytoene dehydrogenase. Strains
BPY69 and BPY102 accumulate phytoene, which
can be detected by its characteristic absorption
spectrum, with maxima at 275, 285, and 297. The
structure of the compound is shown at the top of
the figure.
portant roles in the reaction centers as indicated
from the crystal structure.
Cloning a Gene Coding for
Phytoene Dehydrogenase
in Photosynthetic Bacteria
G. Giuliano, D. Pollock, P.A. Scolnik
We are interested in using carotenoid pigments as
a model system for genetic studies in plants. The
chemistry of these compounds has been very well
studied during the last 30 years, but the fact that the
biosynthetic enzymes are labile membrane-bound
proteins has hampered the molecular studies. One
possible approach toward solving this problem is to
use a very simple system, such as photosynthetic
bacteria, to identify the genes responsible for the
biosynthesis of these pigments.
The first five steps of the carotenoid biosynthetic
pathway are common among photosynthetic bacte-
ria and plants, thus opening the way for using in-
formation obtained in this system for the study of
higher plants. A key enzyme in the pathway is phy-
toene dehydrogenase (Pdh), which mediates the
conversion of phytoene into colored carotenoids
(see Fig. 6). To clone the gene responsible for this
step, we analyzed several point mutations in the
carotenoid biosynthetic pathway, and we identified
two strains (BPY69 and BPY102) that accumulate
phytoene (Fig. 3). A search for sequences that com-
plement these mutations resulted in the isolation of
crtl, the gene that presumably codes for Pdh (Fig.
4).
To characterize further the cluster of genes cod-
ing for carotenoid biosynthesis in this bacterium,
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FIGURE 4 Mapping of the crtl gene. A 4.3-kbp BamHI fragment, containing the gene, was cloned in
pBR322. Deletions were constructed with the enzymes listed in the figure, and spectinomycin resistance
gene cartridges were inserted at these sites. This allows the mobilization of these plasmids by conjugation
and the mapping of the mutations. On the basis of this result, the gene is located between the left BamHI
site and the Sphl site.
we constructed several insertions with kanamycin
and spectinomycin gene cartridges (Fig. 5). This
technique allows for the fine structure mapping of
sequences by insertional mutagenesis. We also ana-
lyzed the membrane proteins accumulated by the
different mutants (Fig. 6). Mutations in the early
steps of carotenoid biosynthesis result in the loss of
several abundant membrane proteins. On the basis
of these results, we postulate that carotenoids exist
in the membrane in a stable form only if they are
bound to structural proteins. The carotenoid and
its binding protein(s) would stabilize each other;
the loss or inactivation by mutation of either com-
ponent would result in a pleiotropic effect in which
both carotenoids and binding proteins are missing
from the membrane.
This model has an immediate application on our
plant projects, for it is very likely that carotenoid
binding proteins also exist in plants. This implies
that carotenoid mutants can be obtained by either
deficiencies in the biosynthetic enzymes or in the
binding proteins, which is highly consistent with
the genetic information available from several plant
systems.
The Molybdenum-Pterin Binding Protein
in Clostridium pasteurianum
S. Hinton, C. Slaughter, W. Eisner, B. Merritt, T Fischer
The known metabolic function of molybdenum
(Mo) is as a component of two distinct cofactors
found in various redox enzymes. We have been
studying Mo metabolism to understand how molyb-
date, Mo042, is processed for its eventual incor-
poration into molybdoenzymes. We have identified
several molybdoproteins in Clostridium pasteuria-
num that have characteristics which suggest that
they may play a role in Mo metabolism. The evi-
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FIGURE 5 Mapping of the carotenoid biosynthetic cluster by site-directed gene car-
tridge mutagenesis. The phenotype of the insertions allows the mapping of the different
genes.
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FIGURE 6 Biochemical-genetic map of the carotenoid biosynthetic pathway in R. capsulata. Question marks indicate genes that
have not been identified.
dence prompted us to propose the hypothesis that
during the biogenesis of Mo cofactors, precursors
of the cofactor are protein-bound and therefore
may be isolated and characterized.
The major Mo-binding protein (Mop) we identi-
fied in C. pasteurianum was isolated and biochemi-
cally characterized. The isolated protein contains
approximately 1 Mo atom per molecule of 5700
molecular weight as determined by gel electropho-
resis. Native Mop has a peak absorbancy at 293 nm,
and the oxidized protein releases a pterin-like fluo-
rescent chromophore. The purified chromophore
was treated with alkaline permanganate, which oxi-
dizes 6-alkylpterins to pterin-6-carboxylic acid.
Pterin-6-COOH was isolated and identified from
the oxidized mixture by reverse-phase high-per-
formance liquid chromatography. Mop appears to
bind a Mo atom and a pterin derivative, which are
the components of the Mo-cofactor (Mo-co). The
molybdopterin species dissociated from Mop was
not catalytically active in the biological Mo-co as-
say. Elemental analysis of the molybdopterin spe-
cies showed that unlike the active cofactor, the
pterin is not phosphorylated, suggesting that the in-
active molybdopterin associated with Mop might
be a precursor to Mo-co.
The mop gene cloned in Escherichia coli was de-
tected by immunoscreening a genomic library of C.
pasteurianum, and the protein from the clone
cross-reacting with Mop antisera was shown to have
the same electrophoretic mobility as purified pro-
tein. The identity of the gene was established by se-
quencing the insert of clostridial DNA, and the
deduced amino acid sequence of an open reading
frame proved to be identical to the first 12 residues
of the purified protein. The DNA sequence flank-
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ing the mop gene contains promoter-like consensus
sequences observed in promoter regions in E. coli.
The putative promoter and Shine-Dalgarno se-
quences before the initiation codon are probably
responsible for the expression of Mop in E. coli.
The deduced amino acid sequence of Mop has
been helpful in understanding the biochemical
properties of the protein and in predicting a func-
tion. The amino acid composition shows that the
protein is hydrophobic (50% of the residues are
nonpolar), lacks aromatic and cysteine residues,
and has a calculated molecular weight of 7038. The
absence of aromatic amino acids in Mop suggests
that the UV absorbancy of Mop is attributed to the
bound pterin chromophore. The aminoterminal re-
gion is rich in positively charged amino acids
(30%), and the pattern and type of residues suggest
that regions may form an a-helix-turn-a-helix
structure observed in DNA-binding proteins. The
aminoterminal amino acid sequence of Mop has
30% sequence homology with the DNA-binding re-
gion in the bacteriophage P22 repressor protein.
Presently, we are investigating the DNA-binding
properties of Mop because of the high degree of ho-
mology with DNA-binding proteins.
Aminoterminal amino acid sequence analysis of
Mop revealed that there are two or more related
proteins in the purified protein preparation, be-
cause there appear to be two amino acid residues at
several positions. The results suggest that the mop
gene has been duplicated and the Mop variants co-
purify. We have isolated and sequenced three dis-
tinct mop genes; the deduced amino acid sequence
from the three genes accounts for all of the ambig-
uity observed in the amino acid sequence data and
revealed two additional amino acid substitutions. A
comparison of the DNA sequence of the mop genes
(family) showed greater than 90% homology with-
in the coding region. The DNA sequence flanking
the mop genes is not conserved except within a
15-nucleotide sequence (TGTATAATAATAAGT),
which is a direct inverted repeat spanning the puta-
tive TATAATA box.
In previous studies, we demonstrated that the
level of molybdoproteins in C. pasteurianum re-
sponds to "Mo availability," and it seems reason-
able that Mop may be a regulatory protein binding
the anabolic source of Mo, allowing the cell to regu-
late molybdoenzyme synthesis according to the
availability of an essential component, molybde-
num.
Bacterioferritin from Azotobacter
vinelandii
S. Hinton, C. Slaughter, W. Eisner, T. Fischer
Azotobacter vinelandii has the ability to accumu-
late iron at levels above its needs for growth. The
iron appears to be stored in magnetically ordered
aggregates, and the molecule harboring the iron,
bacterioferritin, appears to be similar to ferritin in
that it contains an average of 1600 Fe atoms in
an oxide-hydroxide-phosphate core. However, bac-
terioferritin is a 13-type cytochrome isolated from
the soluble fraction of the cell lysate. It has been
proposed that bacterioferritin may be an iron-
storage protein.
We devised a large-scale purification scheme in
which milligram quantities of bacterioferritin crys-
tals are isolated in three steps. The aminoterminal
amino acid sequence revealed high sequence ho-
mology with the Escherichia coli bacterioferritin,
but there appears to be no homology with ferritin
(horse spleen). Oligonucleotides were synthesized
on the basis of the aminoterminal amino acid se-
quence of the protein, and Southern hybridization
of total genomic DNA showed a 1.6-kb Xhol-Sall
fragment that has homology with two distinct bac-
terioferritin oligonucleotide probes. The Xhol-Sall
fragment has been cloned into M13 mpl8 for re-
striction mapping, site-specific mutagenesis, and
DNA sequencing analysis. Our goal is to under-
stand the physiological role of bacterioferritin.
Site-directed mutagenesis for structure-function
studies may help determine the effect mutations
have on iron metabolism.
Biogenesis of the Molybdenum Cofactor
S. Johann, S. Hinton
Our goal is to understand how the nutrient molyb-
date, Moat', is biologically processed or chemi-
cally transformed into a biological catalyst. In
Klebsiella pneumoniae, five gene products (nifB, Q,
N, E, and V) are required for the synthesis, modi-
fication, and/or insertion of the unique iron-
molybdenum cofactor of nitrogenase. In Esche-
richia coli, there are also five known gene products
(chlA, B, D, E and G) thought to be involved in the
biosynthesis of the molybdenum (Mo) cofactor.
Even though the two Mo cofactors are distinct, it
has been proposed that the chlD gene product may
be a common step early in their biogenesis.
We have isolated several clones that comple-
mented each of the chl (Mu insertion) mutations,
and Southern hybridization analysis showed that
the clones have sequence homology with the chro-
mosomal DNA flanking the Mu insertion in their
respective chl mutant. DNA sequence analysis of
the DNA fragment containing the chlD gene re-
vealed an open reading frame that appears to code
for a protein with a deduced molecular weight of
approximately 34,000.
The ch1G gene, which is thought to be involved
in the insertion of Mo into the cofactor, has been
cloned and is presently undergoing DNA sequence
analysis. We are interested in looking at the
deduced amino acid sequence of chlD and ch1G
gene products for structure-function studies of the
chl gene products that appear to be directly in-
volved in transforming molybdate into the molyb-
denum cofactors.
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CELL BIOLOGY
Over the past year, we have continued our studies into the biology and biochemis-
try of cell transformation and differentiation. We have employed growth factors, on-
cogene proteins, monoclonal antibodies, heat shock, somatic-cell microinjection,
two-dimensional gel electrophoresis, and molecular biology to further our analysis
into these biological systems. Joining us this year as a Senior Staff Investigator
was David Spector from Baylor, who uses electron microscopy to look at cell ar-
chitecture, especially the nuclear structure. He brings a new expertise to our
studies involving oncogenes and transformation. David Helfman and Bill Welch
were promoted to Staff Investigator and Senior Staff Investigator, respectively, ap-
pointments that are well deserved. Below is an account of the work carried out
over this past year.
MOLECULAR BIOLOGY OF THE CYTOSKELETON
D.M. Helfman S. Cheley Y. Yamawaki-Kataoka
E. Kuismanen L.A. Finn
The major emphasis of our research continues to be
the molecular and cellular biology of the cytoskele-
ton. During the past year, we have concentrated our
efforts on studying tropomyosins in nonmuscle
cells (rat fibroblasts) and the genes that encode
these proteins. Significant progress has been made
in elucidating the structure of three of the five fi-
broblast tropomyosins. The complete structure of
rat skeletal-muscle 13-tropomyosin was also deter-
mined. Interestingly, we have found that rat em-
bryonic fibroblast tropomyosin 1 and skeletal-
muscle [3-tropomyosin are expressed from a single
gene via tissue-specific RNA splicing. In addition,
we have isolated cDNA clones to a number of cellu-
lar proteins including the 90-kD heat-shock pro-
tein, nonerythroid spectrin, and the type II regula-
tory subunit of cAMP-dependent protein kinase. A
brief description of these studies is given below.
Characterization of cDNA Clones
Encoding Nonmuscle Tropomyosins
Y. Yamawaki-Kataoka, D.M. Helfman
To study the molecular basis for the five tropomyo-
sin isoforms expressed in rat fibroblasts, we have
been isolating and characterizing cDNA clones en-
coding these proteins. Last year, we described the
complete primary amino acid sequence of rat em-
bryonic fibroblast tropomyosin 1 (TM-1) deduced
from cDNA clones (Yamawaki-Kataoka and He lf-
man, J. Biol. Chem. 260: 14440 [1985]). These
studies revealed that TM-1, like smooth muscle and
skeletal muscle, contained 284 amino acids. How-
ever, comparison of the sequence of TM-1 with that
for skeletal-muscle tropomyosins indicated that
these isoforms differ in only two regions: an inter-
nal region (amino acids 189-213) and a region at the
carboxyterminal domain (amino acids 258-284).
These two isoform-specific regions correspond to
the troponin-T-binding domains of skeletal-muscle
tropomyosin. Since nonmuscle cells do not contain
a troponin complex, these different regions in
TM-1, compared with those of the skeletal-muscle
protein, likely provide specialized function(s) to the
molecule. Using our cDNA clones to TM-1 as a
probe to analyze mRNAs expressed in various rat
tissues, we identified a 1.1-kb transcript present in
rat fibroblasts, stomach, and uterus, but a 1.3-kb
transcript in skeletal muscle. These studies sug-
gested a high degree of homology between the fi-
broblast and skeletal-muscle transcripts and
prompted further studies on the skeletal-muscle
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transcript. We subsequently isolated cDNA clones
encoding the skeletal-muscle mRNA and corre-
sponding genes that encode both the fibroblast and
skeletal-muscle mRNAs. These studies showed that
tissue-specific splicing and polyadenylation are
responsible for the generation of nonmuscle and
muscle isoforms from a single gene (see below).
This year, we have extended our studies to cDNA
clones encoding rat embryonic fibroblast tropo-
myosin 2 (TM-2) and 4 (TM-4). Although analyses
of these clones are still in progress, we have deter-
mined most of the amino acid sequence of TM-2
and the complete amino acid sequence of TM-4. It
appears that TM-2 contains 284 amino acids,
whereas TM-4 was found to contain only 247
amino acids. This is due to two 21-amino-acid dele-
tions at positions 23-43 and 60-80 of the skeletal-
muscle sequence, and a 5-residue extension at the
amino terminus. These structural features of TM-4
correlate well with functional differences in the
protein, compared with those of other nonmuscle
tropomyosins. For example, it was recently reported
that TM-4 shows less ability for head-to-tail poly-
merization and lower affinity to actin than the
high-molecular-weight fibroblast tropomyosins
(TM-1, TM-2, and TM-3) (Matsumura and Yama-
shiro-Matsumura,
Comparison of the amino acid sequences of TM-2
and TM-4 with sequences of other nonmuscle and
muscle (skeletal, cardiac, and smooth) tropomyo-
sins shows them to be highly homologous. Never-
theless, structural differences do exist among the
various isoforms. Interestingly, TM-1, TM-2, and
TM-4 smooth-muscle and platelet tropomyosins
were all found to be highly homologous to each
other at their carboxyterminal domains, compared
with skeletal and cardiac tropomyosins. These
divergent regions likely represent functional do-
mains of the protein.
The function(s) of each of the nonmuscle tropo-
myosins is presently unclear. Whether the altera-
tions in patterns of tropomyosins expressed in fi-
broblasts following transformation are directly
responsible for the changes in the organization of
microfilaments and changes in cell shape are not
known. Presently, we wish to ask questions about
the function of the various isoforms expressed in fi-
broblasts. By using our cloned cDNA, we hope to
express particular tropomyosin isoforms in trans-
formed cells where the cellular gene product is
repressed. Such studies may determine if expression
of tropomyosin results in changes in microfilament
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organization and cell shape. In addition, experi-
ments are currently under way to study the molecu-
lar basis for the alterations of tropomyosin expres-
sion following transformation.
Characterization of cDNA Clones
Encoding Muscle and Nonmuscle
Tropomyosins: Evidence for
Tissue-specific RNA Processing
S. Cheley, D.M. Helfman
Using the cDNA clones encoding rat embryonic fi-
broblast TM-1 as a probe to study mRNA in vari-
ous rat tissues, we identified a 1.1-kb mRNA in rat
fibroblasts and a 1.3-kb mRNA in skeletal muscle.
These studies indicated a high degree of homology
between the fibroblast and skeletal-muscle mRNAs
and prompted structural studies on the skeletal-
muscle transcript. To isolate cDNA clones encod-
ing skeletal-muscle tropomyosins, a cDNA library
was constructed in the plasmid expression vectors
pUC8 and pUC9. The library was screened with
"P-labeled DNA prepared from cDNA clones en-
coding rat embryonic fibroblast TM-1. A series of
overlapping clones encoding rat skeletal-muscle (3-
tropomyosin were identified. DNA sequence analy-
sis was performed in order to determine the amino
acid sequence of the protein. One clone was found
to contain the entire coding and 3'-untranslated
regions as well as a portion of the 5'-untranslated
region. The complete nucleotide sequence of the
skeletal-muscle cDNA and the deduced amino acid
sequence are shown in Figure 1. The amino acid se-
quence of the rat skeletal-muscle cDNA is identical
with that of rabbit skeletal-muscle 3- tropomyosin.
Comparison of the rat skeletal-muscle1:3-tropomyo-
sin-coding sequence with that of the rat embryonic
FIGURE 1 Nucleotide and derived amino acid sequence
comparison of cDNA clones encoding rat skeletal-muscle (3-
tropomyosin (RSM) and rat embryonic fibroblast tropomyosin 1
(REF). The deduced amino acid sequences for the skeletal-
muscle and fibroblast tropomyosins are shown above and be-
low, respectively, the corresponding nucleotide sequences.
Nucleotide sequences specifying the entire coding region of
284 amino acids as well as the 5'- and 3'-untranslated regions
are shown. The polyadenylation signal AATAAA is underscored.
Boxed areas indicate the isoform-specific coding sequences.
Most of the fibroblast cDNA sequence is shown as dashed
lines, indicating identity with the skeletal-muscle tropomyosin
isoform.
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FIGURE 1 (See facing page for legend.)
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fibroblast TM-1 revealed some interesting struc-
tural features (Fig. 1). The skeletal-muscle tropo-
myosin was found to be identical with the fibroblast
isoform except for two distinct regions: one internal
region (amino acids 189-213) and one carboxyter-
minal region (amino acids 258-284). In this regard,
biochemical studies from other laboratories have
indicated the presence of two troponin-T-binding
sites on skeletal-muscle tropomyosin. One tropo-
nin-T-binding site is located at the carboxyl termi-
nus of the tropomyosin molecule, and the second
site is located near Cys-190. It is apparent from the
sequence comparison presented in Figure 1 that
these troponin-T-binding domains correspond to
those regions where the sequences differ between
the fibroblast and skeletal-muscle isoforms. Thus,
these isoform-specific regions appear to delineate
functional domains of the protein. The skeletal-
muscle cDNA was found to have a relatively long
3'-untranslated region (233 nucleotides), compared
with that from fibroblasts (73 nucleotides). These
differences in the 3'-untranslated region explain the
size difference observed between the skeletal-
muscle mRNA and the fibroblast mRNA.
Since muscle and nonmuscle cells contain differ-
ent tropomyosin isoforms, we investigated the tis-
sue specificity of the skeletal-muscle cDNA clone.
Northern transfer analysis of various rat tissue
RNAs using our skeletal-muscle cDNA as a probe
revealed the existence of two hybridizing classes of
mRNA: a 1.3-kb mRNA species present in adult
skeletal muscle and a 1.1-kb mRNA expressed in
smooth muscle (stomach, uterus, and vas deferens)
and nonmuscle cells (embryonic fibroblasts). Car-
diac muscle, on the other hand, contains neither
mRNA species. This is consistent with previous
reports which indicate that rat cardiac muscle con-
tains a single isoform of tropomyosin that is likely
encoded by the same gene that encodes rat skeletal-
muscle a-tropomyosin. To determine which se-
quences encoding amino acids 189-213 in skeletal-
muscle or fibroblast RNA were expressed in various
smooth-muscle cells, SI-nuclease analysis was per-
formed. The results indicated that identical tropo-
myosin isoforms are expressed in fibroblast and
smooth-muscle cells. In no case have we detected
mRNAs containing a combination of the "fibro-
blast-specific" sequences with the "skeletal-muscle-
specific" sequences. This suggests that co-expression
of specific isotype-switch regions (amino acids
189-213 and 258-284) is essential to the function of
these tropomyosin isoforms. In agreement with
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Northern blot analyses, no S1- nuclease -protected
fragment was detected in cardiac muscle. This fur-
ther confirms that rat cardiac tissue does not ex-
press the II isoform of tropomyosin.
Since the nucleotide sequence of the rat skeletal-
muscle cDNA was found to be identical with the se-
quence of the rat embryonic fibroblast TM-1 cDNA,
except for the two isoform-specific regions and the
3'-untranslated sequences, the data strongly sug-
gest that both mRNAs arise from a common gene
via alternative RNA processing. In this regard, we
have analyzed rat tropomyosin genomic clones and
have determined that both mRNAs are expressed
from a single gene via tissue-specific processing (see
below).
Nonmuscle and Muscle Tropomyosin
Isoforms Are Generated from a
Single Gene by Alternative RNA
Splicing and Polyadenylation
D.M. Helfman, S. Cheley, E. Kuismanen, L. Finn,
Y. Yamawaki-Kataoka
Two possibilities exist to explain the expression of
the fibroblast and skeletal-muscle mRNAs de-
scribed in the previous section. Either a single gene
codes for these two isoforms via tissue-specific
RNA processing or both fibroblast and skeletal-
muscle tropomyosins are encoded by two genes that
are highly conserved. The cDNA clones we isolated
to rat embryonic fibroblast TM-1 and skeletal-
muscle 0-tropomyosin were used to assess the num-
ber and structure of the corresponding genes. Anal-
ysis of genomic clones indicated that there are two
separate loci in the rat genome that contain se-
quences complementary to the fibroblast and
skeletal-muscle cDNA clones. One locus contains a
functional gene and the other represents a pro-
cessed pseudogene.
Analysis of genomic clones representing the
functional gene indicated that one clone (3.17) con-
tained sequences to both the 5'- and 3'-untranslated
sequences of the fibroblast and skeletal-muscle
cDNAs. Since this clone appeared to contain se-
quences to the entire functional gene, including the
5'- and 3'-flanking regions, 3,17 was selected for
detailed analysis. By using restriction enzyme anal-
ysis, we constructed a complete restriction map of
the DNA (Fig. 2). Positions of the coding regions
were determined by Southern blot analysis using
32P- labeled cDNA clones as probes and then by di-
rect DNA sequence analysis. As shown in Figure 2,
the gene is divided into 11 exons and spans approxi-
mately 10 kb. As predicted from the cDNA analy-
sis, common exons were found for amino acids
1-188 (exons 1 through 5) and for amino acids
214-257 (exons 8 and 9). Exon 6 was found to con-
tain sequences for amino acids 189-213 in fibro-
blasts, whereas exon 7 was found to contain se-
quences for amino acids 189-213 in skeletal-muscle
tropomyosin. In addition, exon 10 was found to
encode sequences to the carboxyterminal region
of skeletal-muscle tropomyosin (amino acids 258-
284), including the 3'-untranslated sequences through
the polyadenylation site. Likewise, exon 11 was
found to encode sequences to the carboxyterminal
region of fibroblast tropomyosin (amino acids
258-284), including the 3'-untranslated sequences
through the polyadenylation site. The organization
of this gene indicates that a combination of both
alternative RNA splicing and polyadenylation is
responsible for the generation of the tissue-specific
isoforms. Southern blot analysis of high-molecular-
weight DNAs from a variety of cells and tissues (fi-
broblast, liver, heart, skeletal muscle, brain, and
stomach) reveals no rearrangement of the DNA at
this level of detection, suggesting that the mRNAs
are not generated by DNA rearrangements.
To determine if all mRNAs expressed from this
gene are transcribed from the same promoter,
primer-extension and Sl-nuclease experiments were
carried out. These studies demonstrated that all
mRNAs (fibroblast, stomach, uterus, vas deferens,
and skeletal muscle) contain identical 5'-untrans-
lated regions and involve the use of the same pro-
moter. Thus, the two different species of mRNA
generated from this gene are processed from a tran-
script that has identical 5' ends. Furthermore, the
first exon contains the entire 5'-untranslated se-
quences in addition to the first 38 amino acids of
the protein.
The structural features of the tropomyosin gene
raise a number of questions concerning the mecha-
nisms involved in the tissue-specific expression of
this gene. Figure 3 represents a schematic model for
the generation of protein isoforms from the tropo-
myosin gene. Although capping of the primary
transcript is known to occur very early after tran-
scription begins, the temporal order of polyadenyl-
ation and splicing remains to be determined. In the
case of the tropomyosin gene where both alterna-
tive splicing and polyadenylation are involved,
regulation could occur at both the levels of splice
site selection and polyadenylation. The mecha-
nism(s) responsible for generating the two tropo-
myosin isoforms must be under regulatory control.
In no case have we detected both the 1.1-kb and
1.3-kb mRNAs in the same cell type, nor have we
observed mRNAs containing a combination of
the fibroblast-specific exon and a skeletal-muscle-
specific exon, i.e., exon 6 with exon 10 or exon 7
with exon 11. These results clearly indicate that
utilization of tissue-specific exons does not occur in
a random manner but is under fine control. The tis-
sue specificity of the RNA processing events im-
plies developmental regulation of these processes.
Understanding the mechanism(s) by which differ-
ent mRNAs arise from the tropomyosin gene has
important implications for understanding muscle
gene regulation and the determination of muscle
type (e.g., smooth vs. skeletal muscle). In addition,
the mechanisms by which different proteins are
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FIGURE 2 Physical map of the tropomyosin gene contained in 1. clone 17. Boxes represent exons, and lines represent introns.
The amino acids encoded by each exon were determined by sequence analysis and are indicated. Positions of the fibroblast and
skeletal-muscle-specific exons encoding amino acids 189-213 and 258-284 are indicated by F and S, respectively. All other exons
are common to the fibroblast and skeletal-muscle mRNAs. The restriction sites for BamHl (B), Ctal (C), EcoRl (R), Kpnl (K), and
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turned on and off during myogenesis are not
known. When myoblasts fuse to form myotubes,
there is cessation of cell division together with
repression of the fibroblast TM-1 synthesis, fol-
lowed by fusion of the myoblasts with induction of
skeletal-muscle 11-tropomyosin. Understanding the
various levels of control involved in tropomyosin
gene expression should provide a fundamental un-
derstanding of how various tissues are developmen-
tally regulated. Work is currently under way to
study the molecular mechanisms responsible for
the tissue-specific expression of this gene.
Identification of cDNA Clones
Encoding the 90-kD Stress Protein
D.M. Helfman, J.R. Feramisco [in collaboration
with M. Grazia-Catelli and N. Binart,
Inserm Lab, Bicetre, France]
Steroid hormone receptors found in the cytosol of
target cells have an approximate 8S sedimentation
coefficient corresponding to an oligomeric struc-
ture with a molecular mass of 250-300 kD. This
oligomeric complex contains a nonhormone-bind-
ing 90-kD component. The 90-kD protein is more
abundant (approximately 100 times) than the ste-
roid-hormone-binding subunits and is present in all
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tissues of the chick. Recently, it was reported that
the 90-kD protein is identical with the 90-kD heat-
shock protein (hsp 90) or stress protein (Grazia-
Catelli et al., EMBO J. 4: 3131 [1985]). No function
is known for hsp 90, a protein widely conserved
among species, whose expression is regulated dur-
ing development and a variety of stress conditions.
Only the yeast hsp 90 cDNA and the Drosophila
hsp 83 gene have been cloned. Comparison of hsp
90 cDNA and deduced amino acid sequences be-
tween different species, as well as gene structure
and regulatory elements, may help in further analy-
sis of the role of hsp 90 in cell function. To isolate
cDNA clones for the 90-kD heat-shock protein, a
cDNA expression library prepared from smooth
muscle was screened using both polyclonal and
monoclonal antibodies. One colony was identified
that reacted with both antibodies. Plasmid 9.11
(,4100-bp insert) was found to hybrid-select mRNA
for the 90-kD heat-shock protein. Northern blot
analysis revealed that RNA isolated from various
tissues contains a single mRNA of approximately
3 kb. Heat-shock treatment of fibroblasts resulted
in increased steady-state levels of a 3-kb mRNA in
both poly(A)* and poly(A)- RNA fractions. South-
ern blot analysis of chick genomic DNA indicated
that the cDNA hybridizes to a single copy sequence.
Sequence homology shows that the cDNA clone
displays a high degree of homology with the 5' por-
tion of the yeast 90-kD heat-shock protein.
Identification of cDNA Clones
Encoding Nonerythroid Spectrin
D.M. Helfman [in collaboration with C.S. Birkenmeier,
D.M. Bodine, and J.E. Barker, The Jackson Laboratory,
Bar Harbor Maine; E.A. Repasky, Roswell Park Memorial
Institute, Buffalo, New York; S.H. Hughes, Frederick
Cancer Research Facility, Frederick, Maryland]
Spectrin is a membrane structural protein that is
localized on the inner surface of the cell membrane.
Originally, it was thought to be unique to erythro-
cytes but has since been identified in nonerythroid
tissues. Biochemical and immunological studies
demonstrate the existence of multiple forms of
spectrin with tissue-specific distribution and differ-
ential expression during development. Spectrin
proteins are heterodimeric, with a and 13 subunits
ranging in size from 220 kD to 265 kD. The f3 sub-
units are heterogeneous, with three avian and two
mammalian tissue-specific p subunits known thus
far. It appears that a common a-subunit occurs
in all avian tissues, whereas in mammals, the
erythroid a-subunit is distinct from the nonery-
throid a-subunit. The avian a-subunit is immuno-
logically closely related to the mammalian nonery-
throid a-subunit but only weakly related to the
mammalian erythroid a-subunit. The existence of
multiple forms of spectrin with tissue-specific pat-
terns of expression poses interesting questions
about the number and structure of the genes that
encode the spectrin proteins.
A cDNA clone for nonerythroid a-spectrin was
identified by direct immunological screening of a
chicken smooth-muscle cDNA library. Northern
blots of poly(A). RNA from various tissues of
chicken and mouse show that the cDNA hybridizes
to an 8-kb mRNA. The cDNA hybridized to a
single-copy sequence on Southern blots of chicken
genomic DNA. The complete nucleic acid sequence
of the clone has a single open reading frame of 1419
bp. The derived amino acid sequence is organized
into two partial and three complete 106-amino-acid
repeats that show homology with the repeats de-
scribed for human erythroid a-spectrin and 13-spec-
trin. Immunological and biochemical data indicate
that chicken nonerythroid and human erythroid a-
spectrin are two of the more widely diverged mem-
bers of the spectrin family. In this respect, the de-
gree of homology found between them was unex-
pected. The data suggest a common evolutionary
origin for these two a-spectrin molecules.
Isolation of cDNA Clones Encoding
the Type II Regulatory Subunit of
cAMP-dependent Protein Kinase
D.M. Helfman, M. Zoller [in collaboration with J. Scott
and E.G. Krebs, Howard Hughes Medical Institute,
University of Washington, Seattle, Washington]
cAMP is known to regulate numerous cell func-
tions and biological events. Most, if not all, of the
actions of cAMP in eukaryotic cells are thought to
be mediated through the action of cAMP-dependent
protein kinase. cAMP-dependent protein kinase is
composed of two regulatory subunits and two cata-
lytic subunits. The regulatory subunits bind two
molecules of cAMP per monomer, and the binding
of cAMP leads to dissociation of the complex, with
release of the catalytic subunits, which are now ac-
tive. Two major classes of cAMP-dependent protein
kinase are present in most cells, termed type I and
type II. The two isoforms contain identical cata-
lytic subunits but different regulatory subunits
(termed R' and R "). The isolation of cDNA clones
encoding the type I regulatory subunit of bovine
cAMP-dependent protein kinase has been reported
(Lee et al., Proc. Natl. Acad. Sci. 80: 3608 [1983]).
To analyze further the molecular basis for the two
regulatory subunits and to study their expression,
we have isolated cDNA clones encoding the type
II regulatory subunit. Briefly, a 100,000-member
cDNA library was prepared from adult rat skeletal
muscle. The library was screened with a 47-nucleo-
tide-long oligonucleotide probe derived from the
amino acid sequence of mouse and bovine R ".
Positive colonies were isolated, and the cDNA in-
serts were sequenced. One clone was found to con-
tain a sequence for R" from approximately amino
acid 30 through the 3'-untranslated region. The
clone will be used to examine the structure of the
R" subunit and to study the organization and ex-
pression of the genes encoding this protein.
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BIOCHEMISTRY OF CYTOSKELETAL PROTEINS
F. Matsumura S. Yamashi ro-Matsu mu ra
We have previously reported that changes in the ex-
pression of the multiple isoforms of tropomyosin
(TM) are consistently found in a variety of trans-
formed cells, including virus-transformed rat cells,
NIH-3T3 cells transformed with DNA transfec-
tion, BALB/3T3 cells transformed with UV irradi-
ation and chemical carcinogen, and chemically
transformed human fibroblasts (Matsumura et al.,
J. Biol. Chem. 258: 13954 [1983]). During the past
year, we have concentrated our studies on the
molecular functions of the changes in TM expres-
sion that are involved in the reorganization of
microfilaments upon cell transformation. In one
approach, we examined whether these TM isoforms
differentially modulate the actin-bundling activity
of two new actin-bundling proteins (M, = 55,000
and 83,000), whose functions are suggested to orga-
nize microfilament bundles of stress fibers by their
intercellular localization (Yamashiro-Matsumura
and Matsumura, J. Biol. Chem. 260: 5087 [1985]).
In addition, we have continued to produce mono-
clonal antibodies to explore the organization of the
multiple TM isoforms in microfilaments.
Modulations of the Interactions
between Actin and Actin-binding
55-kD and 83-kD Proteins by the
Multiple Isoforms of Tropomyosin
F. Matsumura, S. Yamashiro-Matsumura
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The 55-kD protein is a monomeric globular protein
with a native molecular weight of 57,000. The bind-
ing of the protein to actin is saturated at an approxi-
mate stoichiometry of four actin monomers to
one 55-kD molecule. The protein makes F-actin
aggregate side-by-side into bundles as described for
other F-actin-bundling proteins such as fimbrin
(M, = 68,000) and fascin (M,=58,000). Biochemi-
cal, morphological, and immunological character-
ization, however, revealed that the 55-kD protein
is a new actin-binding protein (Yamashiro-Matsu-
mura and Matsumura, J. Biol. Chem. 260: 5087
[1985]). The protein is localized in microspikes as
well as in stress fibers.
None of the TM isoforms of cultured rat cells sig-
nificantly alter the F-actin-bundling activity of the
55-kD protein, whereas skeletal-muscle TM in-
hibits the bundling activity to about 50%. This is
consistent with the results that cultured rat cell TMs
do not affect actin binding of the 55-kD protein,
whereas skeletal-muscle TM inhibits binding of the
55-kD protein to actin by 50%. Actin binding of
each TM isoform, in contrast, is affected by the 55-
kD protein, depending on the TM isoforms. Most
TMs (80%) with low relative molecular weights
(32,400 [TM-4] and 32,000 [TM-5]) are dissociated
from actin by the 55-kD protein, whereas only 20%
of the TMs with high relative molecular weights
(40,000 [TM-1] and 36,500 [TM-2]) are dissociated
from actin. Immunofluorescence has shown that
although TM was localized in stress fibers, the 55-
kD protein is found in microspikes as well as stress
fibers, both of which are known to contain bundles
of microfilaments. Therefore, we suggest that the
55-kD protein, together with the multiple TM iso-
forms, may regulate the formation of two types of
actin-filament bundles: bundles containing TM
and bundles without TM (Matsumura and Yama-
shiro-Matsumura, J. Biol. Chem. [1986] in press).
The 83-kD protein has previously been identified
as one of the microfilament-associated proteins
(Matsumura et al., J. Biol. Chem. 258: 6636 [1983]).
Actin binding of the 83-kD protein was saturated at
an approximate polypeptide ratio of five to six ac-
tins to one 83-kD protein. The 83-kD protein shares
some physicochemical properties with TM. Both
proteins are heat-stable (unlike other actin-binding
proteins) and are rod-like proteins as determined by
their Stokes' radii and sedimentation coefficients.
Unlike TM, however, the 83-kD protein is a basic
protein. The amino acid composition is consider-
ably different from that of typical TM, especially
showing the presence of many proline residues.
The 83-kD protein also binds to calmodulin in a
calcium-dependent manner. In the presence of
micromolar calcium, calmodulin binds to the 83-
kD protein, and the resulting 83-kD protein cannot
bind to actin. In contrast, in the absence of Ca",
calmodulin cannot bind to the 83-kD protein,
which allows the 83-kD protein to bind to actin.
These results therefore suggest that the 83-kD pro-
tein is similar to nonmuscle caldesmon, recently
purified from bovine adrenal modulla (Sobue et al.,
Proc. Nall. Acad. Sci. 82: 5052 [1985]). The 83-kD
protein makes F-actin aggregate into bundles above
the approximate polypeptide ratio of one 83-kD
protein to eight actins when examined by electron
microscopy. The actin-bundling by the 83-kD pro-
tein is also regulated by calmodulin and micromo-
lar concentrations of Ca" (S. Yamashiro-Matsu-
mura and F. Matsumura, in prep.).
We have investigated whether the 83-kD protein
has any effects on the interaction between actin and
the multiple isoforms of TM. We have recently re-
ported that low-M, TMs have less affinity to actin
than high-M, TMs (Matsumura and Yamashiro-
Matsumura, J. Biol. Chem. 260: 13851 [1985]). The
83-kD protein, however, stimulates the actin bind-
ing of low-M, TMs up to four times higher than
that for the control. This stimulating effect is not
observed for high-M, TMs. Because the actin
binding of the 83-kD protein can be regulated in a
calcium-dependent manner by calmodulin, the 83-
kD protein and calmodulin can also regulate the ac-
tin binding of low-M, TMs in a calcium-dependent
manner. In the absence of Ca", calmodulin does
not bind to the 83-kD protein; thus, the 83-kD pro-
tein can bind to actin and stimulate actin binding
of low-M, TMs. In the presence of Ca", however,
calmodulin binds to the 83-kD protein and the re-
sulting 83-kD protein cannot bind to actin. Thus,
low-M, TMs bind to actin to a lesser extent. Im-
munofluorescence has shown that the 83-kD pro-
tein is present in both stress fibers and membrane
ruffles. Furthermore, the staining patterns of stress
fibers with anti-83-kD protein antibodies were peri-
odic and very similar to those with anti-TM anti-
bodies. These observations suggest that the 83-kD
protein may change the organization of stress fibers
through the regulation of the binding of TMs to
stress fibers.
Organization of the Multiple
Isoforms of Tropomyosin in the
Microfilaments as Examined by
Monoclonal Antibodies
F Matsumura, S. Yamashiro-Matsumura
To explore the organization of the multiple iso-
forms of tropomyosin (TM) in the microfilament,
we have attempted to produce specific monoclonal
antibodies and examined whether these TM iso-
forms bind to microfilaments randomly or selec-
tively. Among many hybridoma clones to TM, we
have found two interesting monoclonal antibodies,
IV15 and IV20. Both ELISA and immunoprecipita-
tion showed that IV20 monoclonal antibody recog-
nized TM-1 strongly and TM-2 and TM-3 weakly
but did not react with TM-4 or TM-5. On the con-
trary, IV15 reacted with all five TM isoforms. Using
these antibodies, we have isolated TM-containing
microfilaments. SDS-gel analyses showed that mi-
crofilaments isolated by either IV15 or IV20 con-
tained all five TM isoforms in spite of the specific-
ity of IV20. Densitometry, however, revealed some
differences in TM compositions. The ratios of
TM-1:TM-2:TM-3 (high-M, TMs) appeared to be the
same for both microfilaments isolated by IV15 and
IV20 monoclones. However, the relative contents
of TM-4 +TM-5 (low-M, TMs) in the microfila-
ments isolated by IV20 were found to be half of
those isolated by IV15. These results suggest that
high- and low-M, TMs co-localize in the same
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microfilaments, although some (,-.20%) of the
microfilaments enrich low-M, TMs.
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CELL BIOLOGY OF ONCOGENE PROTEINS
J.R. Feramisco D. Bar-Sagi K. Riabowal G. Binns
W.J. Welch T Kamata N.F. Sullivan C. Hallaran
J.C. Lamb M.W. Wooten N. Kronenberg
Microinjection of the ras Oncogene
Protein into PC-12 Cells Induces
Morphological Differentiation
D. Bar-Sagi, J.R. Feramisco
The activation of ras genes has been implicated in
transformation in vitro and in tumorigenesis in
vivo, but the role of these genes in the sequential
events leading to the acquisition of the transformed
phenotype is unclear. The ras-encoded proteins in
mammalian cells are approximately 21,000 daltons
(p21), bind guanine nucleotides, and are localized
to the inner face of the plasma membrane. Onco-
genic ras proteins differ from their normal homo-
logs by a single amino acid substitution, usually at
position 12 or 61. These mutations do not affect the
localization or the nucleotide-binding properties of
ras proteins. However, normal p21, encoded by the
Ha-ras gene, has been shown to possess an intrinsic
GTPase activity that is significantly impaired in the
mutated oncogenic protein. By drawing an analogy
between the ras proteins and the regulatory proteins
(G proteins) of the adenylate cyclase system, it has
been proposed that the deficiency in GTPase activ-
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ity of the ras oncogene protein could result in the
derangement of normal regulatory mechanisms that
control cell proliferation.
Recent studies have indicated a role for the ras
proteins in growth-factor-mediated control of cell
proliferation. However, growth factors do not af-
fect solely the proliferative capacity of cells. For ex-
ample, in rat pheochromocytoma cells (PC-12),
nerve growth factor (NGF) promotes cell differenti-
ation rather than cell proliferation. We have under-
taken studies to explore the possible participation
of the ras proteins in this particular growth-factor-
mediated signaling pathway.
PC-12 cells grow indefinitely in culture as round,
chromaffin-like cells. When NGF is added, the cells
differentiate into sympathetic neuron-like cells and
stop growing. In the absence of NGF, microinjec-
tion of the human Ha-ras oncogene protein into
PC-12 cells results in morphological differentiation
similar to that induced by NGF (Fig. 1). These
results indicate that ras proteins may exert different
biological effects in different cell types, perhaps by
utilizing a common molecular mechanism involv-
ing the coupling of growth factors to intracellular
signals.
FIGURE 1 A PC-12 cell was injected with the ras oncogene protein and stained by immunofluorescence
for the injected protein 20 hr later.
Microinjection of the ras Oncogene
Protein Induces DNA Synthesis in
Nonestablished Cells: Potentiation
of Its Action by Growth Factors
and Adenovirus E1A Protein
N.F. Sullivan, J.R. Feramisco [in collaboration with
R.W. Sweet, B.Q. Ferguson, and M. Rosenberg,
Smith Kline and Beckman, Pennsylvania]
In some cell lines cultured in vitro, growth factors
present in serum can interact with specific cellular
receptors apparently to activate both physiologi-
cal and biochemical changes that result in DNA
replication and cell division. A number of studies
have associated growth-factor-mediated pathways
with transformation. For example, both a cellular
growth-factor and a growth-factor-receptor gene
have been found to be homologous to oncogenes of
known acutely transforming retroviruses. In addi-
tion, growth factors can induce the expression of
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oncogenes in either a cell-cycle-dependent or -inde-
pendent manner. Furthermore, transforming growth
factors can be secreted by cells transformed with
the viral Ki-ras gene.
We are studying the role of proteins encoded by
the Ha-ras protein in the control of cellular
proliferation. These oncogenes have been associ-
ated with many types of human tumors and may
contribute at least partially to the malignant phe-
notype. In human cells, the ras gene family consists
of Ha -ras, Ki -ras, and N-ras, each of which appears
to have an oncogenic form (activated, henceforth
ras oncogene protein) and a protooncogenic form
(wild-type, henceforth ras protooncogene protein).
These ras proteins bind guanine nucleotides and
display GTPase activity in vitro. Moreover, the ras
oncogene protein displays less GTPase activity than
the ras protooncogene protein. These results have
suggested similarities between ras and the G protein
of the (3-adrenergic/adenylate cyclase system. In
fact, in yeast, the ras gene products seem to regulate
the adenylate cyclase system. In the ras family, the
transforming lesion can be due to either point mu-
tations that alter the protein sequence or increased
levels of expression. In particular, protooncogenic
ras becomes amplified as a consequence of passage
affect the process of growth and division in animal
cells is unclear, although microinjection of ras on-
cogene protein into established cells results in both
DNA synthesis and cell division. In contrast, ras
protooncogene protein showed no effect upon cell
growth.
We now report on the microinjection of purified
ras oncogene protein into both early- and late-
passage nonestablished rat embryo fibroblasts
(REF). These cells exhibit a markedly different re-
sponse to ras oncogene protein than established
cells, and their response changes significantly with
continued passage; i.e., late-passage but not early-
passage cells proliferate in response to the ras on-
cogene protein. We show that co-microinjection of
ras with the human adenovirus serotype-C 13S
mRNA gene product enables early-passage cells to
respond more like late-passage cells by proliferat-
ing. Moreover, we have found that conditioned
medium from late-passage rat embryo fibroblasts
supports growth of 49F cells in soft agar while
early-passage cells do not and that this medium
potentiates the effects of the microinjected ras pro-
tein (Fig. 2).
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Rapid Induction of Cell-surface
Activities in Quiescent Fibroblasts
following Microinjection of
Ha-ras Proteins
D. Bar-Sagi, J R Feramisco
We have studied the early morphological and bio-
chemical events that occur in response to microin-
jection of human Ha-ras proteins into quiescent rat
embryo fibroblasts. Within 30 minutes to 1 hour
after microinjection of the Ha-ras proteins, the in-
jected cells show a marked increase in surface ruf-
fles. The increase in ruffling activity is accompa-
nied by an increase in fluid-phase pinocytosis, as
measured by the uptake of fluorescein-conjugated
dextran (Fig. 3). We have shown previously that the
Ha-ras oncogene protein stimulates cell prolifera-
tion when microinjected into quiescent fibroblasts,
whereas the protooncogenic protein is not mito-
genic in this assay. The rapid enhancement of mem-
brane ruffling and pinocytosis is induced by both
the protooncogenic form and the oncogenic form
of the Ha-ras protein. However, the effects pro-
duced by the oncogenic protein persist for more
than 20 hours after microinjection, whereas the ef-
fects of the protooncogenic protein are short-lived,
being restricted to a 3-hour interval after injection.
The stimulatory effect of ras proteins on ruffling
and pinocytosis is dependent on the amount of in-
jected protein, requires extracellular calcium, and is
independent of ongoing protein synthesis. Analysis
of the phospholipid composition of "P-labeled
cells reveals an apparent increase of 1.5-2-fold in
levels of lysophosphatidyl choline and lysophos-
phatidyl ethanolamine by 1 hour after injection of
the ras oncogene protein. These rapid changes in
cell-membrane activities induced by ras proteins are
the earliest ras-mediated effects detected to date
and, as such, may represent primary events in the
mechanism of action of ras proteins.
Production of Monoclonal Antibodies
to the fos Oncogene
K. Riabowol, W.J. Welch, N. Sullivan, N. Kronenberg,
G. Blose, J.R. Feramisco [in collaboration with B. Vosatke
and E. Ziff, New York University Medical Center]
Viral fos is the transforming gene of two murine
retroviruses that induce osteosarcomas and trans-
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FIGURE 2 Conditioned medium from 1°REF (A), passaged REF (B), 1°REF to which fresh serum was
added (C), REF52 cells (C), REF52 cells to which serum was added (E), or ras-transformed NRK cells
(F) was incubated with 49F NRK cells in soft agar.
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FIGURE 3 Confluent REF52 cells were microinjected with the ras oncogene protein (a) or with control
protein (b) and incubated with FITC-dextran for 10 min. Note the increased uptake of the fluorescent marker
(b, which is the same field as a) by the ras-injected cells compared with the control injected cell (d, which
is the same field as c). Arrowheads mark the areas of ruffling and pinocytosis.
form fibroblasts in vitro. Transcriptional induction
of c-fos mRNA occurs within 5 minutes of mitogen
stimulation and reaches a level at least tenfold
higher than in unstimulated cells. Although se-
quences necessary for (1) the transforming ability
of v-fos and (2) the mitogen regulation of c-fos
mRNA have been identified by mutational analy-
sis, little is known about the function of the nu-
clear-localized fos gene product p55.
To address questions of function and synergism
with other oncogenes, we are preparing monoclo-
nal antibodies directed against a trp-fos fusion pro-
tein produced in bacteria (supplied by B. Vosatke
and E. Ziff). Several hybridomas positive to the fu-
sion protein (but not to trp alone) recognize a pro-
tein with a relative molecular weight of 55,000, by
both immunoblot and immunoprecipitation as-
says, and selectively stain the nuclei of cells when
used in immunofluorescence analysis. We are now
in the process of both characterizing these antibod-
ies and developing a system for the bacterial
production of p55°-f" for use in generating anti-
bodies directed solely against fos p55.
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Cell Biology of cAMP-dependent
Protein Kinase
J.C. Lamb, M.W. Wooten, W.J. Welch, J.R. Feramisco
[in collaboration with Dave Glass, Emory University]
Over a number of years, studies of the phospho-
protein substrates for cAMP-dependent protein
kinase (A-kinase) have identified a number of sub-
strates for this kinase. The nature of the substrates
has led to the implication of the kinase in a number
of cellular events including cell division and cellu-
lar morphology. To test these hypotheses, we have
initiated living-cell assays for A-kinase in which the
purified catalytically active protein is directly in-
jected into cells, and the biological effects are as-
sessed. Using this assay, we have found dramatic ef-
fects on the morphology of the cells and the state
of phosphorylation of certain proteins within the
cell.
Using a concentration that produces reversible
changes in cellular morphology, we have injected
small numbers of cells with the protein kinase or
control substances. Following pulse labeling with
"P, we have identified a number of the protein
substrates for the kinase in cells as well as temporal
variation in the kinase-substrate specificity. We re-
port that there are apparently fewer substrates for
the kinase in vivo than have been found in vitro,
and we have tentatively identified a number of
these to be major cytoskeletal proteins (Fig. 4).
A number of recent reports have suggested that
changes in the phosphorylation state of vimentin
may be regulatory in the control of intermediate
filament (IF) assembly. Similar implications have
previously been made with respect to the assembly
of microfilament (MF) networks involving myosin
light-chain kinase (MLCK). We have therefore ex-
tended our present studies to determine if there is
any significance in the specific phosphorylation of
these proteins by A-kinase. Using double-label im-
munofluorescence with antibodies specific for vi-
mentin (V9), tubulin (DMA IA), and phalloidin
(a stain specific for F-actin), we have investigated
whether there are any changes in the integrity of the
IF, microtubulin (MT), and MF networks as a re-
sult of injecting the catalytic subunit. We have been
able to identify a direct temporal correlation be-
tween the changes in the distribution of actin MF
A
and vimentin IF with the changes in substrate phos-
phorylation following injection (Fig. 5). After in-
jection of the kinase, significant changes in both
MF and IF networks occur, including the complete
dissolution of the MF network and the bundling of
the IF. Concomitant with these changes, cellu-
lar morphology is altered and the cells become
rounded. Additionally, we have noted a number of
other effects resulting from injection, including the
partial condensation of the chromatin and rear-
rangement of the nuclear envelope. We have shown
that these effects are complete by 90 minutes and
stable for at least 24 hours. By 36 hours, the effects
have completely reversed; i.e., the distribution of
both MF and IF networks, as well as cellular mor-
phology, resembles that in uninjected cells. We can
elicit similar changes in the distribution of the IF
and MF networks with agents that increase the level
of cAMP, although to a lesser extent than following
injection of high levels of the active protein kinase.
The significance of these changes awaits further
characterization. The interrelationship of the cAMP-
dependent kinase and calmodulin and a number of
other kinases in vitro is intriguing. Reports have
suggested A-kinase, calmodulin, and cGMP-depend-
ent protein kinase effect phosphorylation changes
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FIGURE 4 Two-dimensional analysis of the phosphoprotein patterns in rat embryo fibroblasts following
microinjection of A-kinase. REF52 cells ("-,150 cells) growing on 2x4-mm glass chips were microinjected
with either injection buffer (100 mM K' glutamate, 40 mM K* citrate, 1 mM MgSO4 at pH 7.30) (A) or 50
Rg/m1 A-kinase in injection buffer (8). After injection (30 min), the cells were labeled for 30 min with 100
RCi 32P in phosphate-free Dulbeccds modified Eagle's medium (DMEM) containing no serum. Following
the labeling period, the cells were solubilized in two-dimensional gel electrophoresis sample buffer and
then analyzed by isoelectric focusing (pH 5-7 ampholines), followed by electrophoresis on 12.5% SDS-
acrylamide gels. Autoradiograms of the gels are shown with the acidic end to the left. (V) Vimentin; (MLCK)
myosin light-chain kinase; (MLC) myosin light-chain; (L) nuclear lamins; (Vinc) vinculin.
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FIGURE 5 Effects of microinjection of the catalytic subunit of A-kinase on the distribution of microfilaments or intermediate filaments.
Rat embryo fibroblasts grown on glass coverslips were microinjected with 50 µg /ml of the catalytic subunit of A-kinase in injection
buffer. The cells were fixed after different incubation periods following injection and stained by double-label fluorescence with an
antibody specific for vimentin (B,E , H ,K ,N) and FITC-phalloidin (a stain specific for F-actin) (C,F,I,L,0). Phase micrographs (A ,D,G,J,M)
correspond to the double-label fluorescent micrographs for each row. (A,B,C) Cells injected with buffer and incubated for 90 min
postinjection; (D,E,F) cells injected with A-kinase and further incubated for 30 min postinjection; (G ,H ,I) cells injected with kinase
and further incubated for 60 min postinjection; (J,K,L) cells injected with the kinase and further incubated for 90 min postinjection;
(M,N,O) cells injected with the kinase and incubated for 36 hr postinjection.
that occur when cells enter mitosis, and one possi-
bility that we are currently investigating is that
these changes reflect those involved in the induc-
tion of cell division. The changes in vimentin struc-
ture clearly resemble those seen when cells proceed
into mitosis, and a similar case applies to the
changes in cellular morphology, the condensation
of chromatin, and the redistribution of actin. An-
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other and not mutually exclusive possibility is that
the changes represent alterations in the interaction
between IF and MT, and actin and its associated
proteins. As it is our aim to deduce precisely within
living cells the biological and biochemical role of
cAMP-dependent protein kinase in these physiolog-
ical functions, this assay should prove useful in this
goal.
PUBLICATIONS
Bar-Sagi, D. and J.R. Feramisco. 1985. Microinjection of the ras
oncogene protein into PC12 cells induces morphological
differentiation. Cell 42: 841-848.
Catelli, M.G., N. Binart, I. Jung-Testas, J.M. Renoir, E.E. Baulieu,
J.R. Feramisco, and W.J. Welch. 1985. The common 90kDa
protein component of non-transformed "8S" steroid recep-
tors is a heat-shock protein. EMBO J. 4: 3131-3135.
Feramisco, J.R., R. Clark, G. Wong, N. Arnheim, R. Milley, and
F. McCormick. 1985. Transient reversion of ras oncogene-
induced cell transformation by antibodies specific for amino
acid 12 of ras protein. Nature 314: 639-642.
Grazia-Catelli, M., J.R. Feramisco, E.E. Baulieu, and D.M. Hell-
man. 1985. Isolation and characterization of a cDNA clone
to the 90,000 molecular weight heat shock protein. Nucleic
Acids Res. 13: 6035-6047.
Welch, W.J. and J.R. Feramisco. 1985. Rapid purification of
mammalian 70,000-dalton stress proteins: Affinity of the pro-
teins for nucleotides. Mol. Cell. Biol. 5: 1229-1237.
MAMMALIAN STRESS RESPONSE
W.J. Welch J. Lamb G. Blose
J.R. Feramisco M. Wooten N. Kronenberg
J. Suhan L. Miranda
During the past year, substantial progress has been
realized with regard to our understanding of the
physiological changes occurring in mammalian
cells confronted with environmental trauma. Our
studies, utilizing classical methods in cell biology,
protein biochemistry, and immunology, have begun
to provide a solid foundation for future experi-
ments designed to address how cells both recognize
abrupt changes in their local environment and trig-
ger subsequent events at both the transcriptional
and translational levels, leading to the increased
production of the stress proteins. In addition, con-
siderable efforts are being directed toward deter-
mining the biochemical function(s) of the in-
dividual stress proteins. As discussed below, these
efforts have now begun to provide us with a better
understanding of some of the properties of the
stress proteins in both the normal cell and the
stressed cell. Finally, we plan to accelerate our ef-
forts in determining the molecular basis underlying
the known hypersensitivity of various transformed
cells and/or human tumors to physiological stress.
We hope that these latter studies will eventually
prove useful in exploiting the use of various forms
. 1985. Disruption of the three cytoskeletal networks in
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protein translocation changes induced by heat shock. Mol.
Cell. Biol. 5: 1571-1581.
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of physiological stress in the successful clinical
treatment of human tumors.
The 70-kD Family of Stress
Proteins Bind ATP
W.J. Welch, J.R. Feramisco
During the course of studies designed to assess vari-
ous in vitro properties of both the constitutively ex-
pressed 73-kD stress protein and the highly stress-
inducible 72-kD protein, we discovered that these
proteins exhibit avid binding to various nucleo-
tides, with the highest binding being observed for
ATP. This observation has now proved most useful
with regard to the rapid isolation of the 72/73-kD
stress proteins from mammalian cells and has
provided us with a new outlook regarding the possi-
ble biochemical function of these proteins. As
shown in Figure 1, we have developed a simple two-
step purification scheme of the 70-kD proteins
utilizing ion-exchange chromatography on DEAE-
cellulose, followed by affinity chromatography on
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FIGURE 1 Rapid purification of the 72/73-kD stress proteins using affinity chromatography on ATP-agarose columns. HeLa cells
grown in suspension were heat-shock treated at 42°C for 3 hr and then returned to 37°C for 5 hr. The cells were collected, washed
with phosphate-buffered saline, and hypotonically lysed by Dounce homogenization. The lysed cells were centrifuged at 12,000g,
and the supernatant was applied to a DE-52 ion-exchange column. The column was then washed, and the proteins were eluted
with a linear gradient of increasing NaCI. Fractions 38-54 were pooled and applied directly to an agarose column containing cova-
lently linked ATP and the column was then washed extensively with numerous cycles of low and high salt. The column was first
developed with 1 mM GTP followed by 10 mM ATP (A) Coomassie-blue-stained gel of the proteins eluting from the DE-52 column;
(8) proteins eluted from the ATP-agarose column. Note that the 72/73-kD proteins eluted in an equimolar fashion and appear homo-
geneous.
agarose columns containing covalently linked ATP
(Welch and Feramisco, Mot Celt Biol. 5: 1229
[1985a]). Using our new procedure, we found that
it is relatively easy to purify milligram quantities of
the 72-kD and 73-kD proteins in a rather short
period of time. The proteins so isolated appear "na-
tive," since they assume their proper locale within
the cell following their reintroduction into cells via
microinjection. In addition, using such microinjec-
tion techniques, we are continuing to examine the
autoregulatory properties of the 70-kD stress pro-
teins, as well as examining their putative role in the
protection of cells from environmental stress. In
addition to these in vivo studies, we are developing
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in vitro assays aimed at dissecting the biochemical
function of the individual 72-kD and 73-kD stress
proteins. It is anticipated that this combined cellu-
lar and biochemical approach will soon provide us
with the function of these proteins in both the nor-
mal cell and the stressed cell.
A Family of ATP-binding Stress
Proteins
W.J. Welch
During the course of our purification studies of the
70-kD stress proteins, we discovered two other
polypeptides that similarly displayed an affinity for
ATP in vitro (Welch and Feramisco, Mol. Cell. Biol.
5: 1229 [1985a]). One of these, a 75-kD protein, is
not synthesized at elevated levels in the stressed cell
and therefore by definition does not constitute a
classical stress protein. The 75-kD protein, how-
ever, does appear to be related to the 72/73-kD
stress proteins by virtue of its similar isoelectric
point and its proteolytic peptide pattern. Therefore,
we are continuing to characterize the 75-kD protein
in more detail and are trying to determine its exact
relationship to that of the 72/73-kD stress proteins.
A second protein found to exhibit avid binding
to ATP in vitro is an 80-kD polypeptide. We have
previously shown that this protein is present pri-
marily in the particulate fraction of cells (specifi-
cally the endoplasmic reticulum) and is one mem-
ber of a group of proteins referred to as the
"glucose-regulated" proteins (GRPs) (Welch et al.,
J. Biol. Chem. 258: 7102 [1983]). The GRPs com-
prise a class of proteins whose synthesis in cells is
markedly affected by extracellular levels of glucose
and/or calcium. For example, depriving cells of ei-
ther extracellular glucose or calcium or treatment
of the cells with calcium ionophores results in in-
duction of the 80-kD as well as a 100-kD protein
and a concomitant repressed synthesis of the 90-kD
stress protein. In many cases, the GRPs appear to
be regulated in an inverse fashion with respect to
that of the stress proteins. For example, other inves-
tigators have reported an induction of the GRPs
following anaerobic treatment, and following re-
lease back to aerobic conditions, both an induction
of the stress proteins and a concomitant repression
of GRP expression occur. These and other observa-
tions then indicate a close relationship between the
regulation of synthesis of these two groups of pro-
teins and perhaps a role for the GRPs and the stress
proteins in certain metabolic pathways. A further
similarity is our observation and that of J. Roth-
man's group at Stanford University that the 80-kD
glucose-regulated protein is immunologically re-
lated to both the 72-kD and 73-kD stress proteins.
Hence, it would appear that there exists a family of
structurally related proteins in eukaryotic cells, all of
which (1) show increased synthesis in response to dif-
ferent environmental traumas, (2) exhibit binding
to ATP, but (3) have different intracellular locales
and therefore probably perform different functions
within the cell. Using immunological and biochem-
ical techniques, we are investigating whether the
80-, 75-, 73-, and 72-kD all possess a common pep-
tide domain that is involved in the binding of ATP.
Clathrin Vesicle Uncoating ATPase
Is a Member of the 70-kD Stress
Protein Family
W.J. Welch [in collaboration with T. Chappell,
D. Schlossman, and J. Rothman,
Stanford University]
Studies over the past several years in J. Rothman's
laboratory at Stanford University have focused on
the mechanism of protein trafficking in eukaryotic
cells, with a particular emphasis on the role of
clathrin-coated vesicles. Their efforts have resulted
in the identification and purification of a 70-kD
protein that releases clathrin triskelions from coated
vesicles in an ATP-dependent manner (Schlossman
et al., J. Cell Biol. 99: 723 [1984]). We noted that
the purification scheme of this uncoating ATPase,
and its apparent molecular mass, isoelectric point,
and ability to bind ATP in vitro all were similar to,
if not identical with, the properties we had deter-
mined for the mammalian 70-kD stress proteins. In
a collaborative effort, therefore, we investigated
whether the bovine brain uncoating ATPase was a
member of the mammalian 70-kD stress protein
family. Using two-dimensional gel analysis and
comparative one-dimensional peptide-mapping
procedures, we found that uncoating ATPase was
indeed similar to, if not identical with, the constitu-
tively expressed and abundant 73-kD stress protein
(Chappell et al., Cell [1986] in press). Although this
result provides the first indication of the function
of one of the 70-kD stress proteins, the teleological
ramifications of our observation remain somewhat
obscure; i.e., how do we explain why a protein in-
volved in the uncoating of clathrin-coated vesicles
is also required in the response of cells to environ-
mental stress? While further work will be necessary
to answer this question, we do know already that
physiological stress, particularly heat-shock treat-
ment, results in a significant disruption of intracel-
lular membranous organelles, including the Golgi
complex and endoplasmic reticulum (Welch and
Suhan, J Cell Biol. 101: 1198 [1985]). Hence, during
recovery from heat-shock treatment, the cells must
rebuild these cytoplasmic organelles; and it is quite
possible that clathrin-coated vesicles, which func-
tion in part in membrane biogenesis events, are
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required in this rebuilding process. Indeed, using
indirect immunofluorescence analysis with a mono-
clonal antibody specific for clathrin, we have ob-
served a significant increase in the number of
clathrin-coated vesicles throughout the perinuclear
region during the recovery period following heat-
shock treatment (W.J. Welch, unpubl.). Such cla-
thrin-coated vesicle activity may then represent
repair and/or rebuilding of the Golgi and endoplas-
mic reticulum, and the increased levels of the 73-kD
stress protein in the recovering cells may facilitate
this repair process.
Co-localization of the Major
Stress-induced 72-kD Protein
with Ribosomes
W.J. Welch, J.P. Suhan
Because it is the most highly induced stress protein,
we have continued to pay special attention to the
properties of the 72-kD protein with the aim, of
course, to determine its function in the stressed
cell. Our recent studies have centered on the fate of
the 72-kD stress protein in cells recovering from
physiological stress as induced by (1) heat-shock
treatment, (2) exposure to heavy metals, and (3) ex-
posure to amino acid analogs. Using metabolic
pulse-labeling, we have found that the elevated syn-
thesis of the 72-kD protein and that of the other
stress proteins continue for as long as 12 hours fol-
lowing removal of the particular stress stimulus.
Only after 12-24 hours does the synthesis of the
stress proteins begin to subside and the cells begin
to restore their normal patterns of protein synthe-
sis. Interestingly, we always observe that repression
of 72-kD protein synthesis precedes that of the
other stress proteins. We think it possible then that
regulation of the 72-kD protein synthesis is integral
to the regulation of synthesis of the other stress
proteins. Further studies in which the levels of the
72-kD protein are being manipulated in the recover-
ing cells via microinjection of the purified protein
or its corresponding antibody are in progress to ad-
dress the possible role of the 72-kD protein in the
down-regulation of either its own synthesis or the
synthesis of the other stress proteins.
Using our battery of antibodies specific to the
72-kD protein, we have also been examining its in-
tracellular fate in cells recovering from physiologi-
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cal stress. After induction of the stress response, we
find the majority of the 72-kD protein localized
within the nucleus and nucleolus of the stressed
cells (Welch and Feramisco, J. Biol. Chem. 259:
4501 [1984]). Using light and electron microscopy,
we have observed that in those cells exhibiting a
nucleolar locale of the 72-kD protein, the in-
dividual nucleoli are significantly altered. Specifi-
cally, we find that the nucleoli display a relaxed
condensation state and an accompanying disrup-
tion and aggregation of its granular components
(which consist primarily of pre-ribosomal parti-
cles). Using immunoelectron microscopy, we now
know that the majority of the intranucleolar 72-kD
protein is localized within this disrupted granular
region. At later times following removal of the
stress stimulus, the location of the 72-kD protein in
the cell slowly changes; e.g., 4-8 hours after return
of the shocked cells to normal growth conditions,
the amount of nuclear/nucleolar 72-kD protein be-
gins to decrease and there is a corresponding in-
crease in the level of cytoplasmic 72-kD protein.
The cytoplasmic 72-kD protein is found in both the
perinuclear region and along the border of the cells,
right underneath the plasma membrane where there
also appear to be unusual phase-dense aggregates.
Using immunological methods and electron mi-
croscopy, we now know that these phase-dense
structures are composed of aggregated ribosomes,
many of which also contain significant amounts of
the 72-kD stress protein (Fig. 2) (W.J. Welch and
J.P. Suhan, in prep.).
Thus, one major property of the 72-kD stress
protein is its co-localization with pre-ribosomes
(i.e., those within the granular region of the nucleo-
lus) or cytoplasmic ribosomes. In addition, we
speculate that these nucleolar and cytoplasmic
ribosomes have become altered (i.e., perhaps dena-
tured) as a result of the physiological stress. There-
fore, it is possible that the 72-kD stress protein
somehow functions in binding to denatured ribo-
somes in the stressed cell. Such a function could
perhaps explain why such high levels of the protein
are synthesized in response to stress (i.e., serving a
stoichiometric rather than enzymatic function). In
addition, because the 72-kD protein is an avid
binder of ATP, we speculate that the interaction of
the 72-kD protein with these ribosomes may also
involve an ATP hydrolysis event, perhaps analo-
gous to the situation in which the related 73-kD
stress protein hydrolyzes ATP during its course of
uncoating clathrin-coated vesicles.
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FIGURE 2 Distribution of the 72-kD stress protein within the granular region of he nucleolus. REF52
cells were heat-shock treated for 1 hr at 43°C and then returned to 37°C for 1 hr. The cells were fixed,
permeabilized, and analyzed by either (1) silver staining to detect fibrillar centers involved in ribosomal
RNA synthesis, (2) immunostaining with a mouse monoclonal antibody specific for the 72-kD protein, fol-
lowed by peroxidase-conjugated goat anti-mouse antibody, or (3) combined silver staining and immune-
staining. (A) Nucleoli of cells stained with preimmune serum; (B) nucleoli of cells stained with the anti-72-kD
serum; (C) nucleoli stained with silver to indicate fibrillar centers; (D) combined immunostaining and silver
staining; (e) a higher magnification of one of the nucleoli shown in D. Arrowheads in B-e indicate the silver
staining fibrillar centers, and arrows indicate the granular region containing the 72-kD stress protein. Bars,
1 !AK
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Calcium, C-Kinase, and the
Stress Response
M.W. Wooten, J.R. Feramisco, W.J. Welch
One major effort of the Cell Biology group has cen-
tered on determining the role of the calcium-
sensitive/phospholipid-dependent protein kinase
(C-kinase) in cell proliferation. Other laboratories
have demonstrated that treatment of cells with
tumor-promoting agents, such as the phorbol ester
(PMA), or with various calcium ionophores results
in an activation of C-kinase. Our laboratory had
found previously that exposure of rat fibroblasts to
PMA resulted in a marked increased phosphoryla-
tion of the 28-kD stress protein (Welch, J. Biol.
Chem. 260: 3058 [1985]). In addition, we also ob-
served that treatment of cells with a calcium iono-
phore also resulted in an increased phosphorylation
of the 28-kD protein, as well as affecting the syn-
thesis of three of the other stress proteins (Welch,
J. Biol. Chem. 260: 3058 [1985]; Welch et al., J.
Biol. Chem. 258: 7102 [1983]). Hence, because of
these seemingly overlapping phenomena, we de-
cided to examine whether changes in protein kinase
C activity accompanied the induction of the stress
response.
Biochemical analysis of rat fibroblasts following
a 3-hour heat-shock treatment indicated that in-
deed there were changes occurring with respect to
protein kinase C activity. First, we observed an en-
hanced activity of the enzyme (as assayed by phos-
phorylation of exogenous substrate, lysine-rich his-
tone) following heat-shock treatment and that such
activity quickly returned to basal levels following
return of the cells to normal growth conditions.
Second, we observed increases in the levels of phos-
phatidylinositol-4- phosphate and phosphatidylin-
ositol-4,5- bisphosphate (PIP2). PIP2 serves as a
substrate for phospholipase C, which generates dia-
cylglycerol, the activator of PKC, and inositol-
1,4,5-triphosphate (IP3). Utilizing rEllinositol la-
beling, we have observed a persistent elevation of
IP3 in stressed cells and a return to normal levels
upon reversal of the cells to normal conditions. Fi-
nally, we have found a rapid but transient increase
in the uptake of extracellular calcium into the cells
following a short exposure to heat-shock treatment
(M.W. Wooten et al., in prep.). Although still pre-
liminary, we think these results are suggestive of
there being an involvement of calcium and protein
kinase C in the early stages of the stress response.
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Further studies are in progress to test this hypothe-
sis. In addition, using the purified C-kinase protein
both in in vitro assays and in microinjection
studies, we are investigating whether phosphoryla-
tion of the 28-kD stress protein is mediated by
C-kinase itself or perhaps another kinase, itself
activated by a C-kinase-mediated phosphorylation
event.
The Stress Response in Normal and
Transformed Human and Rodent Cells
W.J. Welch, J.R. Feramisco
Although it has been observed for many years that
transformed cells in vitro or tumors in vivo are
generally very hypersensitive to heat-shock treat-
ment, the molecular basis underlying this hypersen-
sitivity remains obscure. Consequently, we have ini-
tiated efforts to determine the basis for the high
sensitivity of transformed cells to physiological
stress and to develop experimental protocols utiliz-
ing physiological stress that may prove useful in the
treatment of tumors in vivo. Due to a shortage of
manpower, these studies have progressed rather
slowly, but we anticipate a more intensive effort
over the next few years.
We have elected to study the effects of physiolog-
ical stress in transformed cells utilizing two ex-
perimental systems: (1) normal and transformed rat
embryo fibroblasts and (2) various human tumors
grown in vitro. For the former, we have been ex-
amining both normal rat embryo fibroblasts
(REF52) and REF52 cells stably transformed by ei-
ther SV40 (WT6 cells) or adenovirus (Ad5d4A
cells). As illustrated in Figure 3, a 3-hour heat-
shock treatment of cells resulted in a less than 10%
cell killing of the normal REF52 cells but a greater
than 95% cell killing of either of the two transfor-
mants. Even more dramatic differences in the sur-
vival curves are observed when sodium arsenite is
used as the elicitor of the stress response. As de-
scribed in last year's Annual Report, the survival
curves can also be greatly affected by simply
manipulating the metabolic state of the cells prior
to stressing the cells. For example, removal of ex-
tracellular glucose or calcium, lowering the pH of
the growth medium, or interfering with mitochon-
drial function can greatly enhance the cell killing
resulting from the heat-shock treatment. These
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types of studies, which again reinforce our ideas re-
garding the importance of the stress proteins in cer-
tain metabolic pathways (i.e., sensitivity to glucose
levels, calcium, etc.), will hopefully provide new in-
sight regarding the mechanism responsible for the
hypersensitivity of the transformed cells to physio-
logical stress. We hope that these types of in vitro
studies may someday prove useful in clinical studies
utilizing physiological stress in the successful treat-
ment of human tumors.
We have also been examining the expression of
the 72-kD stress protein in various normal and
transformed human and rodent cell lines. These
studies were prompted in part from the previous
observations of other investigators showing that
the adenovirus E1A gene product (13S) stimulated
the expression of the 72-kD protein in various hu-
man cell lines (Nevins, Cell 29: 913 [1983]; R.
Morimoto, pers. comm.). Indeed, we have found
that 293 cells, which constitutively express the E1A
and E1B gene products, synthesize extremely high
levels of the 72-kD proteins even at their normal
physiological growth temperature. In addition,
analysis of a number of other human tumor cell
lines, many of which contain the oncogenic form of
the ras protein (provided by M. Wig ler, Molecular
Genetics of Eukaryotic Cells Section), reveals that
they also constitutively produce modest levels of
the 72-kD protein (W.J. Welch, unpubl.). This con-
stitutive expression of the 72-kD protein is also ob-
served in normal human foreskin fibroblasts but at
a somewhat lower level than that observed for the
various transformed human cell lines.
We should also point out that the constitutive ex-
pression of the 72-kD protein in human cells ap-
pears to be cell-cycle-regulated as well as stimulated
by the addition to cells of fresh serum (R.
Morimoto, pers. comm.). Hence, it will be impor-
tant to determine the relevance of this constitutive
72-kD protein expression apparently unique to
different human cell lines and to assess the effects
of transformation on 72-kD protein expression.
The expression of the 72-kD protein in normal
and transformed rodent cell lines is very much
different from that observed for the various human
cell lines. At physiological growth temperatures,
there is little or no constitutive expression of the 72-
kD protein in either normal or transformed rat
cells. Moreover, even in rat cells stably transformed
by the adenovirus E1A gene, induction of the 72-kD
protein is not observed. Thus, although E1A ap-
pears to promote expression of the 72-kD protein
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in human cells, it appears to have little or no effect
on 72-kD protein expression in the rodent cells.
Again, it should be emphasized, however, that in
the normal human cell lines (but not the rodent
cells), there already exists a low level expression of
the 72-kD protein. Hence, E1A could conceivably
act in some manner to amplify this constitutive ex-
pression of the 72-kD protein, but it would have no
effect in the rodent cells where there does not al-
ready occur a basal level of the 72-kD protein ex-
pression. Suffice it to say that at the present time
we do not understand the basis for this differential
expression of the 72-kD protein in both normal and
transformed human and rodent cell lines and that
much continued effort will be required to sort out
this confusing issue.
Polyclonal and Monoclonal Antibody
Production
W.J. Welch, J.R. Feramisco, N. Kronenberg, G. Blose
Over the past year, we have succeeded in producing
a number of different monoclonal antibodies to
some of the stress proteins as well as to the ras on-
cogene protein. In the case of the stress proteins, we
have approximately ten different monoclonal an-
tibodies specific for the 72-kD stress protein. We
have also produced a polyclonal and monoclonal
antibody that appears to recognize the related fam-
ily of ATP-binding proteins, namely, the 72-, 73-,
and 80-kD proteins. Current effort is being directed
at obtaining antibodies specific to the small 28-kD
stress protein, the 80-kD glucose-regulated protein,
and the 90-kD stress protein.
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J.I. Garrels C. Chang J. Kos J. Ross
B.R. Franza, Jr. M. Hannaford P. Mailloux H. Sacco
M.E. Lambert D. Harty P. Myers S. Scheib
We have continued and expanded our efforts to
apply quantitative electrophoresis technologies
(QUEST) to the development of novel and widely
useful protein databases. Standardized two-
dimensional gel electrophoresis, followed by de-
tailed computer analysis, allows us to quantify and
compare the changes of several thousand proteins
in each of our experimental systems. Databases,
containing baseline characterizations and regula-
tory information for each detected protein, are now
being assembled to include the results of hundreds
of separate experiments. Our primary goal has been
to develop protein databases for cancer research.
These databases, which are a proving ground for
the standardized electrophoresis and image analysis
procedures we have developed over the past several
years, have already begun to reveal interesting
regulatory data about many proteins never before
described.
The past year has been a year of scaling up. We
have received funding from the National Institutes
of Health to become a Biotechnology Resource Fa-
cility for the purpose of large-scale database devel-
opment and dissemination. The first year of the
new program has been devoted largely to equip-
ment acquisition, software conversion and en-
hancement, and, in the last few months, hiring of
the resource staff. New quarters in the Grace Au-
ditorium are nearly ready for our occupancy. A
detailed description of the activities of the resource
facility is presented below.
A new postdoctoral fellow, Michael Lambert, has
joined the laboratory to pursue studies of chemical
carcinogenesis and responses to DNA damage.
Michael comes from the laboratory of I.B. Wein-
stein at Columbia University and brings a wide
knowledge of systems of experimental carcinogene-
sis. He will study the effects of DNA-damaging
agents in detail using the REF52 family of normal
and transformed cell lines and is developing epithe-
lial cell systems in which induced responses to DNA
damage can be studied in the context of multistep,
multifactor transformation.
Our efforts to develop the REF52 family of cell
lines as a controlled experimental system for cancer
research and for protein database development
have accelerated. Led by Robert Franza, and as-
sisted by several collaborators, REF52 cells trans-
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formed by cloned oncogenes have been studied at
the biochemical level and at the level of tumorige-
nicity. Even prior to generating the capacity for
routine analysis of all the electrophoretic data, in-
teresting findings have already been made about
the differential responses of these lines to external
stimuli.
A Resource Facility for
Two-dimensional Gel
Protein Databases
J.I. Garrels, B.R. Franza,
A Biotechnology Resource facility has been estab-
lished for the purpose of developing and dis-
seminating databases derived from quantitative
analysis of two-dimensional gels. The intent of the
Resource Award is to foster the development of
several pioneering databases of great scientific util-
ity. Electrophoresis and computer methods worked
out over the past few years will be applied to the
routine analysis of two-dimensional gel data from
many experiments involving the REF52 family,
mouse embryo cells, and yeast. The construction of
large, internally consistent, and easily accessible
databases in these areas is the major challenge of
the new facility.
SCOPE OF THE RESOURCE ACTIVITIES
The core research component of the Resource Facil-
ity will build the nucleus of each database through
a series of baseline experiments. These experiments
are necessary for the proper interpretation of all
subsequent experiments. The core experiments in-
clude extensive controls for the reproducibility of
the electrophoresis and analysis procedures, con-
trols for the reproducibility of cell-labeling under
normal culture conditions, and a set of basic ex-
perimental characterizations of each cell system
under study. Other experiments needed for the nu-
cleus of each database are (1) behavior of cells
throughout the range of normal culture conditions;
(2) variability between clones or strains; (3) re-
sponses to physiological stresses such as heat,
anoxia, or oxidative stress; and (4) responses to de-
fined growth factors or hormones. Additional
studies will investigate intrinsic parameters of each
protein that may help to reveal its identity. Labeling
the cells with several different amino acid precur-
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sors, one at a time, can reveal the relative amino
acid ratios in each detected protein, and these can
be compared to the amino acid compositions of
known proteins. Incorporation of radiolabeled
phosphate, sugars, or lipids can reveal which pro-
teins are posttranslationally modified. Pulse-chase
kinetics can reveal which proteins are stable and
which are rapidly turning over. Subcellular frac-
tionations can serve to classify proteins by localiza-
tion in nuclei, membranes, mitochondria, etc. Such
characterizations provide fundamental knowledge
for each detected protein and are necessary for
proper interpretation of experiments directed at
specific biological questions.
Another core activity of no less importance is the
identification of the known proteins on our two-
dimensional maps. Hundreds of specific antibodies
and purified proteins are available which, through
immunoprecipitation, immunoblotting, and direct
comigration, can be used to identify a particular
spot on our two-dimensional maps. Each time a
spot is identified, its name, source of antibodies,
and literature citations can be added to the data-
base. Approximately half the time of our core re-
search staff will be devoted to protein identifica-
tions.
The facility will engage in in-house and col-
laborative experiments in each database area to add
new information from the leading edge of research
in each field. Many of our collaborators in the
transformation field are mentioned in our current
and previous reports. The mouse and yeast data-
bases depend primarily on collaborations. In the
mouse field, prior work with L. Silver and col-
leagues is now being extended through the active in-
terest of D. Hanahan and D. Solter (Wistar Insti-
tute). For the yeast database, D. Beach and C.
McLaughlin (University of California, Irvine) will
carry out most of the initial experiments. As each
database grows and matures, other collaborations
will allow in-depth work in specific subfields of
mutual interest.
The databases would be of little value to the sci-
entific community if they were not widely accessi-
ble. Our resource has provisions for service use and
for dissemination of databases to other laborato-
ries. Outside researchers with projects directly relat-
ing to our databases can have gels run in our labo-
ratory and can use our facilities for analysis. In
addition, interested researchers can visit our labo-
ratory to use the databases, and database materials
(tapes, maps, spot graphs) can be sent to other
laboratories. Several of our resource technicians
will be trained to help the service users and to re-
spond to outside requests for information.
PHYSICAL FACILITIES
The two-dimensional gel resource facilities will be
housed, in early 1986, on the lower floor of the new
Grace Auditorium. A large computer room, confer-
ence room, reception area, offices, and workstation
rooms have been designed specifically for our pur-
pose. The workstations are MASSCOMP 32-bit
computers with integrated graphics and array
processors. Each workstation will have over 400
megabytes of disk storage and all are connected via
Ethernet to each other and to the other laboratory
computers. A rotating drum scanner is presently
available, and a fast laser scanner will be purchased
in 1986.
RESOURCE STAFF
In addition to J. Garrels and R. Franza, the staff
consists of Cecile Chang (operations supervisor),
Jim Kos (programmer/analyst), and Mary Han-
naford (office administrator).
come database manager in 1986, Susan Scheib and
Janet Ross will assist with database development
and analysis, and two additional core research tech-
nicians will be hired. The gel laboratory (P. Myers,
D. Harty, and P. Mailloux) is formally a separate
facility funded by user charges, but much of its ca-
pacity is reserved for users of the Biotechnology Re-
source. Users of the facility will communicate with
Cecile on matters of sample preparation and elec-
trophoresis and with Cecile or Heidi on details of
analysis. Both Heidi and Jim Kos will help users to
learn to use the workstations.
EQUIPMENT ACQUISITION AND SOFTWARE
CONVERSION
Most of the first-year budget has been for equip-
ment acquisition and for software conversion. Af-
ter careful survey of available equipment, the
MASSCOMP workstations were chosen because
of the cost/performance ratio and because they
support UNIX and a standard assortment of
peripherals. Being compatible with Ethernet, the
MASSCOMP machines can easily communicate
with the PDP-11, SUN, and VAX computers that
may exist at Cold Spring Harbor Laboratory now
or in the future. Our facility will contain four
MASSCOMP workstations, each with an internal
array processor and graphics processor. Each work-
station, without its array processor, has about the
power of a VAX-11/750, but with the array proces-
sor, it is at least tenfold faster for our application.
Software conversion has been a major undertak-
ing that has occupied much of the first year. The
original software was written in Fortran under
RSX-11M for a PDP-11 with small address space. It
was necessarily split into many separate data and
program units. The new software is written in C
language under the UNIX operating system operat-
ing in 16 megabytes of virtual memory space. Obvi-
ously, in the course of conversion, substantial con-
densation and enhancement could be effected.
Among the enhancements are real-time synthetic
image generation (images are created from spot
lists as they are displayed), true two-dimensional
gaussian fitting, and fast multipass matching using
the array processor. The entire program now is an
integrated unit so that any operations of spot-
fitting, editing, matching, or data analysis can be
performed and repeated by the user at will. An en-
tire experiment, involving as many as 20-30 gels,
can be loaded into
matching as a unit. Through these enhancements of
function and performance, the old system, which
served as proof of principle, has been converted
into a routine production system.
Inducible Cellular Responses to
DNA Damage in Mammalian Cells
M.E. Lambert, J.I. Garrels
We have begun to study the ordered sequence of
cellular responses elicited in mammalian cells after
exposure to different DNA-damaging agents, in-
cluding known human chemical carcinogens and
radiation. As an approach, we are examining
changes in the patterns of cellular protein expres-
sion in both rat fibroblasts and epithelial cells by
use of the QUEST system. Our objective is to iden-
tify specific markers for inducible responses to
different classes of DNA-damaging agents and to
study the involvement of these proteins in tissue-
specific repair processes and in cellular transfor-
mation.
In preliminary experiments (in collaboration
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with I.B. Weinstein, Columbia University), we have
found that single low-dose exposures of REF52
cells to either of two direct-acting chemical carcino-
gens, benzo(a)pyrene-trans 7,8-dihydrodiol, 9,10 -
epoxide (anti) (BPDE) or N-acetoxy-2-acetyl-amino-
fluorene (NAAF), induce the rapid appearance of
a common major protein species of 30K and an IEF
of pH 5.0. This newly identified protein, which we
call carcinogen inducible protein 1 (CIN 1), is a spe-
cific marker for treatment with these agents and is
not induced by growth arrest alone. Studies are un-
der way to characterize the subcellular localization,
rate of synthesis and half-life, posttranslational
modifications (including poly[ADP] ribosylation),
and transcriptional regulation of both CIN 1 and
other, less abundant, cellular proteins induced by
these two chemical carcinogens.
We are extending our survey of inducible re-
sponses to DNA damage in REF52 cells to other
agents and regimens, including exposure to ionizing
radiation (in collaboration with C. Borek, Colum-
bia University), UV light, bleomycin, hydrogen
peroxide, and microinjection of carcinogen-modi-
fied DNA substrates. Using antibodies to known
DNA replication and repair enzymes, including
DNA polymerase alpha, topoisomerase 1 and 2,
and thymidine kinase, we are focusing, in particu-
lar, on changes in nuclear proteins during the acute
phase of cellular responses to DNA damage.
We are also exploring the involvement of induc-
ible cellular responses to DNA damage in multistep,
multifactor cellular transformation. In one study
(in collaboration with N. Sullivan), we are examin-
ing changes in cellular protein expression during
immortalization and transformation of nonestab-
lished rat kidney epithelial cells in culture by either
chemical carcinogens or viral and cellular on-
cogenes. Chemical carcinogens, such as N-methyl-
N'-nitro-N-nitrosoguanidine (MNNG), induce a
high frequency of both preneoplastic and neoplas-
tic changes in rat epithelial cells. The molecular ba-
sis of these high-frequency transitions is not known
but may involve the induction of a eukaryotic
"SOS"-like response. In our study, we are develop-
ing both cell-type-specific and stage-specific cellu-
lar protein markers on the basis of a systematic
comparison of both partial and full transformants
derived independently by either treatment with
MNNG or transfection of cloned oncogenes. Such
markers may also be of value in the early detection
of human cancers of epithelial origin.
Finally, we are utilizing the QUEST system to
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study the synergy between specific chemical car-
cinogens, such as methyl methane sulfonate (MMS)
and the cold-sensitive host-range mutant of human
adenovirus type 5, Hrl, in transformation of the rat
embryo fibroblast line CREF (in collaboration with
P. Fisher, Columbia University). We have designed
protein-labeling experiments to distinguish be-
tween the individual effects of treatment with
MMS (or infection with Hrl) and the synergistic ef-
fects that lead to full transformation, which result
from combined treatment with both carcinogen
and virus. Using QUEST, we can now ask whether
the molecular and cellular bases of this synergy
may lie in part in the ability of MMS to induce the
altered expression of specific cellular proteins that
enhance the transforming potential of Hrl.
Oncogenic Transformation
Discriminated from In Vitro
Morphologic Transformation
B.R. Franza, J.I. Garrels, C. Chang, J. Ross [in collaboration
with S. Blose, Protein Databases Inc., Huntington,
New York; B.R. Bloom and R. Goldschmidt, Albert
Einstein College of Medicine, New York; and
H.E. Ruley, Massachusetts Institute of Technology]
We have derived an interesting family of cells by
transfecting various oncogenes into the rat cell line,
REF52. Unlike many rodent cell lines, the REF52
line is not oncogenically transformed by activated
ras genes. Although REF52 is established, i.e., it
grows continuously in tissue culture when supplied
with serum growth factors, it still requires as yet un-
defined biochemical activities provided by adeno-
virus 5 early region lA gene (Ad5E1A) products
that appear to collaborate with activated ras gene
products in generating in vitro growth characteris-
tics classically referred to as transformed. As a re-
sult of these unique responses to different classes of
oncogenes, we have been able to isolate lines that
constitutively express either the Ad5E1A products
or the products of the activated ras genes or both.
Early in this project, several of the lines that
coexpressed both the Ad5E1A and T24 Ha-ras-1
oncogenes were screened for oncogenesis in syn-
geneic F344 rats. Of interest was the fact that al-
though certain clones always generated tumors,
other clones never generated detectable tumors. Of
additional interest was the fact that using tech-
niques that allow for detection of cell-surface pro-
teins, one of the clones that induced tumors had
several labeled polypeptides significantly different
from those of a clone that did not yield tumors.
At this point in the project, we were fortunate to
be able to form a collaboration with colleagues at
the Albert Einstein College of Medicine. We specif-
ically designed experiments to explore whether the
tumorigenicity of the two transformed clones could
be related to their immunogenicity. Since there is
considerable evidence that natural killer (NK) cells
have the ability to recognize and lyse many virus-
infected target cells and tumor cell lines, we were in-
trigued by the possibility that one of the trans-
formed cell lines that failed to grow in vivo may be
susceptible to attack by NK cells and that the clone
that is able to grow may be resistant to immunologi-
cal attack.
Results of in vivo studies in which each clone is
transplanted subcutaneously into syngeneic F344
rats indicated consistently that one clone (1A7)
failed to produce tumors even at inocula of 106
cells. However, when the animals were treated with
anti-asialo-GM1 antibodies known to react with
and inactivate NK cells in vivo and in vitro, two
thirds of the animals transplanted with clone 1A7
now exhibited tumors at 10 days: all tumors re-
gressed by day 17. In contrast, all animals trans-
planted with clone 1A9, irrespective of being in-
jected with anti-asialo-GM1, exhibited tumor for-
mation by day 6. In addition, all clone 1A9 tumors
regressed by day 14. These results suggested that fail-
ure of clone 1A7 to generate tumors might be the
consequence of rejection via an NK cell mechanism.
Consequently, these experiments were repeated
in athymic nude rats that lack the ability to generate
cytotoxic T lymphocytes or produce lymphokines
such as y-interferon. Once again, clone 1A7 cells
failed to produce tumors unless the animals were
inoculated with anti-asialo-GM1 antibodies. Clone
1A9 cells did not require inoculation with the anti-
asialo-GM1 antibodies to produce tumors. In all
cases when tumors did form, they did not regress as
they did in the normal F344 rats.
Provisional interpretation of these experiments
would be that NK cells, which can be blocked by
anti-asialo-GM1 antibodies, are able to recognize
some determinant present on clone 1A7 cells and
lacking on clone 1A9 cells and thereby initiate early
rejection of the 1A7 cells. Regression occurs in in-
tact rats but not in athymic rats, suggesting that in
addition to an early rejection by NK cells, there is
sensitization by both clones leading to the develop-
ment of cytotoxic T lymphocytes that appear to be
able to recognize determinants on both tumor
lines -a process that does not occur in athymic
animals.
Preliminary in vitro experiments are now under
way to examine the susceptibility of the different
clones to killing by NK cells and cytotoxic T cells.
In addition, tumor explants are being grown in tis-
sue culture to enable comparative studies between
the transplanted clone and the resulting tumor-
derived cells. Efforts are also under way to deter-
mine if metastases have formed and if so, attempts
will be made to expand these cells in culture.
From our earliest studies with REF52, we were
encouraged by the fact that expression of a single
oncogene did not result in oncogenic transforma-
tion, yielding an in vitro system for the study of
multistep acquisition of an oncogenic potential.
Equally encouraging is the fact that even the coex-
pression of two oncogenes is not sufficient for on-
cogenic transformation as noted in this report. We
now have a family of cells, derived from a very
stable parental line, that exhibit a range of growth
and oncogenic properties allowing for a number of
experimental strategies that take advantage of
the ability to compare such a related series of cell
lines differentially- a process largely dependent on
and database capabilities of the
QUEST computerized system for two-dimensional
gel analysis.
PUBLICATIONS
Francoeur, A.M., E.K.L. Chan, J.I. Garrels, and M.B. Mathews.
1985. Characterization and purification of Lupus antigen La,
an RNA-binding protein. Mo/. Cell. Biol. 5: 586-590.
Garrels, J.I. and B.R. Franza, Jr. 1985. Construction of protein
databases for comparison of normal and transformed cells.
In Cell transformation (ed. J. Celis and A. Graessmann), vol.
94. Plenum Press, New York.
. 1985. Building protein databases with the QUEST sys-
tem of computer-analyzed two-dimensional gel electropho-
resis. In Proceedings of the 6th Symposium on Two-
dimensional Electrophoresis, Port-A-Mousson (ed. G. Siest
and M. Galteau). Karger, Basel.
Garrels, J.I., S. Yamashiro-Matsumura, J.J.-C. Lin, and F. Mat-
sumura. 1985. A set of actin-filament associated proteins
characterized by quantitative two-dimensional gel elec-
trophoresis. Adv. Exp. Med. Biol. 182: 223-230.
Harlow, E., B.R. Franza, and C. Schley. 1985. Monoclonal anti-
bodies specific for adenovirus early region 1A proteins: Ex-
tensive heterogeneity in early region 1A products. J. Virol.
55: 533-546.
Ruley, H.E., J. Moomaw, C. Chang, J.I. Garrels, M. Furth, and
B.R. Franza, Jr. 1985. Multistep transformation of an estab-
lished cell line by the adenovirus E1A and T24 Ha-ras 1
genes. Cancer Cells 3: 257-264.
145
In Press, Submitted, and In Preparation
Franza, B.R., Jr, K. Maruyama, J.I. Garrets, and H.E. Ruley.
1986. In vitro establishment is not a sufficient prerequisite for
transformation by activated ras oncogenes. Cell 44: (in
press).
Harlow E., P. Whyte, B.R. Franza, and C. Schley. 1986. Associa-
146
tion of the adenovirus early region 1A proteins with cellular
polypeptides. Mol. Cel. Biol. (in press).
Lambert, M.E., J.I. Garrels, J. McDonald, and I.B. Weinstein.
1986. Inducible cellular responses to DNA damage in mam-
malian cells. In Mechanisms of antimutagenesis and an-
ticarcinogenesis (ed. Shankel et al.). Plenum Press, New
York. (In press.)
NEUROBIOLOGY
Since the middle of the last century, neurologists have considered that specialized
neural functions of the human organism were represented in discrete areas of the
brain. In experimental animals, different functions have been localized to specific
areas using a variety of techniques. How does the brain achieve and maintain the
parcellation of discrete functions to specific areas? How can different areas be
identified and studied? One possible explanation of functional differences among
neurons holds that the neurons themselves are molecularly identical, but differ-
ences in interconnections alone determine functional divisions. Alternatively, neu-
rons may be molecularly heterogeneous in a pattern that might reflect functional
subdivisions of the brain. The experiments of the neurobiology group have shown
that intrinsic molecular differences exist among neurons that appear identical by
morphological criteria. These molecular differences can be used to study the de-
velopment and the functional organization of the brain in experimental animals and
potentially in humans. Our studies in the last year have extended our earlier work
identifying neural cell types and have provided important new information about
the organization of the human brain.
Characterization of Cellular Diversity
in the Mammalian Nervous System
with Monoclonal Antibodies
S. Hockfield, B. Friedman, S. Zaremba, C. Bautista,
E. Waldvogel
ORGANIZATION OF THE CORTEX IS REVEALED
WITH MONOCLONAL ANTIBODY CAT-301
Functionally Related Areas of Monkey Cortex Are
Antigenically Related. Visual stimuli are pro-
cessed as parallel channels of component informa-
tion. In simplified terms, motion, color, and form
are each carried separately through a series of mul-
tiple relays in the brain. In the visual cortex, neu-
rons can be identified that respond selectively to
one of these features of visual information. In the
monkey, at least ten different areas process visual
stimuli, each performing a characteristic set of
computations on incoming information. Some
areas, or subdivisions of an area, are apparently
dedicated to one information channel. Monoclonal
antibody Cat-301 recognizes neurons in several, but
not all, visual cortical areas. Our analyses using
double-labeling techniques and correlating anti-
body-staining patterns with electrophysiologically
generated maps of cortical function suggest that
Cat-301 selectively recognizes neurons involved in
processing the motion component of visual stimuli.
Five areas that constitute consecutive relays in the
motion channel contain Cat-301-positive neurons.
Differences in staining characteristics (number and
location of antibody-positive neurons) allow us to
map the boundaries of each area accurately.
In each area that contains Cat-301-positive neu-
rons, only a subset of neurons are recognized by the
antibody. The pattern of antibody-positive neurons
reveals distinctive features of the organization of
each area. For example, in the primary visual corti-
cal area, V1, Cat-301-positive neurons line up in
rows that reflect the alternating input from right
and left eyes (the ocular dominance organization).
In the secondary visual area, V2, Cat-301-positive
neurons form strips that correspond to the subdivi-
sion of V2 that relays motion information to the
next cortical area, MT (the middle temporal area).
A subset of the neurons in MT are Cat-301-positive
neurons, as are neurons in the area to which it
projects, MST (the medial superior temporal area).
Functionally distinct neuronal subsets in MT and
MST have not yet been identified, but staining with
Cat-301 suggests that functional subdivisions may
exist within these higher-order processing areas.
Now that we have shown that the general maps
of "motion" areas and Cat-301-positive areas over-
lap, we would next like to know if individual neu-
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rons of the motion channel are Cat-301-positive.
Our current experiments combine a metabolic
tracer of neuronal activity (2-deoxyglucose) with
Cat-301 immunohistochemistry to resolve at the
level of single neurons whether motion stimuli
selectively activate the population of neurons iden-
tified with Cat-301.
Cat-301 Demonstrates the Functional Organization
of the Human Cortex. Our studies of the organi-
zation of the cortex have relied on a large body of
data generated from investigations in experimental
animals. The organization of the human cortex has
been more difficult to determine, as the experimen-
tal manipulations used to demonstrate selective
cortical involvement in specific tasks often require
invasive techniques. Descriptions of human corti-
cal organization have relied on analogies in subtle
features of the cellular organization between hu-
man and experimental animals and on studies of in-
dividuals with cortical injuries. Recent advances in
tissue visualization methods, the PET and CAT
scanners, have demonstrated localization of corti-
cal function, but these techniques generate a rela-
tively low resolution picture and do not provide in-
formation at the level of individual nerve cells.
The conservation of antigens through evolution
potentially allows studies in experimental animals
to be extended to the human nervous system. Previ-
ously, we showed that Cat-301 recognizes an anti-
gen in the human cortex that is related to the anti-
gen in monkey and cat. Recently, we have used
Cat-301 to study the organization of the human vi-
sual cortex. In the first visual cortical area, VI, the
human cortex displays a periodicity with Cat-301
similar to that found in the monkey. We know from
our earlier studies that Cat-301-positive neurons
mark the center of each ocular dominance stripe.
The width of an ocular dominance stripe in mon-
key is 0.5 mm. We have now shown with Cat-301
that the human visual cortical area VI is also orga-
nized in periodic stripes and that these stripes are
1 mm in width. In the monkey, the end of the area
containing the stripes marks the boundary between
area VI and the adjacent area V2. Similarly, the
border of human VI is marked by the end of the re-
gion containing the 1-mm-wide Cat-301 stripes.
The organization of V2 in monkey has been stud-
ied with electrophysiological, histochemical, and
mapping techniques (as described above), but it has
not been mapped in human. As in the monkey area
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V2, in human area V2, Cat-301 shows that a subset
of neurons line up to form thick strips, oriented
perpendicular to the border between V2 and V1.
These strips are therefore homologous to the thick
strips in monkeys which contain neurons that par-
ticipate in the motion channel. We next plan to
localize areas MT and MST in the human. From
these results, it is clear that reagents like Cat-301
can be enormously useful in dissecting functionally
significant areas of the human brain.
Expression of Cat -301 Is Controlled by Early Vi-
sual Experience. Early experience can perma-
nently alter the structure and function of the mam-
malian brain. In the visual system, deprivation
from birth through a "critical period" of develop-
ment profoundly alters the shape and physiology of
neurons in central visual areas. How such changes
are mediated is not well understood. We have found
that visual deprivation results in a loss of the Cat-
301 antigen from areas that would normally receive
the deprived input. The loss is not tied simply to a
reduction in neuronal activity, as visual deprivation
in an adult does not affect antigen expression. This
suggests that the phenotypic changes in neurons
consequent to early experience are reflected by the
expression of particular molecules. We are now
identifying other experience-dependent molecules
in order to obtain a description of the molecular
events associated with late developmental events.
One potential use of such markers will be to de-
scribe developmentally significant periods in hu-
man neural development.
The Antigen Recognized by Cat-301 Is a Pro-
tein. Do all Cat-301-positive neurons express the
same antigen or do different groups of neurons ex-
press distinct molecular species that share only the
epitope recognized by Cat-301? Do Cat-301-nega-
tive neurons express a molecule related to the Cat-
301 antigen? To address these questions, we are
characterizing and purifying the antigen recognized
by Cat-301. As the subcellular localization of the
antigen is consistent throughout the nervous system
and in all species, it is likely that related molecules
are expressed by all Cat-301-positive neurons. Our
ultrastructural studies suggest that Cat-301 may
recognize some component of the extracellular ma-
trix. Biochemical studies have shown that the anti-
gen is soluble in deoxycholate and that an acidic
species is specifically eluted from a Cat-301 cyano-
gen-bromide-activated Sepharose column, charac-
teristics that might be consistent with a component
of the extracellular matrix. Immunoreactivity is
lost after digestion with several proteases, suggest-
ing that the antigen contains protein. On Western
blots, the eluted fractions from a Cat-301 affinity
column show 30-kD and 20-kD immunoreactive
bands. Our current efforts are to purify enough of
the antigen to obtain a partial protein sequence to
then use in conjunction with the monoclonal anti-
body in an effort to clone the molecule.
GROWING NEURONS NAVIGATE ON NONNEURONAL
CELLS AND ON PREVIOUSLY ESTABLISHED
AXON TRACTS
How neurons find the appropriate routes to grow
along to make correct connections has been a ma-
jor focus of our work over the past 4 years. In cell
culture, axons have been shown to prefer some sub-
strates to others and to grow readily on other axons
or on nonneuronal cells. Studies of axon growth
substrates in vivo have been very difficult due to the
greater complexity of the intact nervous system.
One of our goals has been to obtain markers for cell
types present early in development that could be
used to follow the events in axon outgrowth.
Surface differences have been postulated to
mediate route and target specificity of axons. In our
early experiments in the leech, we showed that
growing axons carry antigenically distinct surface
glycoproteins. In the adult, axons that express a
common surface molecule travel together in bun-
dles, suggesting that these surface molecules might
provide routing cues. While axon-axon interactions
might guide axons into a particular route, the first
axons grow into an environment devoid of other
neuronal elements. Even so, these first axons grow
along defined routes. What guides the first axons?
We now have evidence that nonneuronal cells,
specifically a cell called the Schwann cell, may be
involved in the earliest stages of axon growth. This
work contradicts the classic notion that early ver-
tebrate axons are naked and blaze their own trail to
their targets. One of the monoclonal antibodies we
generated to the developing nervous system, Rat-
401, recognizes an antigen expressed by a popula-
tion of cells that delineate early nerve routes. These
cells precede and predict axon routes into the pe-
riphery. The Rat-401-positive cell is temporally and
spatially suited to serve as a substrate for new axon
growth, and early axons are found juxtaposed to
its membrane both in tissue culture and in vivo.
We have now shown that these cells are not a tran-
sient embryonic cell type, but persist into adult-
hood. This conclusion is based on the observation
that Rat-401 stains morphologically recognizable
Schwann cells in developing and in mature nerves.
In the adult, the Schwann cell is intimately as-
sociated with mature axons, it forms the myelin
sheath that accelerates nerve conduction, and, in
addition, it has been implicated in supporting nerve
regeneration.
Because of the difficulty of definitively dis-
criminating Schwann cells from other cell types in
vivo, cultures of Schwann cells and of mixed popu-
lations of Schwann cells and fibroblasts were
stained to show that Rat-401 specifically recognizes
Schwann cells. This result suggests that the early
Rat-401-positive cell is actually a Schwann cell
precursor and that this nonneuronal, axon-
associated Schwann cell guides initial axonal out-
growth. Rat-401, then, provides a marker for
Schwann cells throughout their life history, prior to
axon ensheathment and during and after myelina-
tion of axons.
Two classes of Schwann cells have previously
been described based on morphological criteria:
Schwann cells that form myelin sheaths around
axons and Schwann cells that are intimately as-
sociated with axons but do not form myelin. Our
recent experiments suggest that Rat-401 recognizes
one of the two classes of Schwann cells, those that
form myelin. Neither the unmyelinated axons of the
sympathetic trunk nor the unmyelinated axons of
the olfactory nerve have associated Rat-401-positive
cells, in contrast to the prevalent Rat-401-positive
cells found in most axon tracts that contain large
proportions of myelinated axons. Our immuno-
chemical and immunohistochemical studies have
shown that Rat-401 recognizes a species distinct
from structural components of myelin.
Previous work suggested that the expression of
myelin by a Schwann cell is signaled entirely from
the axon and that nonmyelinating and myelinating
Schwann cells are interconvertible members of one
cell class. The observation that different classes of
Schwann cells express different molecules suggests
that there are two molecularly distinct classes of
Schwann cells. To establish definitively whether the
antigenic dichotomy between Schwann cells holds,
we are currently examining cultures of Schwann
cells prepared from sciatic nerve (a source of
myelin-producing Schwann cells) and from the
sympathetic trunk (a source of nonmyelinating
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Schwann cells). One of our current goals is to iden-
tify further antigens expressed in subsets of
Schwann cells. These markers will allow us to fol-
low the genesis and differentiation of Schwann cells
and to examine the role of each class in axon route
formation and axonal myelination.
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Recto: Meeting participants enjoy informal discussions and quiet vistas on the lawn behind
Blackford Hall.
50TH COLD SPRING HARBOR SYMPOSIUM
ON QUANTITATIVE BIOLOGY
Molecular Biology of Development
May 29 - June 5
254 participants
Developmental biologists are an audacious breed. Their ambition is to provide
an intellectually satisfying account of the forces that guide the development of
multicellular organisms around the circle from fertilized egg to embryo to adult to
gamete. These processes, however, lie close to the border beyond which ge-
netics may not be feasible nor necessarily useful; furthermore, meaningful bio-
chemical studies pose extraordinary challenges because of the small amounts of
material that are available and the general rapidity of events in the early embryo.
In the face of these difficulties it is not surprising that for many years develop-
mental biology was essentially a branch of anatomy, in that it was exclusively de-
scriptive in nature. Accurate and elegant though these descriptions were, they
led to an understanding of developmental processes less frequently than to an
amazement at their beauty.
In recent years, however, developmental biology has undergone a dramatic
change and has matured from a descriptive to an analytical science. This
change stems almost entirely from two technical advances-the ability to use
molecular cloning to isolate and characterize wild-type and mutant versions of
genes that control or are expressed at specific developmental stages and, sec-
ond, the ability to generate transgenic organisms in which the expression of the
introduced gene(s) is correct both spatially and temporally. In consequence, the
developmental biologist has the capacity not only to describe but also now to
analyze and influence the events that guide a fertilized egg to its destiny. Our
choice of the topic molecular embryology for this year's Symposium-the 50th -
celebrates this new-found freedom.
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The traditional introduction, given on the first evening by John Gurdon, was
an appropriate mixture of philosophy, history, and foresight. We then heard talks
from Seymour Benzer, Sydney Brenner, and Anne McLaren who reminisced
about earlier Cold Spring Harbor Symposia and spoke about aspects of develop-
mental biology of particular interest to them. The 50th Symposium therefore
started on a high intellectual plane that was sustained through the 110 formal
presentations given during the next 6 days. Despite this length, most of the 254
people attending the Symposium stayed for the entire meeting. The final talk was
given by Gerry Rubin who provided an excellent summary of the highlights of the
meeting.
This meeting was supported in part by the National Science Foundation, De-
partment of Energy, and the National Cancer Institute, National Institutes of
Health.
Welcoming remarks: J.D. Watson
Introduction: J. Gurdon, Cambridge University, England
SESSION I DEVELOPMENTAL PERSPECTIVES
Chairperson: S. Benzer, California Institute of Technology, Pasadena
Benzer, S., California Institute of Technology, Pasadena: A
fly's eye view of development.
Brenner, S., Medical Research Council, Cambridge, Eng-
land: Lineages in development.
McLaren, A., Medical Research Council, London, England:
Gametogenesis and embryogenesis.
SESSION 2 NUCLEAR/CYTOPLASMIC INTERACTIONS IN EARLY DEVELOPMENT
Chairperson: J. Gurdon, Cambridge University, England
Wassarman, P., Bleil, J., Florman, H., Greve, J., Roller, R.,
Salzmann, G., Dept. of Biological Chemistry, Harvard
Medical School, Boston, Massachusetts: The mouse egg's
receptor for sperm-What is it and how does it work?
Rebagliati, M., Weeks, D., Perry, H., Melton, D., Dept. of Bio-
chemistry and Molecular Biology, Harvard University,
Cambridge, Massachusetts: Maternal mRNA localization
in frog and ascidian eggs.
Dawid, I.B., Sargent, T.D., Jamrich, M., NICHD, National In-
stitutes of Health, Bethesda, Maryland: Gene expression
in Xenopus embryogenesis.
Wylie, C.C., Snape, A., Heasman, J., Dept. of Anatomy, St.
George's Hospital Medical School, London, England:
Germ plasm is not an early determinant for the germ line
in Xenopus embryos.
Soifer, D., McGrath, J., Wistar Institute, Philadelphia, Penn-
sylvania: Nuclear transfer in mouse embryos-Activation
of embryonic genome.
Schierenberg, E., Max-Planck-Institute, Gottingen, Federal
Republic of Germany: Cytoplasmic determination of em-
bryonic development in the nematode Caenorhabditis ele-
gans.
Hirsh, D., Kemphues, K., Stinchcomb, D., Jefferson, R.,
Dept. of Molecular, Cellular and Developmental Biology,
University of Colorado, Boulder: Genes affecting early de-
velopment in Caenorhabditis elegans.
Miller, K., Carr, T., Walter, M., Alberts, B., Dept. of Biochem-
istry and Biophysics, University of California, San Fran-
cisco: Cytoplasmic organization in the early Drosophila
embryo.
SESSION 3 LINEAGE AND SEGMENTATION/PATTERN FORMATION
Chairperson: D. Hogness, Stanford University Medical Center, California
Horvitz, R., Ambros, V., Desai, C., Ellis, H., Finney, M.,
Fixsen, W., Greenwald, I., Ruvkun, G., Sternberg, P., Dept.
of Biology, Massachusetts Institute of Technology, Cam-
bridge: Genes that affect the development of the nema-
tode Caenorhabditis elegans.
Gergen, J.P., Coulter, D., Wieschaus, E., Dept. of Biology,
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Princeton University, New Jersey: Cell identities and the
detailed segment pattern.
Lawrence, RA., Laboratory of Molecular Biology, Cam-
bridge, England: Development of the Drosophila meso-
derm.
Gelbart, W.M., Hoffman, F.M., Irish, V.F., Posakony, L., St.
Johnston, D., Segal, D., Spencer, F., Irick, H., Blackman,
R., Grimaila, R., Figueroa, P., Taylor, M., van Doren, M.,
Kerkhof, L., Dept. of Cellular and Developmental Biology,
Harvard University, Cambridge, Massachusetts: Structure
and expression of the decapentaplegic gene complex in
Drosophila.
Frei, E.,' Baumgartner, S.,' EdstrOm, J.-E.,2 Noll, M.,'
'Dept. of Cell Biology, Biocenter, University of Basel,
Switzerland; 2EMBL, Heidelberg, Federal Republic of
Germany: Isolation and identification of the extra sex
combs gene of Drosophila.
Howard, K.R., Ingham, P.W., Pinchin, S.M., Rush low, C.A.,
Howe, K.R., Ish-Horowicz, D., Imperial Cancer Research
Fund, London, England: Molecular and genetic analysis
of the hairy locus in Drosophila.
Nusslein-Volhard, C., Freidrich Miescher Laboratory, Tubin-
gen, Federal Republic of Germany; Genes affecting the
segmental subdivision of the Drosophila embryo.
Flytzanis, C.F., Hough-Evans, B.R., Katula, K.S., Franks,
R.R., Britten, R.J., Davidson, E.H., California Institute of
Technology, Pasadena: Initial specification of cell lineage
in the sea urchin embryo studied by gene transfer.
Grant, S.R., Woodward, H.D., Farach, M.C., Lennarz, W.J.,
University of Texas System Cancer Center, M.D. Anderson
Hospital and Tumor Institute, Houston: Developmental
expression of cell-surface (glyco) proteins involved in gas-
trulation and spicule formation in sea urchin embryos.
SESSION 4 HOMEOTIC MUTANTS
Chairperson: E.B. Lewis, California Institute
Lewis, E.B., California Institute of Technology, Pasadena: Cis-
regulation of the bithorax gene complex.
Sanchez-Herrero, E., Casanova, J., Morata, G., Universidad
Aut6noma de Madrid, Spain: Anatomy and function of the
bithorax complex of Drosophila.
Bender, W.,' Karch, F.,' Weiffenbach, B.,' Lewis, E.B.,2
'Dept. of Biological Chemistry, Harvard Medical School,
Boston, Massachusetts; 2Division of Biology, California In-
stitute of Technology, Pasadena: Domains of polarity in the
bithorax complex in Drosophila.
Hogness, D.S., Beachy, PA., Lipshitz, H., Peattie, D., Paro,
R., Gavis, E., Harte, P., Dept. of Biochemistry, Stanford
University School of Medicine, California: Regulation and
products of the Ubx domain of the bithorax complex of
Drosophila.
Akam, M.E.,1 Martinez-Arias, A.,2 'Dept. of Genetics, 2MRC
Laboratory of Molecular Biology, Cambridge, England:
Expression of the Ultrabithorax domain of the bithorax
complex within the Drosophila embryo.
Ingham, P.W., Imperial Cancer Research Fund, London,
England: The regulation of antennapedia and bithorax
complex expression in Drosophila melanogaster.
Harding, K., Wedeen, C., Doyle, H., Levine, M., Columbia
University, New York, New York: Spatial regulation of hom-
eotic gene expression in Drosophila.
Steward, R., Ambrosio, L., Schedl, P, Dept. of Biology,
Princeton University, New Jersey: Molecular andlysis of
dorsal, a gene essential for polarity in the Drosophila em-
bryo.
D. Hogness
Ali, Z., Coleman, K., Drees, B., Gustayson, E., Karr, T., Kau-
ver, L., Poole, S., Soeller, W., Weir, M., Kornberg, T., Dept.
of Biochemistry and Biophysics, University of California,
San Francisco: Studies of the Drosophila engrailed lo-
cus-A gene controlling segment and compartment for-
mation.
D. Baltimore, R. Jaenisch
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SESSION 5 INDUCED DEVELOPMENTAL DEFECTS
Chairperson: M. Lyon, Medical Research Council, Oxon, England
Jaenisch, Harbers, K.,2 Jahner, D.,2 Kratochwil, K.,3
LOhler, J.,2 'Whitehead Institute, Cambridge, Massachu-
setts; 2Heinrich-Pette-Institut, Hamburg, Federal Repub-
lic of Germany; 3Osterreichische Akademie de Wissen-
schaften, Salzburg, Austria: Retroviruses and mouse
development.
Mintz, B., Covarrubias, L., Nishida, Y., Institute for Cancer
Research, Fox Chase Cancer Center, Philadelphia, Penn-
sylvania: Early developmental mutations caused by rear-
rangements accompanying DNA insertions in the mouse
genome.
Lacy, E., Signorelli, K., Mark, W., Memorial Sloan-Kettering
Cancer Center, New York, New York: A recessive lethal
mutation in a transgenic mouse line.
Leder, P., Woychik, R., Stewart, T., Dept. of Genetics, Har-
vard Medical School, Boston, Massachusetts: A limb de-
forming mutation produced by insertional mutagenesis in
a transgenic mouse.
SESSION 6 CELLULAR DIFFERENTIATION
Chairperson: D. Kaiser, Stanford University, California
Lodish, H.F., Cappello, J., Cohen, S., Handelsman, K.,
Whitehead Institute, Cambridge, Massachusetts: Gene
expression during early differentiation of Dictyostelium
discoideum.
Loomis, W.F., Dept. of Biology, University of California, San
Diego: Regulation of cell-type specific differentiation in
Dictyostelium.
Blaschke, A., Prause, I., MacWilliams, H., Zoologisches In-
stitut der Ludwig-Maximilians-Universitat, Munchen, Fed-
eral Republic of Germany: Feedback regulation of cell-type
proportioning in Dictyostelium.
S. Brenner, F Jacob,
and S. Benzer
Hanahan, D., Alpert, S., Cold Spring Harbor Laboratory, New
York: Perturbation by oncogene expression in the devel-
opment of the endocrine pancreas.
Weintraub, H.,' Izant, J.G.,' Harland, R.,2 Roberts, J.,'
'Dept. of Genetics, Fred Hutchinson Cancer Research
Center, Seattle, Washington; 2Virus Laboratory, University
of California, Berkeley: Constitutive and conditional
suppression of exogenous and endogenous genes by anti-
sense RNA.
Rosenberg, U.B., Preiss, A., Seifert, E., Jackie, H., Knipp le,
D.C., Max-Planck Institut fur Entwicklungsbiologie, Tubin-
gen, Federal Republic of Germany: Production of pheno-
copies by Kruppel antisense RNA injection into Droso-
phila embryos.
Malmberg, R.L., Mclndoo, J., Hiatt, A.G., Lowe, B., Cold
Spring Harbor Laboratory, New York: Polyamine mutants
and developmental switches in the tobacco flower.
Devreotes, P., Klein, F, Theibert, A., Knox, B., Fontana, D.,
Sherring, J., Dept. of Biological Chemistry, Johns Hopkins
University Medical School, Baltimore, Maryland: Reversi-
ble cyclic AMP-induced cyclic AMP receptor modification
as a possible adaptation mechanism in Dictyostelium.
Brydoff, B., Crowley, T., Datta, S., Gomer, R., Mann, S.,
Mehdy, M., Nel len, W., Reymond, C., Silan, C., Sivertsen,
A., Firtel, R.A., Dept. of Biology, University of California,
San Diego, La Jolla: Regulation of cell-type differentiation
in Dictyostelium.
Gerisch, G., Max-Planck-Institute kir Biochemie, Martins-
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vied, Federal Republic of Germany: Bypassing steps in the
control of early Dictyostelium development by sequential
mutagenesis.
Kaiser, D., Kroos, L., Kuspa, A., Dept. of Biochemistry, Stan-
ford University, California: Cell interactions govern the
temporal pattern of Myxococcus development.
Shapiro, L., Dept. of Molecular Biology, Albert Einstein Col-
lege of Medicine, Bronx, New York: Temporal and spatial
regulation of flagellar (fla) and chemotaxis (che) gene
products in Caulobacter.
Edelman, G.M., Rockefeller University, New York, New York:
Cell adhesion molecules in induction and morphogenesis.
SESSION 7 HOMED BOXES
Chairperson: W. Gehring, University of Basel, Switzerland
Gehring, W.J., Biocenter, University of Basel, Switzerland:
Homeotic genes and the control of development.
Scott, M.P., Bermingham, J., Carroll, S., Laughon, A., Dept.
of Molecular, Cellular and Developmental Biology, Univer-
sity of Colorado, Boulder: A protein encoded by the anten-
napedia gene-Features common to several homeotic
proteins in Drosophila.
McGinnis, W., Dept. of Molecular Biophysics and Biochem-
istry, Yale University, New Haven, Connecticut: The con-
servation of the homeo box in genes of Drosophila and in
the genomes of other metazoans.
De Robertis, E.M., Fritz, A., GOtz, J.M., Salo, E., Smith, G.D.,
Mattaj, I.W., Wright, C., Zeller, R., Martin, G., Biocenter,
University of Basel, Switzerland: The Xenopus homeo
boxes.
Ruddle, FN.,' Hart, C.P.,1 Awgulewitsch, A.,' McGinnis,
W.,2 'Dept. of Biology; 2Dept. of Molecular Biophysics
and Biochemistry, Yale University, New Haven, Connecti-
SESSION 8 CONTROL OF GENE EXPRESSION
J.D. Watson
cut: Organization and expression of homeo box se-
quences in the mouse (Mus muscu/us).
Colberg-Poley, A.M., Voss, S.D., Chowdhury, K., Dony, C.,
Gruss, P., Center for Molecular Biology, University of Hei-
delberg, Federal Republic of Germany: Analysis of murine
genes containing homeo boxes and their expression in
murine development.
Hauser, C.A.,' Joyner, A.L.2 Martin, G.M.,2 Tjian, R.,1
'Dept. of Biochemistry, University of California, Berkeley;
2Dept. of Anatomy, School of Medicine, University of Cali-
fornia, San Francisco: Structure and expression of human
and mouse genes containing homeo box sequences.
Joyner, A.L.,' Kornberg, T.,2 Martin, G.M.,' Depts. of
'Anatomy, 2Biochemistry and Biophysics, University of
California, San Francisco: Isolation of a mouse sequence
containing an engrai/ed-like homeo box and studies of its
expression in embryos and teratocarcinoma cells.
Chairperson: D. Brown, Carnegie Institution of Washington, Baltimore, Maryland
Losick, R., Zuber, P., Igo, M., Youngman, P., Perkins, J.,
Sandman, K., Dept. of Cellular and Developmental Biol-
ogy, Harvard University, Cambridge, Massachusetts:
Complex regulation of developmental promoters in a sim-
ple organism.
Struhl, K., Dept. of Biological Chemistry, Harvard Medical
School, Boston, Massachusetts: Yeast promoters.
Ashburner, M.,' Savakis, C.,2 'Dept. of Genetics, University
of Cambridge, England; 2Institute of Molecular Biology
and Biotechnology, Crete, Greece: The developmental
regulation of the Adh gene of Drosophila melanogaster.
Posakony, J.W., Fischer, J.A., Corbin, V., Maniatis, T., Dept.
of Biochemistry and Molecular Biology, Harvard Univer-
sity, Cambridge, Massachusetts: Analysis of the larval to
adult switch in Drosophila alcohol dehydrogenase (Adh)
gene expression.
Wensink, P., Brandeis University, Waltham, Massachusetts:
Independent control elements that determine yolk protein
gene expression in alternative tissues.
Orr-Weaver, T, deCicco, D., Kalfayan, L., Kelley, R., Levine,
J., Parks, S., Wakimoto, B., Spradling, A., Dept. of Em-
bryology, Carnegie Institution of Washington, Baltimore,
Maryland: Amplification and expression of Drosophila
chorion genes.
Kafatos, PC., Mitsialis, S.A., Delidakis, C., Spoerel, N., Lin-
gappa, J., Mariani, B., Dept. of Cellular and Develop-
mental Biology, Harvard University, Cambridge, Massa-
chusetts: Regulated expression and amplification of
chorion genes.
Brown, D.D., Schlissel, M.S., Dept. of Embryology, Carnegie
Institution of Washington, Baltimore, Maryland: Discrimi-
nation between the 5S RNA genes in Xenopus.
Ausubel, F, Buikema, W., Lang-Unnasch, N., Marvel, D.,
Dept. of Genetics, Harvard Medical School and Dept. of
Molecular Biology, Massachusetts General Hospital, Bos-
ton, Massachusetts: Symbiotic nitrogen fixation-Devel-
opmental genetics of nodule formation.
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SESSION 9 SEX DETERMINATION
Chairperson: D. Botstein, Massachusetts Institute of Technology, Cambridge
Wilson, K., Johnson, A., Fields, S., Mitchell, A., Herskowitz,
I., Dept. of Biochemistry and Biophysics, University of Cal-
ifornia, San Francisco: A master regulatory locus deter-
mines yeast cell type.
Klar, A.J.S., Cold Spring Harbor Laboratory, New York: De-
velopmental potential for fission yeast mating-type switch-
ing is chromosomally inherited.
Wood, W.B.,' Strome, S.,2 Meneely, P.,. Schedin, P,'
Scholey, S.,' Donahue, L.,' Quarantillo, B.,' Trent, C.,'
'Dept. of Molecular, Cellular, and Developmental Biology,
University of Colorado, Boulder; 2Dept. of Biology, Indi-
ana University, Bloomington; *red Hutchinson Cancer
Research Center, Seattle, Washington: Control of early de-
velopmental decisions in embryos of Caenorhabditis ele-
gans.
SESSION 10 CELL-CYCLE EFFECTS
Hodgkin, J., Doniach, T, Shen, M., MRC Laboratory of Mo-
lecular Biology, Cambridge, England: Genes that deter-
mine sex in the nematode C. elegans-Variations on a
theme.
Maine, E., Salz, H., Cronmiller, C., Schedl, P., Cline, T., Dept.
of Biology, Princeton University, New Jersey: Molecular
analysis of sex-lethal, a major sex-determining gene in
Drosophila.
Belote, J., McKeown, M., Baker, B., Dept. of Biology, Uni-
versity of California, San Diego, La Jolla: Sex determina-
tion in Drosophila melanogaster.
NOthiger, R., Steinmann-Zwicky, M., Zoological Institute,
University of Zurich, Switzerland: Sex determination-Ap-
parent variety in hiding a common principle.
Chairperson: M. Birnstiel, Institute for Molecular Biology, University of Zurich, Switzerland
Botstein, D., Dept. of Biology, Massachusetts Institute of
Technology, Cambridge: The yeast cell cycle and cyto-
skeleton as models for the genetic analysis of develop-
ment.
Reed, S., de Barros Lopes, M., Ferguson, J., Hadwiger, J.,
Ho, J. -Y., Horwitz, R., Jones, C., Ltirincz, A., Mendenhall,
M., Peterson, T., Richardson, S., Wittenberg, C., Dept. of
Biological Sciences, University of California, Santa Bar-
bara: Genetic and molecular analysis of division control in
yeast.
Wig ler, M., Kataoka, T, Toda, T, Birchmeier, C., Broek, D.,
Powers, S., Cold Spring Harbor Laboratory, New York:
Function of RAS genes.
Breeden, L., Miller, A., Nasmyth, K., MRC Laboratory of Mo-
lecular Biology, Cambridge, England: Cell-type-specific
and cell-cycle-regulated transcription of the yeast HO
gene.
SESSION 11 TISSUE SPECIFICITY/POSITION EFFECTS
Chairperson:
Beach, D., Cold Spring Harbor Laboratory, New York: rant
controls the transition from mitotic division to meiosis in
fission yeast.
Newport, J., Dept. of Biology, University of California, San
Diego, La Jolla: Regulation of the cell cycle during early
embryonic development in Xenopus laevis.
Laskey, R.A.,' Mills, A.D.,' Dingwall, C.,' Dilworth, S.M.,'
Kleinschmidt, J.,2 'CRC Molecular Embryology Group,
Dept. of Zoology, University of Cambridge, England;
2lnstitut far Zell and Tumorbiologie, Deutsches Kresfor-
schumgszentrum, Heidelberg, Federal Republic of Ger-
many: Chromosome replication in early Xenopus em-
bryos.
Birnstiel, M.L., Schamperli, D., Buss linger, M., Institut fur
Molekularbiologie II der Universitat, Zurich, Switzerland:
Regulation of histone gene expression in cell cycle and
development.
N. Federoff, Carnegie Institution of Washington, Baltimore, Maryland
Federoff, N., Banks, J., Kelly, S., Carnegie Institution of
Washington, Dept. of Embryology, Baltimore, Maryland:
Transposable controlling elements in maize.
Emmons, S.W., Ruan, K., Yesner, L., Dept. of Molecular Bi-
ology, Albert Einstein College of Medicine, Bronx, New
York: Tissue-specific regulation of the Tcl transposable
element in C. elegans.
Rubin, G.M., Hazelrigg, T., Laski, F., Laverty, T., Levis, R.,
Rio, D., Spencer, F., Zuker, C., Dept. of Biochemistry, Uni-
versity of California, Berkeley: Germ-line specificity of P
element transposition and some novel patterns of expres-
sion of transduced copies of the white gene.
Bingham, P., Zachar, Z., Chapman, C., Dept. of Biochemis-
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try, State University of New York, Stony Brook: Cis- and
Trans-acting regulators of developmentally programmed
transcription in Drosophila.
Meyerowitz, E., Crosby, M., Garfinkel, M., Martin, C., Math-
ers, P., Raghavan, K.V., Division of Biology, California In-
stitute of Technology, Pasadena: cis- and trans-acting reg-
ulators of the Drosophila 68C glue gene cluster.
Costantini, F., Magram, J., Chada, K., Dept. of Human Ge-
netics and Development, College of Physicians & Sur-
geons, Columbia University, New York, New York: Devel-
opmental regulation of cloned globin genes in transgenic
mice.
Krumlauf, R.,' Hammer, R.E.,2 Brinster, R.,2 Chapman, V.,2
Tilghman, S.M.," Institute for Cancer Research, Philadel-
phia, Pennsylvania; 2University of Pennsylvania School of
Veterinary Medicine, Philadelphia; 3Roswell Park Memo-
rial Institute, Buffalo, New York: Developmental regulation
of a-fetoprotein genes in transgenic mice.
D. Baltimore, F. Jacob,
W. Gilbert, L. Shapiro,
and D. Hogness
Van Dyke, T, Finlay, C., Teresky, A.J., Levine, A.J., Dept. of
Molecular Biology, Princeton University, New Jersey:
Characterization of several lines of mice transmitting the
SV40 early-region genes in the germ line.
SESSION 12 EXPRESSION OF GENES INTRODUCED INTO TRANSGENIC ORGANISMS
Chairperson: A. McLaren, Medical Research Council, London, England
Hammer, R.E.,' Palmiter, Brinster, R.L.,"School of
Veterinary Medicine, University of Pennsylvania, Philadel-
phia; 2Dept. of Biochemistry, University of Washington,
Seattle: Expression of bovine and human growth hormone
fusion genes in transgenic mice.
Evans, Wineberger, C.,1 Hollenberg, S.:, Swan-
son, L.,1 Nelson, C.,2,2 Rosenfeld, M.G.,2 'Gene Expres-
sion Laboratory, Salk Institute; 2Dept. of Biology, 2School
of Medicine, University of California, San Diego: Inducible
and developmental control of neuroendocrine genes.
Ornitz, D.M.,1 Palmiter, R.C.,1 Hammer, R.E.,2 Brinster,
R.L.,2 'Dept. of Biochemistry, University of Washington,
Seattle; 2School of Veterinary Medicine, University of
Pennsylvania, Philadelphia: The elastase-I promoter re-
gion directs expression of human growth hormone and
SV40 T antigen to pancreatic acinar cells in transgenic
mice.
Westphal, H., Overbeek, RA., Khillan, J.S., Chepelinsky,
A.B., Schmidt, A., Mahon, K.A., Piatigorsky, J., de Crom-
brugghe, B., NCI, National Institutes of Health, Bethesda,
Maryland: Promoter sequences of murine a A-crystallin,
marine a 2(I)-collagen, or avian sarcoma virus genes linked
to the bacterial chloramphenicol acetyl transferase (CAT)
gene direct tissue-specific patterns of CAT expression in
transgenic mice.
Baltimore, D.,' Grosschedl, R.,' Weaver, D.,' Imanishi-Kari,
T,2 Costantini, F.,3 'Whitehead Institute for Biomedical
Research, 2Center for Cancer Research, Cambridge,
Massachusetts; 2Columbia University, New York, New
York: Control of immunoglobulin (Ig) heavy-chain gene
expression and rearrangement.
Evans, M., Dept. of Genetics, University of Cambridge, Eng-
land: Transformation of EK cell lines and formation of Chi-
meric mice.
Schell, J., Max-Planck Institut fur Zeuchtungsforschung,
Cologne, Federal Republic of Germany: Transfer and reg-
ulation of expression of chimeric genes in plants.
Horsch, R., Fraley, R., Rogers, S., Corporate Research Lab-
oratories, Monsanto Co., St. Louis, Missouri: Transgenic
plants.
A. McLaren
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SESSION 13 PLURIPOTENT CELLS/ONCOGENES
Chairperson: F. Jacob, Institut Pasteur, Paris, France
Wagner, E.,' Rather, U.,' Stewart, C.,' Muller, R.,' Keller,
G.,2
'European Molecular Biology Laboratory, Heidel-
berg, Federal Republic of Germany; 2Basel Institute for
Immunology, Switzerland: Expression of foreign genes in
murine stem cells and mice.
Gorman, C., Cooper, A., Reith, A., Watson, C., Lane, D.,
Rigby, P., Dept. of Biochemistry, Imperial College of Sci-
ence and Technology, London, England: Gene expression
in the murine teratocarcinoma cells and embryos.
Verma, I.M., Salk Institute, San Diego, California: Proto-on-
cogenes- Role in development, growth, and differentia-
tion.
SESSION 14 DEVELOPMENTAL NEUROBIOLOGY
Mulligan, R., Massachusetts Institute of Technology, Cam-
bridge: Tissue specific expression of genes introduced into
mammalian cells via retrovirus vectors.
Bishop, J.M.,1 Katzen, A.,2 Kornberg, T.,2 Montarras, D.,1
Simon, M.,2 H ooper Research Foundation; 2Dept. of
Biochemistry and Biophysics, University of California, San
Francisco: Proto-oncogenes in Drosophila melanogaster.
Nicolas, J.F., Rubenstein, J.L.R., Jacob, F., Institut Pasteur,
Paris, France: Recombinant retroviruses with an internal
promoter are efficient vectors to transduce and express
genes in multipotential embryonic cells.
Chairperson: S. Brenner, Medical Research Council, Cambridge, England
Yedvobnick, B., Muskavitch, M.A.T., Wharton, K.A., Grim-
wade, B.G., Markopoulou, K., Schlessinger-Bryant, R., Ar-
tavanis-Tsakonas, S., Dept. of Biology, Yale University, New
Haven, Connecticut: Molecular genetics of Drosophila
neurogenesis.
Anderson, D.J., Stein, R., Axel, R., Columbia University Col-
lege of Physicians & Surgeons, New York, New York: Mo-
lecular probes for the development and plasticity of neural
crest derivatives.
Summary: G. Rubin, University of California, Berkeley
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Young, M.W.,' Jackson, F.R.,1 Shin, H.-S.,2 Bargiello, TA.,1
'Rockefeller University; 2Memorial Sloan-Kettering Can-
cer Center, New York, New York: A biological clock in Dro-
sophila.
Goodman, C.S., Dept. of Biological Sciences, Stanford Uni-
versity, California: Cell recognition during neuronal devel-
opment.
MEETINGS
Molecular Biology of Hepatitis B Viruses
May 2-5
ARRANGED BY
Harold Varmus, University of California, San Francisco
Jesse Summers, Institute for Cancer Research, Philadelphia, Pennsylvania
171 participants
The 1985 meeting on the Molecular Biology of Hepatitis B viruses was attended
by more than 170 conferees. The international flavor of the meeting was evident
from the attendance of 63 scientists from overseas. Sessions for oral presenta-
tion were divided into broad topics covering the replication cycle of hepatitis B
viruses; the gene products; pathogenesis, tropism, immune response, and host
range; expression of viral genes; and hepatocellullar carcinoma.
The meeting produced for the first time a synthesis of the major steps and
details of the replication cycle of hepadnaviruses as determined by comparisons
of the four members of the hepadnavirus family. Significant new information con-
cerning the reverse transcription pathway for production of virion DNA, the main-
tenance of the intracellular transcriptional template, and the behavior of viral
gene products expressed in heterologous cells was presented. Integration of he-
padnavirus DNA into the genome of hepatocellular tumors obtained from all over
the world was extensively described and compared in an ongoing attempt to
fathom the possible role of viral information in the origin of these cancers. It was
clear that the application of molecular genetic techniques and the increasing use
of animal models to study hepadnavirus infections have moved this important
area of biomedical research onto a new stratum of understanding.
This meeting was supported in part by the National Science Foundation, Cold
Spring Harbor Laboratory Cancer Center Grant and the following divisions of the
National Institutes of Health: National Institute of Allergy and Infectious Diseases,
National Institute of Arthritis, Diabetes, and Digestive and Kidney Diseases, and
National Cancer Institute.
SESSION 1 THE REPLICATION CYCLE OF HEPATITIS B VIRUSES
Chairperson: W. Robinson, Stanford University School of Medicine, Stanford, California
Buscher, M., Reiser, W., Will, H., Schaller, H., Dept. of Micro-
biology, ZMBH, Heidelberg, Federal Republic of Ger-
many: Transcripts and the putative pregenome of DHBV -
Implications for reverse transcription.
Will, H., Reiser, W., BOscher, M., Pfaff, E., Sprengel, R., Cat-
taneo, R., Schaller, H., Dept. of Microbiology, ZMBH, Hei-
delberg, Federal Republic of Germany: Structure of tran-
scripts and of the DNA minus strand of human HBV -
Implications for transcription, translation, replication, and
integration.
Enders, G.H.,' Ganem, D.,2.2 Varmus, H.,1.2 Depts. of
'Biochemistry and Biophysics; 2Microbiology and Immu-
nology; 3Medicine, University of California, San Fran-
cisco: Definition of the two major classes of viral tran-
scripts in GSHV-infected livers.
MorOy, T.,' Etiemble, J.,' Trepo, C.,2 Tiollais, P.,' Buendia,
M.A.,' 'INSERM, Institut Pasteur, Paris; 2UER Alexis Car-
rel, Lyon, France: Transcription of WHV in chronically in-
fected liver.
Roggendorf, M., Summers, J., Fox Chase Cancer Center,
Philadelphia, Pennsylvania: Studies of the replication of
WHV in chronically infected liver cells.
Lien, J.-M., Petcu, D.J., Molnar-Kimber, K.L., Aldrich, C.E.,
Mason, W.S., Institute for Cancer Research, Philadelphia,
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J. Summers, H. Varmus, J. Gerin
Pennsylvania: RNA is covalently linked to the 5' end of the
plus strand of DHBV DNA.
Newbold, J.E., Dept. of Microbiology and Immunology, Uni-
versity of North Carolina School of Medicine, Chapel Hill:
Analysis of DHBV liver core particles in buoyant CsCI den-
sity gradients.
Tuttleman, J., Pugh, J., Mason, W., Summers, J., Institute for
Cancer Research, Fox Chase Cancer Center, Philadel-
phia, Pennsylvania: An in vitro experimental infection of
primary duck hepatocyte cultures with DHBV.
Tuttleman, J., Pourcel, C., Summers, J., Institute for Cancer
Research, Fox Chase Cancer Center, Philadelphia, Penn-
sylvania: Mechanism of synthesis of covalently closed cir-
cular DNA of DHBV.
Seeger, C.,' Ganem, Varmus, H.E.,' Depts. of
'Microbiology and Immunology, 2Medicine, University of
California, San Francisco: A genetic approach to hepad-
navirus replication-In vitro mutagenesis of the GSHV ge-
nome.
Volovitch, M.,' Mazzolini, L.,2 Yot, p,2 'Institut Curie, Paris;
2Groupement Scientifique Microbiologie, Toulouse,
France: CaMV reverse transcription step in viroplasms-
Analysis of nucleic acids and DNA polymerase activity in-
volved in asymmetric replication.
Hohn, T.,' Pietrzak, M.,' FOtterer, J.,' Pfeiffer, P.,2 'Friedrich
Miescher-lnstitut, Basel, Switzerland; 2Institut de Biologie
Moleculaire du CNRS, Strasbourg, France: The reverse
transcriptase of cauliflower mosaic virus, a dsDNA plant
virus.
SESSION 2 PRODUCTS OF HEPATITIS B VIRUS STRUCTURAL GENES
Chairperson: W. Gerlich, Hygiene Institute, Gottingen, Federal Republic of Germany
Salfeld, J.,' Pfaff, E.,' Will, H.,' Leban, J.,2 Schaller, H.,'
'Dept. of Microbiology, ZMBH, University of Heidelberg,
Federal Republic of Germany; 2Biogen S.A., Geneva,
Switzerland: HBV antigens-Mapping in the genome, de-
terminants, and mechanisms of biosynthesis.
Offensperger, W.,' Wahl, S.,' Price, P.,' Christman, WK.,'
Acs, G.,' Neurath, A.R.,2 Strick, N.,2 Kent, S.B.H.,3
'Mount Sinai School of Medicine, New York; 2New York
Blood Center, New York; 3California Institute of Technol-
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ogy, Pasadena: Cloning and expression of the pre-S1 re-
gion of HBV in E. coli.
Neurath, A.R.,' Kent, S.B.H.,2 Strick, N.,' Sproul, P,"New
York Blood Center, New York; 2Division of Biology, Califor-
nia Institute of Technology, Pasadena: Direct involvement
of pre-S gene-coded protein domains in attachment of
HBV to liver cells.
Persing, D.H., Varmus, H.E., Ganem, D., Dept. of Biochem-
istry and Biophysics, University of California, San Fran-
cisco: Biosynthesis and functions of presurface proteins of
mammalian hepadnaviruses.
Wong, D.T.,' Prince, A.,2 Sninsky, J.J.,' Nath, N.,3 'Dept.
of Microbiology and Immunology, Albert Einstein College
of Medicine, Bronx, New York; 2New York Blood Center,
New York; 3American Red Cross Blood Laboratories, Be-
thesda, Maryland: HBV polypeptides encoded by the en-
tire pre-S ORF- Identification and possible clinical signifi-
cance.
Schaeffer, E.,' Snyder, R.,2 Sninsky, J.J.," Dept. of Molec-
ular Biology, Albert Einstein College of Medicine, Bronx,
New York; 2Penrose Research Laboratory, Zoological So-
ciety of Philadelphia, Pennsylvania: Identification of novel
WHV polypeptides containing pre-S encoded amino acids.
Moriarty, A.,' Alexander, H.,' Mitamura, K.,2 Thornton, G.,3
Lerner, R.," Dept. of Molecular Biology, Scripps Clinic,
La Jolla, California; 2Dept. of Medicine, University of Tsu-
kuba, Japan; 3Johnson and Johnson, Biotechnology
Center, San Diego, California: The screening of HBV serum
samples for X antigen and studies on the molecular nature
of p28.
Kay, A.,' Mandart, E.,' Trepo, C.,2 Galibert, F.,'
1Laboratoire d'Hematologie Experimentale, Hopital Saint-
Louis; 2INSERM, Faculte de Medecine Alexis Carrel, Lyon,
France: The HBV X gene expression in E. coli is recog-
nized by sera from hepatitis patients.
Uy, A., Bruss, V., Michel, H., Thomssen, R., Gerlich, W.H.,
Dept. of Medical Microbiology, University of Gottingen,
Federal Republic of Germany: Effect of the precore se-
quence on functions of the hepatitis B core protein.
Ou, J.,' Laub, 0.,2 Rutter, W.J.," Hormone Research Lab-
oratory, University of California, San Francisco: 'Dept. of
Virology, Weizmann Institute of Science, Rehovot, Israel:
Expression of HBcAg and HBeAg in mammalian cells.
Hirschman, S.Z., Tackney, C., Dept. of Medicine, Mount Sinai
School of Medicine, New York, New York: Viral RNA tran-
scripts in mouse cells synthesizing HBeAg following trans-
fection with DNA encompassing the HBcAg gene.
Hirschman, S.Z., Tackney, C., Dept. of Medicine, Mount Sinai
School of Medicine, New York, New York: Synthesis of
HBeAg by mouse cells transfected with HBcAg DNA.
SESSION 3 MECHANISMS OF PATHOGENESIS, TROPISM, IMMUNE RESPONSE, HOST RANGE
Chairperson: J.L. Gerin, Georgetown University, Rockville, Maryland
Bonino, F, Rosina, F, Rizzi, R., Chiaberge, E., Actis, G.C.,
Rizzetto, M., Verme, G., Dept. of Gastroenterology, Moli-
nette Hospital, Turin, Italy: Chronic anti-HBe hepatitis and
serum HBV-DNA-A separate clinical entity.
Gerin, J.,' Tennant, B.,2 Popper, H.,3 Tyeryar, F.,4 Purcell,
R.,4 'Georgetown University, Rockville, Maryland;
'Cornell University, Ithaca, New York; 'Mount Sinai School
of Medicine, New York, New York; 4NIAID, National Insti-
tutes of Health, Bethesda, Maryland: Chronic hepatitis and
hepatocellular carcinoma in woodchucks following exper-
imental WHV infection.
Millman, I., Venkateswaran, P, Halbherr, T, Feitelson, M., Fox
Chase Cancer Center, Philadelphia, Pennsylvania: Exper-
imental induction in woodchucks of chronic infections with
WHV.
Seeger, C.,' Ganem, D.,1'2 Varmus, H.E.,' Depts. of
'Microbiology and Immunology, 'Medicine, University of
California, San Francisco: In vitro recombinants between
GSHV and WHV are viable and offer an approach to de-
terminants for species specificity and pathogenicity.
Korba, B.E., Gerin, J.L., Georgetown University Medical
Center, Rockville, Maryland: HBV in peripheral blood lym-
phocytes-A comparison between chronically infected
patients and animal models.
Pasquinelli, C., Laura, F, Romet-Lemonne, J.L., Degos, F.,
Tiollais, P., Brechot, C., INSERM, Institut Pasteur, Paris,
France: HBV DNA blood in mononuclear cells-An early,
frequent, and stable event which reflects the liver cells' sta-
tus.
Zeldis, J.B.,' Mugishima, H.,2 Steinberg, H.,' Neir, E.,3
Gale, R.P.,2 'Beth Israel Hospital, Harvard Medical School,
Boston, Massachusetts; 'University of California Medical
School, Los Angeles; 'Los Angeles Children's Hospital,
University of Southern California School of Medicine: Mye-
loid stem cell inhibition by HBV.
Cells, E., Kato, I., Miller, R.W., Chang, T.W., Centocor Inc.,
Malvern, Pennsylvania: Regulation of the human immune
response to HBsAg- Factors influencing antigen capture
by monocytes and stimulation of helper T cells.
Milich, D.R.,1 Thornton, G.B.,2 Neurath, A.R.,' Kent, S.B.,4
Michel, M.,5 Tiollais, P.,5 Chisari, F.V.,"Scripps Clinic and
Research Foundation, La Jolla, California; 'Johnson and
Johnson, Biotechnology Center, San Diego, California;
'New York Blood Center, New York; 4California Institute of
Technology, Pasadena; 5lnstitut Pasteur, Paris, France:
Circumvention of nonresponse to HBsAg by immunization
with pre-S containing particles.
SESSION 4 MECHANISMS OF EXPRESSION OF VIRAL GENES
Chairperson: P. Tiollais, Institut Pasteur, Paris, France
Shaul, Y.,' Rutter, W.J.,2 Laub, 0.,' Depts. of 'Virology,
'Genetics, Weizmann Institute of Science, Rehovot, Israel;
'Hormone Research Institute, University of California, San
Francisco: The human HBV contains an enhancer ele-
ment.
Elfassi, E., Haseltine, W., Dana-Farber Cancer Institute, Har-
vard Medical School, Boston, Massachusetts: Localiza-
tion of enhancer elements in HBV genome -Comparison
of enhancer activity in human hepatoma, lymphoid, and
myeloblastoid cell lines.
Tur-Kaspa, R., Burk, R.D., Shafritz, D.A., Liver Research
Center, Albert Einstein College of Medicine, Bronx, New
York: Glucocorticoids stimulate HBV enhancer activity.
Negro, F, Chiaberge, E., Isabella, L., Actis, G.C., Bonino, F.,
Dept. of Gastroenterology, Molinette Hospital, Turin, Italy:
Simultaneous detection of intrahepatic HBV-DNA and
HBcAg. P Tiollais
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K. Matsubara, P Hofschneider
Price, P., Sells, M.A., Zelent, A., Christman, J.K., Acs, G.,
Mount Sinai School of Medicine, New York, New York:
Characterization of RNA transcribed from the "short"
SESSION 5 POSTER SESSION
Hartley, J.L., Berninger, M., Jessee, J.A., Bloom, FR., BRL/
GIBCO Division of Life Technologies, Inc., Gaithersburg,
Maryland: Nonradioactive detection of HBV-DNA in serum.
Romet-Lemonne, J.L.,1.2 Thornton, G.B.,. Dubois, F,' Es-
sex, M.,2 Milich, D.R.,4 Chisari, F.V.4 'Faculte de Mede-
cine, Tours, France; 2Dept. of Cancer Biology, Harvard
School of Public Health, Boston, Massachusetts;
.Johnson and Johnson Biotechnology Center, San Diego,
California; 4Scripps Clinic and Research Foundation, La
Jolla, California: Early detection of antibodies to pre-S an-
tigen in the preclinical phase of hepatitis B.
Lok, A.S.F.,' Lai, C.L.,1 Wu, P.C.,' Wong, V.,1 Yeoh, E.K.,2
Lin, H.J.,"Depts. of Medicine, Pathology, Obstetrics, and
Clinical Biochemistry Unit, University of Hong Kong;
2Queen Elizabeth Hospital, Republic of China: Intrafamilial
spread of HBV infection in Chinese.
Muller, R., Brunkhorst, R., Klein, H., Schmidt, F.W., Zentrum
Innere Medizin, Medizinische Hockschule Hannover, Fed-
eral Republic of Germany: Antiviral treatment with inter-
feron-gamma in chronic active hepatitis B.
Pontisso, P., Bortolotti, F., Fattovich, G., Diodati, G., Schia-
von, E., Alberti, A., Realdi, G., Institute di Clinics Medics,
University of Padua, Italy: Relevance of serum HBV-DNA
in acute and chronic hepatitis type B.
Jilg, W., Delhoune, C., Deinhardt, F., Max von Pettenkofer-
Institute, Munich, Federal Republic of Germany: Anti-
bodies to protein subunits of HBsAg in sera of persons
vaccinated against hepatitis B and individuals after natural
infection.
McGlynn, K., London, W.T., Lustbader, E., McMahon, B.,
Heyward, W., Fox Chase Cancer Center, Philadelphia,
Pennsylvania, and Centers for Disease Control, Indian
Health Service, Anchorage, Alaska: Prevention of chronic
liver disease and liver cancer- HBV replication and tub-
erculin reactivity.
Mondelli, M., Chemello, L., Bortolotti, F, Schiavon, E., Al-
berti, A., Rondanelli, E.G., Realdi, G., Dept. of Infectious
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strand of HBV DNA integrated into the genome of mouse
3T3 cells.
Eble, B.,' Lingappa, V.,2.3 Ganem, D.,13 Depts. of 'Mi-
crobiology and Immunology, 2Physiology, .Medicine,
University of California, San Francisco: The transmem-
brane translocation of HBsAg.
Kasambalides, E.J., Gilja, B.K., Gerber, M.A., Dept. of Pa-
thology, Mount Sinai School of Medicine and City Hospital
Center, Elmhurst, New York: Expression of receptors for
polymerized human serum albumin (pHSA-R) by HBsAg
in vitro.
Chisari, F.V.,1.2 Milich, D.R.,1 Moriarty, A.,1 Filippi, P.,' Pal-
miter, R.,3 Pinkert, C.,4 Brinster, R.,4 'Scripps Clinic and
Research Foundation, La Jolla, California; 2lnstitut Pas-
teur, Paris, France; .University of Washington, Seattle;
4University of Pennsylvania, Philadelphia: Expression of
HBV gene products in transgenic mice.
Pourcel, C., Farza, H., Morello, D., Hadchouel, M., Babinet,
C., INSERM, Institut Pasteur, Paris, France: Expression of
HBsAg in transgenic mice.
Diseases, University of Pavia; Institute di Clinics Medica,
University of Padua, Italy: Enhanced natural killer cell ac-
tivity in the early phase of acute HBV infection.
Lai, C.L.,' Gregory, RB.,2 Wu, P.C.,' Wong,K. P. , 1 Lok,
A.S.F.,' Ng, M.M.T.,1 'University of Hong Kong, Republic
of China; 2Stanford University, California: Primary liver cell
cancer in men and women.
Kodama, K., Ogasawara, N., Gerin, J., Yoshikawa, H., Mu-
rakami, S., Cancer Research Institute, Kanazawa Univer-
sity, Japan, and Dept. of Microbiology, School of Medi-
cine, Georgetown University, Rockville, Maryland:
Nucleotide sequence of a cloned WHV genome- Evolu-
tionary relationships between hepadnaviruses.
Tagawa, M., Omata, M., Okuda, K., Dept. of Medicine, Chiba
University School of Medicine, Japan: Early events during
the initiation of DHBV infection.
Chow, T-Y, Chen, C.-S., Institute of Botany, Academia Sin-
ica, Taiwan, Republic of China: Expression of HBsAg with
presequence in E. coli.
Chow, T-Y., Chen, C.-S., Chen, R.-Y., Cheng, C.-T., Chang,
J.-H., Institute of Botany, Academia Sinica, Taiwan, Re-
public of China: Cloning of HBV genome and expression
of HBsAg with presequences in E. coll.
Michel, M.L.,1 ,2 Pontisso, P.,3 Sobczak, E.,' Malpiece, Y.,'
Streeck, R.,1 Tiollais, P.,2 1Groupement de Genie Gene-
tique; 2INSERM, Institut Pasteur, Paris, France; .Instituto
di Clinica Medica, University of Padua, Italy: Synthesis of
HBsAg particles containing the pre-S region expression
product.
Elfassi, E.,' Romet-Lemonne, J.L.,' Dienstag, J.,2 Hasel-
tine, W.," Dana-Farber Cancer Institute, Harvard Medical
School; 2Massachusetts General Hospital, Boston: Mo-
lecular cloning and expression of the X gene in E. coli.
Meyers, M.L.,1 Trepo, L.V.,2 Nath, N.,3 Sninsky,
Depts. of 'Molecular Biology, 4Microbiology and Immu-
nology, Albert Einstein College of Medicine, Bronx, New
York; 2lnstitut National de la Sante at de la Recherche
Medicale, Lyon, France; 'American Red Cross Blood
Laboratories, Bethesda, Maryland: HBV polypeptide X -
Expression in E. co/i and identification of specific anti-
bodies in sera from HBV-infected humans.
Feitelson, M., Fox Chase Cancer Center, Philadelphia, Penn-
sylvania: Products of the X gene in HBV and related vi-
ruses.
Mimms, L.,' Mayer, K,,' Fox, L.,2 Sarin, V.,2 Depts. of
'Hepatitis Research and Development, 'Molecular Biol-
ogy, Abbott Laboratories, North Chicago, Illinois: Pre-S
proteins of HBsAg contain epitopes recognized by AU-
SAB positive human sera.
Salanoubat, M.,' Sonigo, P.,1 Courrouce, A.M.,' Wain-Hob-
son, S.,' Tiollais, P.," INSERM, Institut Pasteur; 2Ets Ca-
banel, Paris, France: Molecular basis of HBsAg subtypes.
Siddiqui, A., Jameel, S., Gholson, C., Mapoles, J., Dept. of
Microbiology, University of Colorado Medical School,
Denver: Expression of HBsAg gene in mammalian cells.
Delpeyroux, F., Chenciner, N., Lim, A., Malpiece, Y., Streeck,
R.E., Groupement de Genie Genetique, Institut Pasteur,
Paris, France: Effect of insertions in the HBsAg gene on
secretion and antigenicity of 22-nm particles.
Chenciner, N.,' Delpeyroux, P,' Lim, A.,' Lambert, M.,'
Ma Ipiece, Y.,1 Streeck, R.E.,1 Houssais, J.F.,2
'Groupement de Genie Genetique, Institut Pasteur, Paris;
2C.N.R.S. et institut Curie, Orsay, France: Effect of cell fu-
sion with primary adult hepatocytes on the expression of
the HBsAg.
Tackney, C., Hirschman, S.Z., Dept. of Medicine, Mount Sinai
School of Medicine, New York, New York: Production of
hepatitis B antigens by fragments of viral DNA packaged
in pseudovirions of Moloney leukemia virus.
Yoakum, G.H.,' Korba, B.E2 Wilson, V.L.,1 Boumpas,
D.T.,1 'NCI, National Institutes of Health, Bethesda;
'Georgetown University School of Medicine, Rockville,
Maryland, Studies of HBV core gene-Expression and
cytopathology.
Ma, X.-K., Ding, G., Zho, P, Huang, Y., Shi, C., Lu, H., Zhu,
Y., Laboratory of Molecular Genetics, Institute of Molecu-
lar Genetics, Institute of Basic Medical Sciences, Beijing,
Republic of China: Properties of HBcAg synthesized in E.
coli and its conversion to e antigen.
Sureau, C.,' Roingeard, P.N.,' Romet-Lemonne, J.L.,1.2 Es-
sex, M.," Dept. of Cancer Biology, Harvard School of
Public Health, Boston, Massachusetts; 'Dept. Biologie
Humaine, Faculte de Medecine, Tours, France: Expres-
sion of a nuclear-associated antigen in human hepatoma
cell line Hep G2 after transfection with circular HBV-DNA.
Sastry, K.J.,' Radhakrishna, G.,2 Chan, T-S.,2 'Dept. of Pa-
thology, M.D. Anderson Hospital and Tumor Institute,
J. Zeldis, J. Gerin
Houston; 'Dept. of Microbiology, University of Texas
Medical Branch, Galveston: Oncogene expression in a
human hepatocellular carcinoma cell line, HCC36.
Chan, T-S.,' Lee, C.-S.,2 Radhakrishna, G.," Dept. of Mi-
crobiology, University of Texas Medical Branch, Galves-
ton; 'Department of Surgery, National Taiwan University
College of Medicine, Republic of China: A newly estab-
lished hepatocellular carcinoma cell line (HCC36) carrying
integrated HBV.
Freytag von Loringhoven, A.,' Koch, S.,' Hofschneider,
P.H.,1 Koshy, R.,2 'Max-Planck-Institute, Martinsried,
Federal Republic of Germany; 'Dept. of Medicine, State
University of New York, Stony Brook: Hybrid host-virus
mRNAs augment HBV gene expression.
Su, T.,' Chang, C.,' Chou, C.,' Ting, L.' Han, S.,' Lui, W.,2
P'eng, F.,2 Depts. of 'Medical Research, 'General Sur-
gery, Veterans General Hospital, Taiwan, Republic of
China: Study of HBV-DNA and RNA in hepatoma.
Unoura, M., Kobayashi, K., Fukuoka, K., Matsushita, F., Mor-
imoto, H., Ohshima, T., Kaneko, S., Morioka, K., Ohno, A.,
Hattori, N., Murakami, S., Yoshikawa, H., Cancer Re-
search Institute, First Dept. of Internal Medicine, Kana-
zawa University, Japan: Establishment of a cell line of tis-
sue culture of a woodchuck hepatocellular carcinoma.
Brechot, C., Tiollais, R, Dejean, A., INSERM, Institut Pasteur,
Paris, France: Analysis of HBV integration site in cellular
DNA of two different liver tumors.
Chen, J.-Y1, Harrison, T.J.,1 Lee, C.S.,2 Chen, D.S.,2
Zuckerman, A.J.,' 'Dept. of Medical Microbiology, Lon-
don School of Hygiene and Tropical Medicine, England;
'College of Medicine, National Taiwan University, Taipei,
Republic of China: Oncogenesis of hepatitis B virus-A
study of thirty Taiwanese hepatomas.
SESSION 6 HEPATOMA AND INTEGRATION OF VIRAL DNA
Chairperson: K. Matsubara, Osaka University, Suita City, Japan
Su, C.Y., Rog ler, C.E., Liver Research Center, Albert
Einstein College of Medicine, Bronx, New York: Structure
of cloned WHV integrations from chronically infected
woodchuck liver.
Yaginuma, K.,' Kobayashi, H.,' Kobayashi, M.,' Morish-
ima, T,2 Matsuyama, K.,3 Koike, K.," Dept. of Gene Re-
search, Cancer Institute, Tokyo; 'Dept. of Pediatrics, Na-
goya University; 'Nagoya First Red Cross Hospital,
Japan: Analysis of integrated HBV sequences in human
hepatoma and chronic active hepatitis tissues.
Hino, Shows, TB.,2 Rogler, C.E.,"Liver Research
Center, Albert Einstein College of Medicine, Bronx, New
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I Millman, B. Tennant
York; 2Dept. of Human Genetics, Roswell Park Memorial
Institute, Buffalo, New York; °Dept. of Pathology, Cancer
Institute, Tokyo, Japan: Structure and chromosomal local-
ization of HBV integrations from hepatocellular carcino-
mas.
Kaneko, S., Kodama, K., Ohshima, T., Unoura, M., Kobay-
ashi, K., Hattori, N., Yoshikawa, H., Murakami, S., Cancer
Research Institute, First Dept. of Internal Medicine, Medi-
cal School, Kanazawa University, Japan: Stable integra-
tion of WHV in established cells of tissue culture from a
woodchuck primary hepatocellular carcinoma and struc-
ture of the integrated viral DNA.
Fung, Y.K.,' Lai, C.L.,2 Lok, A.,2 Todd, D.,2 Varmus, H.E.,'
'Dept. of Microbiology and Immunology, University of Cal-
ifornia, San Francisco; 2Dept. of Medicine, Queen Mary
Hospital, University of Hong Kong, Republic of China:
Analysis of HBV-associated human hepatocellular carci-
nomas for oncogene expression and structural rearrange-
ment.
Shih, C.,' Zeldis, J.,' Burke, K.,' Chou, M.J.,2 Yang, C.S.,2
Lee, C.S.,2 Isselbacher, K.,' Wands, J.,' Goodman,
H.M.,1 'Massachusetts General Hospital, Boston;
2National Taiwan University, Republic of China: Site-spe-
cific recombination of HBV in human hepatoma cells.
Matsubara, K., Nagaya, A., Fukushige, S., Fujiyama, A.,
Tsurimoto, T., Chisaka, 0., Shinya, T., Nakamura, T., Insti-
tute for Molecular and Cellular Biology, Osaka University,
Japan: Studies with junctions between integrated HBV-
DNA and host chromosomal DNA.
Koike, K., Yaginuma, K., Iwami, M., Imazeki, F., Kobayashi,
M., Dept. of Gene Research, Cancer Institute, Tokyo, Ja-
pan: HBV integration and expression of the c-myc gene in
human hepatoma cells.
Chang, C., Chou, C.-K., Ting, L. -P., Su, C.-S., Han, S.-H., Hu,
C.-P., Graduate Institute of Microbiology and Immunology,
National Yang Ming Medical College, and Dept. of Medi-
cal Research, Veterans General Hospital, Taiwan, Repub-
lic of China: The cellular and antigenic properties of hu-
man hepatoma cell lines.
Roingeard, P., Romet-Lemonne, J.L., Barin, F., Goudeau, A.,
Lesage, G., Faculte de Medecine, Tours, France: Hepa-
toma patients have antibodies directed toward an 18-kD
cytoplasmic protein present in human hepatoma cell lines,
PLC/PRF/5 and Hep 3 B.
Chromosome Structure and Expression
May 8 - May 12
ARRANGED BY
Michael Grunstein, University of California, Los Angeles
Gary Felsenfeld, National Institutes of Health, Bethesda, Maryland
146 participants
More than 50 abstracts were presented at the Spring 1985 meeting on Chromo-
some Structure and Expression. These presentations were organized into eight
sessions including such topics as DNA Structure, Chromatin Structure, Chromo-
some Structure and Genetic Approaches, and Nuclear Structures.
Genetic information is carried in DNA, but the expression of that information
depends on a variety of factors, many yet unknown. Discussed at the meeting
was the manner in which DNA conformation and structural proteins that contrib-
ute to chromosome structure influence gene expression. The meeting also de-
scribed the interactions that take place between chromosomes and the nuclear
matrix, interactions that affect chromosome shape and function. These problems
brought together investigators working in areas as diverse as X-ray crystallogra-
phy, cytology, classical biochemistry, and genetics.
This meeting was supported in part by the National Science Foundation.
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SESSION 1 DNA STRUCTURES
Chairperson: J. Wang, Harvard University, Cambridge, Massachusetts
Wang, J.C.,' Snyder, L.,2 Goto, T.,' Giaever, G.,1 'Dept. of
Biochemistry and Molecular Biology, Harvard University,
Cambridge, Massachusetts; 2Dept. of Microbiology,
Michigan State University, East Lansing, Michigan: On the
degree of supercoiling of intracellular DNA.
Azorin, F., Fenton, M., Rich, A., Dept. of Biology, Massachu-
setts Institute of Technology, Cambridge: Z-DNA binding
proteins in SV40 minichromosomes.
SESSION 2 DNA UNDER STRESS
Jovin, TM., Robert-Nicoud, M., Arndt-Jovin, D., MPI for Bio-
physical Chemistry, Goettingen, Federal Republic of Ger-
many: Z-DNA in chromatin during growth and differentia-
tion.
Bird, A.P., Taggart, M., Frommer, M., Miller, 0.J., Macleod,
D., MRC Mammalian Genome Unit, Edinburgh, Scotland:
Islands of nonmethylated, CpG-rich DNA in the vertebrate
genome.
Chairperson: M. Gellert, National Institutes of Health, Bethesda, Maryland
Menzel, R., Gellert, M., NIADDK, National Institutes of
Health, Bethesda, Maryland: Supercoiling-sensitive pro-
moters in E. coll.
Bonven, B.J., Gocke, E., Westergaard, 0., Dept. of Molecu-
lar Biology and Plant Physiology, University of Aarhus,
Denmark: Is rRNA synthesis regulated by a sequence-
specific topoisomerase I activity associated with DNase I
hypersensitive sites?
Villeponteau, B., Martinson, H.G., Dept. of Chemistry and
Biochemistry, University of California, Los Angeles: Tor-
sional stress, topoisomerases and active chromatin.
SESSION 3 CHROMATIN STRUCTURE
Sternglanz, R., DiNardo, S., Thrash, C., Voelkel-Meiman, K.,
Brill, S.J., State University of New York, Stony Brook: Roles
of yeast DNA topoisomerases I and II in DNA replication
and transcription.
Georgiev, G.P.,' Luchnik, A.N.,2 Bakayev, V.V.,' Zbarsky,
I.B.,2 'Institute of Molecular Biology; 2lnstitute of Devel-
opmental Biology, Union of Soviet Socialist Republics
Academy of Sciences, Moscow: Torsional strain in tran-
scriptionally active chromatin.
Ruberti, I., Worcel, A., University of Rochester, New York:
Analysis of the process of chromatin assembly in vitro.
Chairperson: J. Thomas, University of Cambridge, England
Allfrey, V.G., Johnson, E.M., Sterner, R., Hoffman, H.P.,
Rockefeller University, New York, New York: Changes in
nucleosome structure and composition during transcrip-
tion of ribosomal and p-globin genes.
Bradbury, E.M., Dept. of Biological Chemistry, School of
Medicine, University of California, Davis: Histone modifi-
cations, H1°, and chromatin structure.
Lambert, S.F., Thomas, J.0., Dept. of Biochemistry, Univer-
sity of Cambridge, England: Core histone-DNA interac-
tions in chromatin-A chemical approach.
Sen, D., Crothers, D.M., Dept. of Chemistry, Yale University,
New Haven, Connecticut: Chromatin structure and con-
SESSION 4 ACTIVE AND INACTIVE CHROMATIN
densation determined by photochemical dichroism and
rotational relaxation.
van Holde, K.E.,1 Yager, T.,2 Ausio, J.,"Dept. of Biochem-
istry and Biophysics, Oregon State University, Corvallis;
2lnstitute of Molecular Biology, University of Oregon, Eu-
gene: Salt-dependent conformational changes and disso-
ciation of hypo- and hyperacetylated nucleosomes.
Olins, A.L., Biology Division of the Oak Ridge National Lab-
oratory, University of Tennessee, Oak Ridge: Chromatin
structure-Three-dimensional reconstruction using elec-
ton microscope tomography (EMT).
Chairperson: R. Simpson, National Institutes of Health, Bethesda, Maryland
Simpson, R.T., Thoma, F., Fitz Gerald, PC., Clarke, M.,
NIADDK, National Institutes of Health, Bethesda, Mary-
land: Mechanisms of nucleosome positioning.
Cap lin, A., Kimura, T., Allan, J., Gould, H.J., Dept. of Bio-
physics, King's College, London, England: Proteins re-
quired to establish and maintain the open conformation of
the chicken adult /3- globin gene in erythroid chromatin.
Mirzabekov, A., Bavykin, S., Usachenko, S., Schick, V., Be-
lyaysky, A., Lishanskaya, A., Undritsov, I., Institute of Mo-
lecular Biology, Union of Soviet Socialist Republics Acad-
emy of Sciences, Moscow: The structure of
transcriptionally active and inactive chromatin,
Zachau, H.G., Bauer, H.G., Falkner, Klobeck, H.G.,
Lotscher, E., Pech, M., Pohlenz, H.D., Straubinger, B., In-
stitut far Physiologische Chemie, Physikalische Biochemie
and Zellbiologie der Universitat, MOnchen, Federal Re-
public of Germany: Immunoglobin light-chain genes.
Udvardy, A., Schedl, P., Dept. of Biology, Princeton Univer-
sity, New Jersey: Chromatin structure of the 87A7 heat-
shock locus of Drosophila melanogaster.
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Szent-Gyorgyi, C., Gross, D.S., Finkelstein, D.B., Garrard,
WT., Dept. of Biochemistry, University of Texas Health Sci-
ence Center, Dallas: Chromatin structure of the yeast
HSP82 gene-Mapping 12 kb of the locus with single nu-
cleotide resolution of the promoter region.
SESSION 5 SITE-SPECIFIC FACTORS
Wang, X.-F., McDougall, S., Mercola, M., Ca lame, K., Dept.
of Chemistry, University of California School of Medicine,
Los Angeles: Ability of the immunoglobulin heavy chain
enhancer to activate multiple promoters and to activate
promoters located 17 kb away.
Chairperson: K.R. Yamamoto, University of California, San Francisco
Zaret, K.S., Yamamoto, K.R., Dept. of Biochemistry and Bio-
physics, University of California, San Francisco: Forma-
tion of a DNase I hypersensitive structure appears essen-
tial for glucocorticoid-dependent enhancer function.
Berk, A.J., Gaynor, R.B., Yoshinaga, S.K., Dean, N., Feld-
G. Felsenfeld, M. Grunstein
man, L.T., Molecular Biology Institute, University of Cali-
fornia, Los Angeles: Evidence that adenovirus E1A func-
tions stimulate transcription of class III genes by increasing
the activity of transcription factor IIIC.
Wu, C., NCI, National Institutes of Health, Bethesda, Mary-
land: Protein-binding sites in chromatin and regulation of
heat-shock genes.
Felsenfeld, G., Emerson, B., Jackson, D., Lewis, C.,
NIADDK, National Institutes of Health, Bethesda, Mary-
land: Chromatin structure near an expressed gene.
Zenke, M., Wildeman, A., Matthes, H., Schatz, C., Grund-
strom, T., Winterith, M., Takahashi, K., Chambon, P, CNRS,
INSERM, Strasbourg, France: Functional anatomy of the
simian virus 40 enhancer.
Learned, R.M., Tjian, R., Dept. of Biochemistry, University of
California, Berkeley: Transcription and binding properties
of A factor that confers promoter specificity to RNA poly-
merase I.
Hennighausen, L., Sieben list, U., Davis, L., Danner, D.,
Chung, J., Leder, R, Dept. of Genetics, Harvard Medical
School, Boston, Massachusetts: Sequence-specific pro-
tein-DNA interaction- Impact on gene expression.
SESSION 6 CHROMOSOME STRUCTURE AND GENETIC APPROACHES I
Chairperson: E. Blackburn, University of California, Berkeley
Blackburn, E., Budarf, M., Challoner, P., Cherry, M., Greider,
C., Henderson, E., Larson, D., Ryan, T., Shampay, J.,
Spangler, E., Dept. of Molecular Biology, University of Cal-
ifornia, Berkeley: Structure and formation of telomeric DNA
in lower eukaryotes.
Varshaysky, A., Javaherian, K., McCartney, J., Pan, R.,
Snapka, R., Solomon, M., Strauss, F., Dept. of Biology,
Massachusetts Institute of Technology, Cambridge: Stud-
ies on chromatin.
Grunstein, M., Schuster, T., Han, M., Kayne, P., Choe, J., Mo-
lecular Biology Institute, University of California, Los An-
geles: Histone function and evolution.
Wagner, D., Carson, M., Koshland, D., Hartwell, H., Dept. of
Genetics, University of Washington, Seattle: Genes in-
volved in mitotic chromosome transmission.
Elgin, S.C.R., Amero, S.A., Cartwright, I.L., Dietrich, V., Eis-
senberg, J.C., Flick, J.T., James, T.C., Siegfried, E.,
Thomas, G.H., Zhu, J., Washington University, St. Louis,
Missouri: DNA and chromatin structural patterns related
to gene expression in Drosophila.
Cantor, C.R., Morse, R., Benezra, R., Axel, R., College of
Physicians and Surgeons, Columbia University, New York,
New York: Aspects of nucleosome organization and topol-
ogy relevant to gene expression.
Allis, C.D.,' Horowitz, 5.,2 Gorovsky, M.A.,2 'Dept. of Bio-
chemistry, Baylor College of Medicine, Houston, Texas;
2Dept. of Biology, University of Rochester, New York: His-
tone variants and histone genes in Tetrahymena.
SESSION 7 CHROMOSOME STRUCTURE AND GENETIC APPROACHES II
Chairperson: W. Fangman, University of Washington, Seattle
Hill, A., Bloom, K., University of North Carolina, Chapel Hill:
Structural requirements for a yeast centromere.
Fangman, W.L., Mc Carroll, R.M., Brewer, B.J., Zweifel, S.G.,
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Dept. of Genetics, University of Washington, Seattle: ARS
elements and chromosome replication in yeast.
Murray, A.W., Schultes, N.P., Dawson, D., Szostak, J.W.,
Dept. of Molecular Biology, Massachusetts General Hos-
pital, Boston: Behavior of artificial chromosomes in yeast.
Gottschling, D.E.,' Zakian, V.A.,' Cech, T.R.,2 'Fred Hutch-
inson Cancer Research Center, Seattle, Washington;
2Dept. of Chemistry, University of Colorado, Boulder: Tel-
osome-A DNA-protein complex containing the molecular
ends of Oxytricha macronuclear DNA.
Moreland, R.,' Straussberg, R.,2 Garcia, R.,' Hereford, L.,'
'Dana Farber Cancer Institute, Boston, Massachusetts;
2Genex Corporation, Gaithersburg, Maryland: Sequences
required for nuclear localization of yeast H2B-1.
SESSION 8 NUCLEAR STRUCTURES
Struhl, K., Dept. of Biological Chemistry, Harvard Medical
School, Boston, Massachusetts: Relationships between
chromatin structure and gene expression in yeast.
Beckendorf, S.K., Shermoen, A.W., McNabb, S., Heem-
skerk, J., Jongens, T, Dept. of Molecular Biology, Univer-
sity of California, Berkeley: The use of gene transfer ex-
periments to study expression of the SGS-4 glue protein
gene.
Chairperson: U.K. Laemmli, University of Geneva, Switzerland
Gasser, S.M., Mirkovitch, J. Laemmli, U.K., Depts. of Molec-
ular Biology and Biochemistry, University of Geneva,
Switzerland: Higher-order chromatin loops-Evidence for
cell-cycle and differentiation-dependent changes.
McKeon, F.D.,' Kirschner, M.W.,1 Sanchez-Pescador, R.,2
Caput, D.,2 'Dept. of Biochemistry and Biophysics, Uni-
versity of California, San Francisco; 2Chiron Corporation,
Emeryville, California: Molecular cloning and expression
of human nuclear lamin cDNAs using human autoantibod-
ies.
Pienta, K., Coffey, D., Johns Hopkins University School of
Medicine, Baltimore, Maryland: The nuclear matrix-An
organizing structure for the interphase nucleus and chro-
mosome.
Fey, E.G., Penman, S., Dept. of Biology, Massachusetts In-
stitute of Technology, Cambridge: The nuclear ma-
trix-intermediate filament scaffold -Protein and RNA
components revealed by sequential fractionation and res-
inless TEM sections.
Olins, D.E., Biology Division of the Oak Ridge National Lab-
oratory, University of Tennessee, Oak Ridge: Analysis of
C. elegans
macronuclear structure in the protozoan Euplotes eurys-
tomus.
Mathog, D., Hochstrasser, M., Gruenbaum, Y., Agard, D.,
Sedat, J., Dept. of Biochemistry and Biophysics, Univer-
sity of California, San Francisco: The three-dimensional
nuclear arrangement of Drosophila polytene interphase
chromosomes.
Belmont, A., Sedat, J., Agard, D., Dept. of Biochemistry,
University of California, San Francisco: The three-dimen-
sional structure of mitotic chromosomes.
Additional Abstracts
Vanderbilt, J.N., Brown, J.W., Anderson, J.N., Dept. of Bio-
logical Sciences, Purdue University, West Lafayette, Indi-
ana: Analysis of HMG proteins 1, 2a, and 2b.
Villeponteau, B., Martinson, H., Dept. of Chemistry and Bio-
chemistry, University of California, Los Angeles: Topoiso-
merases bind to enhancer-like DNA sequences in the his-
tone gene cluster of Drosophila.
May 15 - May 19
ARRANGED BY
H. Robert Horvitz, Massachusetts Institute of Technology, Cambridge
Robert H. Waterston, Washington University School of Medicine, St. Louis, Missouri
Scott Emmons, Albert Einstein College of Medicine, Bronx, New York
Donna Albertson, Medical Research Council, Cambridge, England
238 participants
The 1985 Cold Spring Harbor C. elegans meeting allowed the assembly of es-
sentially all researchers who study this microscopic roundworm. Both communi-
cation and spirit were outstanding, and recent successes in molecular biology
provided the basis for considerable excitement. For example, methods are now
available for the molecular cloning of the many genes known from genetic stud-
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ies to affect development and/or behavior. In addition, about 65% of the genome
has been "fingerprinted," and the definition of a complete physical map seems to
be a realistic short-term goal. Molecular studies of morphogenesis were de-
scribed that should now lead to an understanding of muscle thick-filament as-
sembly and of the process that generates an elongated worm from an ellipsoidal
embryo. Many similarities between C. elegans and higher animals were reported
at both the phenomenological and molecular levels; the DNA sequence homol-
ogy between lin-12, a developmental control gene implicated in cell interactions,
and the precursor for mammalian epidermal growth factor was particularly strik-
ing. Detailed genetic pathways were described that control sex determination,
cell lineage, and neurogenesis. A newly developed technique for mosaic analy-
sis has allowed the site of action of particular genes to be identified at the level of
resolution of single cells. Studies of the nervous system have moved from ana-
tomical description to functional analysis. In addition, specific and interesting
neuroanatomical lesions were described in certain behaviorally uncoordinated
mutants. Many other biological problems were discussed, including aging, neu-
ronal degeneration, programmed cell death, collagen, and nonmuscle motility.
This meeting was supported in part by the National Science Foundation, and
the following divisions of the National Institutes of Health: National Institute on
Aging, and Division of Research Resources.
SESSION 1 GENOME ORGANIZATION AND MOLECULAR BIOLOGY
Chairperson: D. Hirsh, University of Colorado, Boulder, Colorado
Coulson, A., Sulston, J., MRC Laboratory of Molecular Biol-
ogy, Cambridge, England: Physical map of the C. elegans
genome.
Albertson, D.G., MRC Laboratory of Molecular Biology,
Cambridge, England: Mapping genes by in situ hybridi-
zation using biotin-labeled probes.
Beckenbach, K.A., Baillie, D.L., Dept. of Biological Sci-
ences, Simon Fraser University, Burnaby, Canada: Molec-
ular studies in the region around unc-22.
Ruvkun, G.,' Ambros, V.,2 Horvitz, R.,' 'Dept. of Biology,
Massachusetts Institute of Technology; °Dept. of Cellular
and Developmental Biology, Harvard University, Cam-
bridge: Molecular genetic analysis of the lin-14 locus.
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Howell, A.M., Rose, A.M., Dept. of Medical Genetics, Uni-
versity of British Columbia, Vancouver, Canada: Identifi-
cation of essential genes in the sDp2 region of LG I.
Mello, C.,1 Roberts, J.,2 Hirsh, D.,2 Stinchcomb, D.,' 'Dept.
of Cellular and Developmental Biology, Harvard Univer-
sity, Cambridge, Massachusetts; 2Dept. of Molecular, Cel-
lular, and Developmental Biology, University of Colorado,
Boulder: C. elegans DNA that directs segregation in S.
cerevisiae.
Felsenstein, K.M., Emmons, S.W., Albert Einstein College of
Medicine, Bronx, New York: Organizational and functional
analysis of interspersed repetitive DNA sequences.
Ward, S., Burke, D.J., Hogan, E., Dept. of Embryology, Car-
negie Institution of Washington, Baltimore, Maryland: The
organization of expressed MSP genes.
Roberts, S., Sanicola, M., Saltzberg, L., Emmons, S., Childs,
G., Depts. of Genetics and Molecular Biology, Albert Ein-
stein College of Medicine, Bronx, New York: Genomic or-
SESSION 2 GAMETOGENESIS AND EMBRYOGENESIS
Chairperson: S. Strome, Indiana University, Bloomington,
Roberts, T.M., Pavalko, FM., Dept. of Biological Science,
Florida State University, Tallahassee: Membrane and cy-
toplasmic proteins are transported in the same organelle
complex during nematode spermatogenesis.
Sepsenwol, S.,' Johnson, C.D.,2 'Dept. of Biology, Univer-
sity of Wisconsin, Stevens Point; 2Dept. of Zoology, Uni-
versity of Wisconsin, Madison: Monoclonal antibodies
against sperm-activating factor in Ascaris.
Schierenberg, E., Max-Planck-Institute, GOttingen, Federal
Republic of Germany: Determination of early cleavage
pattern in embryos of C. elegans.
Edgar, L.G., McGhee, J.D., Dept. of Medical Biochemistry,
University of Calgary, Alberta, Canada: Embryonic
expression of a gut-specific esterase in C. elegans.
Kemphues, K.,' Priess, J.,2 'Section of Genetics and De-
SESSION 3 POSTER SESSION I
Aamodt, E., Culotti, J., Dept. of Biochemistry, Molecular Bi-
ology, and Cellular Biology, Northwestern University, Ev-
anston, Illinois: Isolation and partial characterization of mi-
crotubules and microtubule-associated proteins from C.
elegans.
Albert, P.S., Riddle, D.L., Division of Biological Sciences,
University of Missouri, Columbia: Genetics, development,
and ultrastructure of dauer-like larvae.
Ardizzi, J.P., Epstein, H.F., Dept. of Neurology, Baylor Col-
lege of Medicine, Houston, Texas: In situ localization of
MHC isoforms in adults and larvae of C. elegans.
Austin, J., Kimble, J., University of Wisconsin, Madison: glp-
1, a gene central to germ-line development.
Avery, L., Horvitz, R., Dept. of Biology, Massachusetts Insti-
tute of Technology, Cambridge: Factors that affect the rate
of pharyngeal pumping.
Barstead, R., Schriefer, L., Moerman, D., Benian, G., Fran-
cis, R., Waterston, R., Dept. of Genetics, Washington Uni-
versity, St. Louis, Missouri: A new expression vector- Li-
braries and unc-22.
Barton, M.K., Schedl, T.B., Kimble, J.E., University of Wis-
consin, Madison: Characterization of fem-3 semidominant
alleles.
Bennett, K.L., Ward, S., Carnegie Institution of Washington,
Baltimore, Maryland: Cloning and analysis of the germ-
line-specific gene coding for the MSP from A. lumbri-
coides.
Bhatt, H., Hedgecock, E., Roche Institute of Molecular Biol-
ogy, Nutley, New Jersey: Culturing embryonic cells.
Bird, D.M., Riddle, D.L., Division of Biological Sciences, Uni-
versity of Missouri, Columbia: Molecular cloning of the
ama-1 IV gene of C. elegans.
ganization and sequence analysis of C. elegans histone
genes.
Rogalski, TM., Bullerjahn, A.M., Riddle, D.L., Division of Bi-
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polymerase II genetics.
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timing of cell division, and cytoplasmic segregation.
Priess, J., MRC Laboratory of Molecular Biology, Cam-
bridge, England: e2072-An embryonic determinant?
Durbin, R.M., Priess, J., Thomson, J.N., MRC Laboratory of
Molecular Biology, Cambridge, England: Early develop-
ment of the ventral nerve cord.
Manser, J., Wood, W.B., Dept. of Molecular, Cellular, and De-
velopmental Biology, University of Colorado, Boulder: Mu-
tants defective in embryonic cell migrations.
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stitute of Technology, Cambridge: Characterization of two
loci that affect nuclear migrations during development.
Burr, A.H., Dept. of Biological Sciences, Simon Fraser Uni-
versity, Burnaby, Canada: Light and temperature changes
modulate reversal frequency.
Cassada, R., Biology Institute, University of Freiburg, Fed-
eral Republic of Germany: Attempts to approach embry-
onic/cytoplasmic actin genetically.
Chen, V.,' Hieb, W.,2 Depts. of 'Biophysical Science,
2Biological Sciences, State University of New York, Buf-
falo: Laser diffraction spectra of T. aceti and C. elegans.
Clokey, G., Zigmond, D., Bashor, 0.J., Jacobson, L., Dept.
of Biological Sciences, University of Pittsburgh, Pennsyl-
vania: daf-4 mutants-Three characters in search of an or-
der.
D. Hirsch, D. Albertson
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Conklin, D., Hawdon, J., Jacobson, L., Dept. of Biological
Sciences, University of Pittsburgh, Pennsylvania: A screen
for mutants deficient in protein degradation.
Cummins, C., Anderson, P., Dept. of Genetics, University of
Wisconsin, Madison: MLC genes of C. elegans.
Curry, A.M., Waterston, R.H., Dept. of Genetics, Washington
University, St. Louis, Missouri: Gene interactions in thick-
filament formation.
Denich, K., Otsuka, A. Dept. of Genetics, University of Cal-
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cal identification of C. elegans MHC genes.
Otsuka, A., Dept. of Genetics, University of California,
Berkeley: sup-3 directly controls the accumulation of a
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SESSION 5 POSTEMBRYONIC DEVELOPMENT AND AGING
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SESSION 7 SEX DETERMINATION AND DOSAGE COMPENSATION
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teractions in sex determination.
Kimble, J., Schedl, T., Barton, K., Rosenquist, T., Ahringer,
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sperm-oocyte decision.
Doniach, T., MRC Laboratory of Molecular Biology, Cam-
bridge, England: Hermaphroditism, the dotted line, oo-
cytes and sperm.
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compensates for differences in X-chromosome dosage.
Schedin, P., Wood, W.B., Dept. of Molecular, Cellular, and
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Intestinal mosaicism for expression of vitellogenin genes
in C. elegans intersexes.
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Friends and neighbors in the C. elegans nervous system.
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2Dept. of Physics, University of San Francisco, California:
Effect of heavy ion irradiation on C. elegans.
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'Northwestern University, Evanston, Illinois; 2Dept. of Cell
Biology, Roche Institute, Nutley, New Jersey; 3MRC Lab-
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Prenger, J., Tollefson, A., Bullerjahn, A., Golomb, M., Divi-
sion of Biological Sciences, University of Missouri, Colum-
bia: Monoclonal antibodies against RNA polymerase II
from C. elegans.
Priess, J., MRC Laboratory of Molecular Biology, Cam-
bridge, England: Morphogenesis in C. elegans embryos.
Rattray, B., Rose, A., Dept. of Medical Genetics, University
of British Columbia, Vancouver, Canada: Characterization
of rec-1. II. Mutation rate and competitive ability.
Reilly, E., Dean, E., Chalfie, M., Dept. of Biological Science,
Columbia University, New York, New York: Benomyl-resis-
tant mutants of C. elegans.
Rioux, S.D., Moerman, D.G., Waterston, R.H., Dept. of Ge-
netics, Washington University, St. Louis, Missouri: Domi-
nant suppressors of unc-52.
Rosenbluth, R.E., Turner, L.M., Bail lie, D.L., Dept. of Biolog-
ical Sciences, Simon Fraser University, Burnaby, Canada:
Deficiency mapping and crossover suppression on LGV
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Ruan, K.-S., Emmons, S.W., Dept. of Molecular Biology, Al-
bert Einstein College of Medicine, Bronx, New York: Extra-
chromosomal copies of transposon Tcl in C. elegans.
Salvato, M., Sulston, J., Albertson, D., MRC Laboratory of
Molecular Biology, Cambridge, England: C. elegans gene
for calmodulin,
Sanicola, M., Roberts, S., Childs, G., Emmons, S.W., Depts.
of Molecular Biology and Genetics, Albert Einstein Col-
lege of Medicine, Bronx, New York: Expression of the C.
elegans histone gene family.
Shakes, D., Ward, S., Dept. of Embryology, Carnegie Insti-
tution of Washington, Baltimore, Maryland: Effect of cal-
modulin inhibitors on spermiogenesis in C. elegans.
Shen, M., Kenyon, C., Hodgkin, J., MRC Laboratory of Mo-
lecular Biology, Cambridge, England: A new sex determi-
nation mutant, "yolk-maker."
Siddiqui, S.,' Kaminuma, T.,2 Takano-Ohmuro, H.,2 Miwa,
J.,3 Tabuse, Y.,3 'Dept. of Biochemistry and Neurobiol-
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ogy, Physiology, Northwestern University, Evanston, Illi-
nois; 2Tokyo Metropolitan Institute of Medical Sciences;
3N EC Corporation, Fundamental Research Laboratories,
Kamagawa, Japan: Nerve-specific monoclonal antibodies
raised against C. elegans.
Siddiqui, S., Culotti, J., Depts. of Biochemistry and Neuro-
biology, Physiology, Northwestern University, Evanston, Il-
linois: C. elegans shares neural antigenic determinants
with other invertebrates and vertebrates.
Sigurdson, C., Herman, R., Horton, C., Kari, C., Pratt, S.,
Dept. of Genetics and Cell Biology, University of Minne-
sota, St. Paul: An X-autosome fusion chromosome of C.
elegans.
Simpson, V.,' Johnson, T.,' Klass, M.,2 'Dept. of Molecular
Biology and Biochemistry, University of California, Irvine;
2Dept. of Biology, University of Houston, Texas: Absence
of 5-methylcytosine in DNA at any age.
Sithiogorngul, A, Johnson, C.D., Stretton, A.O.W., Dept. of
Zoology, University of Wisconsin, Madison: Monoclonal
antibodies to neural antigens in Ascaris generated after
specific immunosuppression.
Snutch, T.S.,' Beckenbach, K.A.,' Bail lie, D.L.,' Mawji,
N.R.,3 Rose, A.M.,2 'Dept. of Biological Sciences, Simon
Fraser University, Burnaby; 2Dept. of Medical Genetics,
University of British Columbia, Vancouver, Canada: For-
mation of closed, circular Tcl is not dependent on Tcl
copy number.
Stern, B., Russell, R., Dept. of Biological Sciences, Univer-
sity of Pittsburgh, Pennsylvannia: Purification and cellular
localization of class C acetylcholinesterase (coming attrac-
tion-class D).
Strome, S.,' Kemphues, K.,2 Priess, J.,3 Morten, D.,2
'Dept. of Biology, Indiana University, Bloomington; 2Dept.
of Genetics and Development, Cornell University, Ithaca,
New York; 3MRC Laboratory of Molecular Biology, Cam-
bridge, England: A grandchildiess mutant that exhibits al-
tered P-granule distribution.
Strome, S.,' Scholey, S.,2 Wood, W.B.,2 'Dept. of Biology,
Indiana University, Bloomington; 2Dept. of Biology, Uni-
versity of Colorado, Boulder: Biochemical characteriza-
tion of P-granule antigens in C. elegans.
Thomas, J., Horvitz, R., Dept. of Biology, Massachusetts In-
stitute of Technology, Cambridge: Extragenic suppressors
of a lin-12 dominant allele.
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Trent, C., Wood, W.B., Dept. of Molecular, Cellular, and De-
velopmental Biology, University of Colorado, Boulder: Die-
poxybutane as a mutagen in C. elegans.
Trent, C., Wood, W.B., Dept. of Molecular, Cellular, and De-
velopmental Biology, University of Colorado, Boulder: Iso-
lation of cloned sequences in the vicinity of her-1 V.
Uchida, K., Otsuka, A., Dept. of Genetics, University of Cal-
ifornia, Berkeley: Immunocompetition experiments utiliz-
ing two-dimensional protein gel blots.
Veretto, F., Otsuka, A., Dept. of Genetics, University of Cali-
fornia, Berkeley: Phosphotyrosine is present in acid hy-
drolysates of C. elegans.
Villeneuve, A.M., Meyer, B.J., Dept. of Biology, Massachu-
setts Institute of Technology, Cambridge: egl-16- A ma-
ternal-effect sex-determining gene.
Walthall, B., Chalfie, M., Dept. of Biological Science, Colum-
bia University, New York, New York: Postembryonic devel-
opment of the touch sensory neurons in C. elegans.
Ward, S.,' Roberts, T.,2 Strome, S.,. Pavalko, F.,2 'Carnegie
SESSION 10 TRANSPOSITION AND TRANSFORMATION
Institution of Washington, Baltimore, Maryland; 2Dept. of
Biological Science, Florida State University, Tallahassee;
.Dept. of Biology, Indiana University, Bloomington: Mono-
clonal antibodies that recognize a polypeptide epitope
shared by multiple sperm-specific proteins.
Williams, S.A.,1.2 De Simone, S.M.,' McReynolds, L.A.,2
'Smith College, Northampton; 2New England Biological
Laboratories, Beverly, Massachusetts: Cloning and se-
quence analysis of repeat family DNA from the human
parasitic nematodes B. malayi and B. pahangi.
Wolinsky, E., Horvitz, R., Dept. of Biology, Massachusetts In-
stitute of Technology, Cambridge: Pharmacological and
genetic studies of C. elegans egg laying.
Yuan, J., Ellis, H., Horvitz, R., Dept. of Biology, Massachu-
setts Institute of Technology, Cambridge: Studies of the
cross-reactivity with C. elegans of monoclonal antibodies
directed against the Drosophila nervous system.
Zucker, E., Blumenthal, T, Dept. of Biology, Indiana Univer-
sity, Bloomington: The vitellogenin genes of C. briggsae.
Chairperson: B. Meyer, Massachusetts Institute of Technology, Cambridge, Massachusetts
Stinchcomb, D.,1 Shaw, J.,2 Hirsh, D.,2 'Dept. of Cellular
and Developmental Biology, Harvard University, Cam-
bridge, Massachusetts; 2Dept. of Molecular, Cellular, and
Developmental Biology, University of Colorado, Boulder:
Extrachromosomal DNA transformation of C. elegans.
Shaw, J.E.,1 Stinchcomb, D.T.,2 Hirsh, D.,1 Wood, W.B.,'
'Dept. of Molecular, Cellular, and Developmental Biology,
University of Colorado, Boulder; 2Dept. of Cellular and
Developmental Biology, Harvard University, Cambridge,
Massachusetts: Transformation of C. elegans with linear
DNA.
Jefferson, R.A., Burgess, S.M., Wolf, N., Hirsh, D., Dept. of
Molecular, Cellular, and Developmental Biology, Univer-
sity of Colorado, Boulder: Expression of chimeric genes in
C. elegans.
Klass, M.R., Dept. of Biology, University of Houston, Texas:
Expression of an MSP-13 glucuronidase fusion gene in
transformed worms.
RNA Tumor Viruses
Fire, A., MRC Laboratory of Molecular Biology, Cambridge,
England: Transient expression of microinjected sup-7 DNA
and a stable transgenic suppressor line.
Emmons, S.W., Yesner, L., Dept. of Molecular Biology, Albert
Einstein College of Medicine, Bronx, New York: Tissue-
specific regulation of the Tcl transposable element in C.
elegans.
Benian, G.M., Mori, I., Moerman, D.G., Waterston, R.H.,
Dept. of Genetics, Washington University, St. Louis, Mis-
souri: Some properties of Tcl transposition in C. elegans.
Eide, D., Anderson, P., Dept. of Genetics, University of Wis-
consin, Madison: Transposition and excision of Tcl.
Anderson, P., Saari, B., Collins, J., Dept. of Genetics, Uni-
versity of Wisconsin, Madison: Elevated Tc/ activity in mu-
tator (mut) strains.
May 21 - May 26
ARRANGED BY
Joan Brugge, State University of New York, Stony Brook
Doug Lowy, National Institutes of Health, Bethesda, Maryland
413 participants
This year's RNA Tumor Virus meeting continued to attract a large, diverse group
of investigators. The field has generated enormous interest because it represents
an area where many basic findings continue to have direct relevance to clinical
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medicine. Abstracts on viral and cellular oncogenes accounted for about one-
half the presentations. These studies included comparisons between viral onco-
genes and their cellular homologs, regulation of oncogene expression, identifica-
tion of new oncogenes, mechanisms of oncogene activation, functional and bio-
chemical activities of oncogene products, and interaction of oncogene products
with other macromolecules. Among significant findings reported, the fms proto-
oncogene was identified as the macrophage CSF-1 receptor, a new erb,contain-
ing retroviruses that induced erythroblastosis in only one strain of chickens were
described, a viral ras oncogene was found to induce differentiation (instead of
proliferation) of a rat neuroectocrine cell line, and the viral mos gene product was
shown to have serine kinase activity.
The meeting also gave considerable attention to retroviruses that do not con-
tain oncogenes. There were sessions devoted to the human retroviruses associ-
ated with T-cell lymphomas and the acquired immune deficiency syndrome and
related animal models, to oncogenesis by animal viruses lacking oncogenes, to
viral biology and genetics, to viral proteins and replication, to control of transcrip-
tion by cis- and trans-acting factors, and to retroviral vectors. These sessions in-
cluded reports of avian retroviruses making the gag-pol fusion proteins by ribo-
somal frameshifting, molecular studies of the cis and trans control elements of
HTLV transcription, aspects of the mechanism by which the pot endonuclease
mediates viral LTR cleavage, and new viral integration sites associated with dis-
ease.
This meeting was supported in part by the Cold Spring Harbor Laboratory
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ifornia, San Francisco: Synthesis in vitro of the protein
product of the int-1 gene.
Dickson, C., Casey, G., Brookes, S., Smith, R., Peters, G.,
Imperial Cancer Research Fund Laboratories, London,
England: Isolation and sequence analysis of the human
int-2 locus.
Moore, R., Dixon, M., Peters, G., Dickson, C., Imperial Can-
cer Research Fund Laboratories, London, England: The
sequence and structure of the MMTV int-2 locus-Isola-
tion of cDNA clones.
Escot-Theillet, C., Hogg, E., Callahan, R., NCI, National In-
stitutes of Health, Bethesda, Maryland: Mammary tumori-
genesis in feral Mus cervicolor popaeus-MMTV proviral
insertion in common int loci.
Gallahan, D., Hogg, E., Kozak, C., Callahan, R., NCI, Na-
tional Institutes of Health, Bethesda, Maryland: Analysis of
a new common insertion region (int-3) in MMTV (Czech II)-
induced mammary tumors of M. musculus musculus.
Tsichlis, P.N., Strauss, PG., Lohse, M.A., Fox Chase Cancer
Center, Philadelphia, Pennsylvania: Concerted DNA rear-
rangements in Mo-MLV-induced thymomas.
Villeneuve, L., Leganiere, B., Rassart, E., Jolicoeur, P., Clin-
ical Research Institute of Montreal, Canada: The fre-
quency of Mis-1 rearrangement in Mo-MLV-induced rat
thymomas is host dependent.
Selten, G., Cuypers, H.T., Berns, A., Dept. of Biochemistry,
University of Nijmegan, The Netherlands: Expression of
the putative oncogene Pim-1 is restricted to distinct he-
matopoietic cell lineages.
O'Donnell, P., Fleissner, E., Lonial, H., Koehne, C., Reicin,
A., Wolter, R., Memorial Sloan-Kettering Cancer Center,
New York, New York: Multistage events in MCF virus-ac-
celerated leukemia in AKR mice.
Mucenski, M.,1 Taylor, B.,2 Jenkins, N.,' Copeland, N.,'
'Laboratory of Mammalian Genetics, NCI-Frederick Can-
cer Research Facility, Frederick, Maryland; 2Jackson
Laboratory, Bar Harbor, Maine: AKXD recombinant inbred
191
mice-Molecular genetic approach for studying mouse
lymphomas.
Simon, M.C.,13 Smith, R.E.,3 Hayward, W.S.,"Memorial
Sloan-Kettering Cancer Center, New York, New York;
2Colorado State University, Fort Collins; 3Rockefeller Uni-
versity, New York, New York: Pathogenicity of subgroup
ALVs is associated with the 3' portion of the viral genome.
Molecular Biology of Yeast
Shipp, M.,' Diamond, A.,2 Billings, P.,3 Ritz, J.,' Cooper,
G.,2 'Division of Tumor Immunology, 3Molecular Carcin-
ogenesis, Dana-Farber Cancer Institute and Harvard
Medical School, Boston; 3Division of Radiobiology, Har-
vard School of Public Health, Boston, Massachusetts:
Identification of the putative protein product of the human
Blym transforming gene.
August 13 - August 18
ARRANGED BY
James Hicks, Amar Klar, David Beach,
Mark Zoller, Michael Wigler, Cold Spring Harbor Laboratory
437 participants
Continuing the trend of the last three biennial yeast meetings at Cold Spring
Harbor, the 1985 meeting brought more than 450 scientists to the laboratory for
ten intensive sessions of oral presentations and three large poster sessions. As
usual, much of the excitement centered on developments in the molecular ge-
netics of gene regulation and expression, where the ease of nucleic acid manip-
ulation has clearly made Saccharomyces cerevisiae the organism of choice. The
detailed structure of several yeast promoters and their associated regulatory
sites is rapidly being revealed. In some systems, both cis- and trans-acting ele-
ments for gene control have been identified.
This year, however, more attention than ever was paid to genetic and biochem-
ical studies of cell structure and whole-cell processes, including protein localiza-
tion, chromosome structure, and RNA processing and control of the cell cycle.
Now that homologs for many so-called higher eukaryote functions have been
found, yeast is rapidly becoming a fashionable subject for cell biology as well as
genetics.
This meeting was funded in part by the Anheuser-Busch Companies, Gist-Bro-
cades, Miller Brewing Company, Smith Kline & French Laboratories, and Zymo-
Genetics, Inc.
SESSION 1 GENE REGULATION I-TY ELEMENTS AND CELL TYPE
Chairperson: A. Hinnebusch, National Institutes of Health
Boeke, J.D., Garfinkel, D.J., Styles, C.A., Fink, G.R., Dept.
of Biology, Massachusetts Institute of Technology, Cam-
bridge: Reverse transcription and Ty transposition.
Gafner, J., Muller, ET, Ciriacy, M., Institut fOr Mikrobiologie,
Universitat Dusseldorf, Federal Republic of Germany: A Ty
.
element encodes both a 6-specific endonuclease and a
reverse transcriptase.
Garfinkel, D.J., Boeke, J.D., Fink, G.R., Whitehead Institute
for Biomedical Research, Massachusetts Institute of Tech-
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nology, Cambridge: Ty element transposition and virus-like
particles.
Tavianini, M.A., Worthington, M., Young, E.T., Dept. of Bio-
chemistry, University of Washington, Seattle: Character-
ization of cis-acting control sequences in Tyl elements.
Company, M., Yarnell, W., Connell, L., Errede, B., Dept. of
Chemistry, University of North Carolina, Chapel Hill: A
multicomponent structure for the Tyl activator.
Winston, F., Minehart, P., Dept. of Genetics, Harvard Medi-
cal School, Boston, Massachusetts: Analysis of SPT3 and
newly identified genes that affect Ty transcription,
Margolskee, J., Kassir, Y., Simchen, G., Dept. of Genetics,
Hebrew University, Jerusalem, Israel: Positive regulation
is involved in the genetic control of meiosis.
Mitchell, A.P., Herskowitz, I., Dept. of Biochemistry and Bio-
physics`; University of California, San Francisco: Isolation
of the RME1 gene, a gene that mediates mating-type con-
trol of sporulation.
Marshall, M.,' Hicks, J.,2 Broach, J.,' 'Dept. of Molecular
Biology, Princeton University, New Jersey; 2Cold Spring
Harbor Laboratory, New York: Structural and genetic anal-
ysis of SIR4.
Schnell, R., Kimmerly, W., Rine, J., Dept. of Biochemistry,
University of California, Berkeley: Genetic and biochemi-
cal characterization of the regulation of the silent mating-
type genes of S. cerevisiae.
SESSION 2 RNA PROCESSING
Chairperson:
M. Rolfe, D. Beach
C. Guthrie, University of California, San Francisco
Rymond, B.C, Jacquier, A., Rosbash, M., Dept. of Biology,
Brandeis University , Waltham, Massachusetts: A scan-
ning model for lariat formation of the RP51 intron.
Fouser, L., Friesen, J.D., Dept. of Medical Genetics, Univer-
sity of Toronto, Canada: Mutations in the S. cerevisiae ac-
tin intron define nucleotides required for the two stages in
mRNA splicing.
Patterson, B., Guthrie, C., Dept. of Biochemistry and Bio-
of an essential snRNA in yeast.
Zagorski, J.,' Thompson, J.R.,' Woolford, J.L.,2 Fournier,
M.J." Dept. of Biochemistry, University of Massachu-
setts, Amherst; 2Dept. of Biological Sciences, Carnegie-
Mellon University, Pittsburgh, Pennsylvania: Characteriza-
tion of the small nuclear RNA genes of yeast-Structure
and demonstration of nonessentiality of a gene for a 189 -
base snRNA.
Atkinson, N.S., Dunst, R.W., Traglia, H.M., Hopper, A.K.,
Dept. of Biological Chemistry, M.S. Hershey Medical Cen-
ter, Pennsylvania: RNA 1- Characterization of the gene, its
product, and a new allele with a novel phenotype.
SESSION 3 POSTER SESSION I
Ty Elements
Stotz, A., Pridmore, D., Fleig, U., Jager, D., Philippsen, P.,
Dept. of Microbiology, Biozentrum, University of Basel,
Switzerland: Ty transposition mechanism.
Schirmaier, F., Philippsen, P., Dept. of Microbiology, Biozen-
trum, University of Basel, Switzerland: Site-directed muta-
genesis of the yeast translation elongation factor EF1a.
Jager, D., Philippsen, P., Dept. of Microbiology, Biozentrum,
University of Basel, Switzerland: Length polymorphism in
chromosomal DNA from Saccharomyces strains.
Yu, K., Elder, R.T., Dept. of Molecular Genetics and Cell Bi-
ology, University of Chicago, Illinois: The Ty-D15 element
Phizicky, E., Clark, M., Westaway, S., Abelson, J., Division of
Biology, California Institute of Technology, Pasadena: S.
cerevisiae tRNA ligase- Isolation of the structural gene
and intracellular localization of the protein.
Greer, C.L., Dept. of Biological Chemistry, University of Cal-
ifornia College of Medicine, Irvine: Assembly of a tRNA
splicing complex in vitro.
Nichols, M., Willis, I., SOII, D., Dept. of Molecular Biophysics
Yale University, New Haven, Connecti-
cut: In vitro generated mutations in Schizosaccharomyces
pombe UGA suppressor serine tRNA genes-Studies of
transcription, processing, and suppression.
Cumsky, M.G., Trueblood, C.E., Poyton, R.O., Dept. of Mo-
lecular, Cellular, and Developmental Biology, University of
Colorado, Boulder: RNA processing regulates expression
of the COX5b gene product in yeast.
Peebles, C.L.,' Mecklenburg, K.L.,2 Perlman, P.S.,2 Pe-
trillo, Mi.,' Dietrich, R.C.,2 Romiti, L.,1 'Dept. of Biolog-
ical Sciences, University of Pittsburgh, Pennsylvania;
2Dept. of Genetics, Ohio State University, Columbus: oxi3
intron 7 represents a new type of self-splicing intron.
contains an internal transcriptional activating sequence
that has properties significantly different from those of an
enhancer sequence.
Heidler, S., Liebman, S.W., Dept. of Biological Sciences, Uni-
versity of Illinois, Chicago: Ty transposition into the CAN1
gene.
Fulton, A., Malim, M., Mellor, J., Wilson, W., Kingsman, A.,
Kingsman, S., Dept. of Biochemistry, University of Oxford,
England: Variants of the yeast transposable element, Ty.
Liao, X., Clare, J., Farabaugh, P., Dept. of Microbiology, Uni-
versity of Connecticut Health Center, Farmington: Deletion
analysis of a Ty promoter.
Kapakos, J., Farabaugh, P, Dept. of Microbiology, Univer-
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sity of Connecticut Health Center, Farmington: Compari-
son of the mating-type regulation of Ty91 7 transcription to
adjacent transcription.
Errede, B.,' Hutchison, C.A. 111,2 Depts. of 'Chemistry,
2Microbiology and Immunology, University of North Caro-
lina, Chapel Hilt: Replacement of a Ty1 activator region
with a synthetic regulatory element.
RNA Processing and Translation
Strobel, M.C.,' 2 Abelson, J.,2 'Dept. of Biology, University
of California, San Diego; 2Division of Biology, California
Institute of Technology, Pasadena: Effect of intron muta-
tions on splicing of S. cerevisiae SUP53 pre-tRNA.
Kaufer, N.F.,1 Simonis, V.,2 Nurse, P.,2 'Institut kir Bioch-
emie and Molekularbiologie, Freie Universitat Berlin, Fed-
eral Republic of Germany; 2lmperial Cancer Research
Fund Laboratories, London, England: Splicing of foreign
introns in fission yeast.
Last, R.L., Woodford, J.L., Carnegie-Mellon University, Pitts-
burgh, Pennsylvania: Evidence for related function of the
RNA2, RNA3, and RNA4 genes of S. cerevisiae.
Nagasu, T.,' McConaughy, B.L.,2 Hall, B.D.,2 'Eisai Co.,
Ltd., Tsukuba Research Laboratories, Japan; 2Dept. of
Genetics, University of Washington, Seattle: Splicing of a
neurospora intron by Schizosaccharomyces pombe.
Jacquier, A., Rosbash, M., Dept. of Biology, Brandeis Uni-
versity, Waltham, Massachusetts: Genetic analysis of cis-
acting elements involved in splicing of the RP51 intron.
Knapp, G., Lee, M.-C., Solvason, H.B., Dept. of Microbiol-
ogy, University of Alabama, Birmingham: Yeast tRNA
splicing requires that the 3' splice junction be single-
stranded.
Jackson, S.P., Beggs, J.D., Dept. of Molecular Biology, Uni-
versity of Edinburgh, Scotland: Molecular cloning of S.
cerevisiae genes implicated in RNA splicing.
Dihanich, M.,' Najarian, D.,2 Gillman, E.,' Martin, N.C.,2
Hopper, A.K.,"Dept. of Biological Chemistry, M.S. Her-
shey Medical Center, Hershey, Pennsylvania; 2Dept. of
Biochemistry, University of Texas Health Science Center,
Dallas: mod5, a gene involved in modification of both cy-
toplasmic and mitochondria! tRNAs.
Fabian, G.R., Hopper, A.K., M.S. Hershey Medical Center,
Hershey, Pennsylvania: Molecular and genetic analysis of
rrpl -A mutation affecting ribosomal RNA processing.
Couto, J.R., Tamm, J.A., Parker, R., Guthrie, C., Dept. of Bio-
chemistry and Biophysics, University of California, San
Francisco: Suppressors that restore RNA splicing.
Cigars, M., Donahue, T.F., Dept. of Molecular Biology, North-
western University Medical School, Chicago, Illinois:
Translation initiation-Mutational analysis of tRNAwlei.
BystrOm, A.S., Fink, G.R., Whitehead Institute for Biomedical
Research, Cambridge, Massachusetts: Cloning of the me-
thionine initiator tRNA genes in yeast.
Wilson, PG., Culbertson, M.R., University of Wisconsin,
Madison: Analysis of the suf12 gene and gene product.
Winey, M., Mendenhall, M., Culbertson, M., University of
Wisconsin, Madison: Intron splicing of frameshift suppres-
sor pre-tRNA.
Ranu, R.S., Dept. of Microbiology, Colorado State Univer-
sity, Fort Collins: Protein kinases and the regulation of pro-
tein synthesis in S. cerevisiae.
194
Gill, G.,' Zaworski, P.,' Sharma, S.,' Adams, L.,' Murak-
ami, K.,2 'Research Laboratories, Upjohn Company, Ka-
lamazoo, Michigan; 2Tsukuba University, Japan: Recog-
nition of an S. cerevisiae protein by an antibody to human
resin.
Maicas, E., Pluthero, FG., Friesen, J.D., Dept. of Medical
Genetics, University of Toronto, Canada: Posttranscrip-
tional control of the synthesis of ribosomal protein L3 in S.
cerevisiae.
Chen, J.-Y, Bodley, J.W., Livingston, D.M., Dept. of Bio-
chemistry, University of Minnesota, Minneapolis: Yeast
mutants resistant to the in vitro action of diptheria toxin.
Cottrelle, P., Buhler, J.-M., Cool, M., Thiele, D., Huet, J., Sen-
tenac, A., Service de Biochimie du Departement de Biol-
ogie, Den Saclay, Gif-sur-Yvette, France: Expression of the
TEF1 and TEF2 genes encoding yeast elongation factor
EF-1 a
Warner, J.R., Elton, E.A., Post-Beittenmiller, M., Dept. of Cell
Biology, Albert Einstein College of Medicine, Bronx, New
York: A run-on transcription system for yeast.
Kruse, C., Johnson, S.P., Warner, J.R., Dept. of Cell Biology,
Albert Einstein College of Medicine, Bronx, New York:
Phosphorylation of the yeast equivalent of ribosomal pro-
tein S6 is not essential for growth.
Hussain, I., Leibowitz, M.J., Dept. of Microbiology, UMDNJ-
Rutgers Medical School, Piscataway, New Jersey: Trans-
lation of homologous and heterologous mRNAs in a yeast
cell-free system.
McCusker, J.H., Haber, J.E., Rosenstiel Center, Brandeis
University, Waltham, Massachusetts: Characterization of
cycloheximide-resistant, temperature-sensitive lethal (cr1)
mutations.
Friden, P., Schimmel, P, Dept. of Biology, Massachusetts In-
stitute of Technology, Cambridge: Yeast leucyl-tRNA syn-
thetase- Evidence for isolation of mutants and cloning of
the gene.
Liebman, S.W., Robyn, J.A., Griffin, E.W., Song, J.M., Dept.
of Biological Sciences, University of Illinois, Chicago: New
omnipotent suppressors and allosuppressors.
Tricks of the Trade
Tschopp, J.F., Brust, PE, Cregg, J.M., Stillman, C.A., Gin-
geras, T.R., Salk Institute Biotechnology/Industrial Associ-
ates, Inc., La Jolla, California: Two methanol-regulated
promoters used in the construction of yeast expression
vectors-Studies on the mechanism of regulation and
comparative promoter strengths in Pichia pastoris and S.
cerevisiae.
Klein, H., Dept. of Biochemistry, New York University Medi-
cal Center, New York, New York: Separation of whole yeast
chromosomes-Altered mobility in transformed strains.
Hadfield, C., Cashmore, A., Meacock, P., Leicester Bio-
centre, University of Leicester, England: A shuttle chlor-
amphenicol-resistance marker for the efficient transfor-
mation of haploid and polyploid strains of S. cerevisiae and
E. colt.
Hadfield, C., Cashmore, A., Meacock, P., Leicester Bio-
centre, University of Leicester, England: The construction
of APT gene cartridges and their use in E. col/ -yeast shut-
tle resistance determinants against aminoglycoside anti-
biotics.
Metnick, L., Sherman, F. University of Rochester, New York:
Gene cluster associated with the CYCI and CYC7 genes.
Wakem, P., Sharma, G., Sherman, F, University of Roches-
ter, New York: A new method for chromosomal assign-
ment of mutations in yeast.
Chisholm, V.T., Kline, C.J., Willis, I., Burkard, U., Nichols, M.,
SOII, D., Dept. of Molecular Biophysics and Biochemistry,
Yale University, New Haven, Connecticut: Classical ge-
netics with a molecular twist: A novel approach to the iso-
lation of genes associated with tRNA metabolism.
Expression of Foreign Genes
Hitzeman, R., Chen, C., Dept. of Cell Genetics, Genentech,
Inc., South San Francisco, California: Human, yeast, and
hybrid 3-phosphoglycerate kinase gene expression in
yeast.
Davidow, L.S., Apostolakos, D., Stasko, I., DeZeeuw, J.R.,
Dept. of Molecular Genetics, Pfizer Central Research,
Groton, Connecticut: Cloning genes by complementation
form an integrating vector library in the yeast Y. lipolytica.
Wright, C., Thiele, D., Walling, M.J., Hamer, D., NCI, Na-
tional Institutes of Health, Bethesda, Maryland: Structure
and function of yeast copperthionein.
Schenberg-Frascino, A.C.,' Filho, S.A.,2 Galembeck, E.V.,'
Faris, J.B.," Chemistry Institute, Universidade de Sao
Paulo, Spain; 2Biological Sciences Institute, Universidade
de Brasilia, Brazil: Stable yeast transformants secreting
mouse pancreatic a-amylase.
Meyhack, B., Marki, W, Heim, J., Hinnen, A., Ciba-Geigy
AG, Biotechnology, Basel, Switzerland: High-level expres-
sion of a proteinase inhibitor in yeast.
Kurtz, M.B., Cortelyou, M.W., Kirsch, D.R., Dept. of Cellular
Biology, Squibb Institute for Medical Research, Princeton,
New Jersey: Integrative transformation of Candida albi-
cans using a cloned Candida ade2 gene.
Ying, T., Kuang, D., Shanghai Institute of Cell Biology, China:
Expression of p-hCG (p- subunit of human chorionic go-
nadotropin) gene in yeast and secretion of the gene prod-
uct.
Egan, K.M., Koski, R.A., Jones, M., Fieschko, J.C., Bitter,
G.A., Amgen, Thousand Oaks, California: Regulated
expression of human immune interferon in S. cerevisiae.
Kim, S., Mellor, J., Dobson, M., James, P., Kingsman, A.,
Kingsman, S., Dept. of Biochemistry, University of Oxford,
England: Structural analysis of the TRP1 promoter direct-
ing human interferon a-2 gene expression on a high-copy-
number plasmid.
Itaya, M., Hinnebusch, A.G., Crouch, R.J., NICHD, National
Institutes of Health, Bethesda, Maryland: Cloning of a yeast
ribonuclease H gene by complementing an E. coli rnh de-
ficiency.
Hsiao, C.-L., Mason, B.B., Dheer.,S:K., Hung, RR, Davis,
A.R., Microbiology Division, Wyeth Laboratories, Inc.,
Philadelphia, Pennsylvania: Expression of rotavirus gly-
coprotein VP7 in yeast.
Growth Control and Cell Cycle, Part I
Thill, G.,' Barber J.,2 Deschamps, J.,2 Lair, S.,1 Verma, I.,2
'Salk Institute Biotechnology/Industrial Associates, Inc.,
San Diego; 2Molecular Biology and Virology Laboratory,
Salk Institute for Biological Studies, La Jolla, California:
Expression of fos proteins in S. cerevisiae.
Schmitt, I-1.D., Molenaar, C., Rauh, A., Wagner, P. Gallwitz,
D., Physiologisch-Chemisches Institut, Universitat Mar-
burg, Federal Republic of Germany: The ras-related YP2
gene of S. cerevisiae-Characterization of insertion and
point mutations.
Hanes, S.D., Shank, P.R., Bostian, K.A., Division of Biology
and Medicine, Brown University, Providence, Rhode Is-
land: Characterization of a potential yeast homolog of the
simian sarcoma virus oncogene v-sis.
DNA Replication and Chromosome Structure, Part I
Fournier, P.,' Gaillardin, C.,' Persuy, M.-A.,' Klootwijk, J.,2
van Heerikhuizen H., 2 1Laboratoire Genetique, Institut
National Agronomique, Paris, France; 2Biochemisch Lab-
oratory, Vrije Universiteit, Amsterdam, The Netherlands:
Heterogeneity in the ribosomal DNA family of the yeast
Yarrowia lipolytica-Genomic organization and segrega-
tion studies.
Klootwijk, J.,1 van Heerikhuizen, H.,' Ykema, A.,' Gaillar-
din, C.,2 Bailas, C.,2 Fournier, P.,2 iBiochemisch Labo-
ratory, Vrije Universiteit, Amsterdam, The Netherlands;
2Laboratorie Genetique, Institut National Agronomique,
Paris, France: Heterogeneity in the ribosomal DNA family
of the yeast Yarrowia lipolytica-Molecular cloning and
analysis of two different repeated units.
Wu, L.-C.C.,' Broach, J.R.,2 Fisher, PA.,' 'Dept. of Phar-
macological Sciences, State University of New York, Stony
Brook; 2Dept. of Molecular Biology, Princeton University,
New Jersey: Identification and characterization of the yeast
nuclear matrix.
Conrad, M.N., Zakian, V.A., Fred Hutchinson Cancer Re-
search Center, Seattle, Washington: Plasmid interactions
with the yeast nuclear matrix.
Sweeney, R., Zakian, V., Fred Hutchinson Cancer Research
Center, Seattle, Washington: The nibbled phenotype and
2-micron DNA.
Conrad, M.N., Hager, L.J., Zakian, V.A., Fred Hutchinson
Cancer Research Center, Seattle, Washington: ARS be-
havior on plasmids and chromosomes.
Peterson, B.C., Pausch, M.H., Dumas, L.B., Dept. of Bio-
chemistry, Molecular Biology, and Cell Biology, North-
western University, Evanston, Illinois: Purification and
analysis of the yeast DNA polymerase-DNA primase com-
plex using monoclonal antibodies.
Pocklington, M.J., Orr, E., Dept. of Genetics, University of
Leicester, England: Genes that determine resistance to
novobiocin in S. cerevisiae.
Goetsch, L., Byers, B., Dept. of Genetics, University of
Washington, Seattle: Mutational analysis of a major chro-
mosomal protein abundant in meiotic yeast.
Gibson, S., Surosky, R., Tye, B.-K., Section of Biochemistry,
Molecular and Cell Biology, Cornell University, Ithaca, New
York: A minichromosome maintenance mutant with a pos-
sible defect in initiation of DNA replication.
Giroux, C.N.,' Tiano, H.F.,' Dresser, M.,2 Moses, M.,2
'National Institute of Environmental Health Sciences, Re-
search Triangle Park; 2Dept. of Anatomy, Duke University
Medical School, Durham, North Carolina: Functional and
structural analysis of meiotic chromosome metabolism
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C. McGill, J. Strathern
during mieosis- SP011.
Zea ley, G.,' Wheals, A.,' Goodey, A.,' Carter, B.,2
'Microbiology Group, School of Biological Sciences, Uni-
versity of Bath; 2G.D. Searle Ltd., High Wycombe, Eng-
land: Studies on plasmid copy number in S. cerevisiae.
Norris, D.N., Hereford, L.M., Dana-Farber Cancer Institute,
Boston, Massachusetts: Genetic analysis of histone func-
tion.
Thompson, A., Oliver, S.G., Dept. of Biochemistry and Ap-
plied Molecular Biology, UMIST, Manchester, England:
DNA fragments with ARS activity in both S. cerevisiae and
Kluyveromyces lactis.
Palzkill, 11,12 Matz, K.,' Hardeman, K.,1.2 Kim, K.,' New-
Ion, C.S.,2 'Dept. of Biology, University of Iowa, Iowa City;
'Dept. of Microbiology, UMDNJ-New Jersey Medical
School, Newark: Autonomously replicating sequences
from chromosome III.
Warmington, J.R.,' Anwar, R.,' Pizzigallo, P.,' Patel, N.,'
Waring, R.B.,' Indge, K.J.,' Newlon, C.S.,2 Oliver, S.G.,'
'Dept. of Biochemistry and Applied Molecular Biology,
UMIST, Manchester, England; 'Dept. of Microbiology,
UMDNJ-New Jersey Medical School, Newark: Nucleotide
sequence of chromosome III from yeast.
Amin, A.A., Pearlman, R.E., Dept. of Biology, York Univer-
sity, Toronto, Canada: Nucleotide sequence requirements
for ARS function of a class of non-yeast replication origins.
O'Rear, J., Rine, J., Dept. of Biochemistry, University of Cal-
ifornia, Berkeley: Precocious centromere division of a
novel yeast chromosome.
Murray, J.A.H., Cesareni, G., European Molecular Biology
Laboratory, Heidelberg, Federal Republic of Germany: Ef-
fects of transcription in the ORI region of the stability of 2-
micron plasmid derivatives.
Mittman, B.A., Smith, M.M., Dept. of Microbiology, Univer-
sity of Virginia, Charlottesville: Generation and analysis of
histone H4 mutations in yeast.
Moore, C., Jones, C., Wall, L., University of Rochester School
of Medicine, New York: Treated intact (whole) cells exhibit
internucleosomal chromatin cleavage.
Mead, D.J., Gardner, D.C.J., Oliver, S.G., Dept. of Biochem-
istry and Applied Molecular Biology, UMIST Manchester,
England: Profound differences in the stability of the yeast
2-micron plasmid between haploid and diploid cells.
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Fragrelius, T.J., Strand, A.D., Livingston, D.M., Dept. of Bio-
chemistry, University of Minnesota, Minneapolis: An anal-
ysis of the effect of 2-micron DNA gene products on
DNAase-l-sensitive sites in plasmid chromatin.
Haggren, W., Burgum, A., Kolodrubetz, D., Dept. of Micro-
biology, University of Texas Health Science Center, San
Antonio: Analysis of genes encoding the chromatin-asso-
ciated HMG proteins of yeast.
Brier ley, R.A.,1.2 Groppi, V.E.,3 Klein, R.D.,2 'Worcester Po-
lytechnic Institute, 'Molecular Biology Research, 3Cell Bi-
ology Research, Upjohn Company, Kalamazoo, Michigan:
Plasmid stability and segregation under various fermen-
tation conditions.
Heyer, W.-D.,' Sipiczki, M.,2 Koh li, J.," Institute of General
Microbiology, University of Bern, Switzerland; 'Dept. of
Genetics, University of Debrecen, Hungary: Replicating
plasmids in Schizosaccharomyces pombe- Improvement
of symmetric segregation by a new genetic element.
Harford, N., Gathoye, A.-M., Fievet, F., De Wilde, M., Dept.
of Molecular Genetics, Smith Kline-RIT, Rixensart, Bel-
gium: Displacement of endogenous 2-micron circles by
LEU2-based, moderate-copy-number vectors.
Horowitz, H., Haber, J.E., Rosenstiel Center, Brandeis Uni-
versity, Waltham, Massachusetts: The behavior of marked
telomeres in S. cerevisiae.
Fournier, P,' Heslot, H.,' Goursot, R.,2 Dedieu, A.,2 Ehr-
lich, S.D.,2 1Laboratoire Genetique, Institut National
Agronomique; 2CNRS, Institut J. Monod, Universite Paris,
France: Behavior of a Staphylococcus aureus plasmid in
the yeast Schizosaccharomyces pombe.
Gaudet, A., McGrew, J., Fitzgerald-Hayes, M., Dept. of Bio-
chemistry, University of Massachusetts, Amherst: Single-
base-pair mutations in centromere element III can cause
aberrant chromosome segregation.
Cramer, J.H.,' Bowen, B.,2 Lea, K.,' Idler, K.,' Cullis, C.,2
'Agrigenetics Corp., Advanced Research Division, Madi-
son, Wisconsin; 'John Inner Institute, Norwich, England:
Characterization of a monocot chloroplast DNA restriction
fragment displaying ARS activity in S. cerevisiae.
Crowley, J.C.,1 Steensma, H.Y,2 Lamb, J.,' Koepp, L.,3
Kaback, D.B.,"UMDNJ, New Jersey Medical School,
Newark; 'Delft University of Technology, The Nether-
lands; 3Bloomfield College, New Jersey: The molecular
organization of chromosome I.
Cregg, J.M., Barringer, K.J., Madden, K.R., Salk Institute
Biotechnology/Industrial Associates, Inc., La Jolla, Califor-
nia: Pichia pastoris and S. cerevisiae ARSs- Heterologous
host function analysis and DNA sequence comparison.
Genbauffe, F., Cooper, T, University of Tennessee Center for
the Health Sciences, Memphis: Sequences required for in-
duction and repression of the urea amidolyase (DUR1,2)
gene.
Gorman, J.A.,1 Koltin, Y,2 Clark, R," Dept. of Molecular
Genetics, Smith Kline and French Laboratories, Philadel-
phia, Pennsylvania; 'Dept. of Microbiology, Tel-Aviv Uni-
versity, Israel: Isolation and characterization of genes in-
volved in sorbitol utilization from Candida albicans.
Heinisch, J., Zimmermann, F.K., Institut fur Mikrobiologie,
Technische Hochschule Darmstadt, Federal Republic of
Germany: Isolation of the genes coding for yeast phos-
phofructokinase and increasing the enzyme activity.
Janowicz, Z.A., Eckart, M., Roggenkamp, R., Hollenberg,
C.P., Institut fOr Mikrobiologie, Universitat Dusseldorf,
Federal Republic of Germany: Characterization of genes
involved in methanol utilization from Hansenula polymor-
pha.
Trumbly, R.J., Wadsworth Center for Laboratories and Re-
search, New York State Dept. of Health, Albany: Charac-
terization of mutants resistant to catabolite repression of
invertase.
Williamson, V.M., Paquin, C., Walton, J., ARCO Plant Cell
Research Institute, Dublin, California: A new yeast alcohol
dehydrogenase-Increased expression due to Ty inser-
tion or gene amplification.
SESSION 4 RECOMBINATION/DNA REPAIR
Wing, R.A., Ogrydziak, D.M., Institute of Marine Resources,
University of California, Davis: Cloning of the alkaline ex-
tracellular protease gene from Yarrowia lipo/ytica.
Yoo, H.-S., Cooper, R.G., Dept. of Microbiology and Immu-
nology, University of Tennessee Center for the Health Sci-
ences, Memphis: A new allantoin degradative gene in the
DAL gene cluster of chromosome IX.
Chen, W., Struhl, K., Dept. of Biological Chemistry, Harvard
Medical School, Boston, Massachusetts: Yeast transcrip-
tional initiation sites are determined primarily by specific
sequences, not by the distance from the TATA element.
Chairperson: J. Strathern, NCI, Frederick Cancer Research Facility
Strathern, J.,' McGill, C.,' Shafer, B.,' Klar, A.,2 Hicks, J.,2
Model, P.,3 Fulton, W. 111,3 'NCI-Frederick Cancer Re-
search Facility, Frederick, Maryland; 2Cold Spring Harbor
Laboratory, New York; 3Rockefeller University, New York,
New York: Site-specific gene conversion.
Zoller, M.J., Kostriken, R.G., Johnson, K.E., Cold Spring
Harbor Laboratory, New York: Point mutations in the yeast
MATa gene that affect cleavage by HO endonuclease.
Kolodkin, A.,' Klar, A.,2 Stahl, F.,"Institute of Molecular
Biology, Eugene, Oregon; 'Cold Spring Harbor Labora-
tory, New York: Double-strand breaks and meiotic recom-
bination.
Klar, A., Cold Spring Harbor Laboratory, New York: Double -
stranded DNA break, meiotic gene conversion, and chro-
mosomally inherited developmental potential for fission
yeast MAT switching.
Rudin, N., Connolly, B., Klucznik, M., Haber, J., Rosenstiel
Center, Brandeis University, Waltham, Massachusetts: Ef-
fect of interchromosomal mating-type switching in S. cere-
visiae.
Colleaux, L.,' d'Auriol, L.,2 Demariaux, M.,' Dujon, B.,1
Galibert, F.,2 Jacquier, A.,"Centre de Genetique mole-
culaire du CNRS, 2Laboratoire d'Hematologie experimen-
tale, Centre Hayem, Hopital Saint Louis, Paris, France:
Expression in E. coli of a universal code equivalent of a
yeast mitochondrial intron reading frame involved in the
integration of an intron within a gene.
Zinn, A., Zhu, H., Butow, R., Macreadie, I., Dept. of Bio-
chemistry, University of Texas Health Science Center, Dal-
las: A yeast mitochondrial intron encodes a protein re-
quired for transposition of that intron.
Ronne, H., Rothstein, R., Dept. of Human Genetics and De-
velopment, Columbia University, New York, New York: Ge-
netic evidence for heteroduplex DNA formation during mi-
totic recombination.
Resnick, M.A.,1,2 Westmoreland, J.,' Bloom, K.,2 'National
Institute of Environmental Health Sciences, Research Tri-
angle Park; 'University of North Carolina, Chapel Hill:
DNA repair, damage, and chromosome stability in yeast.
Elledge, S.J., Davis, R.W., Dept. of Biochemistry, Stanford
University School of Medicine, California: The isolation of
genes from yeast encoding proteins immunologically re-
lated to the RecA protein.
Wagstaff, J., Gottlieb, S., Easton Esposito, R., University of
Chicago, Illinois: RAD50-dependent and -independent
pathways of meiotic intrachromosomal recombination.
SESSION 5 DNA/REPLICATION AND CHROMOSOME STRUCTURE
Chairperson: J. Broach, Princeton University
Brill, S.J., Thrash, C., DiNardo, S., Voelkel-Meiman, K.,
Sternglanz, R., State University of New York, Stony Brook:
Roles of yeast DNA topoisomerases I and II in DNA repli-
cation and transcription.
Volkert, F.,1 Armstrong, K.,' Som, T.,' Seale, R.,' Wu, L.,2
Fisher, P.,2 Broach, J.,"Dept. of Molecular Biology,
Princeton University, New Jersey; 'Dept. of Pharmacol-
ogy, State University of New York, Stony Brook: Mecha-
nism of stable propagation of yeast plasmid 2-micron cir-
cle.
Mc Carroll, R.M., Fangman, W.L., Dept. of Genetics, Univer-
sity of Washington, Seattle: Replication timing during the
S phase.
Passmore, S., Chan, C., Tye, B.-K., Section of Biochemistry,
Molecular and Cell Biology, Cornell University, Ithaca, New
York: Hierarchy of DNA replication origins in yeast.
Zakian, V.A., Blanton, H.M., Wetzel, L., Dani, G.M., Fred
Hutchinson Cancer Research Center, Seattle, Washing-
ton: Creation and maintenance of telocentric chromo-
somes.
Walmsley, R.M., Dept. of Biochemistry and Applied Molecu-
lar Biology, UMIST, Manchester, England: Telomere length
is affected by the number of telomere-associated se-
quences present in a strain.
Hill, A., Bloom, K., Dept. of Biology, University of North Car-
olina, Chapel Hill: Genetic manipulation of yeast centrom-
eres.
Hegemann, J.H.,' Pridmore, D.,' Panzeri, L.,2 Landonio,
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L.,2 Stotz, A.,' Huberman, J.,' Jager, D.,' Zonneveld,
B.,' Philippsen, R,' 'Dept. of Microbiology, Biozentrum,
Basel, Switzerland; 2Instituto de Genetica, University di
Milano, Italy: In-vitro-mutated yeast CEN DNA.
Kaback, D.B., Fajardo, J.E., UMDNJ Graduate School of
Biomedical Sciences, New Jersey Medical School, New-
ark: Segregation of CEN-containing plasmids away from
intact chromosomes during meiosis I in S. cerevisiae.
SESSION 6 POSTER SESSION II
DNA Replication and Chromosome Structure, Part II
Cashmore, A., Hadfield, C., Albury, M., Meacock, P, Leices-
ter Biocentre, University of Leicester, England: The role of
2-micron-encoded functions in plasmid maintenance.
Brown, J.A., Smith, M.M., Dept. of Microbiology, University
of Virginia, Charlottesville: Analysis of yeast H3 and H4
histone gene chromatin structure.
Lucchini, G., Brandazza, A., Foiani, M., Plevani, R, Badar-
acco, G., Dept. di Biologia, Universita de Milano, Italy:
Yeast DNA polymerase I gene-Cloning by immunos-
Greening.
Blowers, A., DiGate, R.J., Hinkle, D.C., Dept. of Biology, Uni-
versity of Rochester, New York: Purification, characteriza-
tion, and cloning of yeast DNA polymerase I.
Araki, H., Jearnpipatkul, A., Kaisho, Y, Matsuzaki, H., Osh-
ima, Y., Dept. of Fermentation Technology, Osaka Univer-
sity, Japan: Functional organization of yeast plasmid pSR1.
Jong, A.Y.-S., Campbell, J.L., Divisions of Biology and
Chemistry, California Institute of Technology, Pasadena:
Single-stranded of yeast.
Hamatake, R.K., Sakai, A., Alexander, RS., Desai, R., Sug-
ino, A., NIEHS, National Institutes of Health, Research Tri-
angle Park, North Carolina: Purification, characterization,
and gene cloning of three different yeast single-stranded
DNA-binding proteins.
Berman, J., Tye, B.-K., Dept. of Biochemistry, Molecular, and
Cellular Biology, Cornell University, Ithaca, New York:
J. Broach
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Campbell, J.L.," Johnson, L.M.,1 Jong, A.Y.S,,' Srienc, F.,'
Sweder, K.,' Snyder, M.P.,2 'Divisions of Biology and
Chemistry, California Institute of Technology, Pasadena;
2Stanford University School of Medicine, California: Dis-
section of the yeast DNA replication apparatus.
Identification and characterization of a telomere-binding
protein from S. cerevisiae.
Alonso, W., Nelson, D., Dept. of Biochemical and Biophysi-
cal Sciences, University of Houston, Texas: A novel his-
tone deacetylase activity coisolated with yeast nuclei.
Snyder, M., Davis R.W., Dept. of Biochemistry, Stanford Uni-
versity School of Medicine, California: Molecular analysis
of chromosome segregation in yeast.
Recombination/DNA Repair
Kunes, S., Botstein, D., Fox, M., Dept. of Biology, Massachu-
setts Institute of Technology, Cambridge: On a mechanism
of double-strand-break repair that yields inverted repeats.
Muster-Nassal, C., Kolodner, R., Dana-Farber Cancer Insti-
tute, and Dept. of Biological Chemistry, Harvard Medical
School, Boston, Massachusetts: Repair of mismatched
nucleotides by cell-free extracts of S. cerevisiae.
Naumovski, L., Friedberg, E.C., Dept. of Pathology, Stanford
University School of Medicine, California: Functional or-
ganization of the RAD3 gene of S. cerevisiae.
Willis, K., Klein, H.L., Dept. of Biochemistry, New York Uni-
versity Medical Center, New York, New York: Intrachro-
mosomal recombination events leading to increased
expression of a selectable marker.
Vincent, A., Petes, T.D., Dept. of Molecular Genetics and Cell
Biology, University of Chicago, Illinois: The effect of mitotic
gene conversion on the number of Ty elements in yeast.
Jinks-Robertson, S., Petes, T.D., Dept. of Molecular Ge-
netics and Cell Biology, University of Chicago, Illinois: Re-
combination between repeated genes in S. cerevisiae.
Wallis, J.W., Chrebet, G., Beniaminovitz, A., Rothstein, R.,
Dept. of Human Genetics and Development, Columbia
University College of Physicians & Surgeons, New York,
New York: Control of delta recombination.
Keil, R.L., Voelkel-Meiman, K., Roeder, G.S., Dept. of Biol-
ogy, Yale University, New Haven, Connecticut: A mitotic
recombination-stimulating activity in the ribosomal DNA of
yeast.
Sutton, P., Picologlou, S., Downs, K., Dicig, M., Kovarik, P.,
Leibman, S., Dept. of Biological Sciences, University of
Illinois, Chicago: Ty-mediated rearrangements and the ef-
fect of rad52.
White, J.H., DiMartino, J.F., Fogel, S., Dept. of Genetics,
University of California, Berkeley: Gene conversion and
postmeiotic segregation patterns in graded deletion series
at ADE8.
Blechl, A.E., Whittaker, S.G., Fogel, S., Dept. of Genetics,
University of California, Berkeley: Characterization of the
arg4-8 allele.
Maloney, D.H., Fogel, S., Dept. of Genetics, University of
California, Berkeley: Recombination and unequal cross-
ing over at a nontandem duplication of the ade8 locus in
yeast.
Fasullo, M.T., Davis, R.W., Dept. of Biochemistry, Stanford
University School of Medicine, California: Characterization
of the RAD52 dependence and the environmental induc-
tion of specific chromosome rearrangements in S. cerevis-
iae.
Vollrath, D.,' Hieter, P.,2 Davis, R.W.,"Dept. of Biochem-
istry, Stanford University School of Medicine, California;
2Dept. of Molecular Biology and Genetics, Johns Hopkins
University School of Medicine, Baltimore, Maryland: Phys-
ical mapping of chromosomal sites using orthogonal field
alternation gel electrophoresis and integrative recombi-
nation.
Schmitt, E.S., Olson, M.V., Dept. of Genetics, Washington
University School of Medicine, St. Louis, Missouri: The de-
velopment of UGA suppressor genetics for the study of
intergenic conversion in S. cerevisiae.
Rolfe, M., National Institute for Medical Research, London,
England: UV-inducible transcripts from S. cerevisiae.
Chaudhury, A., Resnick, M.A., National Institute of Environ-
mental Health Sciences, Research Triangle Park, North
Carolina: Mutants of S. cerevisiae elevated in sister chro-
matid exchange.
Nitiss, J.L.,1,3 Resnick, M.A.,1,2 Edwards, C.,3 Malone, R.,3
'Illinois Institute of Technology, Chicago; 2National Insti-
tute of Environmental Health Sciences, Research Triangle
Park, North Carolina; 3Loyola Medical Center, Maywood,
Illinois: Meiosis induced recombination in rad52 and rad57
mutants.
Nitiss, J.L.,1,2 Resnick, M.A.,2 'Illinois Institute of Technol-
ogy, Chicago; 2National Institute of Environmental Health
Sciences, Research Triangle Park, North Carolina: DNA
strand breaks in rad52 and rad57 mutants during meiosis.
Chow, T.Y.-K., Resnick, M.A., National Institute of Environ-
mental Health Sciences, Research Triangle Park, North
Carolina: Identification and characterization of a rad52 -
controlled deoxyribonuclease in S. cerevisiae.
Malone, R.E., Cramton, S., Dept. of Microbiology, Stritch
School of Medicine, Loyola University, Chicago, Illinois:
Gene conversion in the HIS2 region of S. cerevisiae.
Hoekstra, M.F., Malone, R.E., Dept. of Microbiology, Loyola
University Medical School, Maywood, Illinois: Interactions
between repair functions involved in mitotic recombina-
tion and the cloning of REM1.
Lovett, S.T., Mortimer, R.K., Dept. of Biophysics, University
of California, Berkeley: Characterization of the RAD55
gene.
Lichten, M., Borts, R.H., Haber, J.E., Rosenstiel Center,
Brandeis University, Waltham, Massachusetts: Physical
and genetic analysis of meiotic exchange between dis-
persed, homologous sequences.
Larimer, F.W., Hardigree, A.A., Biology Division, Oak Ridge
National Laboratory, Tennessee: Isolation and partial
characterization of the REV1 gene of S. cerevisiae.
Jayaram, M., Dept. of Molecular Biology, Research Institute
of Scripps Clinic, La Jolla, California: 2-micron circle-A
model substrate for gene conversion.
Bruschi, C.V.,1,3 Howe, G.A.,3 'Dept. of Microbiology,
School of Medicine, 2Dept. of Biology, East Carolina Uni-
versity, Greenville, North Carolina: Visual screen of in vivo
phenotypic expression of 2-micron site-specific recombi-
nation in the yeast S. cerevisiae.
Bishop, D.,1.2 Kolodner, R.,"Dana Farber Cancer Institute,
Boston; 2Dept. of Cellular and Developmental Biology,
Harvard University, Cambridge, Massachusetts: Mitotic
mismatch repair in vivo.
Proteau, G., Gronostajski, R., Sadowski, P., Dept. of Medical
Genetics, University of Toronto, Canada: Determination of
the minimal DNA sequences required for site-specific re-
combination catalyzed by the FLP protein of the yeast 2-
micron plasmid in vitro.
Friesen, H., Sadowski, P.D., Dept. of Medical Genetics, Uni-
versity of Toronto, Canada: Mating-type switching in an a/
a diploid.
Gene Regulation and Transcription, Part I
Heiser, TL.,2 Healy, A.M.' Zitomer, R.S.," Dept. of Biolog-
ical Sciences, State University of New York, Albany; 2Dept.
of Chemistry, State University of New York College,
Oneonta: Transcriptional start signals in the CYC7 gene.
Hahn, S., Hoar, E., Guarente, L., Dept. of Biology, Massa-
chusetts Institute of Technology, Cambridge: Multiple TATA
elements promote transcription from CYCI - Identification
of a new element that determines the site of transcription
initiation.
Pinkham, J.L., Hahn, S., Guarente, L., Dept. of Biology,
Massachusetts Institute of Technology, Cambridge: Clon-
ing and molecular analysis of the HAP2 and HAP3 loci,
global regulators of respiratory genes in S. cerevisiae.
Spevak, W., Hartig, A., Bissinger, P., Schanz, M., Ruis, H.,
Institut fOr Allgemeine Biochemie der Universitat Wien and
Ludwig Boltzmann-Forschungsstelle fur Biochemie, Vi-
enna, Austria: Heme control regions of the catalase T
(CTT1) gene of S. cerevisiae.
Van Arsdell, S.W., Stetler, G.L., Thorner, J., Dept. of Micro-
biology and Immunology, University of California, Berke-
ley: Yeast transposable element, sigma, functions as a
hormone-inducible promoter.
Sandmeyer, S.B.,1 Clark, D.J.,' Brodeur, G.M.,2 'Dept. of
Microbiology and Molecular Genetics, University of Cali-
fornia, Irvine; 2Dept. of Pediatrics and Genetics, Washing-
ton University School of Medicine, St. Louis, Missouri:
Characterization of the sigma family of transposable ele-
ments.
Kurjan, J., Dept. of Biological Sciences, Columbia Univer-
sity, New York, New York: The mfal::URA3A mutation pro-
duces a hybrid gene product that is inhibitory to a mating.
Klar, A.J.S., Kakar, S.N., Ivy, J.M., Hicks, J.R., Livi, G.P.,
Miglio, L.M., Cold Spring Harbor Laboratory, New York:
SUM/ -An apparent positive regulator of the cryptic mat-
ing-type loci in S. cerevisiae.
Lin, C.-I.P., Ivy, J.M., Klar, A.J.S., Cold Spring Harbor Labo-
ratory, New York: Isolation and analysis of suppressors of
mar2 mutations in S. cerevisiae.
Jarvis, E.,' Hagen, D.,' Clark, K.,' Sprague, G.,' Chaleff,
D.,2 'Institute of Molecular Biology, University of Oregon,
Eugene; 2E1 du Pont Co., Wilmington, Delaware: Identi-
fication of an element upstream from the a-specific STE3
gene of yeast that is sufficient for regulation by mating
type.
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Fields, S., Herskowitz, I., Dept. of Biochemistry and Biophys-
ics, University of California, San Francisco: Activators of
cell-type-specific genes.
Michaelis, S., Herskowitz, I., Dept. of Biochemistry and Bio-
physics, University of California, San Francisco: Genetic
and molecular characterization of a-factor biosynthesis.
Sternberg, P., Stern, M., Herskowitz, I., Dept. of Biochemis-
try and Biophysics, University of California, San Fran-
cisco: Mutations that allow HO expression in the absence
of swi gene products.
Holmberg, S.,' Petersen, J.G.L.,' Nilsson-Tillgren, T.,2 Kiel-
land-Brandt, M.C.," Dept. of Physiology, Carlsberg Lab-
oratory; 2lnstitute of Genetics, University of Copenhagen,
Denmark: Multivalent repression of the ILV1 and ILV5
genes of S. cerevisiae is caused by general control.
Potier, S., Souciet, J.L., Hubert, J.C., Lacroute, F, Labora-
toire de Genetique Physiologique, IMBC du CNRS, Stras-
bourg, France: Aspects of the URA2 gene of S. cerevisiae.
Crabeel, M., Devos, K., Research Institute CERIA-VUB,
Brussels, Belgium: Sequence similarities between the reg-
ulatory regions of ARG3 and newly isolated ARG1 genes.
Scherens, B.,' Messenguy, F.,2 'Dept. of Microbiologie, Vrije
Universiteit Brussels; 2lnstitut de Recherches du CERIA,
Brussels, Belgium: Nucleotide pools and amino acid pool
compartmentation in mutants affected inthe "general con-
trol" of amino acid biosynthesis.
Verschueren, K.,' Tylzanowski, P.,2 Messenguy, F.,2 Du-
bois, E.,2 'Dept. of Microbiology, Vrije Universiteit Brus-
sel; 2lnstitut de Recherches du CERIA, Brussels, Belgium:
Measurements of ARG3, ARG5-6, CPA1, and CAR1
mRNAs isolated from polysomes in S. cerevisiae.
Ramos, F.,' Dubois, E.,2 Pierard, A.,'2 'Laboratoire de Mi-
crobiologie, Universite Libre de Bruxelles; 2lnstitut de Re-
cherches du CERIA, Brussels, Belgium: Regulation of
genes LYS9 and L YS14 required for the synthesis of sac-
charopine dehydrogenase (glutamate-forming) in S. cere-
visiae.
Verschueren, K.,' Tylzanowski, P.,2 Messenguy, F.,2 Glans-
dorff, 'Dept. of Microbiologie, Vrije Universiteit
Brussel; 2lnstitut de Recherches du CERIA, Brussels, Bel-
gium: Nuclease hypersensitive sites in ARG3 chromatin.
Scherens, B.,' Messenguy, F.,2 'Microbiologie, Vrije Univ-
ersiteit Brussel; 2lnstitut de Recherches du CERIA, Brus-
sels, Belgium: Nucleotide pools and amino acid pool com-
partmentation in mutants affected in the "general control"
of amino acid biosynthesis.
Dubois, E.,' Messenguy, F.,' Descamps, F.,2 'Institut de
Recherches du CERIA, 2Microbiologie, Universite Libre
de Bruxelles, Belgium: Sense and anti-sense RNAs could
be necessary to produce the arg R II regulatory molecule.
Percival-Smith, A., Segall, J., Dept. of Biochemistry, Univer-
sity of Toronto, Canada: Mutation of SPS2, a gene prefer-
entially expressed during sporulation in S. cerevisiae, re-
sults in an asporogenous phenotype.
Greenberg, MI.,' Skvirsky, R.C.,1.2 Myers, P.L.,' Landry,
D.,' Greer, H.,' 'Dept. of Cellular and Developmental Bi-
ology, Harvard University, Cambridge; 2Dept. of Biology,
Simmons College, Boston, Massachusetts: A new nega-
tive regulatory gene (GCD5) and new positive regulatory
genes (GCN6, 7, 8, and 9) involved in the general control
of amino acid biosynthesis.
Drain, R, Schimmel, P., Dept. of Biology, Massachusetts In-
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stitute of Technology, Cambridge: A yeast locus that func-
tions in leucine biosynthesis is required for growth on ace-
tate, glycerol, or lactate as the sole carbon source.
Beltzer, J.P., Chang, L.-F.L., Hinkkanen, A., Kohlhaw, G.B.,
Dept. of Biochemistry, Purdue University, West Lafayette,
Indiana: The yeast LEU4 gene-Structure, function, and
regulation.
Benjamin, P, Wu, J.L., Mitchell, A.P, Magasanik, B., Dept.
of Biology, Massachusetts Institute of Technology, Cam-
bridge: Regulation of glutamine synthetase in S. cerevis-
iae occurs at the transcriptional level.
Braus, G., Furter, R., Prantl, F., Niederberger, R, Huetter, R.,
Mikrobiologisches Institut, Zurich, Switzerland: Expres-
sion of the TRP1 gene of S. cerevisiae.
Folch Mallol, J.L., Gonzalez, A., Centro de Investigacion
sobre Fijacien de Nitr6geno, Cuernavaca, Mexico: Ge-
netic and phenotypic characterization of a mutant of S.
cerevisiae that lacks glutamate synthase.
Sober6n, M., Gonzalez, A., Centrol de InvestigaciOn sobre
Fijacion de Nitr6ge, Cuernavaca, Mexico: Glutamine as-
similation in S. cerevisiae- Regulation of the enzymes of
the cu-amidase pathway and of a glutaminase.
Rodriguez, L., Lara, F., Sober6n, M., Gonzalez, A., Centro
de InvestigaciOn sobre Fijacion de NitrOge, Cuernavaca,
Mexico: Nitrogen distribution in a glutamate auxotroph of
S. cerevisiae.
Jund, R., Weber, E., Chevallier, M.R., Laboratoire de Gene-
tique Physiologique, CNRS, Strasbourg, France: DNA se-
quence of the uracil permease gene of S. cerevisiae.
Falco, S.C., Dumas, K.S., Ward, R.T., Dept. of Central Re-
search and Development, E.I. du Pont de Nemours and
Co., Wilmington, Delaware: Regulation of the S. cerevisiae
ILV2 gene by the general amino acid control system.
Furter, R., Prantl, F., Braus, G., Niederberger, P., Witter, R.,
Mikrobiologisches Institut, ETH-Zentrum, Zurich, Switzer-
land: Structure, expression, and regulation of the TRP4
gene of S. cerevisiae.
Harashima, S., Hinnebusch, A.G., NICHD, National Insti-
tutes of Health, Bethesda, Maryland: Isolation and char-
acterization of new gcd- mutations in the general amino
acid control of S. cerevisiae.
Keng, T., Alani, E., Guarente, L., Dept. of Biology, Massa-
chusetts Institute of Technology, Cambridge: Targeting of
HEMI-lacZ fusion proteins to the mitochondria.
Kim, K.S.,' Rosenkrantz, M.S.,2 Guarente, L.,2 'Eugene
Tech International, Allendale, New Jersey; 2Dept. of Biol-
ogy, Massachusetts Institute of Technology, Cambridge:
Two genes encode citrate synthase in the yeast S. cerevis-
iae.
Lee, G.S.-F, Ritzel, R.G., von Borstell, R.C. II, Savage, E.A.,
Bendiak, D.S., Tyler, J.M., Quah, S.-K., von Borstell, R.C.,
Dept. of Genetics, University of Alberta, Canada: Base-
sequence alterations of mutants of URA3. in S, cerevis-
iae.
Lowry, C.V., Lieber, R.H., Verbeck, J., Dept. of Biological
Sciences, State University of New York, Albany: Regula-
tion of anaerobic genes in S. cerevisiae.
Teshiba, S., Braus, R., Furter, R., Niederberger, P., HOtter, R.,
Mikrobiologisches Institut, ETH-Zentrum, Zurich, Switzer-
land: Cloning and characterization of the ARG3 gene of S.
cerevisiae.
Wang, S.-S., Brandriss, M.C., Dept. of Microbiology, UMDNJ-
New Jersey Medical School, Newark: Cloning and char-
acterization of the PUT1 gene of S. cerevisiae.
Porter, S., Smith, M., Dept. of Biochemistry, University of
British Columbia, Canada: Location of functional domains
of the MATa2 gene product.
Siliciano, R, Tatchell, K., Dept. of Biology, University of Penn-
sylvania, Philadelphia: The MATa regulatory region can
put heterologous genes under mating type control.
Rosenberg, F., Kurtz, S., Lindquist, S., Dept. of Molecular
Genetics and Cell Biology, University of Chicago, Illinois:
Gene expression during sporulation.
Wang, H.-T., Buckingham, L., Frackman, S., Jensen, L., Eas-
ton Esposito, R., Elder, R., University of Chicago, Illinois:
SP013 encodes a developmentally regulated transcript.
Easton Esposito, R., Klapholz, S., Wagstaff, J.E., Di-
Domenico, B., Frackman, S., Waddell, C.S., Jensen, L.,
Atecheson, C., Elder, R.T., University of Chicago, Illinois:
The SPO1 1 gene.
Elder, R., Malavasic, M., Frackman, S., Jensen, L., Esposito,
R.E., Dept. of Molecular Genetics and Cell Biology, Uni-
versity of Chicago, Illinois: The spol2 region contains two
sporulation genes and the transcripts from these two genes
are complementary at their 3' ends.
Fassler, J.S., Winston, F., Dept. of Genetics, Harvard Medi-
cal School, Boston, Massachusetts: Phenotypes of spt4
mutants include suppression of insertion mutations, y-ray
sensitivity, and cell lysis.
Growth Control and Cell Cycle, Part II
Nadin-Davis, S.A., Yang, R.C.A., Narang, S.A., Nasim, A.,
Molecular Genetics Section, Division of Biology, National
Research Council, Ontario, Canada: Characterization of a
RAS gene from the fission yeast Schizosaccharomyces
pombe.
Levin, D.E., Hammond, C.I., Ralston, R., Bishop, J.M., G.W.
Hooper Foundation, Dept. of Microbiology and Immunol-
ogy, University of California, San Francisco: A yeast gene
homologous to protein kinase oncogenes.
SESSION 7 GENE REGULATION II
Chairperson: F. Sherman, University of Rochester
Hampsey, D.M., Sherman, F., Dept. of Radiation Biology, and
Biophysics and Biochemistry, University of Rochester, New
York: A comparison of mutationally altered forms of yeast
ISO-1-cytochrome c to the phylogenetic series of eukary-
otic cytochromes c.
Wright, C.F., Zitomer, R.S., Dept. of Biological Sciences, State
University of New York, Albany: Point mutations in the reg-
ulatory sequences of the CYC7 gene.
Arcangioli, B., Lescure, B., Dept. of Molecular Biology, Insti-
tut Pasteur, Paris, France: Identification of proteins in-
volved in the regulation of iso-1-cytochrome c expression
by oxygen.
Hill, D.E.,'.2 Struhl, K.,' 'Dept. of Biological Chemistry, Har-
vard Medical School, Boston; 2Genetics Institute, Inc.,
Cambridge, Massachusetts: Regulation of the HIS3
gene-Single-base-pair changes within a conserved reg-
ulatory element alter HIS3 expression.
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sey: Nucleotide metabolism activities associated with the
killer virus of yeast.
Esteban, R., Wickner, R.B., NIADDK, National Institutes of
Health, Bethesda, Maryland: Two different virus-like parti-
cle types containing M, double-stranded RNA in S. cere-
visiae -One may be involved in transcription, the other in
replication.
EI-Sherbeini, M., Bostian, K.A., Division of Biology and Med-
icine, Brown University, Providence, Rhode Island: Infec-
tion of yeast protoplasts with the K1 and K2 dsRNA killer
viruses.
van Loon, A.P.G.M., Hurt, E., Biocenter, University of Basel,
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British Columbia, Canada: Functional and spatial relation-
ship between TATA sequences and transcription start sites
of the S. cerevisiae CYC1 gene.
Nam, N.G.,' Fried, H.M.,2 Depts. of 'Chemistry,
2Biochemistry, University of North Carolina, Chapel Hill:
Sequences specifying the constitutive and temperature-
sensitive transcription of ribosomal protein gene TCM1.
Giniger, E., Lamphier, M., Ptashne, M., Dept. of Biochemis-
try and Molecular Biology, Harvard University, Boston,
Massachusetts: Specific protein binding to the GAL1 pro-
moter.
Brow, D.A., Geiduschek, E.P., Dept. of Biology, University of
California, San Diego, La Jolla: Interaction of 5S ribosomal
RNA with components of a yeast cell-free polymerase III
transcription system.
Struhl, K., Dept. of Biological Chemistry, Harvard Medical
School, Boston, Massachusetts: Constitutive and regula-
tory promoters- Evidence for two distinct molecular
mechanisms.
Switzerland: Cleavable presequences of imported mito-
chondria) precursor proteins contain information for intra-
cellular targeting and for intramitochondrial sorting.
Brandriss, M.C., Krzywicki, K.A., Dept. of Microbiology,
UMDNJ-New Jersey Medical School of New Jersey, New-
ark: Targeting of two pyrroline carboxylate dehydrogen-
ase-p-galactosidase hybrid proteins to different submito-
chondrial compartments in S. cerevisiae.
Koerner, T.J., Tzagoloff, A., Dept. of Biological Sciences, Co-
lumbia University, New York, New York: Mitochondria! bio-
genesis-Nuclear mutants that affect cytochrome c oxi-
dase assembly.
Patterson, T.E., Wright, R.M., Power, S.D., Poyton, R.O.,
Dept. of Molecular, Cellular and Developmental Biology,
University of Colorado, Boulder: Comparison of the poly-
peptide and nucleotide sequences of yeast cytochrome c
oxidase subunits VIII and Vila suggests carboxyterminal
processing.
Anziano, P.O., Lanner-Herrera, C., Gerber, D., Perlman, P.S.,
Dept. of Genetics, Ohio State University, Columbus: Unst-
able revertants of mitochondrial maturaseless mutants-
Cells requiring two mutant mitochondrial genomes for res-
piratory growth.
Costanzo, M.C., Fox, TD., Section of Genetics and Devel-
opment, Cornell University, Ithaca, New York: The product
of the nuclear gene PET494 promotes translation of a spe-
cific mitochondria' mRNA.
SESSION 12 CELL STRUCTURE AND PROTEIN LOCALIZATION
Chairperson: I. Herskowitz, University of California, San Francisco
Rose, M., Fink, G.R., Whitehead Institute for Biomedical Re-
search, Massachusetts Institute of Technology, Cam-
bridge: Role of the KARI gene in the cell-division cycle.
Baum, R, Diem, K., Yochem, J., Byers, B., Dept. of Genetics,
University of Washington, Seattle: Genetic evidence for
calcium regulation of spindle pole body duplication.
Davis, TN.,' Urdea, M.S.,2 Masiarz, FR.,2 Thorner, J.,'
'Dept. of Microbiology and Immunology, University of Cal-
ifornia, Berkeley; 2Chiron Corporation, Emeryville, Cali-
fornia: Isolation of yeast calmodulin and its structural gene.
Gar low, S.J., Hospodar, M.E., Jones, E.W., Dept. of Biologi-
cal Sciences, Carnegie-Mellon University, Pittsburgh,
Pennsylvania: pep7-A gene essential for synthesis and
processing of vacuolar hydrolases.
Bohni, P.C.,1 Tekamp-Olson, P.,3 Schauer, I.,' Schekman,
R.,"Dept. of Biochemistry, University of California,
Berkeley; 2Chiron Corporation, Emeryville, California: Im-
paired proteolytic processing and secretion of invertase
mutants carrying altered signal peptide cleavage sites.
SESSION 13 GENE REGULATION III
Chairperson: A. Klar, Cold Spring Harbor Laboratory
Os ley, M.A., Gould, J., Kim, S., Kane, M., Hereford, L., Dana-
Farber Cancer Institute, Boston, Massachusetts: Negative
and positive control sites in histone gene expression.
Michels, C.A.,' Dubin, R.A.,' Perkins, E.L.,3 Needleman,
R.B.,2 'Dept. of Biology, Queens College of the City of
New York, Flushing, New York; 2Dept. of Biochemistry,
Wayne State University College of Medicine, Detroit, Mich-
igan: Characterization of a second trans-acting regulatory
element controlling maltose fermentation.
Chang, YS.,' Dubin, R.,2 Perkins, E.,' Michels, C.,2
Needleman, R.,"Dept. of Biochemistry, Wayne State
University School of Medicine, Detroit, Michigan; 2Dept.
of Biology, Queens College, Flushing, New York: MAL63
is a positive regulatory gene at the MALE locus of S. carls-
bergensis.
Pretorius, I.S.,1 Chow, T.,2 Modena, D.,2 Marmur, J.,2
'University of the Orange Free State, Bloemfontein, South
Africa; 2Albert Einstein College of Medicine, Bronx, New
York: Characterization of the glucoamylase genes of S.
diastaticus.
Riley, M.,' Hopper, J.,2 Johnston, S.,3 Dickson, R.,' 'Dept.
of Biochemistry, University of Kentucky, Lexington; 2Dept.
of Biological Chemistry, Pennsylvania State University,
Kaiser, C., Botstein, D., Dept. of Biology, Massachusetts In-
stitute of Technology, Cambridge: Mutations in the signal
sequence of invertase.
Bankaitis, V.A., Johnson, L.M., Emr, S.D., Division of Biol-
ogy, California Institute of Technology, Pasadena: Genetic
studies of the mechanism of vacuole assembly in yeast.
Stevens, T.H., Valls, L.A., Hunter, C.P., Rothman, J.H., Insti-
tute of Molecular Biology, University of Oregon, Eugene:
Identification of the localization determinants on vacuolar
proteins.
Elliott, S., Zsebo, K.M., Giffin, J.C., Koski, R., Jones, M., Bit-
ter, G.A., Amgen, Thousand Oaks, California: Heterolo-
gous protein secretion from yeast directed by the prepro-
a-factor leader region.
Fuller, R.S.,' Brake, A.J.,2 Thorner, J.,"Dept. of Microbi-
ology and Immunology, University of California, Berkeley;
2Chiron Corporation, Emeryville, California: Yeast prepro-
a-factor convertase (KEX2 gene product)-A calcium-de-
pendent, Lys-Arg-specific endopeptidase.
Hershey; 3Dept. of Botany, Duke University, Durham,
North Carolina: Involvement of GAL4 in glucose repres-
sion.
Carlson, M., Neigeborn, L., Sarokin, L., Dept. of Human Ge-
netics and Development, Columbia University College of
Physicians & Surgeons, New York, New York: Regulation
of SUC2 expression.
Taylor, Blumberg, H.,' Hartshorne, T,' Yu, J.,' Irani,
M.,' Chan, R.,3 Smith, M.,2 Young, E.,' 'Dept. of Bio-
chemistry, University of Washington, Seattle; 2Dept. of
Biochemistry, University of British Columbia, Vancouver,
Canada: Positive regulation of ADH2 expression by ADR1.
Sumrada, R., Cooper, T., Dept. of Microbiology and Immu-
nology, University of Tennessee Center for the Health Sci-
ences, Memphis: Dual regulation of the arginase gene.
Holland, M., Yip, M., Holland, J., Dept. of Biological Chem-
istry, University of California School of Medicine, Davis:
Regulation of ribosomal RNA synthesis in yeast.
Baker, S.M., Jerome, J.F, Karl, M.R., Jaehning, J.A., Dept.
of Biochemistry, University of Illinois, Urbana: The effect of
copy number and regulatory gene mutants on the tran-
scription of the GAL7 gene in vivo and in isolated nuclei.
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Molecular Genetics of Bacteria and Phages
August 20 - August 25
ARRANGED BY
Sankar Adhya, National Cancer Institute
Pablo Scolnik, Cold Spring Harbor Laboratory
324 participants
The study of prokaryotes continues to be essential for our understanding of basic
processes in molecular biology. The simplicity of the systems used and the
knowledge accumulated during the years provide a solid base for new ap-
proaches such as the study of structure-function relationships by X-ray crystal-
lography. To reflect the growth of the "non-phage" area of the meeting, the title
has been changed from Bacteriophage to the present title. However, this meet-
ing continues to be an almost unique opportunity for the interaction of scientists
from different areas of prokaryotic molecular genetics. The meeting was divided
into ten sessions covering different molecular processes and one general poster
session.
SESSION 1 TRANSPOSONS
Bourret, R.B., Fox, M.S., Dept. of Biology, Massachusetts
Institute of Technology, Cambridge: Lysogenization by
bacteriophage Mu.
Groenen, M.A.M., van de Putte, P., Laboratory of Molecular
Genetics, State University of Leiden, The Netherlands:
Analysis of the attachment sites of bacteriophage Mu us-
ing site-directed mutagenesis.
Szatmari, G.B., Kahn, J.S., Du Bow, M.S., Dept. of Microbi-
ology and Immunology, McGill University, Montreal, Can-
ada: Characterization of bacteriophage Mu and D108 in-
sertion in pSC101.
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Craigie, R., Mizuuchi, K., NIADDK, National Institutes of
Health, Bethesda, Maryland: Protein and DNA substrate
requirements for the DNA strand transfer step in transpo-
sition of bacteriophage Mu.
Miller, J.L., Chaconas, G., Depts. of Biochemistry and Micro-
biology, University of Western Ontario, London, Canada:
Identification and characterization of in vitro transposition
intermediates of Mu DNA by electron microscopy.
Chaconas, G., Giddens, E.B., Miller, J.L., Gloor, G., Depts.
of Biochemistry and Microbiology, University of Western
Ontario, Canada: A truncated form of the bacteriophage
Mu B protein promotes conservative integration but not
replicative transposition of Mu DNA.
LaRossa, R.A., Central Research and Development Dept.,
E.I. du Pont de Nemours and Co., Wilmington, Delaware:
Inhibition of transposase action by the repressor of bac-
teriophage Mu.
Craig, N.L., Arciszewska, L., McKown, R., Waddell, C., Dept.
of Microbiology and Immunology and The Hooper Re-
search Foundation, University of California, San Fran-
cisco: Transposition of Tn7.
De Long, A., Syvanen, M., Dept. of Microbiology and Molec-
ular Genetics, Harvard Medical School, Boston, Massa-
chusetts: Cellular localization of Tn5 transposase and in-
hibitor proteins is differential.
Yin, J., Krebs, M., Reznikoff, W., Dept. of Biochemistry, Uni-
versity of Wisconsin, Madison: The role of the dnaA pro-
tein in Tn5 transposition.
Salvo, J.J., Grindley, N.D.F., Dept. of Molecular Biophysics
and Biochemistry, Yale University, New Haven, Connecti-
cut: Resolvase protein bends res-site DNA.
Bhagwat, A.S., Cold Spring Harbor Laboratory, New York:
Relative frequencies of intermolecular and intramolecular
transposition for Tn3.
SESSION 2 PROMOTERS, ACTIVATORS, AND RNA POLYMERASES
Reznikoff, W.S., Peterson, M., Yu, X.-M., Dept. of Biochem-
istry, University of Wisconsin, Madison: RNA polymerase
binding sites in the /ac controlling elements.
Shanblatt, S.H., Revzin, A., Dept. of Biochemistry, Michigan
State University, East Lansing: CAP and RNA polymerase
contacts at the E. co/i galactose promoter.
Hoopes, B.C., McClure, W.R., Dept. of Biological Sciences,
Carnegie-Mellon University, Pittsburgh, Pennsylvania:
Comparison of the promoter strengths of the three cll-de-
pendent promoters of bacteriophage A.
Basu, S., Maitra, U., Albert Einstein College of Medicine,
Bronx, New York: Specific binding of bacteriophage T3
RNA polymerase to its cognate promoter requires the ini-
tiating nucleoside triphosphate (GTP).
Garges, S., Adhya, S., NCI, National Institutes of Health, Be-
thesda, Maryland: Sites of allosteric shift in the structure
of the cAMP receptor protein of E. co/i.
McKenny, K., NCI, National Institutes of Health, Bethesda,
Maryland: Relating structure to function for the cAMP re-
ceptor protein in E. coli by analysis of crp mutants.
Daniels, D.W., Bertrand, K.P., University of California, Irvine:
Overlapping To10 tet promoters compete for RNA poly-
merase.
Hunt, T., Magasanik, B. Dept. of Biology, Massachusetts In-
SESSION 3 REPRESSORS: PHAGE MORPHOGENESIS
Krause, H.M., Higgins, N.P., Dept. of Biochemistry, Univer-
sity of Alabama, Birmingham: Positive and negative regu-
lation of the Mu operator by Mu repressor and E. coil in-
tegration host factor.
Polymeropoulos, M., Majumdar, A., Adhya, S., NCI, National
Institutes of Health, Bethesda, Maryland: Mechanism of
repression of gal operon.
Bushman, FD., Anderson, J.E., Harrison, S.C., Ptashne, M.,
Harvard University, Cambridge, Massachusetts: Ethyla-
tion interference and x-ray crystallography suggest iden-
tical interactions between 434 repressor and the operator
phosphate backbone.
Maloy, S., Szymski, G., Dept. of Microbiology, University of
Illinois, Urbana: Autogenous regulation of the put ope-
ron -The putA protein is a DNA-binding protein in vitro.
Huo, L., Schleif, R., Dept. of Biochemistry, Brandeis Univer-
sity, Waltham, Massachusetts: In vivo experiments dem-
stitute of Technology, Cambridge: E. coil nitrogen regula-
tion-In vitro transcription of glnA.
Jin, D.J., Gross, C.A., Dept. of Bacteriology, University of
Wisconsin, Madison: Search for structural and functional
domains in the /3 subunit of E. coli RNA polymerase by
studying rifampicin-resistant mutations. II. Sequencing of
rife mutations.
Siegele, D.A., Hu, J.C., Gross, C.A., Dept. of Bacteriology,
University of Wisconsin, Madison: Mutations of rpoD that
change the promoter-recognition properties of E. coif RNA
polymerase.
Tobe, T, Yano, R., Yura, T., Institute for Virus Research, Kyoto
University, Japan: Extragenic suppressors of missense
and nonsense rpoH (=htpR, hin) mutations in E. coll.
Glucksmann, S., Markiewicz, P., Rothman-Denes, L.B., Dept.
of Molecular Genetics and Cell Biology, University of Chi-
cago, Illinois: DNA sequences and host factors required
for N4 virion RNA polymerase transcription.
Abravaya, K., Zehring, W., Rothman-Denes, L.B., Dept. of
Molecular Genetics and Cell Biology, University of Chi-
cago, Illinois: N4 RNA polymerase II activity-Structure
and template requirements.
onstrating that AraC protein binds to the ara/ site during
both inducing and repressing conditions.
Isackson, P.J., Bertrand, K.P., University of California, Irvine:
DNA-binding mutations in the Tn10 tet repressor.
Sternberg, N., Coulby, J.N., E.I. du Pont de Nemours and
Company, Inc., Wilmington, Delaware: Cleavage of the
bacteriophage P1 pac (packaging) site is regulated by
DNA methylation.
King, J.,Yu, M.-h., Haase, C., Siddiqui, J., Dept. of Biology,
Massachusetts Institute of Technology, Cambridge: Tem-
perature-sensitive folding mutations in gene 9 of P22.
Six, E.W.,' Sunshine, M.G.,' Lindqvist, B.H.,2 'Dept. of Mi-
crobiology, University of Iowa, Iowa City; 2lnstitute of
Medical Biology, University of Tromso, Norway: Head-size
control mutants of phage P2.
Drexler, H., Dept. of Microbiology and Immunology, Wake
Forest University Medical Center, Winston-Salem, North
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Carolina: T1pip- A mutant that affects both packaging ini-
tiation and processive packaging of T1 DNA.
Chandrasekhar, G.N.,1 Georgopoulos, C.,1 Woolford, C.,2
Hendrix, R.,2 Tilly, K.,3 'Dept. of Cellular, Viral, and Mo-
lecular Biology, University of Utah, Salt Lake City; 2Dept.
of Biological Sciences, University of Pittsburgh, Pennsyl-
vania; 3Dept. of Physiological Chemistry, University of
Wisconsin, Madison: Purification of the E. col/ groES mor-
phogenetic protein and evidence that it interacts with the
groEL protein.
SESSION 4 TRANSCRIPTION TERMINATION CONTROL
Friedman, D.I., Eades, L.J., Schauer, A.T., Carver, D.L.,
Granston, A.E., Dept. of Microbiology and Immunology,
University of Michigan Medical School, Ann Arbor: Stud-
ies on NusA protein and boxA.
Ghosh, B., Bank, S., Whalen, W., Warren, F., Wolaka, K.,
Sparkowski, J., Das, A., Program in Molecular Biology and
Biochemistry, University of Connecticut, Farmington: Ele-
ments of N-transcription antitermination system-Studies
with cell-free extracts.
Warren, F.,1 Lazinski, 5.,3 Das, A.,3 'Dept. of Molecular Bi-
ology, Princeton University, New Jersey; 2Program in Mo-
lecular Biology and Biochemistry, University of Connecti-
cut, Farmington: Analysis of a silent Rho-dependent
transcriptional terminator located beyond the N cistron of
phage lambda.
Yang, X., Goliger, J.G., Hart, C.M., Grayhack, E.J., Roberts,
J.W., Section of Biochemistry, Molecular and Cell Biology,
Cornell University, Ithaca, New York: Function of an early
pause site in antitermination by Q gene proteins of phages
lambda and 82.
Goliger, J.G., Martin, C.S., Yang, X., Roberts, J.W., Section
of Biochemistry, Molecular and Cell Biology, Cornell Uni-
versity, Ithaca, New York: Mapping a recognition site of
the late gene regulator of phage 82.
Eller, R.,1,3 Edlind, T.,' Ihler, G.,' Benedik, M.,2 Depts. of
'Medical Biochemistry, 2Biology, 3Biochemistry and Bio-
physics, Texas A&M University, College Station: Termina-
tion of transcripts mediated by gpQ product of bacterio-
phage A.
Hasan, N., Szybalski, W., McArdle Laboratory for Cancer
SESSION 5 POSTER SESSION
Polymeropoulos, M., Majumdar, A., Adhya, S., NCI, National
Institutes of Health, Bethesda, Maryland: A promoter vec-
tor for divergent transcription.
Bergs land, K., Kao, C., Green, R., Gumbs, E., Snyder, L.,
Dept. of Microbiology, Michigan State University, East
Lansing: Studies on the E. coil lit gene and its effect on T4
gene expression.
Slilaty, S.N., Rupley, J.A., Cegielska, A., Little, J.W., Dept. of
Biochemistry, University of Arizona, Tucson: Mechanism
of LexA repressor autodigestion.
Patterson, T, Sisk, W., Court, D., Laboratory of Molecular
Oncology, NCI-Frederick Cancer Research Facility, Fred-
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Bazinet, C., King, J., Dept. of Biology, Massachusetts Insti-
tute of Technology, Cambridge: Initiation complex for P22
procapsid assembly.
White, J.H., Richardson, C.C., Dept. of Biological Chemistry,
Harvard Medical School, Boston, Massachusetts: Two
phage proteins involved in processing of concatemers of
bacteriophage T7 -Gene 18 and 19 proteins.
Rennell, D., Poteete, A.R., Dept. of Molecular Genetics and
Microbiology, University of Massachusetts Medical School,
Worcester: Genetic analysis of phage lysozyme structure.
Research, University of Wisconsin, Madison: Analysis of
the coliphage A nutL antiterminator module.
Somasekhar, G., Szybalski, W., McArdle Laboratory for Can-
cer Research, University of Wisconsin, Madison: The left
boundary of the Q-utilization (qut) site required for tran-
scription antitermination in coliphage x.
Zuber, M., Honigman, A., Court, D., NCI-Frederick Cancer
Research Facility, Frederick, Maryland: Analysis of a p-de-
pendent terminator- tR, of A.
Zuber, M., Patterson, T., Court, D., NCI-Frederick Cancer
Research Facility, Frederick, Maryland: Deletion analysis
of the A boxA-nutR region.
Hyman, H.C., Honigman, A., Dept. of Molecular Genetics,
Hadassah Medical School, Jerusalem, Israel: Transcrip-
tion termination and processing sites in the A operon.
Robert, J., Gottesman, M.E., Weisberg, R.A., NCI, National
Institutes of Health, Bethesda, Maryland: nun-A phage-
encoded transcription-termination factor.
Greenblatt, J., Li, J., Goda, Y., Peritz, L., Banting and Best
Dept. of Medical Research, University of Toronto, Canada:
Structures of transcription complexes made termination
resistant at the antiterminator utilization sites (aut sites) of
the leftward early operon of bacteriophage A and the rrnB
operon of E. coli.
Sigmund, C.D., Morgan, E.A., Roswell Park Memorial Insti-
tute, Buffalo, New York: NusA-dependent antitermination
of ribosomal RNA transcription in vitro.
Stewart, V., Yanofsky, C., Dept. of Biological Sciences, Stan-
ford University, California: Transcription antitermination
control of tryptophanase gene expression in E. coil.
erick, Maryland: Role of IHF in the expression of the bac-
teriophage Mu early operon.
Pedersen, D.,' Pedersen-Lane, J.,' Herrington, M.,2 Bel-
fort, M.,"Wadsworth Center for Laboratories and Re-
search, New York State Dept. of Health, Albany; 2Dept. of
Biology, Concordia University, Montreal, Canada: Is the
thyA gene of E. coil regulated by an overlapping 5' gene?
Gruss, A., Novick, R., Public Health Research Institute, New
York, New York: Palindromic sequences are required for
plasmid maintenance in S. aureus but not in B. subtilis.
Majumder, S., Novick, R.P., Dept. of Plasmid Biology, Public
Health Research Institute, New York, New York: A unique
hypersupercoiled molecule as one of the replication prod-
ucts of plasmid pT181.
Gennaro, M.L., Kornblum, J., Novick, P.P., Dept. of Plasmid
Biology, Public Health Research Institute, New York, New
York: S. aureus plasmid pT181 encodes a site-specific re-
combination protein.
Brown, S., Fournier, M.J., Dept. of Biochemistry, University
of Massachusetts, Amherst: Mutational analysis of the 4.5S
RNA of E. coll.
Adams, T.H., Guerinot, M.L., Chelm, B.K., Michigan State
University, DOE Plant Research Laboratory, East Lansing:
Transcriptional control of nif genes in the B. japonicuml
soybean symbiosis.
Scott-Craig, J., Chelm, B.K., MSU-DOE Plant Research Lab-
oratory, Michigan State University, East Lansing: Isolation
of bacterial genes expressed during B. japonicumlsoy-
bean nodule development.
Garrity, R.R., Rutherford, T.J., McCorquodale, D.J., Dept. of
Biochemistry, Medical College of Ohio, Toledo: Apparent
identity of cmrA with trkA of E. colt, and a mechanism for
abortive infection of E. colt (Co/lb) with bacteriophage T5.
Hughes, K.T., Olivera, B.M., Roth, J.R., Dept. of Biology,
University of Utah, Salt Lake City: Transposition of defec-
tive Mu by P22 transduction is rec-dependent.
Brunelle, A., Schleif, R., Dept. of Biochemistry, Brandeis Uni-
versity, Waltham, Massachusetts: Determination of guan-
ine, cytosine, thymine, and adenine contacts between the
E. colt AraC protein and DNA of the area site.
Wilkinson, R.,' Manning, F.,2 Craven, D.,2 Hansen, P.,3
Rubin, R.,' Goldstein, R.,2 'Infectious Disease Unit, Mas-
sachusetts General Hospital, Boston; 2Dept. of Molecular
Genetics and Epidemiology, Boston University School of
Medicine; 3Cambridge Research Laboratory, Massachu-
setts: Uropathogenic E. coil- Expression and molecular
epidemiology of "virulence" factor operons.
Manning, F.," Wilkinson, R.,2 Christiansen, G.,3 Rosas, D.,'
Hansen, P,° Rubin, R.,2 Goldstein, R.,' 'Dept. of Molec-
ular Genetics and Epidemiology, Boston University School
of Medicine, Massachusetts; 2Infectious Disease Unit,
Massachusetts General Hospital, Boston; 3Dept. of Med-
ical Microbiology, Aarhus University, Denmark;
°Cambridge Research Laboratory, Massachusetts: "Viru-
lence" pili-Cloning, expression, assembly, and function.
Card, C., Croft, R., Jager, T., Moran, L., Lunnen, K.,
Nwankwo, D., Slatko, B., Wilson, G., New England Biol-
abs, Inc., Beverly, Massachusetts: Cloning, properties and
expression of restriction and modification genes.
Selick, H.E., Alberts, B.M., Dept. of Biochemistry and Bio-
physics, University of California, San Francisco: Probing
potential replication genes with a T4 insertion/substitution
vector system.
Takiff, H.E., Court, D., NCI-Frederick Cancer Research Fa-
cility, Frederick, Maryland: Characterization of E. coil
RNase III gene.
Bedwell, D.M., Nomura, M., Dept. of Biological Chemistry,
University of California, Irvine: Physiological and regula-
tory effects of increased RNA polymerase concentration
in E. colt.
Greenstein, D., Horiuchi, K., Rockefeller University, New
York, New York: Specific binding of gene II protein to the
replication origin of bacteriophage f1.
Nakamura, Y., Tsugawa, A., Institute of Medical Science,
F. Stahl, P. Scolnik
University of Tokyo, Japan: Isolation and characterization
of the conditionally lethal nusAts mutant of E. colt.
Engelberg-Kulka, H., Dekel-Gorodetsky, L., Schoulaker-
Schwarz, R., Dept. of Molecular Biology, Hebrew Univer-
sity-Hadassah Medical School, Jerusalem, Israel: In vivo
translation products of the E. colt tryptophan operon leader
region.
Lee, F.,' Kurnit, D.,1 Lagos, R.,2 Lin, C.-T.,2 Kim, S.,2 Gold-
stein, R.,2 'Genetics Division, Children's Hospital; 2Dept.
of Molecular Genetics and Epidemiology, Boston Univer-
sity School of Medicine, Massachusetts: Antagonism of
host factor p activity by plasmid P4- Construction and
characterization of a psu. aid- mutant.
Shurvinton, C.E., Stahl, M.M., Stahl, F.W., Institute of Molec-
ular Biology, University of Oregon, Eugene: A large palin-
drome in A.
Reddy, P., Peterkofsky, A., McKenney, K., National Institutes
of Health, Bethesda, Maryland: Translational efficiency of
the E. colt adenylate cyclase gene-Mutating the UUG ini-
tiation codon to GUG or AUG results in increased gene
expression.
Horabin, J.I., Webster, R.E., Dept. of Biochemistry, Duke
University, Durham, North Carolina: Interaction of the gene
I protein of the filamentous bacteriophage f1 with the bac-
terial membrane.
LaRossa, R.A., Van Dyk, T.K., Central Research and Devel-
opment Dept., EL du Pont de Nemours and Co., Wilming-
ton, Delaware: Interactions between the branched chain
amino acid and energy-generating systems of S. typhi-
murium.
Myers, J.A., Beauchamp, B.B., Richardson, C.C., Dept. of
Biological Chemistry, Harvard Medical School, Boston,
Massachusetts: Purification and characterization of gene
product 1.2 from phage T7.
Downs, D., Roth, J., Dept. of Biology, University of Utah, Salt
Lake City: Cryptic phage release after purine starvation in
S. typhimurium.
Condreay, J.P., Molineux, 1,.J., Dept. of Microbiology, Univer-
sity of Texas, Austin, Pseudorevertants of T3 mutants that
overcome F-mediated restriction.
Debouck, C., Rosenberg, M., Gross, M., Dept. of Molecular
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Genetics, Smith, Kline and French Laboratories, Swede-
land, Pennsylvania: Inhibition of gene expression from PL-
containing plasmid vectors by functions of bacteriophage
A.
Paruchuri, D.K., Harshey, R.M., Scripps Clinic and Research
Foundation, La Jolla, California: Color variation in S. mar-
cescens-Correlation with variation of a surface protein.
Kemper, B., Jensch, F, Institute of Genetics, Cologne, Fed-
eral Republic of Germany: Endonuclease VII (gp49) of
phage T4 resolves three-way junctions of recombinant
DNA intermediates in vitro.
Lopes, J.M., Lawther, R.P., Dept. of Biology, University of
South Carolina, Columbia: Genetic and molecular analysis
of an intercistronic promoter pE in the 1IvGEDA operons of
E. coil and S. typhimurium.
Hejna, J.A., Warner, R.C., Dept. of Molecular Biology and
Biochemistry, University of California, Irvine: Resolution of
G4 figure-8 dimers in extracts of E. coil.
Kameyama, L., Guarneros, G., Dept. of Genetics and Molec-
ular Biology, CINVESTAV-IPN, Mexico City, Mexico: sib in-
hibition of a A int-lacZ gene fusion.
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The second Heat Shock meeting was held at Cold Spring Harbor 3 years after
the first meeting on this subject. The 1982 meeting emphasized the generality of
the heat-shock response and the organization of the heat-shock genes, in partic-
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ular identification of regulatory signals responsible for the expression of these
genes in a wide variety of organisms, including bacteria, plants, and animals, un-
der chemical as well as environmental stress. At the 1985 meeting, the major
problems addressed were the identity of the major heat-shock proteins and their
roles in normal growth and development as well as following environmental
stress. The regulation of heat-shock gene expression continued to be a topic of
interest particularly in Escherichia coli where the gene regulating the heat-shock
response has turned out to be a unique sigma factor that alters polymerase to
recognize specifically heat-shock promotor sequences. The complexity of the
cellular response to stress was indicated by the large number of different genes
involved, including genes involved in DNA, RNA, and protein synthesis and in
protein processing and degradation. Particular attention was focused on protein
degradation as an important factor with the discovery that the Ion gene protease
of E. coli is a heat-shock protein and that ubiquitin, also associated with protein
degradation, is expressed following heat shock in vertebrates.
Attention was particularly focused on the role of the major (70K) heat-shock
protein and its normally expressed counterparts in growth and development.
Yeast mutational analysis identified several essential functions for the eight yeast
70K heat-shock genes. The abundant presence of 70K heat-shock proteins or
their homologs in early Drosophila embryos and mouse embryos also suggests a
role for these proteins in normal development. Interesting properties reported for
the eukaryotic 70K heat-shock protein include ATP binding, autoproteolytic activ-
ity, and clathrin uncoating activity. Antibodies to the major heat-shock proteins
allowed localization of the proteins in the cytoplasm and nucleus. Particularly in-
teresting was the observation that the conserved portion of the 70K protein spe-
cifically migrates to the nucleolus following heat shock and appears to speed re-
covery of normal nucleolar morphology following heat
mechanism by which heat-shock proteins might play an essential role in recovery
of protein synthesis following heat shock.
Progress in application of new information to cancer treatment was also re-
ported. Impressive results showed that the combination of heat and radiation is
three times as effective in treatment of some types of cancer as radiation treat-
ment alone. Preliminary studies on the use of synthesis of the 70K heat-shock
protein as a diagnostic tool to estimate heat sensitivity of cancer cells were also
reported.
This meeting was supported in part by the National Science Foundation.
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Louis, Missouri: Ubiquitin and the stress response.
Finley, D., Ozkaynak, E., Swerdlow, R, Varshaysky, A., Dept.
of Biology, Massachusetts Institute of Technology, Cam-
bridge: Regulatory coupling between the heat shock and
ubiquitin systems.
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SESSION 10 CLINICAL APPLICATIONS IN CANCER
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Hospital and Tumor Institute, Houston; 4Cancer and Viral
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Michigan: Hyperthermic stress proteins of metastatic tu-
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DNA Tumor Viruses: Control of Gene Expression and Replication
September 4 - September 8
ARRANGED BY
Michael Botchan, University of California
Terri Grodzicker, Cold Spring Harbor Laboratory
Phillip Sharp, Massachusetts Institute of Technology
190 participants
The DNA tumor viruses have served as model systems for the study of eukary-
otic gene expression, DNA replication, and transformation. The third Cold Spring
Harbor meeting on Cancer Cells brought together investigators who presented
their latest findings in a variety of areas. The enormous growth of this field has
T Grodzicker, B. Stillman, M. Botchan, Y. Gluzman M. Fried, A. Smith
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led to the occurrence of specialized meetings covering the work on one or two
viruses. However, the broader scope of Cancer Cells meeting included studies of
the molecular biology and biochemistry of SV40, polyoma virus, adenoviruses,
papilloma viruses, herpes simplex virus, and Epstein-Barr virus.
There was a great deal of progress in the development of in vitro systems that
are now being used to dissect crucial processes such as DNA replication; RNA
transcription and the interaction of proteins with promoter and enhancer ele-
ments; RNA processing, transcription termination, and poly(A) addition; and con-
trol of translation. The roles of viral trans-activating regulatory proteins, such as
SV40 T antigen, adenovirus El A proteins, herpesvirus immediate early proteins,
and the bovine papilloma virus E2 protein, were emphasized. These proteins af-
fect the transcriptional activity of viral and, in some cases, cellular genes, and at
least for SV40 and adenoviruses, they are also transforming proteins.
During the Cancer Cell meeting, the new Sambrook Laboratory which adjoins
James Laboratory was dedicated. This laboratory is named for Joe Sambrook,
who over the years was responsible for stimulating much of the research on DNA
tumor viruses at Cold Spring Harbor Laboratory. Joe has left his position as As-
sistant Director for Research to take up the chairmanship of the Biochemistry De-
partment at the University of Texas Health Sciences Center at Dallas. The dedica-
tory remarks were given by Renato Dulbecco, and the meeting served as a
B. Sugden
M. Yaniv, J.D. Watson C. Anderson, R. Geste land
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U. Petterson, D. Klessig
H. Westphal, E. Winocour B. Hirt
reunion for many of the scientists who had worked at Cold Spring Harbor and
returned to present their latest results.
This meeting was supported in part by the Cold Spring Harbor Laboratory
Cancer Center Grant from the National Cancer Institute, National Institutes of
Health.
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September 11 - September 15
ARRANGED BY
Robert Chanock, NIAID, National Institutes of Health
Richard Lerner, Research Institute of Scripps Clinic
Fred Brown, Wellcome Biotechnology Ltd.
259 participants
The increase in the number of participants at the highly successful third meeting
on Modern Approaches to Vaccines underscored the great interest in this topic.
As in 1984, the program included papers on viruses, pathogenic bacteria, and
parasites that cause important diseases. There were, however, two important ad-
ditions to the program. First, a complete session was devoted to a single dis-
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ease, AIDS. With one of the greatest microbiological problems of this century
confronting scientists at this time, it was considered opportune to discuss the
prospects for a vaccine against this disease. Much remains to be done on the
structure of the virus itself, despite the intensive effort that has been made in
many laboratories since the causative agent was identified. Clearly, there is still a
need to obtain information about the antigenic sites on the viral envelope glyco-
protein that are involved in protection and to determine the extent of antigenic
variation in these sites among a wide variety of field isolates.
The second session included this year was on immunology. To achieve optimal
effectiveness of new vaccines, it is necessary to reach a better understanding of
the immunological responses that provide maximal resistance to infection and
disease. The session was extremely valuable because it drew attention, quite for-
cibly at times, to how little is known about these aspects of the immune response.
The messages from the immunologists provided a salutary lesson to those who
think that the provision of an antigen in sufficient amounts is sufficient for a new
vaccine.
The meeting was held within two weeks of the deaths of three Nobel Laure-
ates, MacFarlane Burnet, John Enders, and Rodney Porter, whose contributions
to the fields of virology and immunology laid the foundations of much of the work
described in 1985. This meeting was dedicated to their memory.
This meeting was supported in part by the NIH-NIAID Intramural Research
Program, and the Wellcome Biotechnology, Ltd.
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BANBURY CENTER
DIRECTOR'S REPORT
The Banbury Center program of scientific conferences and publications
focusing on recent biological advances that have particular relevance to
environmental, regulatory, public policy, and cancer risk issues was initiated 8
years ago. Looking back over that period, a pattern of increasing program
consolidation and stabilization is discernible.
The Center's first long-term commitment was received from the Alfred P.
Sloan Foundation and was activated in 1980. This grant continues to support
workshops in the biological sciences for either science journalists or congres-
sional staff. Consolidation of targeted private sector support took place in 1984
with the establishment of the Corporate Sponsor Program of Cold Spring
Harbor Laboratory. This enables several small meetings to be held at the
Center each year in areas pertinent to gene regulation, gene expression, and
developing approaches in biotechnology. With ongoing general support from
corporate contributors, as listed separately at the end of this report, and grants
for specific projects from both federal sources and private agencies, the
Banbury Center has also been able to carry on a varied and increasingly well-
recognized series of conferences and publications. Until 1985, however, this
central program of conferences and publications addressing the scientific
underpinnings of a variety of public health, public policy, and environmental
health issues remained without a stable base of support. Thus, the awarding in
1985 of a 3-year grant in support of this core program by the James S.
McDonnell Foundation must be considered the year's single most significant
event with regard to the Center's present performance and future development.
In addition to several future programs already being organized under this grant,
Robertson House provides
housing and dining
accommodations at
Banbury Center
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McDonnell Foundation support is facilitating the successful completion of two
major present projects.
The first of these projects concerns publication of the proceedings from the
April 1985 conference entitled Origins of Female Genital Cancer. Cervical
cancer remains a major neoplastic cause of death among women worldwide.
Identification of its cause would thereby present a major step toward
understanding and potentially controlling this important neoplastic disease.
Recent advances in molecular virology, in combination with ongoing epidemio-
logical approaches, now seem to make this goal highly feasible. It was thus felt
that bringing together the virological, epidemiological, and clinical communities
concerned could be particularly useful in expediting this process. The planning
for this conference with Professor Harald zur Hausen of the German Cancer
Research Center in Heidelberg and Richard Peto of Oxford University began
early in 1984. A subsequent federal grant application review confirmed the
importance of such a project. Funding limitations, however, permitted only a
small portion of meeting costs and no publication costs at all to be covered.
Given the importance of the subject and the role that such a conference and
subsequent publication could play, the decision was made to proceed with the
project with the hope that funding to cover it would be found at a subsequent
date. McDonnell Foundation support will be of tremendous assistance in the
completion of this project.
Another program begun in 1985, which will also be receiving McDonnell
Foundation support, is that on New Aspects of Tobacco Carcinogenesis. A
September 1985 conference on this topic was organized through the joint
efforts of Dr. Dietrich Hoffmann of the American Health Foundation and Dr.
Curtis Harris of the National Cancer Institute. Representative research areas in
as well as laboratory studies in tobacco carcinogenesis were
brought together with molecular and biochemical approaches concerned with
mechanisms and assays of carcinogen-DNA interactions, cytogenetic lesions,
and host factors that may influence susceptibility. Again, excellent grant reviews
resulted in only very limited funding, and McDonnell Foundation funds will be
instrumental in the 1986 publication of these proceedings in the series of
Banbury Reports.
Meeting House, rear view
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In 1985, the number of volumes in the Banbury Reports series was brought
to 21 with the addition of three new titles. Two of these, Risk Quantitation and
Regulatory Policy and Genetic Manipulation of the Early Mammalian Embryo,
resulted from Banbury Center conferences held in 1984. The third book,
Genetically Altered Viruses and the Environment, emanated from a late April,
1985 meeting that was developed as a cooperative agreement between the U.S.
Environmental Protection Agency and the Banbury Center. Representatives from
the fields of ecological virology, clinical virology, and molecular biology, were
brought together to provide a broad perspective on the nature of this topic as
well as to delineate key research concerns for the consideration of participants
from the regulatory community.
In addition to full Banbury programs with publication in the Banbury Reports
series, four workshops were also held at the Center in 1985 as part of the
Corporate Sponsor Program. The first of these, held in March, concerned the
role of cis- and trans-acting genetic elements in the initiation of transcription in
eukaryotic cells. A related meeting in the Sponsor series was held in November,
this one addressing current research in both prokaryotes and eukaryotes on the
regulation of protein synthesis at the translational level. An earlier October
Sponsor's meeting addressed the genetics of cell-cell interactions in plants,
including the genetics of interactions with pathogens, self-incompatibility, fungal
mating types, and problems in the genetics of plant sterility. The final meeting
of the year in this series was held in December and was probably the most
visually exciting meeting to be held at the Center-its subject being the design
and use of computer graphics systems in the study of the structure and
function of biological macromolecules.
The complement of regular Banbury programs in 1985 was completed with
two workshops held under the Alfred P. Sloan Foundation grant described
above. The first of these, held in October for congressional staff, considered
scientific bases and ongoing research in the area of clinical intervention in
problems of reproduction and infertility. The topic presented for journalists
under the Sloan Foundation program concerned newly emerging approaches to
an understanding of, and intervention in, the central nervous system and its
degenerative disorders. This topic was inspired to a large extent as a result of
the utilization of the Banbury Center over the past several years as a site for
the regularly held high-level Cold Spring Harbor Laboratory summer courses in
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neurobiology. The Center was also the site, in March of 1985, of an international
workshop on the immune recognition of protein antigens and in October of a
small workshop, held in conjunction with Pioneer Hi-Bred International, Inc., on
the genetics of higher plants with emphasis on maize. Such programs, held at
the Center in addition to Banbury-originated programs, help to broaden the
dynamic and perspective of the Center, often contributing to the development of
future project concepts.
1985 Support
In addition to the James S. McDonnell Foundation grant, support from the
Alfred P. Sloan Foundation, and endowment funds for upkeep of the estate
grounds and original structures, as provided in the original donation of Charles
S. Robertson, the Center's programs were also supported in 1985 by private
sector Core Contributors, by companies enrolled in the Cold Spring Harbor
Laboratory Corporate Sponsor Program, and by federal grants.
The following contributed toward the general running of the Center as Core
Supporters in 1985: the Bristol-Myers Fund, the Chevron Fund, the Dow
Chemical Company, the Exxon Corporation, the Grace Foundation Inc., Interna-
tional Business Machines, Procter and Gamble, the Rockwell International
Corporation Trust, and the Texaco Philanthropic Foundation Inc.
Cold Spring Harbor Laboratory Corporate Sponsors, whose funds supported
four workshops at the Center in 1985, included Agrigenetics Corporation, Ameri-
can Cyanamid Company Amersham International plc, Becton Dickinson &
Company, Biogen S.A., Cetus Corporation. Ciba-Geigy Corporation, CPC Inter-
national, Inc., E.I. du Pont de Nemours & Company, Genentech, Inc., Genetics
Institute, Hoffmann-La Roche Inc., Johnson & Johnson, Eli Lilly and Company,
Mitsui Toatsu Chemicals, Inc., Monsanto Company, Pall Corporation, Pfizer
Inc., Schering-Plough Corporation, Smith Kline & French Laboratories, and the
Upjohn Company.
The 1985 conference on the Origins of Female Genital Cancer was
supported in part by a grant from the National Cancer Institute with assistance
from a contribution made by Merck, Sharp, and Dohme Research Laboratories.
The National Cancer Institute also helped to support the conference on New
Aspects of Tobacco Carcinogenesis, together with funding from the American
Cancer Society and additional support from the Office on Smoking and Health.
The U.S. Environmental Protection Agency joined in a cooperative agreement
with the Banbury Center in the organization and funding of the conference on
Genetically Altered Viruses and the Environment.
Michael Shodell
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MEETINGS
The Immune Recognition of Protein Antigens
March 3-March 6
ARRANGED BY
W. G. Laver, John Curtin School of Medical Research, Canberra, Australia
G. M. Air, University of Alabama, Birmingham
SESSION 1
Chairperson: G. M. Air, University of Alabama, Birmingham
J. Skekel, National Institute for Medical Research, London,
England: Characterization of antigenic domains on
influenza virus hemagglutinin.
SESSION 2
W. Gerhard, Wistar Institute, Philadelphia, Pennsylvania: B-
T-cell determinants on the hemagglutinin molecule of
influenza virus PR8.
Chairperson: J. Skekel, National Institute for Medical Research, London, England
I. A. Wilson, Research Institute of the Scripps Clinic, La
Jolla, California: Probing the structure and antigenic
determinants of influenza virus hemagglutinin using
antipeptide monoclonal antibodies.
SESSION 3
M.-J. Gething, Cold Spring Harbor Laboratory, New York:
Analysis of mutant and wild-type versions of influenza
virus hemagglutinin produced in different eukaryotic
systems.
Chairperson: J. Sambrook, Cold Spring Harbor Laboratory, New York
A. Caton, Wistar Institute, Philadelphia, Pennsylvania:
Sequences of monoclonal antibodies to influenza virus
hemagglutinin.
M. Weigert, Institute for Cancer Research, Philadelphia,
SESSION 4
Pennsylvania: Antibody diversity in the immune response
to influenza virus hemagglutinin.
M. D. Scharff, Albert Einstein College of Medicine, Bronx,
New York: Somatic mutations in mouse myeloma cells.
Chairperson: T. J. Braciale, Washington University School of Medicine, St. Louis, Missouri
C. Hackett, Wistar Institute, Philadelphia, Pennsylvania: Fine
specificity of antigen recognition by influenza
hemagglutinin-specific helper T cells.
SESSION 5
J. R. Lamb, Hammersmith Hospital, London, England:
Human T-cell recognition of influenza virus antigens.
Chairperson: M. Weigert, Institute for Cancer Research, Philadelphia, Pennsylvania
S. Smith-Gill, National Cancer Institute, Bethesda, Maryland:
Structure-function relationships in antibodies specific for
hen egg-white lysozyme.
SESSION 6
Chairperson: P. M. Colman, CSIRO Division of Protein Che
P. M. Colman, CSIRO Division of Protein Chemistry, Parkville,
Victoria, Australia: Three-dimensional structure of an anti-
neuraminidase Fab fragment.
D. Davies, National Institutes of Health, Bethesda, Maryland:
LaVoie, National Cancer Institute, Bethesda, Maryland: V-
region expression of antibodies specific for hen egg-
white lysozyme.
mistry, Parkville, Victoria, Australia
Crystallographic studies of antibody-antigen complexes.
R. J. Poljak, Institut Pasteur, Paris, France: Three-dimensional
structure of antigen-antibody complex.
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SESSION 7
Chairperson: E. Sercarz, University of California, Los Angeles
Y. Paterson, Scripps Clinic and Research Foundation, La
Jolla, California: Constraints in the recognition of horse
cytochrome c by monoclonal antibodies.
D. C. Benjamin, University of Virginia, Charlottesville:
Antigenic structure of a complex protein-Serum
albumin.
SESSION 9
E. Wimmer, State University of New York, Stony Brook:
Neutralization antigenic sites, antibody binding, and
peptide induction of neutralizing antibodies of poliovirus.
SESSION 8
Chairperson: R. G. Webster, St. Jude's Children's Hospital,
Memphis, Tennessee
T. J. Braciale, Washington University School of Medicine, St.
Louis, Missouri: Viral antigen recognition by cytolytic
T lymphocytes of different subsets.
A. Townsend, John Radcliffe Hospital, Oxford, England: CTL
recognition of the influenza virus nucleoprotein molecule.
C. S. Reiss, Dana-Farber Cancer Institute, Boston,
Massachusetts: Localization of restricting elements on
class I MHC molecules using antiviral CTLS.
E. Huber-Katz, Wistar Institute, Philadelphia, Pennsylvania:
T-cell responses to glycoprotein D of herpes simplex
virus.
Chairperson: P. Colman, CSIRO Division of Protein Chemistry, Parkville, Victoria, Australia
G. M. Air, University of Alabama, Birmingham: Antigenic
structure of influenza virus neuraminidase.
W. G. Laver, John Curtin School of Medical Research,
Canberra, Australia: Preparation of crystalline influenza
virus neuraminidase-antibody complexes.
SESSION 10
P Tulloch, CSIRO Division of Protein Chemistry, Parkville,
Victoria, Australia: Electron diffraction and imaging of
influenza virus neuraminidase antibody complexes.
Chairperson: D. Davies, National Institutes of Health, Bethesda, Maryland
J. A. Berzofsky, National Cancer Institute, Bethesda,
Maryland: Structural and conformation requirements for
myoglobin epitope recognition by T-cell clones-A
contrast with monoclonal antibodies.
J. Rothbard, Stanford University, Palo Alto, California: Anti-
idiotypic antibodies-Comparison of those elicited by
SESSION 11
peptides corresponding to V, regions with those
generated by the intact immunoglobulin.
J. E. Johnson, Purdue University, West Lafayette, Indiana:
Antibody binding to cowpea mosaic virus in the crystal-
line state.
Chairperson: I. A. Wilson, Research Institute of the Scripps Clinic, La Jolla, California
A. C. Bloomer, MRC Laboratory of Molecular Biology,
Cambridge, England: Segmental mobility correlates with
the location of epitopes in proteins.
M. H. V. van Rogenmortel, Institut de biologie moleculaire et
cellulaire CNRS, Strasbourg, France: Segmental mobility
in proteins and the epitopes of tobacco mosaic virus.
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D. Jackson, University of Melbourne, Australia: B- and T-
lymphocyte responses to influenza viruses, protein, and
peptides.
R. F. Anders, Royal Melbourne Hospital, Australia: Immune
recognition of tandemly repeated sequences in asexual
blood-stage antigens of Plasmodium falciparum.
The Role of cis- and trans-acting Elements in the Initiation of
Eukaryotic Transcription
March 24-March 27
ARRANGED BY
Y. Gluzman, Cold Spring Harbor Laboratory, New York
SESSION 1 VIRAL ENHANCERS
G. Khoury, National Cancer Institute, Bethesda, Maryland:
Viruses as models for eukaryotic gene regulation.
P Hearing, Rockefeller University, New York, New York:
Adenovirus enhancer elements.
M. Botchan, University of California, Berkeley: BPV enhancer
and interaction with different promoters.
J. A. Hassell, McGill University, Montreal, Canada: Dual role
of the Py virus enhancer in transcription and DNA
replication.
SESSION 2 CELLULAR PROMOTERS I
W. Schaffner, University of Zurich, Switzerland: Constitutive
and inducible enhancer elements.
R. Palmiter, Howard Hughes Medical Institute, Seattle,
Washington: Metal regulatory elements of mouse
metallothionein gene.
P Chambon, Institut de Chimie Biologique, Strasbourg,
France: Control of transcription by steroid hormones.
D. De Franco, University of California, San Francisco:
SESSION 3 TRANSGEN IC ORGANISMS
K. Arndt, Whitehead Institute for Biomedical Research,
Cambridge, Massachusetts: Cis- and trans-acting
elements in His4 gene expression in yeast.
L. Guarente, Massachusetts Institute of Technology,
Cambridge: Regulation of yeast cytochrome genes.
M. Ptashne, Harvard University, Cambridge, Massachusetts:
Regulation of the gal promoter by specific binding of gal-
4 protein, bacterial /ex protein, and a lex-gal-4 fusion
protein.
J. Hicks, Cold Spring Harbor Laboratory, New York: Reverse
enhancer controls silent mating-type cassettes.
SESSION 4 IN VITRO SYSTEMS
K. Jones, University of California, Berkeley: Gene-specific
RNA polymerase II transcription factors.
A. Berk, University of California, Berkeley: Eta protein
activation of transcription factor IIC.
A. Ephrussi, Massachusetts Institute of Technology,
Cambridge: Footprints of the immunoglobulin enhancer
in living cells and in nuclei.
R. Sen, Whitehead Institute for Biomedical Research,
Cambridge, Massachusetts: DNA elements affecting
immunoglobulin gene transcription in vitro.
P Gruss, University of Heidelberg, Federal Republic of
Germany: In vitro systems to study cell-specific
enhancers.
W. Herr, Cold Spring Harbor Laboratory, New York:
Sequence duplications that restore activity to mutated
SV40 enhancers.
A. Wildeman, Institut de Chimie Biologique, Strasbourg,
France: SV40 enhancer mutants.
P Johnson, Carnegie Institution of Washington, Baltimore,
Maryland: Interactions between cellular components and
viral enhancers.
Regulation of transcription by the glucocorticoid receptor.
M. Walker, University of California, San Francisco: Cell-
specific expression of insulin and pancreatic acinar cell
genes.
M. Fried, Imperial Cancer Research Fund Laboratories,
London, England: Use of expression selection for the
isolation of enhancer sequences.
K. Nasmyth, MRC Laboratory of Molecular Biology,
Cambridge, England: The control of HO transcription in
yeast.
E. Meyerowitz, California Institute of Technology, Pasadena:
Cis- and trans-acting factors in expression of the
Drosophila EEC glue genes.
T Maniatis, Harvard University, Cambridge, Massachusetts:
Identification of DNA sequences required for the develop-
ment and tissue-specific regulation of Drosophila ADH
gene expression.
T Maniatis, E. Ziff, W. Schaffner, P Chambon
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SESSION 5 CELLULAR PROMOTERS II
K. Zinn, Harvard University, Cambridge, Massachusetts:
Human p-interferon gene expression is regulated by an
inducible enhancer element.
S. McKnight, Carnegie Institution of Washington, Baltimore,
Maryland: Properties of the herpes virus Tk promoter.
M. Yaniv, Institut Pasteur Paris: Identification of proteins
that bind to enhancers and upstream activation sites.
N. Heintz, Rockefeller University, New York, New York:
Human histone gene regulation.
R. Treisman, MRC Laboratory of Molecular Biology,
Cambridge, England: Regulation of the human c-fos
gene.
E. Ziff, New York University Medical School, New York, New
York: Growth factor control of gene expression.
Origins of Female Genital Cancer: Virological and Epidemiological
Aspects
April 14-April 17
ARRANGED BY
H. zur Hausen, German Cancer Research Center Heidelberg, FRG, R. Peto, University of Oxford, England
SESSION 1 DESCRIPTIVE AND ANALYTIC EPIDEMIOLOGY OF CERVICAL CARCINOMA
Chairperson: L. A. Brinton, National Cancer Institute, Bethesda, Maryland
R. Peto, University of Oxford, England: Descriptive epidemi-
ology: Geographic correlates and major trends.
I. I. Kessler, University of Maryland School of Medicine,
Baltimore: Social and sexual correlates.
M. P Vessey, University of Oxford, England: Hormonal
SESSION 2 DYSPLASTIC AND PRENEOPLASTIC LESIONS
factors, tobacco, and occupation.
M. Hakama, Finnish Cancer Registry, Helsinki, Finland:
Efficacy of screening for cervical cancer.
L. A. Brinton, National Cancer Institute, Bethesda, Maryland:
Current epidemiological studies: Emerging hypotheses.
Chairperson: L. G. Koss, Montefiore Medical Center, Bronx, New York
E. Brughardt, Geburtshilflich-gynakologische Universitatskli-
nik, Graz, Austria: Classification and natural history of
cervical lesions.
R. Reid, Sinai Hospital of Detroit, Michigan: Is there a
morphological spectrum linking condylomas to cancer?
A. Meisels, Saint -Sacrament Hospital, Sainte-Foy, Quebec,
Canada: Cytology in the assessment of natural history of
cervical lesions.
W. W. Franke, German Cancer Research Center, Heidelberg,
Federal Republic of Germany: Intermediate filaments.
G. Gross, University of Freiburg, Federal Republic of
Germany: Bovenoid papillosis: A venereally transmitted
disease as reservoir for HPV16.
K. Syrjanen, Finnish Cancer Society, Kuopio, Finland:
Prospective follow-up in assessment of the biological
behavior of cervical HPV-associated dysplastic lesions.
S. Franceschi, Mario Negri Institute for Pharmacological
Research, Milan, Italy: Correlations of cervical neoplasia
with sexual factors, including specific venereal diseases.
SESSION 3 EVIDENCE CONNECTING SPECIFIC VIRUSES TO GENITAL CANCER
Chairman: W. E. Rawls, McMaster University, Hamilton, Ontario, Canada
W. E. Rawls, McMaster University, Hamilton, Ontario,
Canada: Seroepidemiological evidence about HSV
involvement.
J. K. McDougall, Fred Hutchinson Cancer Research Center,
Seattle, Washington: The enigma of viral nucleic acids in
cervical neoplasia.
J. R. Schlehofer, German Cancer Research Center
Heidelberg, Federal Republic of Germany: Interactions of
herpes simplex virus infections with host cell DNA.
L. Aurelian, University of Maryland School of Medicine,
Baltimore: General discussion.
G. Orth, Institut Pasteur, Paris, France: Plurality of human
papilloma viruses, and their involvement in skin cancer.
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L. Gissmann, German Cancer Research Center, Heidelberg,
Federal Republic of Germany: HPV DNA in preneoplastic
and neoplastic genital lesions.
D. J. McCance, Guy's Hospital Medical School, London
Bridge, England; A. Lorincz, Bethesda Research
Laboratories, Inc., Gaithersburg, Maryland: General
discussion.
E.-I. Grussendorf-Conen, Technischen Hochschule, Aachen,
Federal Republic of Germany: In situ hybridization with
papilloma virus DNA in genital lesions.
R. S. Ostrow, University of Minnesota Medical School,
Minneapolis: General discussion.
SESSION 4 MOLECULAR MECHANISMS OF HUMAN PAPILLOMA VIRUS INTERACTIONS WITH HOST CELLS
Chairperson: P. M. Howley, National Cancer Institute, Bethesda, Maryland
P M. Howley, National Cancer Institute, Bethesda, Maryland:
Molecular cloning of papilloma virus DNA.
M. Duerst, German Cancer Research Center, Heidelberg,
Federal Republic of Germany: Integration and persist-
ence of HPV DNA.
E. Schwarz, German Cancer Research Center, Heidelberg,
Federal Republic of Germany: Expression of HPV DNA in
cervical cancer biopsies and in tissue culture.
G. H. Sato, W. Alton Jones Cell Science Center, Inc., Lake
Placid, New York: Immune response to specific cervical
carcinoma antigens.
K. V. Shah, Johns Hopkins University, Baltimore, Maryland:
Detection of papilloma virus antigen and DNA in cells
and tissues.
T Broker, University of Rochester, New York: Genetic
organization and expression of human papilloma viruses. G. Orth, K. Shah
SESSION 5 PAPILLOMAVIRUS ASSOCIATIONS AND EPIDEMIOLOGICAL PERSPECTIVE
Chairperson: J. Cairns, Harvard University School of Public Health, Boston, Massachusetts
Y. S. Fu, UCLA Center for the Health Sciences, Los Angeles,
California: Stem line evolution in preneoplastic and
neoplastic genital lesions.
N. B. Atkin, Mount Vernon Hospital, Northwood, Middlesex,
England: Chromosome changes in preneoplastic and
neoplastic genital lesions.
R. Doll, Imperial Cancer Research Fund, Oxford, England:
Implications of epidemiological evidence for future
progress.
J. Cairns, Harvard University School of Public Health,
Boston, Massachusetts: How many important causes of
cervical cancer might we expect?
H. zur Hausen, German Cancer Research Center,
Heidelberg, Federal Republic of Germany: Review of
what is presently established and what remains specula-
tive in the role of viruses in human genital cancer:
Prospects for progress.
Genetically Altered Viruses and the Environment
April 28-May 1
ARRANGED BY
D. Kamely, U.S. Environmental Protection Agency, Washington, D.C.
B. N. Fields, Harvard Medical School, Boston, Massachusetts
M. A. Martin, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland
SESSION 1 LEGISLATIVE & REGULATORY FRAMEWORK
Chairperson: A. H. Teich, American Association for the
Advancement of Science, Washington, D.C.
P B. Hutt, Covington & Burling, Washington, D.C.: Existing
regulatory authority to control the products of
biotechnology.
J. G. Perpich, Meloy Laboratories, Inc., Springfield, Virginia:
The biotechnology industry: Federal regulation of product
development.
E. L. Anderson, Environmental Protection Agency, Washing-
ton, D.C.: Risk assessment/risk management of environ-
mental agents.
S. Schatzow, Environmental Protection Agency, Washington,
D.C.: The role of the Environmental Protection Agency. R. Chanock, G. Khoury
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SESSION 2 ENVIRONMENTAL VIROLOGY
Chairperson: R. L. Dixon, Environmental Protection Agency,
R. E. Shope, Yale University, New Haven, Connecticut: Viral
spread between hosts.
V. Knight, Baylor College of Medicine, Houston, Texas: Air-
borne transmission of viral infections.
T G. Metcalf, Baylor College of Medicine, Houston, Texas:
Distribution of viruses in the water environment.
SESSION 3 TROPISMS
Washington, D.C.
E. D. Kilbourne, Mt. Sinai School of Medicine, New York,
New York: Epidemiology of viruses genetically altered by
man: Predictive principles.
A. P Kendal, Centers for Disease Control, Atlanta, Georgia:
The effects of influenza virus genetic alteration on disease
in man and animals.
Chairperson: M. A. Martin, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland
R. L. Crowell, Hahnemann University, Philadelphia, Pennsyl-
vania: Cellular receptors as determinants of viral tropism.
B. Fields, Harvard Medical School, Boston, Massachusetts:
Effect of genetic manipulation on viral-receptor
interactions.
G. Khoury, National Cancer Institute, Bethesda, Maryland:
Enhancers and tissue specificity.
SESSION 4 HOST INTERACTIONS
N. Hopkins, Massachusetts Institute of Technology,
Cambridge, Massachusetts: Tropism and pathogenicity of
retroviruses.
A. Helenius, Yale University School of Medicine, New Haven,
Connecticut: Membrane proteins in viral tropism and
pathogenicity.
Chairperson: T. C. Merigan, Stanford University School of Medicine, California
T C. Merigan, Stanford University School of Medicine,
California: Variation in viral disease manifestation in
humans related to host defenses.
R. Ahmed, University of California School of Medicine, Los
Angeles: Viral persistence-Role of viral variants and T-
cell responses.
R. C. Gallo, National Cancer Institute, Bethesda, Maryland:
SESSION 5 VIRAL VECTORS
Human T-Iymphotropic retroviruses.
B. Roizman, University of Chicago, Illinois: Genetic engineer-
ing of herpes simplex virus genomes-Virulence and
latency.
R. M. Chanock, National Institutes of Health, Bethesda,
Maryland: Human host responses to genetically altered
viruses.
Chairperson: B. Fields, Harvard Medical School, Boston, Massachusetts
B. Moss, National Institute of Allergy and Infectious
Diseases, Bethesda, Maryland: Vaccinia virus vectors.
R. C. Mulligan, Massachusetts Institute of Technology,
Cambridge: Introduction of genes into cultured cells and
whole animals using retroviral vectors.
P M. Howley, National Cancer Institute, Bethesda, Maryland:
Functions controlling papilloma virus gene expression.
J. Logan, Princeton University, New Jersey: The use of
adenovirus recombinants to study the regulation of viral
gene expression.
M. D. Summers, Texas A&M University, College Station,
Texas: The polyhedrin gene and baculovirus expression
vectors.
New Aspects of Tobacco Carcinogenesis
September 8-September 11
ARRANGED BY
D. Hoffmann, American Health Foundation, Valhalla, New York
C. C. Harris, National Cancer Institute, Bethesda, Maryland
SESSION 1 LABORATORY-EPIDEMIOLOGY STUDIES (A)
Chairperson: C. C. Harris, National Cancer Institute, Bethesda, Maryland
N. J. Haley, American Health Foundation, Valhalla, New A. H. Conney, Hoffmann-La Roche Inc., Nutley, New Jersey:
York: Uptake of smoke components. Studies on the urinary excretion of nitrosamines.
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G. Becher, National Institute of Public Health, Oslo, Norway:
Determination of exposure to PAH by analysis of urine
samples.
H. Bartsch, International Agency for Research on Cancer,
SESSION 2 LABORATORY-EPIDEMIOLOGY STUDIES (B)
Chairperson: D. Hoffmann, American Health Foundation,
K. Randerath, Baylor College of Medicine, Houston, Texas:
Detection of carcinogen-DNA adducts.
M. P Rosin (for H. F Stich), University of British Columbia,
Vancouver, Canada: Micronucleus test-Application to
tobacco uses.
P Correa, Louisiana State University Medical Center, New
Orleans: Validation of smoke exposure with the
Lyon, France: Modifiers of endogenous carcinogen
formation: Studies on in vivo nitrosation in tobacco users.
S. R. Tannenbaum, Massachusetts Institute of Technology,
Cambridge: Detection of carcinogen-protein adducts.
Valhalla, New York
SESSION 3 NEW ASPECTS OF TOBACCO CARCINOGENESIS
micronuclei test.
E. J. LaVoie, American Health Foundation, Valhalla, New
York: Mutagens in the urine of cigarette smokers.
G. Scherer. Forschungsgesellschaft Rauchen and
Gesundheit MBH, Hamburg, Federal Republic of
Germany: Endogenous formation of N-nitrosoproline in
smokers and nonsmokers.
Chairperson: P. N. Magee, Temple University School of Medicine, Philadelphia, Pennsylvania
M. B. Wise, Oak Ridge National Laboratory, Tennessee:
Chemical analysis of the major constituents in clove
cigarette smoke.
C. R. Enzell, Swedish Tobacco Company, Stockholm:
lsoprenoid flavor components of tobacco and their
formation.
H. Tjalve, Swedish University of Agricultural Sciences,
Uppsala: Perinatal metabolism and activation of tobacco
carcinogens.
K. D. Brunnemann, American Health Foundation, Valhalla,
New York: Laboratory studies on oral cancer and
smokeless tobacco.
H. Heck, Chemical Industry Institute of Toxicology, Research
Triangle Park, North Carolina: The formation of DNA-
protein cross-links by aldehyde present in tobacco
smoke.
SESSION 4 NEW ASSOCIATIONS OF TOBACCO USE AND CANCER RISK
Chairperson: W. Winkelstein, Jr., University of California, Berkeley
W. Winkelstein, Jr., University of California, Berkeley:
Cigarette smoking and cancer of the uterine cervix.
P Correa, Louisiana State University Medical Center, New
Orleans: The passive smoking-cancer controversy.
D. M. Winn, National Cancer Institute, Bethesda, Maryland:
Snuff dipping and cancer.
S. D. Stellman, American Cancer Society, New York, New
York: Interactions of tobacco with occupational and
dietary risk factors.
SESSION 5 BIOCHEMICAL, CELLULAR, AND MOLECULAR STUDIES ON HUMAN TISSUES AND CELLS
Chairperson: A. H. Conney, Hoffmann-La Roche Inc., Nutley, New Jersey
I. Parsa, Downstate Medical Center, Brooklyn, New York:
Transformation of human cells by N-nitroso compounds.
S. S. Hecht, American Health Foundation, Valhalla, New
York: Carcinogenic nitrosamines-Recent studies on
metabolic activation of tobacco-specific nitrosamines-
Prospects for dosimetry in humans.
H. N. Autrup, University of Copenhagen, Denmark: Carcino-
genic PAH-Metabolism and DNA binding.
R. Grafstrom, Karolinska Institute, Stockholm, Sweden:
Effects of tobacco-smoke-related aldehydes on DNA,
DNA repair, and N-nitroso compound-induced
mutagenesis.
C. C. Harris, National Cancer Institute: Role of oncogenes in
human respiratory carcinogenesis.
A. E. Pegg, Pennsylvania State University: Factors influenc-
ing activity of O6- alkylguanine -DNA alkyltransferase.
F. A. Be land, National Center for Toxicological Research:
Aromatic amines and tobacco carcinogenesis.
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The Genetics of Plant Cell/Cell Interactions
October 1-October 4
ARRANGED BY
R. L. Malmberg, University of Georgia, Athens
SESSION 1 SELF-INCOMPATIBILITY
M. L. Crouch, Indiana University, Bloomington: Introduction.
D. J. Ockendon, National Vegetable Research Station,
Warwick, England: Genetics and physiology of self-
incompatibility in Brassica.
H. G. Dickinson, University of Reading, England: The
cytophysiological basis of the sporophytically controlled
cell-incompatibility mechanism operating in Brassica.
S. Brown, Indiana University, Bloomington: Self-
incompatibility in the evening primrose, Oenothera
organensis.
SESSION 2 MATING TYPES
R. L. Malmberg, University of Georgia, Athens: Introduction.
P Collin-Osdoby, Washington University, St. Louis, Missouri:
Ch/amydomonas reinhardi mating-type-specific
agglutinins.
R. C. Ullrich, University of Vermont, Burlington: Mating type
in the basidiomycete Schizophyllum commune.
SESSION 3 CELL INTERACTIONS AND DEVELOPMENT
I. Sussex, Yale University, New Haven, Connecticut: Graft
chimeras and the analysis of positional differentiation in
plants.
D. Walker, University of California, Los Angeles: The control
of positional cell differentiation.
SESSION 4 HOST/PARASITE INTERACTIONS
A. H. Ellingboe, University of Wisconsin, Madison: Introduc-
tion to genetic patterns in host-parasite interactions.
A. P Roelfs, University of Minnesota, St. Paul: The Puccina
graminis-Triticum sp. pathogen host interaction.
N. Panopoulos, University of California, Berkeley: Clustering
and conservation of genes controlling the interactions of
Pseudomonas syringae pathovars with plants.
M. J. Daniels, John Inner Institute, Norwich, England:
Molecular genetical analysis of the pathogenicity of
Xanthomonas campestris.
W. R. Bushnell, University of Minnesota, St. Paul: The role of
the haustorium-host interface in host-parasite recognition.
V. M. Morales, University of Wisconsin, Madison: Genetics of
avirulence in Pseudomonas solanacearum.
D. Mills, Oregon State University, Corvallis: Cloning and
characterization of pathogenicity determinants from
phytopathogenic pseudomonads.
D. W. Gabriel, University of Florida, Gainesville: Specific
avirulence genes from Xanthomonas malvacearum.
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D. Mulcahy, University of Massachusetts, Amherst: Pollen-
style interaction.
J. Mascarenhas, National Science Foundation, Washington,
D.C.: Genes expressed during pollen development.
M. Anderson, University of Melbourne, Australia: Molecular
cloning cDNA for a stylar glycoprotein associated with
expression of self-incompatibility in Nicotiana alata.
J. B. Nasrallah, Cornell University, Ithaca, New York: S-gene
expression in pollen and stigma of Brassica.
M. Anderson, A.E. Clarke, R. Malmberg
B. Staskawicz, University of California, Berkeley: Molecular
genetics of race-specific avirulence genes in Pseudomo-
nas syringae pv. glycinea.
A. Kerr, University of Adelaide, Australia: A possible method
to clone a plant gene for disease resistance.
T T Egelhoff, Stanford University, California: Rhizobium
modulation gene products and gene regulation.
M. P Gordon, University of Washington, Seattle: Control of
expression of foreign genes in plants.
0. C. Yoder, Cornell University, Ithaca, New York: Molecular
technology for studying fungus/plant interactions.
N. T. Keen, University of California, Riverside: Pectic
enzymes, a role in specificity?
M. Essenberg, Oklahoma State University, Stillwater:
Sesquiterpenoid phytoalexins and response of cotton to
Xanthomonas campestris pv. malvacearum.
R. Rohringer, Agriculture Canada Research Station,
Winnipeg: Surface macromolecules in the intercellular
space of stem rust-infected wheat leaves.
Congressional Workshop on 'New Reproductive Technologies'
October 9-October 11
ARRANGED BY
M. Shodell, Banbury Center, Cold Spring Harbor Laboratory, New York
SESSION 1
F. Naftolin, Yale University School of Medicine, New Haven,
Connecticut: Overview of reproductive physiology and
development.
SESSION 2
J. E. Buster, L. A. Country Harbor/UCLA Medical Center,
Torrance, California: Embryo transfer.
C. T. Caskey, Baylor College of Medicine, Houston, Texas:
Antenatal monitoring.
SESSION 3
G. D. Hodgen, Eastern Virginia Medical School, Norfolk:
Research approaches.
K. J. Ryan, Brigham and Women's Hospital, Boston,
Massachusetts: Research goals.
Translational Control
A. DeCherney, Yale University School of Medicine, New
Haven, Connecticut: In vitro fertilization.
November 3-November 6
ARRANGED BY
M. B. Mathews, Cold Spring Harbor Laboratory, New York
SESSION 1 INITIATION FACTORS
Chairperson: W. C. Merrick, Case Western Reserve University, Cleveland, Ohio
W. C. Merrick, Case Western Reserve University, Cleveland,
Ohio: Binding of initiation factors to mRNA.
M. J. Clemens, St. George's Hospital Medical School,
London, England: The role of phosphorylation of elF-2a
in translational regulation in nonerythroid cells.
R. L. Malts, Massachusetts Institute of Technology,
Cambridge, Massachusetts: The phosphorylation of elF-
2a and the role of the 60S subunit in translational
control.
R. Kaempfer, Hebrew University-Hadassah Medical School,
SESSION 2 METABOLIC EFFECTS
Chairperson: J. W. B. Hershey, University of California, Davis
R. J. Jackson, University of Cambridge, England: Heat
shock and hypertonic shock of L cells-Properties of the
Jerusalem: Energy metabolism and elF-2 activity.
R. Panniers, University of Rochester Cancer Center, New
York: Regulation of translation through modulation of
energy charge, intracellular calcium level, elF-2
phosphorylation, and elF-4F activity.
J. W. B. Hershey, University of California, Davis: The role of
initiation factor covalent modifications in translational
control-Variable phosphorylation of elF-2, elF-4B, and
elF-4F.
cell-free systems, and rescue by reticulocyte lysate
components.
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C. Baglioni, State University of New York, Albany: Heat-
shock proteins and interferon.
S. Lindquist, University of Chicago, Illinois: Translational
control in the heat-shock response.
A. Colman, University of Warwick, Coventry, England:
Translational control of heat-shock expression in Xenopus
oocytes-Factors influencing the translation of synthetic
SESSION 3 RNA EFFECTS
mRNAs in Xenopus oocytes.
J. D. Richter, Worcester Foundation for Experimental Biology,
Shrewsbury, Massachusetts: RNA binding proteins in
Xenopus oocytes.
R. E. Thach, Washington University, St. Louis, Missouri:
Effect of secondary structure on the translation of
eukaryotic mRNA and its unwinding by initiation factors.
Chairperson: A. J. Shatkin, Roche Institute of Molecular Biology, Nutley, New Jersey
M. Kozak, University of Pittsburgh, Pennsylvania: Selection
of translational start sites in eukaryotic mRNAs.
F Sherman, University of Rochester School of Medicine and
Dentistry, New York: Rules of translation in yeast-Studies
with mutant forms of the CYCI gene.
H. De Boer, Genentech, Inc., South San Francisco, California:
Manipulating the ribosome and its mRNA binding site in
E. coli-Redirecting ribosomes to a single mRNA
species.
SESSION 4 VIRAL SYSTEMS
P Green, Rockefeller University, New York, New York: Use of
artificial micRNA for regulating a specific gene.
S. Sarkar, Boston Biomedical Research Institute,
Massachusetts: A novel cytoplasmic translation inhibitory
RNA of chick embryonic muscle-Possible role in
myogenesis as antimessenger RNA.
P Walter, University of California, San Francisco: Elongation
control by signal recognition particle.
Chairperson: M. B. Mathews, Cold Spring Harbor Laboratory, New York
J. Siekierka, Merck, Sharp & Dohme Research Laboratories,
Rahway, New Jersey: Translational control by
adenovirus-VA RNA1 prevents activation of host double-
stranded RNA activated protein kinase during viral
infection.
R. J. Schneider, New York University Medical Center, New
York: Function of adenovirus VA RNAs.
R. M. Krug, Memorial Sloan-Kettering Cancer Center, New
York, New York: Translational control by influenza virus.
SESSION 5 COMPLEX AND DEVELOPMENTAL SYSTEMS
Chairperson: T. Hunt, University of Cambridge, England
T Hunt, University of Cambridge, England: Control of protein
synthesis at fertilization of marine invertebrate eggs and
oocytes.
M. Nomura, University of California, Irvine: Translational
control of ribosomal protein synthesis in Escherichia coli.
A. G. Hinnebusch, National Institute of Child Health and
Human Development, Bethesda, Maryland: Translational
control of the positive regulator of amino acid
biosynthetic genes in yeast.
J. L. Moller, University of Colorado School of Medicine,
Denver: Regulation of phosphorylation of ribosomal
protein S6.
D. F Klessig, Rutgers University, Piscataway, New Jersey:
Translational regulation of light-induced ribulose
bisphosphate carboxylase gene expression in amaranth.
D. L. Kirk, Washington University, St. Louis, Missouri: Transla-
tional regulation of protein synthesis and the onset of
cytodifferentiation in Vo/vox.
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E. Ehrenfeld, University of Utah School of Medicine, Salt
Lake City: Control of protein synthesis in poliovirus-
infected cells.
N. Sonenberg, Whitehead Institute, Cambridge,
Massachusetts: Involvement of eukaryotic cap binding
protein complex in translational control in uninfected cells
and cells infected with poliovirus.
J. M. Lucas-Lenard, University of Connecticut, Storrs:
Control of protein synthesis in virus-infected cells.
M. Mathews, R. Malts
Journalists' Workshop on Research and Clinical Perspectives in
the Central Nervous System
December 5-December 7
ARRANGED BY
M. Shodell, Banbury Center, Cold Spring Harbor Laboratory, New York
SESSION 1
I. Black, Cornell University Medical College, New York, New
York: An introduction to the nervous system and its
diseases.
SESSION 2
L. Olson, Karolinska Institute, Stockholm, Sweden: Transplan-
tation of brain tissue.
A. J. Aguayo, Montreal General Hospital, Canada: The
regenerative powers of the nervous system.
SESSION 3
M. Mishkin, National Institutes of Health, Bethesda,
Maryland: Experimental approaches to the biological
bases of thought and memory.
Roundtable Discussion: Clinical pressures and research
perspectives in brain function.
Computer Graphics and Molecular Modelling
December 10-December 13
ARRANGED BY
M. Zoller, Cold Spring Harbor Laboratory, New York
R. Fletterick, University of California, San Francisco, School of Medicine
SESSION 1
R. Fletterick, University of California, San Francisco, School
of Medicine: Opening remarks.
J. Greer, Abbott Laboratories, Abbott Park, Illinois: Compara-
tive modeling of blood complement proteins.
C. Chothia, MRC Laboratory of Molecular Biology,
Cambridge, England: The use of sequence homologies
to predict protein structures.
SESSION 2
R. Langridge, University of California, San Francisco: The
future of computer graphics.
T Ferrin, University of California, San Francisco: Hardware
and software status report from the UCSF Computer
Graphics Laboratory.
B. W. Erickson, Rockefeller University, New York, New York:
Betabellin-An engineered protein.
J. E. Anderson, Harvard University, Cambridge,
Massachusetts: Fitting 434 repressor-operator complex
with FRODO.
R. E. Hubbard, University of York, England: Hydra-Current
and future development.
M. E. Pique, University of North Carolina, Chapel Hill:
Technical trends in molecular graphics.
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SESSION 3
C.-I. Branden, University of Uppsala Biomedical Center,
Sweden: Structural principles of active sites in protein
domains.
D. Eisenberg, University of California, Los Angeles:
Hydrophobic moments and solvation energy in protein
folding.
P. Argos, European Molecular Biology Laboratory,
SESSION 4
D. Tronrud, University of Oregon, Eugene: Computer
graphics and its application to the structure and function
of biological macromolecules.
R. J. Feldmann, National Institutes of Health: Thoughts on
the use of parallel computers in molecular graphics.
H. Dayringer, Monsanto Company, St. Louis, Missouri:
Proteus-Graphics software for proteins.
W. Taylor, Birkbeck College, London, England: Prediction of
protein structure from amino acid sequence using
computer graphics and data bases.
T A. Jones, University of Uppsala Biomedical Center,
Sweden: On making use of known protein structures in
macromolecular modeling.
SESSION 5
R S. Stern, Weizmann Institute of Science, Rehovot, Israel:
Normal-mode dynamics-Energy calculations, interactive
graphics, and movies.
M. Karplus, Harvard University, Cambridge, Massachusetts:
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Heidelberg, Federal Republic of Germany: Searching for
weak sequence homologies and testing for their
significance.
W. F. DeGrado, E. I. du Pont de Nemours & Company,
Wilmington, Delaware: The molecular basis for the
fusogenic activity of influenza hemagglutinin.
M. Zoller, ad. Branden, J. Anderson
Dynamics of macromolecules.
A. Hagler, Agouron Institute, La Jolla, California: Conforma-
tionally based design of gonadotropin-releasing hormone
and antagonists.

Recto: Under the tutelage of staff scientist Steve Dellaporta (left), undergraduate researcher
Mark Alfenito learns the subtleties of maize transposable elements.
Postgraduate Courses
The summer program of Postgraduate Courses at Cold Spring Harbor Laboratory
is aimed at meeting the special need for training in interdisciplinary subjects that
are either so new or so specialized that they are not adequately treated by
universities. Our aim is to provide intensive study in the most recent developments
and techniques in these subjects and to prepare students to enter directly into
research in a particular area. To ensure up-to-date coverage of current research
work, we bring together a workshop staff from many laboratories around the world
and supplement this staff with a series of seminar speakers.
Molecular Neurobiology of Human Disease
June 7-June 17
INSTRUCTORS
Breakefield, Xandra 0., Ph.D., E.K. Shriver Center and Harvard Medical School, Boston,
Massachusetts
Black, Ira B., M.D., Cornell University Medical College, New York, New York
Gusella, James F., Ph.D., Massachusetts General Hospital and Harvard Medical School,
Boston
This intensive seminar course explored the molecular and cellular basis of
abnormal neural function. It focused on basic scientific studies that have provided
insight into the etiology and pathogenesis and neurologic and psychiatric
diseases. Topics included: (1) molecular pathology of neurotransmitter derange-
ment; (2) developmental plasticity and choice of neurotransmitter phenotype; (3)
synthesis and regulation of neuropeptides; (4) cellular events in neural regenera-
tion and brain transplantation; (5) neural pathways involved in pain syndromes; (6)
genetic linkage analysis using DNA polymorphisms; (7) defects in DNA repair and
activation of one genes; (8) biochemistry of the lipidoses; (9) autoimmune
diseases; (10) brain imaging and metabolism; (11) epilepsy and seizure disorders;
(12) cell death in degenerative disorders; (13) viral infections of the nervous system;
and (14) experimental models of learning and memory.
PARTICIPANTS
Anthony, Donna T, B.S., Rockefeller University, New York,
New York
Bissette, Garth, Ph.D., Duke University, Durham, North
Carolina
Blum, Andrew, B.A., Rockefeller University, New York, New
York
Buck, Charles R., B.S., Cornell University, Ithaca, New York
Chu, Dorothy C., B.S., University of Michigan, Ann Arbor
Denney, Richard M., Ph.D., University of Texas, Galveston
Donnenfeld, Hyman, M.D., St. Vincent's Hospital, New York,
New York
Farrer, Lindasy A., Ph.D., Riley Hospital, Indiana University,
Indianapolis
Goodman, Gay, Ph.D., E.K. Shriver Center, Boston,
Massachusetts
Gorevic, Peter, State University of New York, Stony Brook
Gray, Patrick W., Ph.D., Genetech, Inc., South San Francisco,
California
Hishinuma, Akira, M.D., Columbia University, New York, New
York
Kaufman, Daniel L., B.S., University of California, Los
Angeles
Knopf, John L., Ph.D., Genetics Institute, Cambridge,
Massachusetts
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Lark, Lisa A., B.A., University of Illinois, Urbana
Lee, James E., M.D., Duke University, Durham, North
Carolina
Lyerla, Timothy A., Ph.D., Clark University, Worcester,
Massachusetts
MacDonald, Marcy, Ph.D., Massachusetts General Hospital,
Boston
Powell, John F., Ph.D., CNRS, Paris, France
Rimvall, Karin, M.D., Zurich University, Switzerland
Taylor, Anne J., B.S., Boston University Medical School,
Massachusetts
Tres ley, Richard M., University of Chicago, Illinois
Trumper, Maria J., Yale School of Medicine, New Haven,
Connecticut
SEMINARS
Black, I., Cornell University Medical School. Pathology of
neurotransmitter disorders.
Breakefield, X., Shriver Center and Harvard Medical School.
Molecular genetic approaches to neurologic diseases.
Gusella, J., Massachusetts General Hospital and Harvard
Medical School. Linkage analysis using recombinant
DNA technology in Huntington's disease.
Breakefield, X., Shriver Center and Harvard Medical School.
Molecular genetic studies of familial amyloid
polyneuropathies.
Ginns, E., National Institutes of Health, and E. Kolodny,
Shriver Center and Harvard Medical School. Molecular
approaches to the lipidosis.
Schwab, M., University of California, San Francisco and W.
Benedict, Children's Hospital, Los Angeles. Oncogenes in
neural tumors.
MoNamar, J., Duke University, and P Schwartzkroin,
University of Washington Medical School. Epilepsy and
seizure disorders.
Caskey, T, Baylor College of Medicine. Molecular lesions in
the Lesch-Nyhan syndrome.
Breakefield, X., Shriver Center and Harvard Medical School.
Deficiencies in DNA repair and metal ion transport that
affect the nervous system.
Raminsky, M., Montreal General Hospital. Neural
regeneration.
Raichle, M., Washington University School of Medicine. Brain
metabolism and imaging.
Wexler, N., Columbia University School of Medicine. Hunting-
ton's disease in Venezuela.
Black, I., Cornell University Medical School. Development,
plasticity, and transmitter phenotype.
Mishkin, M., National Institute of Mental Health. Learning
and memory: Primate models.
Gage, F, University of California, San Diego. Brain
transplantation.
Scheller, R., Stanford University. Genes, polyproteins, and
behavior.
Fields, H., University of California, San Francisco, and
A. Light, University of North Carolina. Pain and
neuropeptides.
Lindstrom, J., Salk Institute. Autoimmune diseases: Myasthe-
nia gravis.
Haase, A., University of Minnesota, and K. Typer, Harvard
Medical School. Viral infections of the nervous system.
Gajdusek, C., National Institutes of Health. Slow viruses and
their molecular pathology.
Immunoglobulins: Molecular Probes of the Nervous System
June 7-June 27
INSTRUCTORS
Hockfield, Susan, Ph.D., Cold Spring Harbor Laboratory, New York
Silberstein, Laura, Ph.D., Stanford University, California
Evans, Christopher, Ph.D., Stanford University, California
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Over the last decade, antibodies have become powerful and popular reagents in
neurobiological research. This course, intended for research scientists of all levels,
was designed to provide an advanced understanding of the power and limitations
of immunoglobulins both as biochemical and anatomical reagents. Through
laboratory work and lectures, we explored immunochemical and
immunohistochemical techniques in detail and the application of these techniques
to current issues in neurobiology.
The laboratory work included: generation of monoclonal antibodies; preparation
and characterization of antibodies to synthetic peptides and to complex antigens;
solid-phase immunoassays; antibody characterization and purification; antigen
purification using antibody affinity methods; Western blotting; antibody conjuga-
tion; biochemical characterization of neuropeptides using RIA; light and electron
microscopic immunohistochemistry using peroxidase, fluorescence, and biotin-
avidin techniques; and methods for the colocalization of multiple antibodies.
A series of lectures by invited speakers covered: structure and function of
immunoglobulins; molecular genetics of antibody diversity; cellular regulation of
the immune response; hybridoma technology; studies using synthetic peptides;
immunlogical characterization of the acetylcholine receptor and the neuromuscular
junction; and immunological characterization of cellular diversity in vertebrate and
invertebrate nervous systems and in cell culture.
PARTICIPANTS
Balak, Kenneth J., Ph.D., University of Utah, Salt Lake City
Barrel, Barbara A., M.D., Harvard Medical School, Boston,
Massachusetts
Bug, William J., B.S., Columbia University, New York, New
York
Burd, Gail D., Ph.D., Rockefeller University, New York, New
York.
Fels, Gregor, Ph.D., Max-Planck Institut, Munich, Federal
Republic of Germany
Grothe, Claudia, Ph.D., Philipps-University Marburg, Federal
Republic of Germany
Gumaraes, Aurea, Ph.D., Universidade Federal Fluminense,
Rio de Janiero, Brazil
Mobbs, Charles Vernon, Ph.D., Rockefeller University, New
York, New York
Sagen, Jacqueline, Ph.D., University of Illinois, Urbana
Shiurba, Robert, Ph.D., Stanford University, California
SEMINARS
Steiner, L. Massachusetts Institute of Technology. Antibodies
and the immunoglobulin super family.
Woodland, R., University of Massachusetts Medical School.
Cellular immunology.
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. B cell function.
Rau let, D., University of Massachusetts Medical School.
T-cell biology and specificity.
Giorgi, J., University of Massachusetts. Flow cytometry and
cell sorting.
Evans, C., University of California, Stanford. RIA.
Pintar, J., Columbia University. Gene expression and peptide
processing during pituitary development.
Lindstrom, J., Salk Institute. Use of monoclonal antibodies to
study acetylcholine receptors and myasthenia gravis.
Matthew, B., Harvard Medical School. Immunological studies
of nerve regeneration.
Kindt, T, National Institutes of Health. Molecular biology of
immunoglobulin synthesis.
Alt, F, Columbia University. Molecular biology of antibody
diversity.
Heitman, D., Cold Spring Harbor Laboratory. Antibodies in
molecular cloning.
Rosenberg, L., Stanford Medical School. Immunocytochemi-
cal localization of single and dual antigens in brain.
Davies, D., National Institutes of Health. Three-dimensional
structure of immunoglobulins.
Scharff, M., Albert Einstein College of Medicine. Somatic
mutation in antibody-producing cell lines.
Advanced Techniques in Molecular Cloning
June 7-June 27
INSTRUCTORS
Mark Zoller, Ph.D., Cold Spring Harbor Laboratory, New York
Atkinson, Tom, B.S., University of British Columbia, Vancouver, Canada
Brosius, Jurgen, Ph.D., Columbia University, New York, New York
MacDonald, Ray, Ph.D., University of Texas Health Science Center, Dallas
ASSISTANTS
Williamson, Vicki, Imperial College, London, England
Swift, Galvin, University of Texas Health Science Center, Dallas
This was a laboratory and lecture course on advanced aspects of molecular
cloning designed for scientists who are familiar with basic recombinant DNA
techniques. It included the chemical synthesis of oligodeoxyribonucleotides of
defined sequence and their characterization by the Maxam-Gilbert sequencing
method. These oligonucleotides were used in various ways, including their use as
probes for the isolation of specific genes from libraries and as reagents for
directing site-specific in vitro mutagenesis. Specific mutants were isolated, and the
sequence of the altered genes was determined. Other methods of in vitro
mutagenesis such as nucleotide misincorporation into DNA, sodium bisulfate
treatment of DNA, and linker insertion were covered in both laboratory exercises
and lectures.
Guest lectures and demonstrations covered the application of these techniques
to analysis of various cloned genes, as well as the use of alternate methods of
mutagenesis, expression, and analysis of cloned genes by immunological
screening.
PARTICIPANTS
Birnbaum, Morris J., M.D., Ph.D., Memorial Sloan-Kettering
Cancer Center, New York, New York
Freund, Erwin, Ph.D., Roche Institute, Nutley, New Jersey
Knight, Regina, M.S., National Institutes of Health, Bethesda,
Maryland
Kolakowski, Lee Franklin, Jr, B.S., University of Pennsylvania,
Philadelphia
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Nagel, Julianne, Ph.D., University of Kentucky, Lexington
O'Halloran, Thomas V., Ph.D., Massachusetts Institute of
Technology, Cambridge
Ohlrogge, John B., Ph.D., USDA Northern Regional
Research Center, Peoria, Illinois
Paddock, Mark L., M.S., University of California, San Diego
Reed, John C., B.A., University of Pennsylvania, Philadelphia
Risuleo, Gianfranco M., Ph.D., Karolinska Institute,
Stockholm, Sweden
Schulman, La Donne, Ph.D., Albert Einstein School of
Medicine, Bronx, New York
Sheares, Bradley T., Ph.D., Massachusetts Institute of
Technology, Cambridge
Siminovitch, Katherine Anne, M.D., Toronto Western Hospital,
Canada
Vernick, Kenneth D., M.S., National Institutes of Health,
Bethesda, Maryland
SEMINARS
Urdea, M., Chiron Corp. Gene synthesis.
Fiddes, J., California Biotechnology, Inc. Structure and
expression of atrial natriuretic factor genes.
Russell, D., University of Texas Health Science Center. The
LDL receptor gene: A mosiac of axons assembled from
other genes.
Sutcliffe, J. G., Scripps Clinic and Research Institute. Cloning
messenger RNA from the brain.
Molecular Biology of Plants
Ullrich, A., Genetech. cDNA approaches.
Noller, H., University of California, Santa Cruz. Probing the
structure and function of large ribosomal RNAs.
Young, R., Massachusetts Institute of Technology.
Immunoscreening of X 6TII recombinant DNA expression
libraries.
Wharton, R., Harvard University. Defining the DNA-binding
surface of a repressor.
Marians, K., Memorial Sloan-Kettering Cancer Center.
Mutational analysis reveals the structure of an origin of
DNA replication.
Kawasaki, G., Zymogenetics. Expression of protein in yeast.
Schatzman, A., Smith, Kline & French. Strategies for the
overproduction of heterologous gene production: Search
for the perfect E. coli system.
Smith, M., University of British Columbia. The use of
oligonucleotides as primers and probes.
June 7-June 27
INSTRUCTORS
Sussex, Ian, Ph.D., Yale University, New Haven, Connecticut
Messing, Joachim, Ph.D., University of Minnesota, St. Paul
Horsch, Robert, Monsanto Company, St. Louis, Missouri
ASSISTANTS
Kerk, Nancy, B.A., Yale University, New Haven, Connecticut
Ludwig, Steven, B.A., University of Minnesota, St. Paul
Kirihara, Julie, B.A., University of Minnesota, Saint Paul
Fry, Joyce, B.A., Monsanto Company, St. Louis, Missouri
Hauptmann, Randy, Ph.D., Monsanto Company, St. Louis, Missouri
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This course will provide an introduction to current techniques for the manipulation
of plant material as applied to experiments in genetics and molecular biology. It is
designed primarily for scientists working in other areas of molecular biology who
wish to pursue research in plants. It is assumed that applicants will have a working
knowledge of molecular techniques, but no previous experience with plants is
required. Laboratory experiments will include: plant anatomy and development,
nucleic acid isolation and manipulation from plant materials, crown gall tumorigen-
esis, cell and protoplast culture techniques, photosynthesis, genetic and
cytogenetic analysis of maize. Guest lecturers will cover both current molecular
genetic research, and also special topics in classical botany and systems unique
to plants.
PARTICIPANTS
Cannon, Maura C., Ph.D., Biotechnica International,
Cambridge, Massachusetts
Chu, Lily L., M.S., Molecular Genetics Inc., Boston,
Massachusetts
Cuozzo, Maria A., M.S., Albert Einstein College of Medicine,
Bronx, New York
De Lisle, Alice J., Ph.D., Indiana University, Bloomington
Garciarrubio, Alejandro, M.S., Nitrogen Fixation Center,
Mexico City, Mexico
Gheysen, Godelieve, M.S., University of Gent, Belgium
Golden, James W., Ph.D., University of Chicago, Illinois
Kjellbom, Per, M.S., University of Lund, Sweden
Nierzwicki-Bauer, Sandra, Ph.D., University of Chicago,
Illinois
Pang, Patty F, Ph.D., Massachusetts Institute of Technology,
Cambridge
Pedersen, Henrik, Ph.D., Rutgers University, New Brunswick,
New Jersey
Shotwell, Mark A., Ph.D., Hospital for Sick Children, Toronto,
Canada
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Singh, Arjun, Ph.D., Genetech, Inc., South San Francisco,
California
Staneloni, Roberto, Ph.D., McMaster University, Ontario,
Canada
Suzuki, Akira, Ph.D., McMaster University, Ontario, Canada
Toenniessen, Gary, Ph.D., Rockefeller University, New York,
New York
SEMINARS
Horsch, R., Monsanto Company. Tissue culture and
transformation.
Sussex, I., Yale University. Organization and development of
plants.
Gengenbach, B., University of Minnesota. Tissue-culture
systems in maize.
Phillips, R., University of Minnesota. Maize cytogenetics.
Theologis, S., Washington University. Hormone-inducible
genes.
Messing, J., University of Minnesota. Plant gene structure.
Bohnert, H., University of Arizona. Molecular biology of the
chloroplast.
Verma, D. P. McGill University. Nodulation genes in
legumes.
Shah. D., Monsanto Company. Molecular biology of
herbicide resistance.
McIntosh, L., Michigan State University. Light-inducible
genes.
Crouch, M., Indiana University. Molecular biology of seed
development.
Ma liga, P, Advanced Genetic Sciences Co. Organelle
genetics.
Levings, S., North Carolina State University. Plant mitochon-
dria) genome structure and function.
Binns, A., University of Pennsylvania. Biology of Agrobac-
terium tumafaciens.
Donner, H., Advanced Genetic Sciences Co. Controlling
elements in maize.
Computational Neuroscience
Shepherd, R., University of Kentucky. Plant DNA viruses.
Meyerowitz, E., California Institute of Technology. Molecular
genetics of Arabidopsis.
Miles, D., University of Missouri. Photosynthetic mutants in
maize.
Cashmore, T., Rockefeller University. Expression of chimeric
genes in plants.
Staskowicz, B., University of California, Berkeley. Molecular
genetics of host-pathogen interactions.
Robertson, H., Rockefeller University. Plant viroids.
Meinke, D., Oklahoma State University. Arabidopsis
development.
Wang, A., Sangene Co. Cytogenetics
Dellaporta, S., Cold Spring Harbor Laboratory. Genetics.
June 20-July 3
INSTRUCTORS
Atkeson, Christopher G., M.S., Massachusetts Institute of Technology, Cambridge
Bizzi, Emilio, M.D., Massachusetts Institute of Technology, Cambridge
Hildreth, Ellen C., Ph.D., Massachusetts Institute of Technology, Cambridge
Movshon, J. Anthony, Ph.D., New York University, New York
Computational approaches to problems in neuroscience have produced important
advances in our understanding of neural processing. The most prominent
successes have come in areas where strong inputs from neurobiological
behavioral and computational approaches can interact. This intensive lecture
course examined two areas: the visual processing of motion information, and
motor control. The theme was that an understanding of the computational
problems, the constraints on solutions to these problems, and the range of
possible solutions can help guide research in neuroscience.
The first half of the course was devoted to studies of visual motion processing.
Topics considered included 1) the anatomical and physiological organization of
motion-sensitive portions of the visual pathway; 2) the construction of motion
detectors and the directional selectivity of visual neurons; 3) analysis of the motion
of complex objects in two and three dimensions; 4) processing of optic flow
information. The second half focused on computational approaches to the study of
motor control, and their interactions with motor control neuroscience. Examples of
computational approaches were taken from 1) single- and multi-articular arm
movements; 2) body posture and locomotion and 3) grasping and utilization of
tactile information. Areas addressed were movement planning, kinematics,
dynamics, control and actuation.
PARTICIPANTS Chipalkatti, Renu, M.S., University of Massachusetts,Amherst
Barash, Shabtai, B.S., Hebrew University Medical School, Cole, Kelly J., Ph.D., University of Wisconsin, Madison
Jerusalem, Israel Dehaene, Stanislas, M.S., Eco le Norma le Superieure, Paris,
Brown, Richard, B.S., University of California, San Francisco France
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Dornay, Menashe, M.S., Weizmann Institute, Rehovot, Israel
Dupoux, Emmanuel, MS., Ecole Norma le Superieure, Paris,
France
Ewer, John, M.S., Brandeis University, Waltham,
Massachusetts
Iberall, Althea, M.S., University of Massachusetts, Amherst
Keifer, Joyce, B.S., University of Wisconsin, Madison
Kruse, Margaret, B.A., University of Minnesota, Duluth
Lackner, Klaus, Ph.D., Los Alamos National Laboratory, New
Mexico
Letelier, Juan-Carlos, M.S., City College of New York, New
York
Liestol, Knut, Ph.D., University of Oslo, Norway
Miller, Kenneth, M.S., Stanford University, California
Minor, Lloyd, M.S., University of Chicago, Illinois
Morris, Edward, B.A., University of California, San Francisco
Ohrbach, Harry, Ph.D., California Institute of Technology,
Pasadena
Reid, Robert Clay, B.S., Rockefeller University, New York,
New York
Stepnoski, R. Aaron, M.S., University of Philadelphia,
Pennsylvania
Szulborski, Robert, B.A., University of Philadelphia,
Pennsylvania
Unnikrishnan, K. F, M.S. Syracuse University, Ithaca, New
York
SEMINARS
Movshon, J. A., New York University. Historical overview of
experimental work on motion analysis.
Organization of subcortical visual pathways.
. Physiological studies of the aperture problem.
Hildreth, E. C., Massachusetts Institute of Technology. The
computational study of vision.
. Computation of the two-dimensional velocity field.
. Computational models of structure from motion.
Adelson, E. H., RCA Laboratories. Spatiotemporal energy
models for motion detection.
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. Psychophysical studies of the aperture problem.
Andersen, R., Salk Institute. Motion analysis in the posterior
parietal cortex.
Ballard, D., University of Rochester. Computational models of
motion correspondence.
. Connectionism and motion processing.
Maunsell, J., Massachusetts Institute of Technology. Separate
cortical pathways for the analysis of form and motion.
Morgan, M. J., University College London. Short-range and
long-range motion processes.
. Psychophysical tests of computational models.
Nakayama, K., Smith-Kettlewell Institute of Visual Sciences.
Psychophysical isolation of motion-sensitive mechanisms.
. The spatial integration of motion information.
. The extraction of higher-order information from the
optic flow field.
Newsome, W., State University of New York, Stony Brook.
Responses of cortical neurons to sampled motion.
Pasternak, T., University of Rochester. The role of cortical
directionality in visual behavior.
Poggio, T., Massachusetts Institute of Technology. Theoretical
properties of motion detection models.
. Biophysical mechanisms for direction selectivity.
. Neurobiological tests of computational models.
Sekuler, R., Northwestern University. Psychophysical studies
of direction-specific mechanisms.
. Integration of stochastic local motions.
Simpson, J. I., New York University School of Medicine.
Integration of visual and vestibular motion signals.
Sperling, G., New York University. Theory and experiments
regarding generalized Reichardt models.
. The role of time and distance in apparent motion.
. Perceptual studies of the recovery of structure from
motion.
Thompson, W., University of Minnesota. Multi-resolution
analysis of time-varying imagery.
. Computational models of discontinuity detection and
analysis.
Van Essen, D., California Institute of Technology. Organiza-
tion of cortical visual pathways.
Wurtz, R., National Institutes of Health. Visual motion
processing for control of pursuit eye movements.
Bizzi, E., Massachusetts Institute of Technology. Single joint
studies: Muscle properties, the equilibrium position
hypothesis and the reference trajectory hypothesis.
Atkeson, C. G., Massachusetts Institute of Technology. What
is computational neuroscience? A motor control
viewpoint.
Mu It joint kinematics.
. Multi joint dynamics.
Review of control theory.
. Improving motor performance with experience.
Hunter, I., McGill University. Muscle and joint mechanical
dynamics.
Hogan, N., Massachusetts Institute of Technology. Using
optimal control theory to model behavior: Minimum jerk
movements.
Neurobiology of Drosophila
. Multi-joint arm mechanics and control.
Mussa- Ivaldi, F, Massachusetts Institute of Technology. Multi-
joint arm studies.
McCollum, G., Good Samaritan Hospital and Medical
Center. Theoretical approaches to sensorimotor control of
posture.
McMahon, T, Harvard University. The mechanics of
terrestrial locomotion.
Raibert, M., Carnegie-Mellon University. The dynamics of
running in robots.
Loeb, G., National Institutes of Health. Muscle spindle: A
biological solution to a classical dilemma in signal theory.
Abbs, J., University of Wisconsin. Coordination of multi-
articulate speech and finger movement.
Hollerbach, J., Massachusetts Institute of Technology. Tactile
sensing and hand control.
June 30-July 20
INSTRUCTORS
Jan, Lily Yeh, Ph.D., University of California, San Francisco
Jan, Yuh Nung, Ph.D., University of California, San Francisco
O'Farrell, Patrick H., Ph.D., University of California, San Francisco
Greenspan, Ralph J., Ph.D., Princeton University, New Jersey
ASSISTANT
Timpe, Leslie, University of California, San Francisco
This laboratory/lecture course was designed for people who may want to use
Drosophila as an experimental system for studying function or development of the
nervous system. One major aim was to introduce students to the various genetic,
molecular, and physiological techniques that are currently available in Drosophila
research and that make it distinctive.
The course began with a crash course on Drosophila genetics (a series of
lectures supplemented with laboratory demonstrations and exercises) to familiarize
the students with classical genetics of Drosophila, strategies of mutant isolation,
methods used to analyze newly isolated mutations, and mosaic analysis. This was
followed by workshops and laboratory projects on molecular genetics and
electrophysiology. In the area of molecular genetics topics covered were strategies
and techniques for cloning genes, in situ hybridization to polytene chromosomes,
PM hybrid dysgenesis, and DNA-mediated transformation, while the electrophysiol-
ogy section covered neuromuscular transmission and voltage clamp analysis, as
applied to mutants with altered ion channels. Additionally, a series of lectures by
invited speakers illustrated the application of these techhiques to current research.
The research topics included: molecular and functional analysis of mutants with
distinctive ion channels, establishment of neuronal pathways in the developing
embryo as well as in imaginal discs, analysis of behavioral mutants, maternal and
zygotic mutations that alter polarity and segmentation, homeotic mutations, and
the use of DNA transformation for the study of gene expression.
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PARTICIPANTS
Bloch linger, Karen, B.S., Swiss Institute for Experimental
Cancer Research, Lausanne, Switzerland
Davies, Jane A., Ph.D., Australian National University,
Canberra
Desplan, Claude R., Ph.D., University of California, San
Francisco
Gil, Daniel W., Ph.D., University of Pennsylvania,
Philadelphia
Isacoff, Ehud Y., Ph.D., McGill University, Montreal, Canada
Johansen, Kristen M., M.A., Yale University, New Haven,
Connecticut
Nichols, Ruthann, Ph.D., Purdue University, Lafayette,
Indiana
Rabin, Bruce A., MS., Albert Einstein College of Medicine,
Bronx, New York
Schmidt, Carl J., B.A., National Institutes of Health,
Bethesda, Maryland
Siwicki, Kathleen K., Harvard Medical School, Boston,
Massachusetts
SEMINARS
Greenspan, R. J., Princeton University. Bean bag genetics.
. Drosophila genetics
Construction and use of stocks.
. Generating and isolating mutations.
Analyzing mutations.
. Advanced chromosomesmanship
Jan, L. Y, University of California, San Francisco. Introduc-
tion to behavioral mutants.
. Mutations affecting synaptic transmission.
Quinn, W. G., Massachusetts Institute of Technology.
Learning mutants.
Greenspan, R. J., Princeton University. The varieties of
mutation experience.
. Complex loci.
Wieschaus, E., Princeton University. Early embryogenesis.
. Segmentation mutants.
. Maternal effects.
O'Farrell, P, University of California, San Francisco. General
recombinant DNA technology.
Pirrotta, V., Baylor College of Medicine. Microdissection;
various cloning vectors.
Spradling, A., Carnegie Institution of Washington. Hybrid
dysgenesis and p element transformation.
. Use of transformation to dissect junctional elements;
chorion amplification.
O'Farrell, P, University of California, San Francisco. Cloning
DNA sequences coding known and unknown products.
Levine, M., Columbia University. In situ localization of
transcripts.
Engrailed and homeotic loci.
Pardue, M. L., Massachusetts Institute of Technology.
Cytogenetics.
Bender, W., Harvard Medical School. Molecular biology of
mutation.
. Combining classical genetics with molecular
biology; homeotic mutations.
Bate, M., University of Cambridge. Development of the
nervous system.
. Pathfinding.
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Molecular Embryology of the Mouse
June 30-July 20
INSTRUCTORS
Rossant, Janet, Ph.D., Brock University, St. Catherinds, Ontario, Canada
Pedersen, Roger, Ph.D., University of California, San Francisco
ASSISTANTS
Vijh, Marian, M.S., Brock University, St. Catherinds, Ontario, Canada
Fox, Niles, Ph.D., Wistar Institute, Philadelphia, Pennsylvania
Robertson, Liz, Ph.D., University of Cambridge, England
This course was designed for biochemists, molecular biologists, and cell biologists
interested in applying their expertise to the study of mouse development. In
particular, the genetic manipulation of the mouse through the introduction of
foreign genes and cells in early embryos was stressed. Through laboratory
exercises and lectures, the participants were introduced to the following
procedures and their possible applications: the isolation and in vitro culture of
germ cells and preimplantation and early postimplantation embryos, the microin-
jection of DNA into fertilized eggs, nuclear transplantation, the formation of
chimeras, dissection of germlayers, the localization of antigens and mRNAs in
embryonic tissue sections, and basic mouse handling and breeding techniques.
Guest speakers discussed current research in related fields.
PARTICIPANTS
Begemann, Martin, M.D., Columbia University, New York,
New York
Calof, Anne L., Ph.D., University of California School of
Medicine, San Francisco
Carey, Frederick J., Ph.D., University of Michigan, Ann Arbor
Ebihara, Lisa, M.D., Ph.D., University of Colorado, Boulder
Goodwin, Maureen M., Ph.D., Memorial Sloan-Kettering
Cancer Center, New York, New York
Leavitt, John C., Ph.D.,Linus Pau ling Institute, Menlo Park,
California
Odom, Daniel P. B.A., Case Western Reserve University,
Cleveland, Ohio
Parada, Luis F, Ph.D., Massachusetts Institute of Technol-
ogy, Cambridge
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Sapienza, Caren, Ph.D., McGill University, Montreal, Canada
Seguin, Carl, Ph.D., National Institutes of Health, Bethesda,
Maryland
Skowronski, Jacek, Ph.D., National Institutes of Health,
Bethesda, Maryland
Surh, Linda C., M.D., Baylor College of Medicine, Waco,
Texas
Trounson, Alan, Ph.D., Monash University, Clayton, Australia
Varmuza, Sue L., MS., McMaster University, Hamilton,
Canada
SEMINARS
Palmiter, R., University of Washington. Transgenic mice
Copp, A., Stanford University. Primordial germ cells.
Schaffer, G.,Florida State University. Cytoskeleton in eggs
and embryos.
Papaidannou, V. E., Tufts University. Mouse mutants in
development.
Damsky, C., Wistar Institute. The importance of cell adhesion
molecules in early development.
Advanced Bacterial Genetics
Lawson, K., Hubrecht Laboratory. Fate mapping the
endoderm.
Angerer, L., University of Rochester. In situ hybridization in
sea urchin embryos.
Mahon, K., National Institutes of Health. In situ hybridization
in transgenic mice
Solter, D., Wistar Institute. Nuclear transfer.
Chapman, V., Roswell Park Memorial Institute. X-inactivation.
Hanahan, D., Cold Spring Harbor Laboratory. Transgenic
mice and oncogenes.
Lacy, L., Memorial Sloan-Kettering Cancer Center. Insertional
mutations affecting mammalian development.
Linney, E., Duke University. Retroviral enhancers and
teratocarcinoma cells.
Schultz, G., University of Calgary. Gene expression in early
embryos.
McGinnis, W., Yale University. Homeo boxes.
Jaenisch, R., Whitehead Institute. Retroviruses and
development.
June 30-July 20
INSTRUCTORS
Silhavy, Thomas J., Ph.D., Princeton University, New Jersey
Berman, Michael L., Ph.D., Litton Institute of Applied Biotechnology, Rockville, Maryland
Enquist, Lynn W., Ph.D., E.I. du Pont de Nemours & Co., Wilmington, Delaware
ASSISTANTS
Miessner, Scott, Ph.D., Litton Institute of Applied Biotechnology, Rockville, Maryland
Trun, Nancy, B.S., Princeton University, New Jersey
Robbins, Alan, Ph.D., E.I. du Pont de Nemours & Co, Wilmington, Delaware
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This course demonstrated the use of gene fusions, transposable elements, and
recombinant DNA for genetic analysis in Escherichia coli. Students learned to
construct gene fusions both in vivo and in vitro. Subsequent experiments stressed
the use of these fusions for monitoring gene expression and, in conjunction with
transposable elements, for obtaining defined mutations (nonsense, deletion, and
insertion) either in the target gene or in regulatory genes. Recombinant DNA was
applied to clone and define physically the target gene, the regulatory genes, and
the sites of action of the regulatory proteins at the target gene. In addition, the
cloned DNA and the defined mutations were used to analyze the genes and the
regulatory system genetically. For the sake of clarity, the course focused on a
particular region; however, the experimental techniques presented are sufficiently
general to be applicable to any gene in E. coli for which there exists a mutation
conferring a recognized phenotype.
PARTICIPANTS
Beaucage, Serge L., Ph.D., Beckman Instruments, Palo Alto,
California
Berg, Howard C., Ph.D., California Institute of Technology,
Pasadena
Champeny, W. Scott, Ph.D., East Tennessee State University
College of Medicine, Johnson City
Davidson, John P, Ph.D., Tuskegee Institute, Alabama
Fikes, John D., B.S., University of North Carolina, Chapel Hill
Kramer, Tina J., B.S., California Institute of Technology,
Pasadena
Mach lin, Sara M., B.A., Gray Freshwater Biological Institute,
Navarre, Minnesota
Puaoi, Deidre L., M.S., University of Kentucky, Lexington
Ray, Catherine C., B.S., Emory University, Atlanta, Georgia
Ruger, Barbara, Ph.D., University of Erlangen, Federal
Republic of Germany
Saber, Diane L., Gray Freshwater Biological Institute,
Navarre, Minnesota
Sacerdot, Christine C., Ph.D., Institut de Biologie Physico-
Chimique, Paris, France
Sanders, May Ellen, Ph.D., Miles Laboratories, Elkhart,
Indiana
Spitznagel, John K., M.D., Emory University, Atlanta,
Georgia
Tully, Raymond E., Louisiana State University, Baton Rouge
Valenzuela, Dario, M.S., Albert Einstein College of Medicine,
Bronx, New York
SEMINARS
Menzel, R., E.I. du Pont de Nemours & Co. The regulation
of E. coli DNA gyrase: A new twist to transcriptional
control.
Irwin, N., Harvard University. Positive control of transcription
in E. coll.
Brown, S., University of Massachusetts. Mutational analysis
of 4.5S RNA of E. coli.
Mauer, R., Case Western Reserve University. Interaction of
DNA polymerase III genes in Salmonella typhimurium.
Birgit, P., University of Texas Medical School. Transposon-
assisted fine structure genetic mapping.
Zagursky, B., E.I. du Pont de Namours & Co. Advances in
rapidly sequencing double-stranded DNA.
Maloy, S., University of Illinois. Autogenous regulation by a
membrane-bound enzyme.
Cellular and Molecular Biology of Behavior
July 12-July 26
INSTRUCTORS
Byrne, Jack, Ph.D., University of Texas Medical School, Houston
Kandel, Eric, M.D., Columbia University College of Physicians & Surgeons, New York, New
York
Pearson, Keir, Ph.D., University of Alberta School of Medicine, Edmunton, Canada
This lecture course provides an introduction to cellular and molecular approaches
used in the study of behavior and behavioral modifications. It is well suited for
both graduate students in neurobiology and research workers in other disciplines
who are interested in obtaining an introduction to cellular neurobiology. The
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course covered a wide variety of topics ranging from gene regulation in the
nervous system to cellular aspects of complex behaviors and learning. Rather than
being an extensive survey, however, the lecture provided an intensive coverage of
four selected areas: 1) introduction to the cell biology of neurons including
membrane biophysics, synaptic transmission and regulation of gene expression; 2)
cellular and subcellular mechanisms underlying neuronal plasticity and their
relationship to simple behavioral modifications; 3) cellular organization and
modifiability of complex behaviors such as locomotion and the control of
movement; and 4) neural approaches to the study of higher forms of behavior
such as communication and language. General principles were illustrated with a
variety of model systems in which modern cell biological approaches (including
the application of recombinant DNA technology) have been applied. To put the
cellular work into perspective, selected examples were also taken from human
behavior and its abnormalities.
PARTICIPANTS
Astrand, Per, M.S., Karolinska Institute, Stockholm, Sweden
Barash, Shabtai, B.S., Hebrew University, Jerusalem, Israel
Brilliant, Murray, Ph.D., Tufts University, Medford,
Massachusetts
Brodin, Lennart, M.S., Karolinska Institute, Stockholm,
Sweden
Colwill, Ruth, Ph.D., Columbia University, New York, New
York
Fujita, Ichiro, Ph.D., National Institute for Physiological
Sciences, Okazaki, Japan
Gilbert, David, B.A., Stanford University, California
Goodman, Gay, Ph.D., E.K. Shriver Center, Boston,
Massachusetts
Gynther, Ian, B.S., University of Alberta, Edmonton, Canada
Haynes, Lynne, Ph.D., Stanford University, California
Johnson, Stephen, MS., University of Iowa, Iowa City
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Kasai, Haruo, M.D., University of Tokyo, Japan
Knapp, Michael, Ph.D., Genetica, Paris, France
Lackner, Klaus, Ph.D., Los Alamos National Laboratory, New
Mexico
Lindstrom, Anders, M.S., Center for Neurobiology/Behavior
Research, New York, New York
Manier, Edward, Ph.D., University of Notre Dame, Indiana
McAfee, Donald, Ph.D., Beckman Research Institute, Duarte,
California
Pettersson, Lars-Gunner, B.S., University of Goteborg,
Sweden
Raskovsky, Sonia, B.S., University of Buenos Aires, Argentina
Schaeffer, Eric, B.A., Albert Einstein College of Medicine,
Bronx, New York
Sonetti, Dario, B.S., University of Modena, Italy
Tang, Andrew, Ph.D., Upjohn Company, Kalamazoo,
Michigan
Tse, Frederick, M.S University of Toronto, Canada
SEMINARS
Kandel, E., Columbia University College of Physicians &
Surgeons. Introduction to the cellular study of behavior.
Quinn, C., Massachusetts Institute of Technology. Introduc-
tion to the study of genes and behavior.
Adler, J., University of Wisconsin. Genes and the behavior of
bacteria.
King, C., University of Wisconsin. Genes and the behavior of
paramecium.
Byrne, J., University of Texas Medical School. Cellular and
biophysical determinants of elementary behavioral acts I.
. Cellular and biophysical determinants of elementary
behavioral acts II.
Wyman, R., Yale University. Genetic approaches to the
analysis of simple behaviors.
Byrne, J., University of Texas Medical School. Synaptic
plasticity and neural modulation.
Kandel, E., Columbia University College of Physicians &
Surgeons. Learning I. Habituation.
. Learning II. Sensitization.
. Learning III. Classical conditioning.
Quinn, C., Massachusetts Institute of Technology. Genetic
approaches to learning.
Scheller, R., Stanford University. Genes, peptides, and
behavior.
Weeks, J., University of California, Berkeley. Hormones and
behavior.
Kupfermann, I., Columbia University. Motivation.
Zigmond, M., University of Pittsburgh. Biochemical
regulation of synaptic function.
Kaplan, B., University of Pittsburgh. Genetic regulation of
synaptic function.
Zigmond, M., University of Pittsburgh. Role of neurotransmit-
ters in behavioral abnormalities.
Pearson, K., University of Alberta School of Medicine.
Introduction to motor sequences.
Marder, E., Brandeis University. Rhythm generation in
invertebrate motor systems.
Pearson, K., University of Alberta School of Medicine.
Central and reflex control of movements.
. Locomotion in vertebrates.
Lisberger, S., University of California. Adaptive regulation in
the oculomotor system.
Hollerbach, J., Massachusetts Institute of Technology.
Strategies for the control of voluntary movement.
De long, M., Johns Hopkins University. Functional organiza-
tion of the basal ganglia.
Wyatt, R., National Institute of Mental Health. Brain grafting
in animals and man.
Pearson, K., University of Alberta School of Medicine.
Introduction to communication.
Suga, N., Washington University. Brain pathways for sound
processing in bats.
Ojemann, G., University of Washington. Exploration of
language areas of the brain by electrical stimulation.
Ross, E., Southwestern Medical School. Language functions
of the human brain and their localization.
Nottebohm, F., Rockefeller University. Brain pathways for
vocal song control in birds.
. Hormonal regulation of synaptogenesis and
neurogenesis.
Single Channel Methods: Expression,
Reconstitution, and Recording
July 22-August 11
INSTRUCTORS
Dionne, Vincent E., Ph.D., University of California, San Diego
White, Michael M., Ph.D., California Institute of Technology, Pasadena
Coronado, Roberto, Ph.D., University of North Carolina, Chapel Hill
Yellen, Gary, Ph.D., Brandeis University, Waltham, Massachusetts
Bean, Bruce, Ph.D., Harvard University, Cambridge, Massachusetts
ASSISTANTS
Stevens, Meg, Harvard University, Cambridge, Massachusetts
Perry, Dave, Wesylan University, Middletown, Connecticut
The technologies of patch-clamping, reconstitution and molecular biology promise
major revisions and novel approaches for the examination of many neurobiological
problems. The application of these methods to study the physiology and
biophysics of ion channels was taught in this intensive laboratory and lecture
course. Students concentrated initially on single-channel recording using the patch
clamp technique. Several practical aspects were covered: fabrication of patch
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electrodes, giga-seal formation, and methods for cell-attached, cell-free and whole-
cell recording. The design and implementation of recording equipment, and the
theory and analysis of single channel currents were discussed during lectures. The
course included two workshops. During one the methods of handling and injecting
foreign mRNA into Xenopus oocytes for expression and study of both voltage-
gated and ligand-gated ion channels were covered. Newly expressed channels in
the oocytes were studied with the two electrode voltage clamp. The second
workshop covered the techniques for reconstitution of functional ion channels into
artificial lipid bilayers. Ion channels from several sources were incorporated into
synthetic membranes on microelectrodes and into large planar films and studied
by single channel methods.
PARTICIPANTS
Braun, Maike, B.S., University of Cambridge, England
Cox, Thomas, Ph.D., Southern Illinois University, Carbondale
Ferguson, James, MS., University of California, Davis
Goldsmith, Mary, Ph.D., Yale University, New Haven,
Connecticut
Greenfield, John, B.A., University of Virginia, Charlottesville
Hill, Joseph, Jr., B.S., Duke University Medical Center,
Durham, North Carolina
Kinnamon, Sue, Ph.D., University of Colorado, Boulder
Sahley, Christie, Ph.D., Yale University, New Haven,
Connecticut
Swanson, Richard, Ph.D., Massachusetts Institute of Technol-
ogy, Cambridge
Weiss, David, B.A., Baylor College of Medicine, Waco, Texas
SEMINARS
Siegelbaum, S., Columbia University College of Physicians &
Surgeons. The role of protein phosphorylation in the
modulation of a K* channel in Aplysia neurons.
Claudio, T, Yale University. Stable expression of AChR cDNA
genes in tissue cultured cells.
French, R. J., University of Maryland. Modulation and
modification of single Na channels in planar lipid bilayers.
Sachs, F., State University of New York, Stony Brook.
Mechano-reception by stretch-activated channels.
Stevens, C. F., Yale University. Kinetic behavior of Na
channels in cultured cells.
Gruol, D. L., Research Institute of Scripps Clinic.
Mechanisms of inter- and intracellular communications in
the vertebrate CNS.
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Molecular Cloning of Eukaryotic Genes
July 22-August 11
INSTRUCTORS
Bothwell, Al, Ph.D., Yale University, New Haven, Connecticut
Alt, Fred, Ph.D., Columbia University College of Physicians & Surgeons, New York, New
York
Lehrach, Hans, EMBL, Heidelberg, Federal Republic of Germany
ASSISTANTS
Bleir, Peter, B.A., Yale University, New Haven, Connecticut
Zimmerman, Kathy, B.A., Columbia University, New York, New York
Poustka, Anna Marie, MIR., EMBL, Heidelberg, Federal Republic of Germany
This laboratory and lecture course covered the principles of recombinant DNA
technology and the application of these procedures to the study of eukaryotic
genes. The isolation and characterization of lymphocyte-specific genes were
emphasized. Among the topics covered were: construction of cDNA libraries in
plasmid or bacteriophage X, vectors, construction of bacteriophage X and cosmid
libraries of high-molecular-weight eukaryotic DNA, screening DNA libraries with
gene-specific hybridization probes and by recombination, purification, and
characterization of recombinant clones using restriction endonuclease and blot
hybridization analyses, and reintroduction and expression of cloned genes in
heterologous systems. Strategies for isolating genes that encode rare mRNA
sequences were discussed. Guest lectures discussed the application of molecular
cloning procedures to the study of specific eukaryotic gene systems.
PARTICIPANTS
Beguinot Laura, M.D., National Cancer Institute, Bethesda,
Maryland
AI-Awqati, Qais, M.B., Ch.B., Columbia University, New York, Carlstedt-Duke, Jan, Ph.D., Karolinska Institut, Stockholm,
New York Sweden
Baekkeskov, Steinunn, Ph.D., Hagedorn Research Dvorak, Harold, M.D., Beth Israel Hospital, New York, New
Laboratory, Denmark York
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Feldman, David, M.D., Stanford University, California
Hockfield, Susan, Ph.D., Cold Spring Harbor Laboratory,
New York
Hoy, Marjorie, Ph.D., University of California, Berkeley
Hughey, Rebecca, Ph.D., University of Pittsburgh,
Pennsylvania
Kalsheker, Noor, M.D., University of Wales, Cardiff
Morgan, Robin, Ph.D., University of California, Berkeley
Nairn, Roderick, Ph.D., University of Michigan, Ann Arbor
Nissley, S. Peter, M.D., National Cancer Institute, Bethesda,
Maryland
Springer, Timothy, Ph.D., Dana Farber Cancer Institute,
Boston, Massachusetts
Unanue, Emil, M.D., Washington University School of
Medicine, St. Louis, Missouri
SEMINARS
Schimke, R., Stanford University. Gene amplification.
Myers, R., Harvard University. Detection of single base
mismatches in eukaryotic DNA.
Goff, S., Columbia University College of Physicians &
Surgeons. In vitro mutagenesis of retrovirus genes.
Yancopoulos, G., Columbia University College of Physicians
& Surgeons. Gene transfer into eukaryotic cells.
Blackwell, K., Columbia University College of Physicians &
Surgeons. Gene transfer into eukaryotic cells.
Yeast Genetics
McKnight, S., Fred Hutchinson Cancer Center. Regulation of
transcription.
Hood, L., California Institute of Technology. The genes
encoding the T-cell receptor.
Fink, G., Whitehead Institute. Ty element as disguised
retroviruses.
Miyada, G., Beckman Research Institute of the City of Hope.
The use of oligonucleotides in screening DNA.
Gluzman, Y, Cold Spring Harbor Laboratory. Eukaryotic viral
vectors.
Kellems, R., University of Texas, Houston. Gene
amplification.
Gething, M.-J., Cold Spring Harbor Laboratory. Studies of
the cellular transport of Fla hemagluttinin mutants.
Hanahan, D., Cold Spring Harbor Laboratory. Transformation
in transgenic mice.
Murray, N., University of Edinburgh. Lambda genetics.
Synder, M., Stanford University. Chromosome segregation in
yeast and the X gt11 expression system.
Lehrach, H., EMBL. The murine T locus and chromosome
walking.
Bothwell, A., Yale Medical School. The tissue-specific
expression of Ig genes and the development of somatic
variants.
Alt, F., Columbia University. The family of myc genes.
July 22-August 11
INSTRUCTORS
Sherman, Fred, Ph.D., University of Rochester, New York
Fink, Gerald, Ph.D., Massachusetts Institute of Technology, Cambridge, Massachusetts
Hicks, James, Ph.D., Cold Spring Harbor Laboratory, New York
ASSISTANTS
Moerschell, Rick, B.S., University of Rochester, New York
Morfeld, Ramona, B.S., Cold Spring Harbor Laboratory
The major laboratory techniques used in the genetic analysis of yeast were
studied, including the isolation and characterization of chromosomal and
mitochondria! mutants, tetrad analysis, chromosomal mapping, mitotic recombina-
tion, and test of allelism and complementation. Micromanipulation used in tetrad
analysis was carried out by all students. Recombinant DNA techniques, including
yeast transformation, filter hybridization, and gel electrophoresis, were applied to
cloning and genetic analysis of yeast DNA. Lectures on fundamental aspects of
yeast genetics were presented along with seminars given by outside speakers on
topics of current interest.
PARTICIPANTS Haltiner, Michele, B.S., University of California, Berkeley
Herscovics, Annette, Ph.D., McGill Cancer Centre, Montreal,
Breviario, Diego, Ph.D., National Institutes of Health, Canada
Bethesda, Maryland Lavi, Sara, Ph.D., Tel Aviv University, Israel
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Lazarow, Paul, Ph.D., Rockefeller University, New York
Lew, Daniel, B.A., Rockefeller University, New York
Ljungdahl, Per, B.A., Dartmouth Medical School, Hanover,
New Hampshire
Nefsky, Bradley, B.A., Cornell University, Ithaca, New York
Neilsen, Ole, Ph.D., University of Aarhus, Denmark
Olempska-Beer, Zofia, Ph.D., National Institutes of Health,
Bethesda, Maryland
Rothman, James, Ph.D., Stanford University, California
Scordilis, Gail, Ph.D., University of Massachusetts, Amherst
Shen, Nancy, B.S., Rutgers University, New Brunswick, New
Jersey
Thevelein, Johan, Ph.D., Katholieke Universiteit, Louvain,
Belgium
White, Terry, Ph.D., University of Texas Medical School,
Houston
Wright, Tony, Ph.D., Imperial College of Science and
Technology, London, England
SEMINARS
Ptashne, M., Harvard University. Regulatory proteins in
yeast.
Pringle, J., University of Michigan. Cellular morphogenesis in
the yeast cell cycle.
Prakash, L., University of Rochester. Structure and function
of DNA repair genes.
Broach, J., Princeton University. Control of plasmid propaga-
tion in yeast.
Fink, G., Massachusetts Institute of Technology. Reverse
transcription in yeast.
Hicks, J., Cold Spring Harbor Laboratory. Regulation and
interconversion of mating types.
Lindquist, S., University of Chicago. Sporulation-specific
gene expression in yeast.
Sherman, F, University of Rochester. Structure and
expression of isol-cytochrome c.
Fitzgerald-Hayes, M., University of Massachusetts. Mutations
of the centromere affecting chromosome segregation.
Petes, T, University of Chicago. Mechanisms that alter yeast
genome structure
Silver, P, Harvard University. Localization of proteins to the
yeast nucleus.
Sternglanz, R., State University of New York, Stony Brook.
Yeast DNA topoisomerases.
Garrard, W., University of Texas, Dallas. Chromatin structure
of a yeast heat-shock locus.
Perlman, P, Ohio State University. Mitochondria! introns:
Maturases and self-splicing.
Wig ler, M., Cold Spring Harbor Laboratory. Function of yeast
RAS genes.
Guthrie, C., University of California, San Francisco. RNA
splicing: Genetic approaches in yeast.
Warner, J., Albert Einstein College of Medicine. Ribosomal
genes and their regulation.
Thorner, J., University of California, Berkeley. Synthesis and
action of the mating pheromones.
Molecular Biology of the Nervous System
July 29-August 11
INSTRUCTORS
Kelly, Regis, Ph.D., University of California, San Francisco
McKay, Ronald D., Ph.D., Massachusetts Institute of Technology
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The technologies of patch-clamping and immunochemistry have revolutionized
molecular neurobiology. Increasingly, the tools of recombinant DNA technology
and molecular genetics are being used to identify and characterize molecules
involved in neuronal function and development. The aim of this lecture course was
to familiarize the participants with recent developments in molecular biology and
to discuss their application to neurobiological problems.
PARTICIPANTS
Bandtlow, Christine, MS., Max-Planck Institute, Martinsried,
Federal Republic of Germany
Benveniste, Etty, Ph.D., University of California, Los Angles
Bodary, Sarah, Ph.D., Institut Swiss de Recherches
Experimentales sur le Cancer, Epalinges, Switzerland
Brar, Anoop, Ph.D., Clinical Research Institute of Montreal,
Canada
Brookhart, Gery, MS., Purdue University, West Lafayette,
Indiana
Cambi, Franca, M.D., E.K. Shriver Center, Waltham,
Massachusetts
Chalmers, Alison, Ph.D., University of California, Riverside
Foote, Alison, Ph.D., E.K. Shriver Center, Waltham,
Massachusetts
Fox, Susan, Ph.D., Rockefeller University, New York, New
York
Hanecak, Ronnis, Ph.D., University of California, Irvine
Johnson, Jeffrey, MS., University of Texas, Houston
Kasahara, Noriyuki, Tokyo Medical and Dental University,
Japan
Liu-Chen, Lee,i'uan, Ph.D., E.I. du Pont de Nemours & Co.,
Wilmington, Delaware
Lowndes, Catherine, B.S., Institute of Neurology, London,
England
Mc Cobb, David, MS., University of Iowa, Iowa City
Methfessel, Christoph, Ph.D., Max-Planck Institute, Gottingen,
Federal Republic of Germany
Ramaswami, Mani, MS., California Institute of Technology,
Pasadena
Rayburn, Helen, Ph.D., California Institute of Technology,
Pasadena
Schmidek, Henry, M.D., University of Vermont, Burlington
Vogel, Michael, Ph.D., Yale University, New Haven,
Connecticut
Wennogle, Lawrence, Ph.D., Ciba-Geigy, Corp. Summit, New
Jersey
Wentzel, Daniel, Ph.D., Cornell University, Ithaca, New York
Wu, Hen Ming, Yale University, New Haven, Connecticut
SEMINARS
Anderson, D., Columbia University College of Physicians &
Surgeons, and L. Zipursky, California Institute of Technol-
ogy. Cloning strategies.
. Sequencing.
. Nucleic acid synthesis and in situ hybridization.
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. Review of gene structure, control, and relationship to
protein structure.
Stuhlmann, H., Massachusetts Institute of Technology.
Expression systems.
Zipursky, L., California Institute of Technology. Retinal
development in Drosophila.
Kelly, R., University of California, San Francisco. Protein
synthesis and targeting.
Yamamoto, K., University of California, San Francisco. Gene
regulation.
Varshaysky, A., Massachusetts Institute of Technology.
Chromosome structure.
Sharp, P, Massachusetts Institute of Technology. RNA
processing.
Evans, R., Salk Institute. Protein expression in transgenic
mice.
Burden, S., Massachusetts Institute of Technology. Structure
of the neuromuscular junction.
Getter, M., Massachusetts Institute of Technology. Antibody
generation I.
. Antibody generation II.
Quinn, W., Massachusetts Institute of Technology. Neurobiol-
ogy of Drosophila.
Rouley, E., Massachusetts Institute of Technology.
Oncogenes.
Struhl, G., Harvard University, Development.
Chalfie, M., Columbia University. Neurobiology of
nematodes.
Wold, B., California Institute of Technology. Antisense
message.
Melton, D., Harvard University. Frog oocytes.
Sheetz, M., University of Connecticut. Organelle transport of
cytoskeletons.
Hynes, R., Massachusetts Institute of Technology. Extracellu-
lar matrix.
Kelly, R., University of California, San Francisco. Membrane
traffic in neurons.
Bange, R., Washington University School of Medicine.
Neuron-glial interaction.
Merlie, J., Washington University School of Medicine.
Biogenesis of the AChR.
Reichardt, L., University of California, San Francisco. Growth
factors.
McKay, R., Massachusetts Institute of Technology. Everything
else.
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Seminars
Cold Spring Harbor Seminars were initiated to provide a semiformal avenue for
communication between the various research groups at the Laboratory. They are
particularly useful for research personnel who have joined the Laboratory during
the summer. The seminars also afford a necessary opportunity for the graduate
students and postgraduate staff to develop their skills in defending, organizing,
and presenting their research. In addition to those listed below, seminars were
given by many others involved in research at this Laboratory.
1984-1985
August
Alexander Varshaysky, Massachusetts Institute of Technology,
Cambridge: Heterochromatin-specific proteins and the
problem of nucleosome positioning.
September
Hartmut Land, Whitehead Institute, Cambridge,
Massachusetts: Cooperation between oncogenes in
cellular transformation.
Rodrigo Bravo, European Molecular Biology Laboratory,
Heidelberg, Federal Republic of Germany: Effect of
growth factors on cyclin and oncogene expression.
October
William Jamieson, Grumman Aerospace Corporation,
Bethpage, New York: Scientific utilization of the space
shuttle.
Ronald Guggenheimer, Memorial Sloan-Kettering Cancer
Center, New York, New York: Enzyme and template
requirements for adenovirus DNA replication in vitro.
George Fey, Scripps Clinic, La Jolla, California: The
compliment C3-alpha 2 macroglobulin gene family-
cDNA structure and RNA expression during acute
inflammations.
Karl Riabiwol, University of Arkansas, Fayetteville: Cloning of
extrachromosomal covalently closed, circular DNA in
human fibroblasts.
November
Asao Fujiyama, University of Osaka Medical School, Japan:
Hepatitis B virus genes-Their identification and their
expression in yeast cells.
Monica Luskey, University of California, Berkeley: Genetic
analysis of the bovine papilloma virus replicon.
Michael Fried, Imperial Cancer Research Fund, London,
England: Viral and cellular gene expression.
Yoram Groner, Weizmann Institute of Science, Rehovot,
Israel: Molecular structure and expression of the gene
locus on human chromosome 21 encoding the Cu/Zn
superoxide dismutase and its relevance to Down's
syndrome.
Dale Dorset, Weizmann Institute of Science, Rehovot, Israel:
Illegitimate recombination of circular and linear SV40
DNA.
Susan Kilkowski, University of California, San Francisco:
Pattern recognition and the structural determination of
proteins.
Rodrigo Bravo, European Molecular Biology Laboratory,
Heidelberg, Federal Republic of Germany: Induction of
cyclin and oncogenes by growth factors in 3T3 cells.
Oliver Bensaude, Institut Pasteur, Paris, France: Heat-shock
protein synthesis during mouse early embryogenesis.
Marilyn Anderson, University of Melbourne, Australia: A
single gene system that prevents self-pollination in the
ornamental tobacco Nicotiana alata.
Marc Yves Fiszman, Institut Pasteur Paris, France: Smooth
muscle and skeletal muscle tropomyosin-From the
protein to the gene.
John Northrup, University of Calgary, Canada: GTP binding
proteins in hormone action-Implication for ras.
Jim Shapiro, University of Chicago, Illinois:
Sociobacteriology.
Bill Dynan, University of California, Berkeley: A mammalian
transcription factor that binds to and activates selected
viral and cellular promoters.
December
Michael Botchan, University of California, Berkeley: Trans-
activation of SV40 enhancer.
Jeff D. Boeke, Whitehead Institute, Cambridge,
Massachusetts: Transposition of Ty elements in yeast.
Danny Reinberg, Rockefeller University, New York, New York:
In vitro RNA polymerase transcription system-A
biochemical approach.
Irwin Greenblatt, University of Connecticut, Storrs: Transposi-
tion of Ac.
George Church, Biogen, Cambridge, Massachusetts: Tissue-
specific contacts to activate immunoglobulin enhancers.
January
Dan Klessig, University of Utah, Salt Lake City: Posttran-
scriptional regulation of plant gene expression.
Philip Coffino, University of California, San Francisco:
Regulation of ornithine decarboxylase.
Robert Horsch, Monsanto Company, St. Louis, Missouri:
Expression of foreign genes in plants.
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February
Mike Levine, Columbia University, New York, New York:
Spatial regulation of homeotic gene expression in
Drosophila.
John Bednarczyk, University of Texas Health Science Center,
Dallas. The effects of ionophores on the processing of
the third component of mouse complement.
Josef Aloni, Weizmann Institute of Science, Rehovot, Israel,
and Princeton University, New Jersey: Attenuation in
SV40, Adeno and MVM. I. A mechanism that regulates
gene expression and II. A mechanism of transcription
termination.
Paul Fisher, State University of New York, Stony Brook: The
molecular architecture of the Drosophila nucleus.
March
David Spector, Baylor College of Medicine, Houston, Texas:
The nucleoplasmid reticulum-A new organelle?
David Schwartz, Columbia University, New York, New York:
Post-field gradient gel electrophoresis- Its use for
analyzing eukaryotic genomes.
David Solter, Wistar Institute, Philadelphia, Pennsylvania:
Transnuclear mice.
Thomas Wilke, University of Washington, Seattle: Mosaicism
and insertional mutagenesis in transgenic mice.
Paul Modrich, Duke University, Durham, North Carolina:
Mismatch repair in vitro.
Andrew Rice, ICRF, London, England: Purification and
characterization of vaccinia virus growth factor.
Richard Palmiter, University of Washington, Seattle:
Expression of genes introduced into mice.
April
Paul Young, Queens University, Kingston, Canada: Control of
cell division in fission yeast.
Thomas Alber, University of Oregon, Eugene: Protein
thermostability-Genetic and structural studies of phage
T4 lysozyme.
John Hassell, McGill University, Montreal, Canada: Dual role
of the polyoma virus enhancer in transcription and DNA
replication.
Loren Field, Roswell Park Memorial Institute, Buffalo, New
York: Structure and expression of mouse renin genes.
Janet Rossant, Brock University, St. Catherines, Canada:
Cellular and molecular aspects of lineage development in
the mouse embryo.
Dona Chikaraishi, Tufts University, Medford, Massachusetts:
Gene expression in mammalian brain.
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May
Roger Brent, Harvard University, Cambridge, Massachusetts:
Turning eukaryotic genes on and off with a prokaryotic
repressor.
Alain Nicolas, University of Paris, France, and Harvard
Medical School, Cambridge, Massachusetts: Genetics of
genetic recombination in Ascobolus.
Tom Sims, University of California, Los Angeles: Organization
and expression of organ-specific genes in soybean and
tobacco.
John Dunn, Brookhaven National Laboratories, Upton, New
York: Development of high-expression vectors based on
bacterial phage P7.
Robert Haselkorn, University of Chicago, Illinois: Gene
rearrangement during development in the cyanobac-
terium Anabaena sp.
Harold Neil Bramson, Rockefeller University, New York, New
York: Synthetic peptides in enzymology and immunology.
Thomas Curran, Hoffmann-La Roche Inc., Nutley, New
Jersey: The fos oncogene-Transformation, differentiation,
and proliferation.
June
Daniel Marshak, NIMH, National Institutes of Health,
Bethesda, Maryland: Structural analysis of proteins from
the nervous system.
Gilbert Morris, Florida State University, Tallahassee: U1 RNA
synthesis in sea urchin embryo extracts.
Kathryn Ely, University of Utah, Salt Lake City: X-ray crystal-
lography as a probe of conformational flexibility.
July
Gerry Both, CSIRO, Sydney, Australia: Expression of the
rotavirus VP7 gene-Construction of secreted variants.
Adrian Kramer, Harvard University, Cambridge,
Massachusetts: In vitro splicing.
Denise Roberts, Harvard University, Cambridge,
Massachusetts: IS10 transposition is regulated by
adenine methylation.
August
Ted Chrisman, Vanderbilt University, Nashville, Tennessee:
Regulation of hepatic phosphorylase kinase activity.
Frances Jurnak, University of California, Riverside: Biochemi-
cal gene crystallography studies of the elongated factor
Tu-GDP
Alex McPherson, University of California, Riverside: Crystal
structures of protein single-stranded DNA complexes.
Undergraduate Research
An important aspect of the summer program at the Laboratory is the participation
of college undergraduate students in active research projects under the supervi-
sion of full-time laboratory staff members. The program was initiated in 1959. Since
that year, 275 students have completed the course, and many have gone on to
creative careers in biological science.
The objectives of the program are to provide (1) a greater understanding of the
fundamental principles of biology, (2) an increased awareness of major problem
areas under investigation, (3) better understanding of the physical and intellectual
tools for modern research and the pertinence of this information to future training,
and (4) a personal acquaintance with research, research workers, and centers for
study.
The following students, selected from a large number of applicants, took part in
the program, which was supported by Metropolitan Life Foundation, Burroughs
Wellcome Fund, and Alfred D. Sloan Foundation.
Mark R. Alfenito, Cornell University
Research Advisor: Stephen Dellaporta
Studies of a controlling element and complex locus in maize.
Pedram Argani, Princeton University
Research Advisor: Yasha Gluzman
Expression of SV40 T antigen by El deleted adenovirus type
5 vectors.
Todd A. Brown, Pittsburg State University
Research Advisor: Douglas Youvan
Isolation of the Rhodopseudomonas capsulate reaction
center and development of transformation protocols.
Gabrielle Costello, Harvard University
Research Advisor: Robert Franza
Cell cycle study of the fission yeast Schizosaccharomyces
pombe.
Lisa Griffin, Notre Dame University
Research Advisor: David Kurtz
Isolation of a transcriptional factor in the hormonal control of
a2u globulin.
Nicholas A. Hanchak, University of Scranton
Research Advisor: Douglas Hanahan
Transformation efficiency in nucleoside transport mutants of
Escherichia coil K12 and the establishment of beta cell
lines from transgenic mice.
Stuart A. MacNeill, University of Glasgow
Research Advisor: Bruce Stillman
Simian virus 40 replication in vitro.
Susan M. McEvoy, University of Wisconsin
Research Advisor: Richard J. Roberts
Establishing E1A-producing cell lines and analysis of restric-
tion endonucleases.
Kevin S. Murphy, Massachusetts Institute of Technology
Research Advisor: James B. Hicks
Transformation of Chlamydomonas reinhardtii.
Robert Paul Ray, University of California, Berkeley
Research Advisor: Ronald Guggenheimer
SV40 replication in vitro.
Geraldine Seydoux, University of Maine
Research Advisor: David Beach
Genetic suppressors of the genes rant and mei3 in
Schizosaccharomyces pombe.
Alyssa Shepard, University of California, Riverside
Research Advisor: Winship Herr
Cell-type specificities of SV40 enhancer elements.
Henry Stapp, Hampshire College
Research Advisor: Pablo A. Scolnik
Location of carotenoid D gene product in Rhodopseudo-
monas capsulata.
Sheila S. Wong, Yale University
Research Advisor: Fevzi Daldal
Cytochromes and the photosynthetic pathway of
Rhodopseudomonas capsulata.
Olney Fellow
Andrew Mirhej, Columbia University
Research Advisor: Clive Slaughter
The use of hydrophobic interaction chromatography as a
new method for the typing of ALP
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Nature Study Program
The Nature Study Program gives elementary and secondary school students the
opportunity to acquire a greater knowledge and understanding of their environ-
ment. Through a series of specialized field courses, students can engage in such
introductory programs as Nature Detectives, Seashore Life, and Pebble Pups, as
well as more advanced programs such as Marine Biology and Nature
Photography.
During the summer of 1985 a total of 410 students participated in the Nature
Study Program. Most classes were held outdoors, when weather permitted, or at
the Uplands Farm Nature Preserve, the headquarters of the Long Island Chapter
of the Nature Conservancy. The Laboratory has equipped and maintains
classrooms/laboratories as well as a darkroom at Uplands Farm. This facility is
used as a base for the student's exploration of the local environment. Field classes
are held on Laboratory grounds, St. John's Preserve, Shu Swamp Preserve,
Caumsett State Park, the Cold Spring Harbor Fish Hatchery, and the Muttontown
Preserve, as well as other local preserves and sanctuaries.
PROGRAM DIRECTOR
William M. Payoski, M.A., Adjunct Professor,
Nassau Community College
INSTRUCTORS
Kathryn Bott, M.S., former science teacher, Friends Academy
Ruth Burgess, B.A., naturalist, Nassau County BOCES
Steven Lander, M.S., science coordinator, Harborfields School District
Fred Maasch, M.S., science teacher, Islip High School
Margret Nathanson, B.A., naturalist, Nassau County BOCES
Linda Payoski, B.A., science teacher, Uniondale High School
COURSES
Nature Bugs
Nature Detectives
Advanced Nature Study
Introduction to Ecology
Frogs, Flippers, and Fins Seashore Life
Pebble Pups Invertebrate Biology
Bird Study Marine Biology
Fresh Water Life Nature Photography
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COLD SPRING HARBOR CURRICULUM STUDY
Genetic engineering, recombinant DNA, cloning, and gene splicing are buzzwords
for the DNA revolution that has brought scientists to the very brink of understand-
ing the molecular basis of life. Upon this explicit knowledge is based a burgeon-
ing biotechnology industry which, like the explosive growth of computer technol-
ogy, promises to profoundly influence American culture.
Although the DNA revolution has been science fact for more than a decade, to
the general public it still largely belongs to the realm of science fiction. Adequate
knowledge of DNA science has not filtered far beyond the doors of academia.
This state of public ignorance threatens the nation's ability to make informed policy
decisions about issues generated by biotechnical enterprise.
Time to Clean a Cluttered Closet
Most critical, there has not yet been a coordinated effort nor national commitment
to update science teaching to take into account the recent, dramatic developments
in biological science. We are in the infancy of a scientific revolution of monumental
proportions, but our children don't know it. We are failing miserably to prepare
young people for the technological world they must inhabit.
Accumulated in the closet of science teaching are anachronistic concepts and
methods that bear little relevance to the real science of discovery. At a time when
biologists are on the verge of understanding cancer and engineering plants to
quell world hunger, biology students are required to memorize terms and
definitions of an historical science no longer practiced at the lab bench.
Peering into a closet cluttered with the accumulated minutiae of bygone days,
one can understand why science teaching fails to capture the excitement of
modern biology. It is time to sweep clean the closet of earthworm anatomy and
frog physiology to make room for gene therapy and molecular engineering.
Addressing the Problems of Science Education
The Cold Spring Harbor Curriculum Study was initiated in January 1985 to bridge
the gap between science and society, and to bring modern molecular biology
down to a level appropriate for precollege and freshman college students. Its goal
is to design novel teaching materials and to train teachers in their use.
The program directly addresses the major problems associated with integrating
up-to-date ideas into science courses at the precollege and freshman college
level: 1) outdated syllabi, 2) lack of teacher retraining programs, 3) lack of teacher
motivation, 4) lack of interactive and lab-oriented teaching materials, and 5) lack of
modern lab equipment. By affecting change at the top of the education
pyramid-at the level of board members, administrators, science chairpersons,
teachers, and professors-we hope that benefits will filter down to the largest
number of students.
Recombinant DNA for Beginners
The pivotal achievement of the Curriculum Study has been the development and
testing of an integrated series of laboratory exercises that give students hands-on
experience in molecular biology. With strong technical help from Dr. Greg Freyer,
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Instructors Greg Freyer and
David Mick los observe
Northport H.S. student
Robert Kehn.
now a research associate at Memorial Sloan-Kettering Cancer Center, we have
successfully adapted protocols and techniques used by practicing researchers so
that they can be safely used in the classroom. These experiments at once excite
imagination and give insight into the process of scientific discovery. When
published in late 1986, these experiments will be the first lab/text available for this
level of instruction.
Another important achievement was the development of Recombinant DNA for
Beginners. Telescoping instruction equivalent to a three-credit college course, this
five-day course gives teachers hands-on experience with the elegant tools of
biotechnology. Using equipment identical to that found in research laboratories,
teachers perform nine experiments that culminate in the production and analysis
of recombinant-DNA molecules, including: microbial culture, gel electrophoresis,
DNA restriction analysis, DNA ligation, plasmid transformation of E. coli, and
purification of plasmid DNA.
Morning lectures introduce major concepts and theories behind the experimen-
tal techniques. Afternoon seminars presented by practicing researchers illustrate
the application of molecular approaches to solve biological problems.
Facilitating Classroom Implementation
In addition to bringing teachers up-to-the-minute with research in molecular
biology, this course is designed to help participants transfer what is learned into
improved classroom methods. Post-lab discussions alert educators to variables
that can influence classroom results and show how to "troubleshoot" when
something goes wrong. One session introduces a small-group approach for
analyzing the personal, social, and biological implications of recombinant DNA.
Another session focuses on practical aspects of starting a laboratory teaching
program, including how to build consensus and support, finding funds for
equipment, how to schedule labs around time constraints, lab safety, and proper
disposal of biologicals.
University of Connecticut Professor Irwin Greenblatt explains maize genetics at Honors
Colloquium for students from 19 local school districts.
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Greg Freyer explains subtleties of bacterial transformation to local high school teachers at the
summer workshop: Steve Sponenberg and Lois Miller, Syosset; and Henrietta Dold,
Wheatley.
An Expanding Role
Only one year after its founding by the Laboratory and eight local school districts,
the Curriculum Study has grown into a consortium of 19 school districts on Long
Island and in Westchester County. The largest program of its kind, the Curriculum
Study serves as a national model for retraining teachers and retooling classrooms
for laboratory-based learning about molecular biology.
During its first year of operation, the Curriculum Study provided approximately
100 hours of advanced instruction to both students and teachers-equivalent to
three college courses. Approximately 40 teachers and 300 students have attended
Curriculum Study seminars, workshops, and training sessions. The number of
students who, in turn, have benefited from the retraining provided to their teachers
can be conservatively estimated at 4,000. This number will compound each year.
In 1986 we are initiating two new projects to expand significantly the scope of
the Curriculum Study:
Vector Mobile DNA Laboratory. In molecular biology, the term vector
describes bacterial plasmids or viruses that are used to ferry new DNA fragments
into a host cell. In the same way, the Vector Mobile DNA Laboratory will carry new
knowledge and teaching methods to educators around the country. We have
purchased and equipped a utility van as a mobile laboratory to transport all
necessary equipment for regional workshops held for up to 36 teachers and/or
students. During summer 1986, the Vector Laboratory will travel to workshop sites
around the country, including: Huntington and Westchester County, New York;
Boston, Massachusetts; Concord, New Hampshire, Milwaukee, Wisconsin;
Chicago, Illinois; and Davis, California.
DNA Education Center and Museum. Serving as a national clearinghouse for
up-to-the minute information on biotechnology and DNA science, the DNA Center
will be unique among educational institutions in the United States. A Science
Media Resource Unit, located within the Center, will explore innovative methods
and technologies for presenting science concepts in an exciting and stimulating
fashion. Through teacher-training courses administered in the teaching laboratory
at Cold Spring Harbor and several mobile laboratories that travel to regional
workshops, the Museum will make its materials and resources available to
educators throughout the country.
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Cold Spring Harbor H.S.
student Alexandra Murray
pipets plasmid DNA
for electrophoresis.
Broad-based Support
The broad-based support for the Curriculum Study attests to growing
awareness of its leadership role in modern biology education. Local core
programs are supported through appropriations from each of the 19 participating
school districts. The Vector Workshop Program is supported through grants from
Citibank, N.A., the J.M. Foundation, and New England Biolabs Foundation.
Private companies, including Fotodyne, Inc. and Amersham Corporation, support
regional training workshops.
A variety of educational associations and institutions are now being drawn into
participation, including: New York State Bureau of Science Education, Science
Teachers Association of New York State, Science Supervisors Association, National
Science Teachers Association, New York State Board of Cooperative Extension
Services, State University of New York at Stony Brook, University of California at
Davis, Marquette University, and Argonne National Laboratory.
David Mick los, Program Director
1985-1986 Curriculum Study Membership
FOUNDING MEMBERS: Cold Spring Harbor Central School District; East
Williston Union Free School District; Great Neck Union Free School District;
Herricks Union Free School District; Jericho Union Free School District;
Northport-East Northport Union Free School District; Oyster Bay-East Norwich
Central School District; Syosset Central School District
NEW MEMBERS: Commack Union Free School District; Half Hollow Hills Central
School District; Huntington Union Free School District; Irvington Union Free School
District; Lawrence Union Free School District; Manhasset Union Free School
District; North Shore Central School District; Plainview-Old Bethpage Central
School District; Port ledge School; Port Washington Union Free School District;
Sachem Central School District at Holbrook
INSTITUTIONAL MEMBERS: Citibank, N.A.; J.M. Foundation; New England
Biolabs Foundation; Fotodyne, Inc.; Amersham Corporation
Elementary school teacher Richard Mick los and high school student Leslie Gould prepare
bacterial cells to receive foreign DNA.
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FINANCIAL STATEMENT
BALANCE SHEET
year ended December 31, 1985
with comparative figures for year ended December 31, 1984
ASSETS
1985 1984
COLD SPRING CURRENT FUNDS
HARBOR Unrestricted
LABORATORY Cash and Short-term investmentsAccounts Receivable
$11,567,359
286,511
$10,963,401
317,217
Prepaid expenses and other assets 480,909 679,516
Inventory of books 218,043 209,329
Due from restricted fund 351,938
Total unrestricted 12,552,822 12,521,401
Restricted
Marketable securities
(quoted market 1985-$850,000;
1984-$287,500) 212,500 212,500
Grants and contracts receivable 6,648,896 4,433,529
Due from unrestricted fund 501,239 -
Total restricted 7,362,635 4,646,029
Total current funds $19,915,457 $17,167,430
ENDOWMENT FUNDS
Robertson Research Fund
Cash 231,649 3,308,119
Marketable securities
(quoted market 1985-$22,240,523;
1984-$14,435,055) 18,393,860 12,772,766
Total Robertson Research Fund 18,625,509 16,080,885
Olney Memorial Fund
Cash 1,138 1,693
Marketable Securities
(quoted market 1985-$41,928;
1984 -$33,247) 32,101 29,418
Total Olney Memorial Fund 33,239 31,111
Total endowment funds $18,658,748 $16,111,996
PLANT FUNDS
Investments 879,871 759,318
Due from unrestricted fund 3,594,835 6,608,932
Land and improvements 1,340,375 1,129,875
Buildings 16,374,820 11,318,113
Furniture, fixtures and equipment 3,846,120 3,490,933
Books and periodicals 365,630 365,630
Construction in progress 406,541 1,461,489
26,808,192 25,134,290
Less allowance for depreciation
and amortization 5,896,757 4,861,975
Total plant funds $20,911,435 $20,272,315
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LIABILITIES AND FUND BALANCES
1985 1984
CURRENT FUNDS
Unrestricted
Accounts payable $ 854,619 $ 747,261
Deferred income 150,000 120,000
Due to Banbury Center 148,944 74,580
Due to plant fund 3,594,835 6,608,932
Due to restricted fund 501,239
Fund balance 7,303,185 4,970,628
Total unrestricted 12,552,822 12,521,401
Restricted
Accounts payable 275,171 65,792
Due to Banbury Center 8,952
Due to unrestricted fund 351,938
Fund balance 7,087,464 4,219,347
Total restricted 7,362,635 4,646,029
Total current funds $19,915,457 $17,167,430
ENDOWMENT FUNDS
Fund balance $18,658,748 $16,111,996
PLANT FUNDS
Accounts payable 121,055
Loan payable 8,000,000 8,000,000
Fund balance 12,911,435 12,151,260
Total Plant Funds $20,911,435 $20,272,315
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BANBURY CENTER
ASSETS
1985 1984
CURRENT FUNDS
Unrestricted
Cash 700 700
Prepaid and deferred expenses 5,726 19,184
Inventory of books 56,299 46,763
Due from CSHL unrestricted fund 103,322 16,497
Total unrestricted 166,047 83,144
Restricted
Grants and contracts receivable 99,141 111,450
Due from CSHL unrestricted fund 45,622 58,083
Due from CSHL restricted fund 8,952
Total restricted 144,763 178,485
Total current funds $ 310,810 $ 261,629
ENDOWMENT FUNDS
Robertson Maintenance Fund
Cash 10,707 597,661
Marketable securities
(quoted market 1985-$3,637,079;
1984-$2,347,644) 3,013,692 2,077,778
Total endowment funds 3,024,399 2,675,439
PLANT FUNDS
Land 772,500 772,500
Buildings 846,028 846,028
Furniture, fixtures and equipment 191,383 180,383
Construction in progress 1,385
1,809,911 1,800,296
Less allowance for depreciation 387,505 357,019
Total plant funds $ 1,422,406 $ 1,443,277
Total Banbury Center $ 4,757,615 $ 4,380,345
Total-All funds $64,243,255 $57,932,086
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LIABILITIES AND FUND BALANCES
1985 1984
CURRENT FUNDS
Unrestricted
Accounts payable $ 8,142 $ 18,466
Fund balance 157,905 64,678
Total unrestricted 166,047 83,144
Restricted
Accounts payable 4,577 1,394
Fund balance 140,186 177,091
Total restricted 144,763 178,485
Total current funds $ 310,810 $ 261,629
ENDOWMENT FUNDS
Fund balance $ 3,024,399 $ 2,675,439
PLANT FUNDS
Fund balance 1,422,406 1,443,277
Total Banbury Center $ 4,757,615 $ 4,380,345
Total-All funds $64,243,255 $57,932,086
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CURRENT REVENUES, EXPENSES AND TRANSFERS
year ended December 31, 1985
with comparative figures for year ended December 31, 1984
1985 1984
COLD SPRING REVENUES
HARBOR Grants and contracts $15,869,438 $12,258,740
LABORATORY Indirect cost allowances on grantsand contracts 4,406,047 4,141,453
Contributions
Unrestricted 332,423 154,046
Restricted and capital 278,483 421,918
Long Island Biological Association 100,000 515,252
Robertson Research Fund Distribution 575,000 475,000
Royalty and licensing fees 197,000 160,000
Summer programs 553,395 487,966
Laboratory rental 20,732 20,732
Marina rental 61,278 58,528
Investment income 903,132 775,231
Publications sales 1,432,527 1,512,667
Dining Hall 638,690 556,931
Rooms and apartments 248,854 309,924
Other sources 22,968 56,998
Total revenues 25,639,967 21,905,386
EXPENSES
Research* 11,710,764 10,628,482
Summer and training programs' 1,660,496 1,388,942
Publications sales* 1,029,060 1,276,015
Dining hall* 769,574 735,044
Research support 400,341 289,493
Library 267,341 236,255
Operation and maintenance of plant 2,413,788 2,179,543
General and Administrative 1,965,647 1,805,567
Depreciation 1,046,630 848,205
Total expenses 21,263,641 19,387,546
TRANSFERS
Capital building projects 3,805,100 2,003,456
Banbury Center 80,420
Total transfers 3,805,100 2,083,876
Total expenses and transfers 25,068,741 21,471,422
Excess of revenues over
expenses and transfers $ 571,226 $ 433,964
* Reported exclusive of an allocation for research support, operation and maintenance of plant, general
and administrative, library, and depreciation expenses.
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1985 1984
BANBURY CENTER REVENUES
Endowment income $ 112,000 $ 106,000
Grants & contributions 335,210 407,806
Indirect cost allowances on grants
and contracts 28,445 2,060
Rooms and apartments 97,026 65,757
Publications 133,164 102,410
Conference fees 22,086 14,697
Dining Hall 42,314 34,884
Transfer from Cold Spring
Harbor Laboratory 80,420
Total revenues 770,245 814,034
EXPENSES
Conferences 188,559 171,095
Publications 124,563 128,181
Operation and maintenance of plant 124,760 120,103
Program administration 222,715 196,244
Depreciation 30,486 36,569
Capital plant 11,000 4,125
Total expenses 702,083 656,317
Excess of revenues over
expenses $ 68,162 $ 157,717
NOTE: Copies of our complete, audited financial statements, certified by our independent auditors, Peat,
Marwick, Mitchell & Co., are available upon request from the Comptroller, Cold Spring Harbor
Laboratory.
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COLD SPRING HARBOR LABORATORY
SOURCES OF REVENUE
YEAR ENDED DECEMBER 31. 1985
Federal Grants and Contracts
48.3%
Endowments
3.5%
Foundation Grants
9.3%
Corporate Contributions
and Grants 14.6%
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Auxiliary Activities
16.3%
Private Contributions
3.3%
Interest and
Miscellaneous 4.7%
1011000111111111111.11111111
G
RANTS
CO
NTRIBUT
Recto: The intricate play of light and shadow creates abstract art forms in the foyer of the
Oliver and Lorraine Grace Auditorium.
GRANTS
January 1, 1985-December 31, 1985
COLD SPRING HARBOR LABORATORY
Grantor Program/Principal Investigator Duration of Grant Total Award
FEDERAL GRANTS
NATIONAL INSTITUTES OF HEALTH
Program Projects Cancer Research Center, Drs. Watson, Sambrook,
Roberts and Mathews 11/77-12/86 18,604,426
Gene Organization, Drs. Watson and Sambrook 4/81- 3/86 5,626,997
Research Support Dr. Beach 12/84-11/87 361,511
Dr. Blose 12/78-11/87 1,094,594
Dr. Dellaporta 7/85- 6/88 534,805*
Dr. Feramisco 7/80- 7/86 686,968
Dr. Feramisco 4/85- 3/88 535,534*
Dr. Franza 9/85- 7/88 478,689*
Dr. Garrets 1/85-12/89 2,028,833*
Dr. Gething 2/83- 8/85 490,114
Dr. Helfman 9/85- 8/88 572,760*
Dr. Hicks 7/81- 6/87 1,710,283
Dr. Hockfield 2/82- 1/85 282,400
Dr. Klar 7/81- 6/86 1,572,978
Dr. Kurtz 4/80- 3/86 606,389
Dr. Mathews 4/80- 3/86 729,283
Dr. Matsumura 7/83-10/85 306,641
Dr. Stillman 7/83- 6/86 677,384
Dr. Watson 4/84- 3/85 103,479
Dr. Watson 4/85- 3/86 146,986*
Dr. Watts 9/84- 1/85 9,557
Dr. Welch 4/84- 3/86 325,239
Dr. Wig ler 7/85- 6/92 8,426,929"
Dr. Zoller 9/85- 8/88 545,752*
Fellowships Dr. Bar Sagi 9/85- 8/87 47,000*
Dr. Bautch 9/83- 8/86 57,244
Dr. Flanagan 9/83- 9/85 36,204
Dr. Gerard 5/84- 4/86 38,204
Dr. Krangel 10/82- 9/85 54,584
Dr. Livi 10/83-10/86 57,244
Dr. McLeod 2/85- 1/88 63,996*
Dr. Quinlan 6/84- 5/87 57,244
Dr. Roth 9/83- 8/85 36,776
Dr. Potashkin 10/85- 9/88 64,886*
Training Institutional, Dr. Grodzicker 7/78- 8/89 1,291,646
Course Support Advanced Bacterial Genetics, Dr. Hicks 5/80- 4/88 302,523
Cancer Center, Dr. Grodzicker 6/82-12/86 657,174
Neurobiology, Dr. Hockfield 6/79- 3/86 646,143
Neurobiology, Dr. Hockfield 5/82- 4/90 723,939
*New Grants Awarded in 1985
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Grantor Program/Principal Investigator Duration of Grant Total Award
Meeting Support 50th Symposium: Molecular Biology of Development 1985 23,320*
Hepatitis B Virus 1985 7,000*
C. Elegans 1985 23,433*
NATIONAL SCIENCE FOUNDATION
Research Support Dr. Malmberg 4/85- 8/85 22,000*
Dr. Malmberg, Dr. Hicks 7/82-12/85 510,832
Dr. Lewis 11/83- 5/85 120,908
Dr. Roberts 3/83- 8/86 40,592
Dr. Roberts 1/83- 6/86 240,000
Dr. Roberts 7/83-12/86 252,000
Dr. Hockfield 3/85- 8/85 40,000*
Course Support Plant Molecular Biology, Dr. Malmberg 5/84- 4/87 121,676
Meeting Support Chromosome Structure & Expression 1985 5,000*
Hepatitis B Virus 1985 3,000*
C. Elegans 1985 6,000*
Heat Shock 1985 3,500*
50th Symposium-Molecular Biology of Development 1985 4,000*
Construction Plant Genetics Facility, Dr. Watson 12/83-11/86 406,350
DEPARTMENT OF AGRICULTURE
Research Support Dr. Dellaporta 9/85- 8/87 124,000*
Dr. Dellaporta 9/84- 8/86 100,000
DEPARTMENT OF ENERGY
Research Support Dr. Dellaporta 9/85- 8/88 217,000*
Meeting Support Symposium: Molecular Biology of Development 1985 9,000*
NONFEDERAL GRANTS
Research Support
A.B.C. Foundation Dr. Wig ler 5/82- 4/87 600,000
Rita Allen Foundation Dr. Herr 9/85- 8/86 30,000*
Rita Allen Foundation Dr. Stillman 1/83-12/87 150,000
American Cancer Society Dr. Beach 1/85-12/86 70,000*
Dr. Gething 1/85-12/86 145,000*
Drs. Stillman, Gluzman - Institutional Award 7/82- 6/86 115,000
Dr. Wig ler 7/84- 6/86 200,000
Amersham International plc Dr. Welch 10/85- 9/87 50,000*
Anonymous General Research 1985 2,000
Avon Products
Foundation, Inc. General Research 1985 70
Cancer Research Institute Dr. Carrels 7/83- 6/85 72,000
Cetus Corporation Dr. Feramisco 1985 5,000*
Russell and Janet
Doubleday Fund General Support 1985 16,750
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Grantor Program/Principal Investigator Duration of Grant Total Award
Exxon Research and
Engineering Company Cooperative Research 1/82-12/86 7,500,000
Grumman Corporation General Research 1985 5,000
Hoffmann-La Roche Inc. Dr. Franza 1985 15,000*
International Foundation
for Cancer Research Dr. Hanahan 10/84- 9/86 50,000
McKnight Foundation Dr. Malmberg 3/83- 2/86 105,000
Monsanto Company Cooperative Research 10/84- 9/89 2,060,252
Muscular Dystrophy
Association Dr. Mathews 7/83- 6/86 78,776
New England Bio labs Dr. Roberts 1985 21,000
New York State Science
and Technology
Foundation Dr. Garrels 10/84- 9/85 25,000
Norden Systems, Inc. General Research 1985 1,000
Pioneer Hi-Bred
International, Inc. Cooperative Research 8/85- 1/91 2,500,000*
Pfizer Inc. Dr. Wig ler 1985-1990 500,000*
Protein Databases Inc. General Research 1985 100,000
Marie Robertson
Memorial Fund Neurobiology 1/85-12/85 125,000*
Fellowships
American Cancer Society Dr. Young 8/84- 7/85 16,500
Anna Fuller Fund Dr. Field 10/85- 9/86 18,000*
Cancer Research Institute Dr. Cone 10/85- 9/86 21,500*
Dr. Young 8/85- 8/86 19,500*
Leukemia Society of
America Dr. Hanahan 7/84- 6/86 44,280
Dr. Powers 12/83-12/85 34,000
Dr. Sadaie 7/84- 8/85 20,702
Muscular Dystrophy
Association Dr. Helfman 7/83- 6/85 37,000
Robert P. Olney
Memorial Cancer
Fund Undergraduate Research 1/85-12/85 2,013*
Rockefeller Foundation Dr. Hicks 9/84- 8/85 25,900
Damon Runyon-Walter
Winchell Cancer Fund Dr. Broek 6/84- 5/86 38,000
Dr. Gallagher 7/84- 9/85 26,000
Dr. Hearing 9/84- 8/86 38,000
Dr. Hiatt 8/84- 7/86 38,000
Dr. Sass 9/84- 8/86 38,000
Dr. White 11/83-10/85 35,000
Training
Burroughs Wellcome
Fund Undergraduate Research Program 1985 11,100*
Citibank, N.A. Curriculum Study 1985 5,000
Grass Foundation Neurobiology Scholarships 1980-1985 81,190
Lucille P. Markey
Charitable Trust Scholarship Support 1985-1988 150,000*
Metropolitan Life
Foundation Undergraduate Research Program 1985 10,000*
Rockefeller Foundation Scholarship Support 1985 16,000*
Alfred P. Sloan
Foundation Undergraduate Research Program 1985-1988 74,000*
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Grantor Program/Principal Investigator Duration of Grant Total Award
Course Support
The Esther A. and
Joseph Klingenstein
Fund, Inc.
Alfred P. Sloan
Foundation
Meeting Support
Anheuser-Busch,
Incorporated
Gist Brocades
Miller Brewery
Smith Kline & French
Laboratories
Zymo Genetics, Inc.
Wellcome Biotechnical
Ltd.
Equipment
Chemapec, Inc.
Samuel Freeman
Charitable Trust
McKnight Foundation
Pandex Laboratories, Inc.
Construction
Anonymous
Charles E. Culpepper
Foundation
Mary Livingston Griggs
and Mary Griggs
Burke Foundation
Neurobiology Support
Computational Neuroscience Course
Yeast Meeting
Yeast Meeting
Yeast Meeting
Yeast Meeting
Yeast Meeting
Modern Approaches to Vaccines
14-liter laboratory fermenter
Computer Facility
Neurobiology Course
Screen machine system
Plant Molecular Biology Facility
Plant Molecular Biology Facility
Plant Molecular Biology Facility
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1982-1988
1985
1985
1985
1985
1985
1985
1985
1985-1986
1984-1985
1985
1985-1987
300,000
26,000*
500*
500*
1,000*
500*
1,000*
5,000"
450,000*
110,000
25,000
75,000
1985 10,000
BANBURY CENTER
Grantor Program/Principal Investigator Duration of Grant Total Award
FEDERAL GRANTS
NATIONAL INSTITUTES OF HEALTH
Meeting Support New Aspects of Tobacco Carcinogenesis 1985 15,000*
Origins of Female Genital Cancer 1985 10,000*
DEPARTMENT OF ENERGY
Environmental Protection Agency
Meeting Support Genetically Altered Mammalian Viruses 1/85-12/85 47,500*
NONFEDERAL GRANTS
Meeting Support
American Cancer Society New Aspects of Tobacco Carcinogenesis 1985 10,000*
James S. McDonnell
Foundation Conference Support 1985-1987 300,000*
Merck Sharp & Dohme Origins of Female Genital Cancer 1985 1,000*
Alfred P. Sloan Foundation Journalists' Workshop 1984-1986 162,000
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Corporate Sponsor Program
Since the founding of the annual Symposium in 1933, Cold Spring Harbor
Laboratory has played a special role in American science as a clearinghouse for
high-level information on quantitative biology. In 1985, more than 3,500 scientists
attended 20 professional conferences and 13 advanced-training courses held at
the Laboratory and its allied Banbury Center. Among the participants were 280
researchers representing 75 companies.
This prominence as a gathering place for researchers from many disciplines-
in addition to a distinguished heritage of pioneering research-makes Cold Spring
Harbor Laboratory an ideal window on the world of molecular biology and its
applications to medicine and industry. The Corporate Sponsor Program was
established in 1984 to offer a select group of companies an opportunity to share
this unique vantage point.
At the same time, the yearly commitment of $15,000 by each Sponsor ensures
a stable base of support for our meetings program, allowing us to devote more
time to planning timely conferences, rather than searching for funding. With the
mandatory budget cuts of the Gramm-Rudman law looming over the National
Institutes of Health and the National Science Foundation, we can only anticipate
that federal support for scientific meetings will virtually dry up over the next
several years. By helping strengthen Cold Spring Harbor's role as a conduit for
high-level information, our Corporate Sponsors send a clear message to the
research community that they care about maintaining the quality of American
science.
Additionally, proceeds from the Corporate Sponsor Program entirely support a
series of Special Banbury Conferences that deal with technical aspects of genetic
engineering especially relevant to industry. Combining high-level science with a
restful country setting conducive to informal exchange, these meetings are unique
in science. The 1985 meetings were "Structure and Function of Eukaryotic
Enhancers, Promoters and Trans-Acting Elements',' "Genetics of Plant Cell/Cell
Interactions:' "Translation Regulation of Gene Expression:' and "Computer Graphics
and Protein Modeling:'
Benefits to Sponsor companies include gratis attendance for six representatives
at Cold Spring Harbor meetings and Special Banbury Conferences, gratis Cold
Spring Harbor and Banbury publications, and recognition in meeting abstracts
and publications.
Since its inception, Corporate Sponsor membership has expanded from 15 to
21 companies. The renewal rate for participating companies is 93 percent. We
take this as a good report card on a program worthwhile to industry. Perhaps the
best recommendation for the Corporate Sponsor Program, however, is its
members-world leaders in the application of biotechnology to health care,
agriculture, and manufacturing:
1985 Members
Agrigenetics Corporation
American Cyanamid Company
Amersham International plc
Becton Dickinson and Company
Biogen S.A.
Cetus Corporation
Ciba-Geigy Corporation
CPC International Inc.
E.I. du Pont de Nemours & Company
Genentech, Inc.
Genetics Institute
Hoffmann-La Roche Inc.
Johnson & Johnson
Eli Lilly and Company
Mitsui Toatsu Chemicals, Inc.
Monsanto Company
Pall Corporation
Pfizer Inc.
Schering-Plough Corporation
Smith Kline & French Laboratories
The Upjohn Company
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Individual Contributors
Dr. and Mrs. Alfred A. Azzoni
Dr. and Mrs. Paul Berg
Mrs. Holly M. Brooks
Ellie and Joe Busman
Mr. and Mrs. Samuel R. Callaway
Miss Patricia K. Casentini
Mr. and Mrs. John P. Cleary
Jerry and Gloria Coopersmith
Mr. and Mrs. Robert A. Cunningham
Dr. and Mrs. Lester Dubnick
James D. and Alma C. Ebert
Murray and Cynthia Forman
Mr. Alan M. Fortunoff
Mr and Mrs. Charles S. Gay
Dr. Martin Gellert
Mrs. Eve Gianatsis and Mother
Dr. and Mrs. H. Bentley Glass
Dr and Mrs. Richard L. Golden
Mr. and Mrs. Martin A. Gorovsky
Mr. Oliver R. Grace
Mrs. Bertha Greenberg
Dr. Gary N. Gussin
The Rev. Linda Peyton Hancock
Mr. and Mrs. Henry U. Harris, Jr.
Mrs. Sinclair Hatch
Dr. and Mrs. Alfred D. Hershey
Dr. Ira Herskowitz
Mrs. Claire Hirsch
Dr. Alexander Hollaender
Becky and David Hub ler
Ms. Joan M. Hutchins
Mrs. David Ingraham
Mr. Bruno Juehelli
Dr. Joan C. Kavenagh
Arthur and Eva Landy
Mr. Ira Levin
Dr. and Mrs. Monroe Levin
Mrs. Ceceil Levinson
Mr. James B. Lewis
Dr and Mrs. Robert V. Lewis
Mr. and Mrs. George Lindsay
Mrs. Toby Lippert
Mr. Alan Long
Ethel and Bill Mahoney
Mrs. Nina Marapodi
Mrs. Marion Marks
Dr. Melvin Mart
Miss Leila Lauglin McKnight
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Dr. Norman E. Melechen
Mrs. Helen M. Miller
Mr. Richard K. Moore
Mr. Norman Morett
Dr. Melvin L. Morris
Dr. Gisela Mosig
Mr. Basil Northam
Mr and Mrs. Walter H. Page
Mr. Arthur B. Pardee
Mr. Vassilos Parthemis
Miss Florence Perperis
Mr. Terry Perperis
Mr and Mrs. J. Gardiner Pieper
Mrs. Claire Platkin
Mr. and Mrs. Joseph Plonski
The Poole Family
Ms. Pamela Peyton Post
Mr. Mike Psipsikas
Mrs. Laurie W. Roebuck
Harold and Phyllis Rosenstein
Mr Harvey E. Sampson
Dr and Mrs. Anthony Scala
Dr. Walter Schaffner
Mrs. Marilyn Louise Schmitt
Phillip A. and Ann H. Sharp
Dr and Mrs. W. Shropshire, Jr.
Dr and Mrs. John J. Siefring
Ms. Violet G. Skelley
John, John, Jr and Robert Storck
Mrs. Richard S. Storrs
Mr and Mrs. Steven E. Summer
Dr. Janey Symington
Mr Irwin Tantleff
Mrs. Jeannette Jennings Taylor
Mr and Mrs. William E. Teehan
Mr and Mrs. Sander E. Tendrick
Ms. Joan Tilney
Dr James C. Wang
Dr James D. Watson
Mr and Mrs. Harold P Weirich
Bill, Joan, Robert and Michael Weisberg
Dr Charles A. Werner
Dr Heiner Westphal
Mrs. Susan Platkin Wexler
Mr William F Whitman, Jr
Mr. Robert J. Zindler
In memory of . . .
Mr. Boyd E. Alford
Mrs. Marie W. Carmody
Mrs. Mary Clum
Mr. Charles Eckelkamp
Mr. Edmund Entin
Mr. William J. Ferguson, Sr.
Mrs. Florence H. Fink
Mrs. Bertha Greenberg
40th anniversary tribute . . .
Dr. and Mrs. Monroe Levin
Mrs. Anita Kasten
Mr. Aaron Kihn
Mr. Jimmy Klecar
Ms. Janet Sonya Psipsikas
Mr. Frank Quinn
Mrs. Sara Delano Redmond
Mr. Joseph Reisig
Mrs. Joyce Royce
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FINANCIAL SUPPORT OF THE LABORATORY
Cold Spring Harbor Laboratory is a nonprofit research and educational institution
chartered by the University of the State of New York. Contributions are tax exempt
under the provisions of Section 501(c)(3) of the Internal Revenue Code. In addition,
the Laboratory has been designated a "public charity" and, therefore, may receive
funds resulting from the termination of "privatd' foundations.
Because its endowment is limited and the uses of research grants are formally
restricted, the Laboratory depends on generous contributions from private
foundations, sponsors, and friends for central institutional needs and capital
improvements.
Over the years, the Laboratory has won a reputation for innovative research
and high-level science education. By training young scientists in the latest
experimental techniques, it has helped spur the development of many research
fields, including tumor virology, cancer genes, gene regulation, moveable genetic
elements, yeast genetics, and molecular neurobiology. However, the continued
development of new research programs and training courses requires substantial
support from private sources.
METHODS OF CONTRIBUTING TO COLD SPRING HARBOR LABORATORY
Gifts of money can be made directly to Cold Spring Harbor Laboratory.
Securities You can generally deduct the full amount of the gift on your income tax return,
and, of course, you need pay no capital gains tax on the stock's appreciation.
We recommend any of the following methods:
(1) Have your broker sell the stock and remit the proceeds to Cold Spring Harbor
Laboratory.
(2) Deliver the stock certificates to your broker with instructions to him to open an account
for Cold Spring Harbor Laboratory and hold the securities in that account pending
instructions from Cold Spring Harbor Laboratory.
(3) Send the unendorsed stock certificates directly to the Laboratory: Comptroller, Cold
Spring Harbor Laboratory, Cold Spring Harbor, New York 11724. In a separate
envelope send an executed stock power.
Bequests Probably most wills need to be updated. Designating Cold Spring Harbor
Laboratory as beneficiary ensures that a bequest will be utilized as specified for continuing
good.
Appreciated real estate or personal property Sizable tax benefits can result from such
donations: the Laboratory can use some in its program and can sell others.
Life insurance and charitable remainder trusts can be structured to suit the donor's
specific desires as to extent, timing, and tax needs.
Conversion of private foundation to "public' status on termination This may be done
by creating a separate fund within Cold Spring Harbor Laboratory whereby the assets of
the private foundation are accounted for as a separate fund and used for the purposes
specified by the donor. Alternatively, the private foundation can be established as a
"supporting organization of Cold Spring Harbor Laboratory!"
For additional information, please contact the Director of Development and Public Affairs,
Cold Spring Harbor Laboratory, Box 100, Cold Spring Harbor, N.Y. 11724, or call
516-367-8455.
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STAFF
Recto: Postdoctoral Fellow Claude Dery draws off plasmid DNA that has been separated
through density-gradient centrifugation.
Laboratory Staff
Research Staff
David Beach
Stephen Blose
Fevzi Daldal
Stephen Dellaporta
James Feramisco
Robert Franza
James Garrels
Yakov Gluzman
Terri Grodzicker
Douglas Hanahan
Edward Harlow
David Helfman
Winship Herr
James Hicks
Stephen Hinton
Tohru Kataoka
Amar Klar
David Kurtz
Michael Mathews
Andrew Rice
Richard Roberts
Pablo Scolnik
Clive Slaughter
David Spector
Bruce Stillman
Paul Thomas
William Welch
Michael Wig ler
Douglas Youvan
Mark Zoller
Postdoctoral Research Fellows
William Addison
Maran Avudaiappan
Dafna Bar-Sagi
Victoria Bautch
Ashok Bhagwat
Carmen Birchmeier
Graeme Bolger
Daniel Broek
Robert Cafferkey
Steven Cheley
Jychian Chen
Roger Cone
Edgar Davidson
Claude Dery
James D. Watson, Director
G. Morgan Browne, Administrative Director
John Maroney, Assistant Administrative Director
William Keen, Comptroller
Jack Richards, Director Buildings & Grounds
Michael Shodell, Banbury Center Director
John Diffley
Shimon Efrat
Jeffrey Field
Howard Fox
Robert Gerard
Giovanni Giuliano
Joan Harper
Janet Hearing
Andrew Hiatt
Tohru Kamata
Yuriko Kataoka
Antal Kiss
Richard Kostriken
Jeremy Lamb
Michael Lambert
John Langstaff
Patsy Lin
George Livi
Brenda Lowe
Maureen McLeod
Elizabeth Moran
Judy Potashkin
Scott Powers
Karl Riabowol
Philip Sass
Petra Schumann
Margaret Sharma
Neil Sullivan
Takashi Toda
Eileen White
Marie Wooten
Dalian Young
Bradley Zerler
Genetics Research Unit
Carnegie Institution
of Washington
Alfred D. Hershey
Barbara McClintock
Visiting Scientists
Diane Esposito
Seth Grant
Mark Homonoff
Esa Kuismanen
Junichi Nikawa
Massimo Romani
Marcel lo Siniscalco
Krystyna Slaska-Kiss
Support Staff
Patricia Bird
Louisa Dalessandro
Marilyn Goodwin
Mary Hannaford
James Kos
Laurie Lowman
Karen Otto
Philip Renna
Joseph Suhan
Madeline Szadkowski
Barbara Weinkauff
Graduate Students
Susan Alpert
Robert Booher
Leonardo Brizuela
Karen Buchkovich
Edward Bylina
Scott Cameron
Mary Chapman
Paul Chomet
Christine Herrmann
Margaret Kelly
Lonny Levin
Duncan McVey
Kenneth Mellits
Christine Mitchell
Robert O'Malley
Brian Ondek
Gregory Prelich
Nora Sarvetnick
Sreenath Sharma
Carmel la Stephens
Peter Whyte
Laboratory Technicians
Barbara Ahrens
Mark Alfenito
Susan Allan
Susan Bader
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Carmelita Bautista
Georgia Binns
Gladys Blose
Cecile Chang
Dolly Chao
Jennifer Clarke
Joan Cossetti
Debra Danna
Michael Delannoy
Barbara Faha
Linda Finn
Thomas Fischer
Jeffrey Hager
Debra Harty
Patricia Hinton
Sajida Ismail
Stephen Johann
Karen Johnson
Nancy Kronenberg
Mark Lacey
Barbara MacDonald
Pamela Mailloux
Lisa Manche
Krystyna Marcinczak
Robert McGuirk
Jean Mclndoo
Lisa Miglio
Lisa Miranda
Ian Mohr
Carolyn Moomaw
Phyllis Myers
Paul Newman
Diane Pascucci
Daniel Pollock
Linda Rodgers
Susan Rook
Janet Ross
Heidi Sacco
Susan Scheib
Carol Schley
Lisa Schoenherr
Patricia Scolnik
Alyssa Shepard
Monika Stein
Sachiko Toda
Gayle Waitches
Patricia Wendel
Jeanne Wiggins
Jonathan Wood
Laboratory Aides
Shinta Cheng
Rodney Chisum
Robert Gensel
Connie Hallaran
Sunhee Lee
John Lillie
Sharon Losee
Eleanor Mathews
William Packer
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Sandra Penzi
Steven Simonte
Gloria Wilson
Medium Makers
Patricia Barnwell
William Eisner
Margaret Falkowski
Mary Freedman
Marie Hallaran
Ronnie Packer
Suzanne Vavrinec
Margaret Wallace
Safety and Core
Facilities Services
Arthur Brings
Safety
Marlene Rubino
Computing Center
Michael Balamuth
Christopher Keller
Harris Animal Facility
Diane Biedermann
Lena DiLacio
Carolyn O'Loughlin
Art Department
Michael Ockler
David Greene
Jean Michaelis
Technical Services
Robert Borruso
August Dulis
Peter Markiewicz
Clifford Sutkevich
Publications
Nancy Ford
Annette Kirk
Dorothy Brown
Judith Cuddihy
Joan Ebert
Martha McMaster
Douglas Owen
Eizabeth Ritcey
Marie Sullivan
Pauline Tanenholz
Library/Marketing
Susan Gensel Cooper
Library
Petra Durnin
Genemary Falvey
Wanda Felker
Cathy Garg
Laura Hyman
Melissa Hyman
Laurie Kennedy
Carol O'Shea
Marketing
Elaine Gaveglia
Amy Gibson
Maureen Spirn
Accounting
Accounting
Guy Cozza
Fran Gerard
Mary Ellen Goldstein
Dorrine Lambert
Fred Lukas
Carlos Mendez
Robert Pace
June Polistina
Fulfillment
Charlaine Apse!
Ann Felten
Barbara Skelly
Barbara Terry
Grants
Susan Schultz
Patricia Kurfess
Patricia Maroney
Development and
Public Affairs
David Micklos
Herb Parsons
Ellen Skaggs
Susan Zehl
Personnel and Meetings
William Putnam
Personnel
Catherine Erb
Marilyn Simkins
Jacqueline Terrence
Meetings
Maureen Berejka
Chris Brett
Gladys Kist
Michela McBride
Barbara Ward
Purchasing
Peter Rice
Deon Baker
Bruce Fahlbusch
Steven Horly
Graceann Lovell
Kevin O'Rourke
James Sabin
Elissa Troisi
Nancy Wysong
Central Administration
Roberta Salant
Andrea Stephenson
Buildings and Grounds
Administration
Charles Schneider
Barbara Cuff
Carpentry and Painting
Diamond Scarduzio
John Chilcott
Lawrence Daw
John Meyer
Stephen O'Connell
Joseph Pirnak
Paul Thomas
Custodial
Willie Gardner
John Berejka
Robert Brymer
George Leedham
Brian Leite
Daniel Jusino
Alfred Nickel
Donald Rose
Steven Tang
Peter Tierney
Banbury Grounds and Maintenance
Peter Stahl
Daniel Miller
Electrical and Mechanical
Maintenance
Robert Collins
Frank Messina
Jerry Reichert
Owen Stewart
Grounds
Hans Trede
Vincent Carey
Joseph Ellis
John Robert Fuchs
Robert lwanejko
Christopher McEvoy
Harry Wozniak
Anthony Zanoni
Housekeeping
Dorothy Youngs
Rita Abrams
Carol Caldarelli
Turid Mikalsen
Barbara Robinson
Cherie Thurn
Plumbing
Douglas Haskett
Lane Smith
Security
Paul Anzalone
Frank Carberry
Banbury Center
Judith Blum
Dessie Carter
Katya Davey
Beatrice To liver
Scientific Staff
Departures during 1985
Tenured Scientist
Joseph Sambrook
Senior Staff Investigators
Mary-Jane Gething
Susan Hockfield
Russell Malmberg
Fuyu Tamanoi
Staff Investigators
Ronald Guggenheimer
John Lewis
Fumio Matsumura
Visiting Scientists
Daniel Birnbaum
Ottavio Fasano
Asao Fujiyama
Eric Hunter
Ling-Pai Ting
Postdoctoral Fellows
Timothy Adams
Philip Bird
Patricia Cotton
Carolyn Doyle
Thomas Flanagan
Howard Fox
Greg Freyer
Beth Friedman
Patricia Gallagher
John Ivy
Michael Krangel
Janet Maclnnes
Shigeko Matsumura
Michael Roth
Reza Sadaie
Kevin Van Doren
Susan Watts
Masao Yamada
Sam Zaremba
Graduate Students
Ramaninder Bhasin
William Costello
Madan Rao
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LONG ISLAND
BIOLOGICAL
ASSOCIATION
Recto: The massive dormers of the Oliver and Lorraine Grace Auditorium echo the Victorian
architecture prevalent on Long Island. Seating 360, the auditorium is the hub of activity for
scientific meetings held during the summer.
Officers Executive Committee
Mr. George W. Cutting, Jr., Chairman
Mr. George J. Hossfeld, Jr., Vice-Chairman
Mrs. James A. Eisenman, Treasurer
Mrs. John P. Campbell, Secretary
Mr. G. Morgan Browne, Asst. Secretary Treasurer
Directors
The Officers, also
Mr. Samuel R. Callaway
Mrs. Duncan Elder
Mrs. Sinclair Hatch
Mrs. Donald Arthur
Dr. Alfred A. Azzoni
Mrs. Gilbert A. Ball
Mr. Samuel R. Callaway
Mrs. John P Campbell
Mrs. Miner D. Crary, Jr.
Mr. Arthur M. Crocker
Mr. Roderick H. Cushman
Mr. George W. Cutting, Jr
Mr. Lawrence L. Davis
Mr. Joseph C. Dey, Jr.
Mr. Charles Dolan
Mr. James A. Eisenman
Mrs. Duncan Elder
Mrs. Henry U. Harris, Jr
Mrs. Sinclair Hatch
Mr George J. Hossfeld, Jr
Mr Edward M. Lamont
Mrs. George N. Lindsay
Mr Arthur C. Merrill
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Mr. William F. Payson, Jr.
Mrs. Richardson Pratt
Mr Edward Pulling
Mr John R. Reese
Mr Harvey E. Sampson
Mr. Charles R. Thompson
Dr. James D. Watson
Mrs. Bradford Weekes Ill
The LONG ISLAND BIOLOGICAL ASSOCIATION (LIBA)
and Its Relation to the Cold Spring Harbor Laboratory
Biological research at Cold Spring Harbor began in 1890 when the Brooklyn Institute of Arts
and Sciences was looking for a place to set up a summer laboratory as the headquarters of
its Department of Zoology. Representatives of the Institute were invited by Eugene S.
Blackford, at that time the Fish Commissioner of the State of New York, to inspect a site on
Bungtown Road across Northern Boulevard (25A) from the Fish Hatchery. The site was
found to be ideal, and so the original Laboratory was organized with Mr. Blackford as
president of the Board of Trustees. The land was leased from Mr. John D. Jones, whose
family since 1819 had operated various industries including shipbuilding, coopering, and
textile manufacture (later whaling, also) at the head of Cold Spring Harbor. Bungtown Road,
which runs through the Lab property, got its name from the factory that specialized in
making bungs-or stoppers-for barrels.
In 1892 the Laboratory's land was leased for a dollar a year from the Wawepex Society,
which Mr. Jones had organized as a corporation for holding real estate and for investing
funds for the propagation of fishes and for scientific research. In 1904 the Wawepex Society
leased additional land to the Carnegie Institution of Washington, which wanted to locate a
Department of Experimental Evolution in the Cold Spring Harbor area. Charles B. Davenport,
who had been directing the Laboratory since 1896, assumed the additional duties of director
of the Carnegie Institution's experimental station. It is interesting to note that Mr. Davenport
lived in what came to be known later as the Carnegie Dormitory, the Victorian house on 25A
built by John D. Jones before the turn of the century, and recently repainted in its original
colors.
The Long Island Biological Association was established in 1924 when the Brooklyn
Institute decided to discontinue its research at Cold Spring Harbor and offered its laboratory
to two universities. Fortunately, a local group of interested neighbors decided to assume
responsibility for the Lab, and thus LIBA came into being. For 38 years LIBA actually
operated the Laboratory in conjunction with the Carnegie Institution, but in 1962 it seemed
advisable for the Laboratory to be reorganized as an independent unit. Therefore, the
property on which it now stands was conveyed to it by LIBA, which, however, still retains
reversionary rights. Today LIBA is one of twelve institutions participating in the support of the
Laboratory, each institution being represented on the Laboratory's Board of Trustees.
What has happened, in effect, is that LIBA has become an expanding group of local
"Friends of the Laboratory" who help support it through annual contributions. Also, from time
to time, the Association undertakes campaigns to finance special important projects for
which the Lab cannot obtain funds from the Federal Government or from other sources. For
instance, in recent years, building the James Laboratory Annex and the renovation of
Blackford Hall, the rebuilding of Williams House, the acquisition of the land formerly
belonging to the Carnegie Institution, and (in part) the construction of the new Grace
Auditorium.
The affairs of LIBA are handled by a board of 28 directors who are elected to office by
the membership at an annual meeting. At least twice a year LIBA members are invited to
bring their friends to a lecture or an open house at the Lab.
Membership in LIBA requires a minimum annual, contribution (tax deductible) of $25
for a husband and wife, $15 for a single adult, $5 for a junior member (under 21). Further
information can be obtained from the Long Island Biological Association, Box 100, Cold
Spring Harbor, N.Y. 11724, or by telephoning the Laboratory at (516) 367-8486.
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CHAIRMAN'S REPORT
The most important event for LIBA in 1985 was the annual meeting of our
members. This is customarily held in December but this year was postponed to
January 12th, 1986. The postponement allowed time for the completion of the
Oliver and Lorraine Grace Auditorium and also of a video documentary depicting
the history and the current functioning of the Laboratory. As our members know,
the financing of the auditorium (to the extent of $600,000) and of the documentary
(in full) were LIBA's most recent projects undertaken in behalf of the Lab.
The overflow crowd of members and our guests who attended the meeting
were thrilled by both the auditorium and the documentary. They greatly admired
the auditorium for its aesthetic qualities, its comfortable seats, and especially for
its remarkable acoustics. Everybody agreed it is exceptionally well suited for its
two purposes. One is to provide an adequate meeting place for the Lab's summer
conferences. Some 3,000 scientists from all over the world come to Cold Spring
Harbor each year for the exchange and distribution of the latest discoveries in
molecular biology. The auditorium's other purpose is to enable the Lab to offer to
its neighboring communities the use of the building for concerts and other
appropriate meetings when it is not needed for the Lab's own functioning.
At the Annual Meeting there was a strong approval given also for the
documentary. We hope it will serve effectively to widen and deepen interest in the
vital research which has brought world-wide prestige to the Laboratory. The value
of the documentary will be enhanced by its availability in half-inch tapes to institu-
tions and individuals either on loan or by purchase for $25.
I think we LIBA members can be justly proud of the success of both these
projects as well as the previous ones accomplished in recent years.
Speaking of our projects, I was pleased to announce that our current one, to
help finance the Labs new Plant Genetics Program, is going very well. I hope that
the generosity of members who have not yet sent in their contributions for this
year will permit us to increase the amount of $110,000 we originally set as our
goal for this most important project. The Lab needs, and will greatly appreciate,
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A record 430 people
attended the LIBA Annual
Meeting in the new
Grace Auditorium
; -
Mr. George W. Cutting, Jr.
and Dr. James D. Watson at
the LIBA Annual Meeting
whatever additional help we can give to it. The chance of increasing our contribu-
tion is enhanced by the fact that the documentary is costing less than anticipated
because the technical equipment of Cablevision was made available to us through
the greatly appreciated courtesy of Mr and Mrs. Charles Dolan.
At the meeting I announced my retirement as LIBA chairman and expressed
my gratitude for the wonderful cooperation my fellow members have given me
during my many very happy years in office. Then I had the pleasure of introducing
as my successor Mr. George W. Cutting, Jr., who had been enthusiastically
elected by the directors at their autumn meeting. He is eminently qualified for the
job and I am fully confident that LIBA's functioning will become increasingly
effective under his leadership. Also, I know that he can count on maximum
support by our directors and members.
In September Mr. Walter Page, chairman of the Laboratory trustees, appointed
a Special Committee comprised of representatives of the Lab's trustees, of its
administrative staff and of LIBA directors. Its purpose was to discuss the basic
question as to whether LIBA should continue to function autonomously in its fund-
raising efforts in behalf of the Lab or preferably should become integrated in some
way with the Lab's own fund-raising procedures.
The unanimous opinion of the Committee was that LIBA should retain its
autonomy, which has proved to be so effective not only in fund raising but also
(and more important in the opinion of the Lab's representatives on the Committee)
in extending and deepening the interest of the community in the Lab. However, it
offered two suggestions for the consideration of our directors regarding ways in
which LIBA might cooperate with the Lab in the major appeal planned for the
occasion of its forthcoming Centenary. One was that LIBA undertake a project in
the next few years which would not only appeal to its membership but also relate
to the Lab's overall campaign. The other suggestion was that our membership list
be studied carefully to identify potentially important donors who might want to
contribute substantially to a Centenary project.
The Committee also commented that repeated re-education of our members is
needed in regard to LIBAs relationship with the Lab (which seems to be
ambiguous in some peoplds minds) and also in regard to the procedure for
obtaining matching gifts. I have taken advantage of both these suggestions in my
recent letters to the membership and Mr. Cutting intends to follow suit in his
communications.
We were fortunate at the Annual Dorcas Cummings Memorial Lecture in May to
have as our speaker Mr. S. Dillon Ripley II, the distinguished retired head of The
Smithsonian Institution. Mr. Ripley gave us a most interesting talk on "Environmen-
tal Degredation in the Tropics."
Again in 1985, as in past years, the Symposium dinner parties given by our
members in June for visiting scientists and members of the Lab's permanent
scientific staff were a great success, enjoyed equally by the hosts and hostesses
and their guests. Dinners were given this year by
Mrs. Donald Arthur
Mr. & Mrs. Norris Darrell, Jr.
Mrs. Eugene DuBois
Mr. & Mrs. Mario Fog
Mr. & Mrs. Oliver R. Grace
Mr. & Mrs. Henry Upham Harris, Jr.
Mr. & Mrs. Sinclair Hatch
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Mr & Mrs. Walter H. Page
Mrs. Francis T. P Plimpton
Mr & Mrs. E. E. Post
Mr. & Mrs. Martin B. Travis, Jr.
Mr. & Mrs. Bronson Trevor, Jr.
Mrs. Ethelbert Warfield
Mrs. Alexander M. White
At the annual meeting, Mrs. John P. Campbell, chairman of the Nominating
Committee, proposed the following for election to the Board of Directors:
For election to the class of 1986
Mrs. George N. Lindsay, Jr.
For election to the class of 1989
Mrs. Bradford G. Weekes
Mrs. Sinclair Hatch
Mr. William F. Payson, Jr.
Mr. Charles R. Thompson
For re-election to the class of 1989
Mr. Samuel R. Callaway
Mr. James A. Eisenman
Mr. Arthur M. Crocker
There being no further nominations from the floor, the above were duly elected.
Then thanks were extended to the members above whose term had expired,
Messrs. Edmund Bartlett, and Stanley S. Trotman, Jr., and also to Mr. Grinnell
Morris who regretfully found it necessary to resign. Very special thanks were
expressed to one retiring secretary, Mrs. James J. Pirtle, Jr, for her twelve years of
most loyal and efficient service.
Edward Pulling, Ex-Chairman
319
Members
of the Long Island Biological Association
Mr. & Mrs. Thomas Ackerman
Mr. Amyas Ames
Mrs. Charles E. Ames
Dr. & Mrs. Hoyt Ammidon
Miss Barbara Amott
Drs. Harold & Shirley Andersen
Mr. Robert W. Anthony
Mr & Mrs. Silas Reed Anthony
Mr & Mrs. S. Arbonies
Mr & Mrs. J. S. Armentrout
Mrs. Donald Arthur
Mr. & Mrs. Henry Austin Ill
Mrs. Robert W. Ayer
Dr. & Mrs. Alfred A. Azzoni
Mr & Mrs. Henry D. Babcock, Jr
Mr. & Mrs. Benjamin H. Balkind
Mrs. Gilbert A. Ball
Mr. & Mrs. William M. Bannard
Mrs. George C. Barclay
Dr & Mrs. Henry H. Bard
Mr & Mrs. Edmund Bartlett
Miss Linda Bennetta
Mr & Mrs. Loren C. Berry
Mr & Mrs. Robert P Beuerlein
Mr. & Mrs. Nicholas Biddle, Jr.
Mrs. William Binnian
Mr. F. Roberts Blair
Mrs. Mary Lenore Blair
Mr. & Mrs. Bache Bleecker
Mrs. Margery Blumenthal
Mr. & Mrs. Elito Bongarzone
Mr. & Mrs. A. L. Boorstein
Mr & Mrs. Murray Borson
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